yourlist:M20191118DA437993067D6F64326E5E763500BDED055040M	isomap:M20191118DA437993067D6F64326E5E763500BDED055040M	Entry	Entry name	Protein names	Gene ontology IDs	Gene ontology (GO)	Gene names
NM_004938		B4DHI4	B4DHI4_HUMAN	cDNA FLJ60536, highly similar to Death-associated protein kinase 1	GO:0004674; GO:0005524; GO:0006915; GO:0007165	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; signal transduction [GO:0007165]	
NM_004938	NM_004938 -> P53355-1	P53355	DAPK1_HUMAN	Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)	GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:2000310	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]	DAPK1 DAPK
NM_018685		A0A024RA49	A0A024RA49_HUMAN	Anillin, actin binding protein (Scraps homolog, Drosophila), isoform CRA_e	GO:0002244; GO:0005654; GO:0030496	midbody [GO:0030496]; nucleoplasm [GO:0005654]; hematopoietic progenitor cell differentiation [GO:0002244]	ANLN hCG_17719
NM_018685	NM_018685 -> Q9NQW6-1	Q9NQW6	ANLN_HUMAN	Anillin	GO:0000281; GO:0000915; GO:0000921; GO:0002244; GO:0003779; GO:0005654; GO:0005826; GO:0007096; GO:0015629; GO:0017049; GO:0030496; GO:0030865; GO:0031106; GO:0032059; GO:0045296; GO:0090521; GO:0099738; GO:1904172; GO:1904498	actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex region [GO:0099738]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; GTP-Rho binding [GO:0017049]; actomyosin contractile ring assembly [GO:0000915]; cortical cytoskeleton organization [GO:0030865]; glomerular visceral epithelial cell migration [GO:0090521]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; protein localization to mitotic actomyosin contractile ring [GO:1904498]; regulation of exit from mitosis [GO:0007096]; septin ring assembly [GO:0000921]; septin ring organization [GO:0031106]	ANLN
NM_032043	NM_032043 -> Q9BX63-1	Q9BX63	FANCJ_HUMAN	Fanconi anemia group J protein (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1)	GO:0000077; GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0008285; GO:0009636; GO:0010629; GO:0010705; GO:0031965; GO:0046872; GO:0051026; GO:0051539; GO:0071295; GO:0071456; GO:0072520; GO:1901796; GO:1904385; GO:1990918	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]	BRIP1 BACH1 FANCJ
NM_015123		B3KNA2	B3KNA2_HUMAN	cDNA FLJ14024 fis, clone HEMBA1003646, highly similar to FERM domain-containing protein 4B			
NM_015123		Q6PEW6	Q6PEW6_HUMAN	FRMD4B protein (Fragment)	GO:0005856	cytoskeleton [GO:0005856]	FRMD4B
NM_015123	NM_015123 -> Q9Y2L6-1	Q9Y2L6	FRM4B_HUMAN	FERM domain-containing protein 4B (GRP1-binding protein GRSP1)	GO:0001726; GO:0005615; GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0090162	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; ruffle [GO:0001726]; establishment of epithelial cell polarity [GO:0090162]	FRMD4B GRSP1 KIAA1013
NM_005711	NM_005711 -> O43854-1	O43854	EDIL3_HUMAN	EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)	GO:0005178; GO:0005509; GO:0007155; GO:0007275; GO:0010811; GO:0062023; GO:0070062; GO:1903561	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811]	EDIL3 DEL1
NM_001211		O60566	BUB1B_HUMAN	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (hBUBR1) (Mitotic checkpoint kinase MAD3L) (Protein SSK1)	GO:0000278; GO:0000776; GO:0000777; GO:0000778; GO:0000940; GO:0004672; GO:0004674; GO:0005524; GO:0005680; GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0006511; GO:0006915; GO:0007093; GO:0007094; GO:0031145; GO:0048471; GO:0051301; GO:0051754; GO:1901990	anaphase-promoting complex [GO:0005680]; condensed chromosome kinetochore [GO:0000777]; condensed chromosome outer kinetochore [GO:0000940]; condensed nuclear chromosome kinetochore [GO:0000778]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic cell cycle [GO:0000278]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	BUB1B BUBR1 MAD3L SSK1
NM_031217		Q8NI77	KI18A_HUMAN	Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A)	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005623; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0006890; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0019886; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	caveola [GO:0005901]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; tubulin-dependent ATPase activity [GO:0070463]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; seminiferous tubule development [GO:0072520]	KIF18A OK/SW-cl.108
NM_014791	NM_014791 -> Q14680-1	Q14680	MELK_HUMAN	Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2)	GO:0000086; GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005938; GO:0006468; GO:0006915; GO:0008283; GO:0008289; GO:0008631; GO:0016020; GO:0030097; GO:0035556; GO:0043065; GO:0046777; GO:0061351	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	MELK KIAA0175
NM_014783	NM_014783 -> Q6P4F7-1	Q6P4F7	RHGBA_HUMAN	Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A)	GO:0005096; GO:0005829; GO:0007165; GO:0051056	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	ARHGAP11A KIAA0013
NM_006101		A8K031	A8K031_HUMAN	Kinetochore associated 2, isoform CRA_a (NDC80 homolog, kinetochore complex component (S. cerevisiae)) (cDNA FLJ77925, highly similar to Homo sapiens kinetochore associated 2, mRNA) (cDNA, FLJ93683, Homo sapiens kinetochore associated 2 (KNTC2), mRNA)	GO:0005623; GO:0005654; GO:0005813; GO:0031262; GO:0051315	cell [GO:0005623]; centrosome [GO:0005813]; Ndc80 complex [GO:0031262]; nucleoplasm [GO:0005654]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]	KNTC2 NDC80 hCG_38410
NM_006101		O14777	NDC80_HUMAN	Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1) (HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC)	GO:0000070; GO:0000132; GO:0000278; GO:0000775; GO:0000776; GO:0000777; GO:0000778; GO:0000942; GO:0005623; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007052; GO:0007059; GO:0008608; GO:0016020; GO:0031262; GO:0042802; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:1905342	cell [GO:0005623]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; kinetochore organization [GO:0051383]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein localization to kinetochore [GO:1905342]	NDC80 HEC HEC1 KNTC2
NM_005708		Q9Y625	GPC6_HUMAN	Glypican-6 [Cleaved into: Secreted glypican-6]	GO:0001523; GO:0005576; GO:0005615; GO:0005634; GO:0005796; GO:0005886; GO:0006024; GO:0006027; GO:0009966; GO:0009986; GO:0016477; GO:0043202; GO:0045202; GO:0046658; GO:0062023; GO:0098696; GO:0098978; GO:0099560; GO:1904929; GO:1905475; GO:1905606	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; cell migration [GO:0016477]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; retinoid metabolic process [GO:0001523]; synaptic membrane adhesion [GO:0099560]	GPC6 UNQ369/PRO705
NM_007174	NM_007174 -> O14578-1	O14578	CTRO_HUMAN	Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21)	GO:0000086; GO:0000278; GO:0000281; GO:0001889; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007030; GO:0008064; GO:0015629; GO:0016020; GO:0017124; GO:0018107; GO:0030165; GO:0030496; GO:0030866; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035556; GO:0043025; GO:0046872; GO:0048699; GO:0051402; GO:0097110	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]	CIT CRIK KIAA0949 STK21
NM_012112		Q643R0	Q643R0_HUMAN	HCTP4 (TPX2, microtubule-associated, homolog (Xenopus laevis), isoform CRA_b) (cDNA, FLJ92922)	GO:0005654; GO:0005874; GO:0019901; GO:0032147; GO:0043203; GO:0045171; GO:0060236; GO:0061676; GO:0072686; GO:0090307	axon hillock [GO:0043203]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; importin-alpha family protein binding [GO:0061676]; protein kinase binding [GO:0019901]; activation of protein kinase activity [GO:0032147]; mitotic spindle assembly [GO:0090307]; regulation of mitotic spindle organization [GO:0060236]	HCTP4 TPX2 hCG_38821
NM_012112	NM_012112 -> Q9ULW0-1	Q9ULW0	TPX2_HUMAN	Targeting protein for Xklp2 (Differentially expressed in cancerous and non-cancerous lung cells 2) (DIL-2) (Hepatocellular carcinoma-associated antigen 519) (Hepatocellular carcinoma-associated antigen 90) (Protein fls353) (Restricted expression proliferation-associated protein 100) (p100)	GO:0000278; GO:0000922; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0006915; GO:0010389; GO:0015630; GO:0019901; GO:0032147; GO:0043203; GO:0045171; GO:0051301; GO:0060236; GO:0061676; GO:0072686; GO:0090307; GO:1901796	axon hillock [GO:0043203]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; importin-alpha family protein binding [GO:0061676]; protein kinase binding [GO:0019901]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; regulation of signal transduction by p53 class mediator [GO:1901796]	TPX2 C20orf1 C20orf2 DIL2 HCA519
NM_018290	NM_018290 -> Q96G03-1	Q96G03	PGM2_HUMAN	Phosphoglucomutase-2 (PGM 2) (EC 5.4.2.2) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphopentomutase) (EC 5.4.2.7)	GO:0000287; GO:0004614; GO:0005576; GO:0005829; GO:0005978; GO:0005980; GO:0006006; GO:0006098; GO:0008973; GO:0019388; GO:0034774; GO:0043312; GO:0046386; GO:0070062; GO:1904813	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098]	PGM2 MSTP006
NM_016343		P49454	CENPF_HUMAN	Centromere protein F (CENP-F) (AH antigen) (Kinetochore protein CENPF) (Mitosin)	GO:0000278; GO:0000775; GO:0000776; GO:0000922; GO:0000940; GO:0001822; GO:0003682; GO:0005623; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005930; GO:0007059; GO:0007094; GO:0007517; GO:0008022; GO:0008134; GO:0008283; GO:0010389; GO:0015031; GO:0016202; GO:0016363; GO:0021591; GO:0030154; GO:0030496; GO:0036064; GO:0042493; GO:0042803; GO:0045120; GO:0045892; GO:0048471; GO:0051301; GO:0051310; GO:0051382; GO:0051726; GO:0070840; GO:0071897; GO:0097539	axoneme [GO:0005930]; cell [GO:0005623]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to drug [GO:0042493]; ventricular system development [GO:0021591]	CENPF
NM_016448	NM_016448 -> Q9NZJ0-1	Q9NZJ0	DTL_HUMAN	Denticleless protein homolog (DDB1- and CUL4-associated factor 2) (Lethal(2) denticleless protein homolog) (Retinoic acid-regulated nuclear matrix-associated protein)	GO:0000209; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005813; GO:0005829; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0009411; GO:0010971; GO:0019985; GO:0031464; GO:0031465; GO:0031965; GO:0042769; GO:0043687; GO:0045732; GO:0048511; GO:0051726; GO:0072425; GO:0080008	centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; DNA replication [GO:0006260]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]	DTL CDT2 CDW1 DCAF2 L2DTL RAMP
NM_003384		Q99986	VRK1_HUMAN	Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1)	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005819; GO:0005829; GO:0006468; GO:0007077; GO:0007084; GO:0018105; GO:0019901; GO:0031493; GO:0035175; GO:0043987; GO:0046777; GO:0051301; GO:0072354; GO:0072355; GO:0090166	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; nucleosomal histone binding [GO:0031493]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic nuclear envelope reassembly [GO:0007084]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	VRK1
NM_014708	NM_014708 -> P50748-1	P50748	KNTC1_HUMAN	Kinetochore-associated protein 1 (Rough deal homolog) (HsROD) (Rod) (hRod)	GO:0000777; GO:0000922; GO:0005634; GO:0005828; GO:0005829; GO:0005886; GO:0007093; GO:0007096; GO:0015629; GO:0051301; GO:0065003; GO:1990423	actin cytoskeleton [GO:0015629]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096]	KNTC1 KIAA0166
NM_004701		O95067	CCNB2_HUMAN	G2/mitotic-specific cyclin-B2	GO:0000079; GO:0000086; GO:0000307; GO:0001701; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007077; GO:0015630; GO:0016020; GO:0016538; GO:0019901; GO:0040008; GO:0043029; GO:0044772; GO:0045296; GO:0048538; GO:0051301; GO:0051726	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic nuclear envelope disassembly [GO:0007077]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of growth [GO:0040008]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]	CCNB2
NM_130398	NM_130398 -> Q9UQ84-1	Q9UQ84	EXO1_HUMAN	Exonuclease 1 (hExo1) (EC 3.1.-.-) (Exonuclease I) (hExoI)	GO:0002455; GO:0003677; GO:0003682; GO:0004523; GO:0004527; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006281; GO:0006298; GO:0006310; GO:0008409; GO:0016446; GO:0016604; GO:0017108; GO:0035312; GO:0045145; GO:0045190; GO:0046872; GO:0048256; GO:0051321; GO:0051908; GO:0090656; GO:1901796	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0051908]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; regulation of signal transduction by p53 class mediator [GO:1901796]; somatic hypermutation of immunoglobulin genes [GO:0016446]; t-circle formation [GO:0090656]	EXO1 EXOI HEX1
NM_017760	NM_017760 -> Q86XI2-1	Q86XI2	CNDG2_HUMAN	Condensin-2 complex subunit G2 (Chromosome-associated protein G2) (CAP-G2) (hCAP-G2) (Leucine zipper protein 5) (Non-SMC condensin II complex subunit G2)	GO:0000796; GO:0001833; GO:0005654; GO:0006366; GO:0007049; GO:0016020; GO:0016607; GO:0030218; GO:0030261; GO:0035064; GO:0043425; GO:0045647; GO:0051301; GO:0061098; GO:0098772; GO:2000273	condensin complex [GO:0000796]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; bHLH transcription factor binding [GO:0043425]; methylated histone binding [GO:0035064]; molecular function regulator [GO:0098772]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261]; erythrocyte differentiation [GO:0030218]; inner cell mass cell proliferation [GO:0001833]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of signaling receptor activity [GO:2000273]; transcription by RNA polymerase II [GO:0006366]	NCAPG2 LUZP5
NM_152259	NM_152259 -> Q7Z2Z1-1	Q7Z2Z1	TICRR_HUMAN	Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)	GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0007093; GO:0010212; GO:0030174; GO:0033314	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; response to ionizing radiation [GO:0010212]	TICRR C15orf42
NM_024629	NM_024629 -> Q71F23-1	Q71F23	CENPU_HUMAN	Centromere protein U (CENP-U) (Centromere protein of 50 kDa) (CENP-50) (Interphase centromere complex protein 24) (KSHV latent nuclear antigen-interacting protein 1) (MLF1-interacting protein) (Polo-box-interacting protein 1)	GO:0000777; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0016032; GO:0034080; GO:0034451; GO:0043009	centriolar satellite [GO:0034451]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; CENP-A containing nucleosome assembly [GO:0034080]; chordate embryonic development [GO:0043009]; viral process [GO:0016032]	CENPU ICEN24 KLIP1 MLF1IP PBIP1
NM_018136		B3KWI2	B3KWI2_HUMAN	cDNA FLJ43117 fis, clone CTONG3002674, highly similar to Abnormal spindle-like microcephaly-associated protein (Fragment)			
NM_018136	NM_018136 -> Q8IZT6-1	Q8IZT6	ASPM_HUMAN	Abnormal spindle-like microcephaly-associated protein (Abnormal spindle protein homolog) (Asp homolog)	GO:0001764; GO:0002052; GO:0005516; GO:0005634; GO:0005737; GO:0005813; GO:0007051; GO:0007283; GO:0008584; GO:0016324; GO:0021873; GO:0021987; GO:0030496; GO:0036449; GO:0045665; GO:0045769; GO:0048477; GO:0048589; GO:0051445; GO:0051653; GO:0051661; GO:0072687; GO:0090263; GO:0090306; GO:0097150; GO:0097431	apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle assembly involved in meiosis [GO:0090306]; spindle localization [GO:0051653]; spindle organization [GO:0007051]	ASPM MCPH5
NM_018304		D2SNZ4	D2SNZ4_HUMAN	Proline rich 11, isoform CRA_a (Transcription repressor of MHCII)			PRR11 hCG_1775215
NM_018304		Q96HE9	PRR11_HUMAN	Proline-rich protein 11	GO:0005634; GO:0005737; GO:0007050; GO:0016020; GO:0051726	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; cell cycle arrest [GO:0007050]; regulation of cell cycle [GO:0051726]	PRR11
NM_005308		P34947	GRK5_HUMAN	G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5)	GO:0004674; GO:0004703; GO:0005080; GO:0005524; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007186; GO:0007188; GO:0007217; GO:0008277; GO:0008284; GO:0016055; GO:0016607; GO:0031965; GO:0043066; GO:0045444; GO:0046777; GO:0047696; GO:0051726	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; phospholipid binding [GO:0005543]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055]	GRK5 GPRK5
NM_007280		A0A024R9N0	A0A024R9N0_HUMAN	Opa interacting protein 5, isoform CRA_a	GO:0010369; GO:0016607; GO:0043231; GO:0046872	chromocenter [GO:0010369]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]	OIP5 hCG_1642334
NM_007280		O43482	MS18B_HUMAN	Protein Mis18-beta (Cancer/testis antigen 86) (CT86) (Opa-interacting protein 5) (OIP-5)	GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0007049; GO:0007059; GO:0007154; GO:0010369; GO:0015030; GO:0016607; GO:0034080; GO:0042802; GO:0043231; GO:0046872; GO:0051301	Cajal body [GO:0015030]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]; chromosome segregation [GO:0007059]	OIP5 MIS18B
NM_001145316		A8K3X3	A8K3X3_HUMAN	cDNA FLJ77685	GO:0000444; GO:0007059; GO:0051301	MIS12/MIND type complex [GO:0000444]; cell division [GO:0051301]; chromosome segregation [GO:0007059]	
NM_001145316	NM_001145316 -> Q9H410-1	Q9H410	DSN1_HUMAN	Kinetochore-associated protein DSN1 homolog	GO:0000070; GO:0000444; GO:0000777; GO:0000818; GO:0000922; GO:0000941; GO:0001650; GO:0005576; GO:0005654; GO:0005730; GO:0005829; GO:0016604; GO:0035578; GO:0043312; GO:0051301	azurophil granule lumen [GO:0035578]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome inner kinetochore [GO:0000941]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; MIS12/MIND type complex [GO:0000444]; nuclear body [GO:0016604]; nuclear MIS12/MIND complex [GO:0000818]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; neutrophil degranulation [GO:0043312]	DSN1 C20orf172 MIS13
NM_018353	NM_018353 -> Q6P0N0-1	Q6P0N0	M18BP_HUMAN	Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog) (HsKNL-2) (P243)	GO:0000778; GO:0000981; GO:0003677; GO:0005654; GO:0007049; GO:0034080; GO:0051301	condensed nuclear chromosome kinetochore [GO:0000778]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]	MIS18BP1 C14orf106 KIAA1903 KNL2 M18BP1
NM_199420	NM_199420 -> O75417-1	O75417	DPOLQ_HUMAN	DNA polymerase theta (EC 2.7.7.7) (DNA polymerase eta)	GO:0000724; GO:0003682; GO:0003684; GO:0003887; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006261; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0017116; GO:0042802; GO:0051260; GO:0051575; GO:0097681; GO:2000042	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA helicase activity [GO:0017116]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446]	POLQ POLH
NM_199420		Q59EE4	Q59EE4_HUMAN	DNA polymerase theta variant (Fragment)	GO:0003677; GO:0003887; GO:0006261	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261]	
NM_021067		Q14691	PSF1_HUMAN	DNA replication complex GINS protein PSF1 (GINS complex subunit 1)	GO:0000811; GO:0001833; GO:0005634; GO:0005654; GO:0005737; GO:0006271; GO:0043138; GO:1902983	cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA strand elongation involved in mitotic DNA replication [GO:1902983]; inner cell mass cell proliferation [GO:0001833]	GINS1 KIAA0186 PSF1
NM_020242	NM_020242 -> Q9NS87-1	Q9NS87	KIF15_HUMAN	Kinesin-like protein KIF15 (Kinesin-like protein 2) (hKLP2) (Kinesin-like protein 7) (Serologically defined breast cancer antigen NY-BR-62)	GO:0000278; GO:0003774; GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0006890; GO:0007018; GO:0008017; GO:0016020; GO:0016887; GO:0019886	centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]	KIF15 KLP2 KNSL7
NM_003504	NM_003504 -> O75419-1	O75419	CDC45_HUMAN	Cell division control protein 45 homolog (PORC-PI-1)	GO:0000076; GO:0000082; GO:0000083; GO:0000727; GO:0003682; GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005656; GO:0005737; GO:0005813; GO:0006260; GO:0006270; GO:0031261; GO:0031298; GO:0031938; GO:0043138; GO:1900087; GO:1902977	centrosome [GO:0005813]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; 3'-5' DNA helicase activity [GO:0043138]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication checkpoint [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication preinitiation complex assembly [GO:1902977]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of chromatin silencing at telomere [GO:0031938]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	CDC45 CDC45L CDC45L2 UNQ374/PRO710
NM_000057		P54132	BLM_HUMAN	Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3)	GO:0000079; GO:0000228; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000729; GO:0000800; GO:0002039; GO:0003677; GO:0003678; GO:0003697; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0007095; GO:0008094; GO:0008270; GO:0009378; GO:0010165; GO:0016363; GO:0016605; GO:0016887; GO:0031297; GO:0032508; GO:0036310; GO:0042803; GO:0043138; GO:0044806; GO:0045893; GO:0045910; GO:0048478; GO:0051259; GO:0051260; GO:0051782; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0071479; GO:0072711; GO:0072757; GO:0090329; GO:0090656; GO:1901796; GO:1905773	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]	BLM RECQ2 RECQL3
NM_001039841		Q3KRB8	RHGBB_HUMAN	Rho GTPase-activating protein 11B (Protein FAM7B1) (Rho-type GTPase-activating protein 11B)	GO:0005829; GO:0007165; GO:0021987; GO:0043547; GO:0051056	cytosol [GO:0005829]; cerebral cortex development [GO:0021987]; positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	ARHGAP11B FAM7B1
NM_018101		Q53HL2	BOREA_HUMAN	Borealin (Cell division cycle-associated protein 8) (Dasra-B) (hDasra-B) (Pluripotent embryonic stem cell-related gene 3 protein)	GO:0000070; GO:0000775; GO:0005623; GO:0005654; GO:0005730; GO:0005829; GO:0007080; GO:0010369; GO:0030496; GO:0032133; GO:0032991; GO:0045171; GO:0051233; GO:0051276; GO:0051301	cell [GO:0005623]; chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; spindle midzone [GO:0051233]; cell division [GO:0051301]; chromosome organization [GO:0051276]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]	CDCA8 PESCRG3
NM_002966		P60903	S10AA_HUMAN	Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (Cellular ligand of annexin II) (S100 calcium-binding protein A10) (p10 protein) (p11)	GO:0001765; GO:0005509; GO:0005576; GO:0005783; GO:0006900; GO:0019897; GO:0042493; GO:0042803; GO:0043547; GO:0044325; GO:0051099; GO:0051290; GO:0051496; GO:0051894; GO:0062023; GO:0070062; GO:0072659; GO:1900026	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; protein homodimerization activity [GO:0042803]; membrane raft assembly [GO:0001765]; positive regulation of binding [GO:0051099]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein heterotetramerization [GO:0051290]; protein localization to plasma membrane [GO:0072659]; response to drug [GO:0042493]; vesicle budding from membrane [GO:0006900]	S100A10 ANX2LG CAL1L CLP11
NM_018248		Q8TAT5	NEIL3_HUMAN	Endonuclease 8-like 3 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase FPG2) (DNA glycosylase/AP lyase Neil3) (Endonuclease VIII-like 3) (Nei-like protein 3)	GO:0000405; GO:0003684; GO:0003690; GO:0003697; GO:0003906; GO:0005634; GO:0005654; GO:0006284; GO:0006289; GO:0008270; GO:0019104; GO:0140078	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; nucleotide-excision repair [GO:0006289]	NEIL3
NM_145018	NM_145018 -> Q8IXT1-1	Q8IXT1	DDIAS_HUMAN	DNA damage-induced apoptosis suppressor protein (Nitric oxide-inducible gene protein)	GO:0005634; GO:0005737; GO:0006915; GO:0071850; GO:0097752; GO:1902230	cytoplasm [GO:0005737]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; mitotic cell cycle arrest [GO:0071850]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; regulation of DNA stability [GO:0097752]	DDIAS C11orf82 NOXIN
NM_015173		B9A6J6	B9A6J6_HUMAN	TBC1 domain family, member 1	GO:0032880	regulation of protein localization [GO:0032880]	TBC1D1
NM_015173		Q6PJJ8	Q6PJJ8_HUMAN	TBC1D1 protein (Fragment)			TBC1D1
NM_015173	NM_015173 -> Q86TI0-1	Q86TI0	TBCD1_HUMAN	TBC1 domain family member 1	GO:0005096; GO:0005634; GO:0005829; GO:0006886; GO:0017137; GO:0032880; GO:0061024; GO:0090630	cytosol [GO:0005829]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; regulation of protein localization [GO:0032880]	TBC1D1 KIAA1108
NM_015173		Q8NC59	Q8NC59_HUMAN	cDNA FLJ32620 fis, clone STOMA2000386, highly similar to TBC1 domain family member 1 (cDNA FLJ90473 fis, clone NT2RP3002571, highly similar to TBC1 domain family member 1)			
NM_145307	NM_145307 -> Q8IZC4-1	Q8IZC4	RTKN2_HUMAN	Rhotekin-2 (Pleckstrin homology domain-containing family K member 1) (PH domain-containing family K member 1)	GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0008284; GO:0030097; GO:0051092; GO:1901224; GO:2001243	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]	RTKN2 PLEKHK1
NM_020796		Q9H2E6	SEM6A_HUMAN	Semaphorin-6A (Semaphorin VIA) (Sema VIA) (Semaphorin-6A-1) (SEMA6A-1)	GO:0001755; GO:0005615; GO:0005887; GO:0006915; GO:0007010; GO:0007166; GO:0007399; GO:0007411; GO:0009887; GO:0016021; GO:0016525; GO:0030215; GO:0030335; GO:0030424; GO:0035924; GO:0045499; GO:0048843; GO:0050919; GO:0070373; GO:0071526; GO:0106089; GO:1900747; GO:1903671; GO:2001224	axon [GO:0030424]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytoskeleton organization [GO:0007010]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion involved in sprouting angiogenesis [GO:0106089]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron migration [GO:2001224]; semaphorin-plexin signaling pathway [GO:0071526]	SEMA6A KIAA1368 SEMAQ
NM_138342		A0A024R3N9	A0A024R3N9_HUMAN	Beta-galactosidase (EC 3.2.1.23)	GO:0004565; GO:0005975	beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	LOC89944 hCG_1811782
NM_138342		Q8IW92	GLBL2_HUMAN	Beta-galactosidase-1-like protein 2 (EC 3.2.1.-)	GO:0004565; GO:0005576; GO:0005773; GO:0005975	extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	GLB1L2 MSTP014 UNQ210/PRO236
NM_006868		Q13636	RAB31_HUMAN	Ras-related protein Rab-31 (Ras-related protein Rab-22B)	GO:0001891; GO:0003924; GO:0005525; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0019003; GO:0030667; GO:0031623; GO:0031901; GO:0032482; GO:0032588; GO:0032869; GO:0036186; GO:0043001; GO:0043312; GO:0045055; GO:0045335; GO:0060100; GO:0090382	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome membrane [GO:0036186]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to insulin stimulus [GO:0032869]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; neutrophil degranulation [GO:0043312]; phagosome maturation [GO:0090382]; positive regulation of phagocytosis, engulfment [GO:0060100]; Rab protein signal transduction [GO:0032482]; receptor internalization [GO:0031623]; regulated exocytosis [GO:0045055]	RAB31 RAB22B
NM_001042517		B4DPV3	B4DPV3_HUMAN	cDNA FLJ58109, highly similar to Protein diaphanous homolog 3 (Fragment)	GO:0003779; GO:0017048; GO:0030036	actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]	
NM_001042517	NM_001042517 -> Q9NSV4-3	Q9NSV4	DIAP3_HUMAN	Protein diaphanous homolog 3 (Diaphanous-related formin-3) (DRF3) (MDia2)	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0007010; GO:0017048; GO:0030036; GO:0030041; GO:0045296	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]	DIAPH3 DIAP3
NM_017409		Q53XI4	Q53XI4_HUMAN	Homeo box C10 (Homeobox C10, isoform CRA_a) (cDNA, FLJ94360, Homo sapiens homeo box C10 (HOXC10), mRNA)	GO:0001501; GO:0005654; GO:0006355; GO:0009952; GO:0009954; GO:0016604; GO:0021520; GO:0030326; GO:0043565; GO:0050905	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; neuromuscular process [GO:0050905]; proximal/distal pattern formation [GO:0009954]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]; spinal cord motor neuron cell fate specification [GO:0021520]	HOXC10 hCG_23354
NM_017409		Q9NYD6	HXC10_HUMAN	Homeobox protein Hox-C10 (Homeobox protein Hox-3I)	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0001501; GO:0005654; GO:0008284; GO:0009952; GO:0009954; GO:0016604; GO:0021520; GO:0030326; GO:0045944; GO:0050905; GO:0120163	nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuromuscular process [GO:0050905]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; skeletal system development [GO:0001501]; spinal cord motor neuron cell fate specification [GO:0021520]	HOXC10 HOX3I
NM_001005735	NM_001005735 -> O96017-9	O96017	CHK2_HUMAN	Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2)	GO:0000077; GO:0000086; GO:0001302; GO:0001934; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0006978; GO:0008630; GO:0016301; GO:0016605; GO:0018105; GO:0019901; GO:0031625; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071157; GO:0071480; GO:0072428; GO:0090307; GO:0090399; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428]	CHEK2 CDS1 CHK2 RAD53
NM_005956		A0A384N5Y3	A0A384N5Y3_HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic (Epididymis secretory sperm binding protein)	GO:0001780; GO:0001843; GO:0004329; GO:0004487; GO:0004488; GO:0005524; GO:0006164; GO:0006555; GO:0007507; GO:0009257; GO:0019346; GO:0035999; GO:0061053	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; heart development [GO:0007507]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; purine nucleotide biosynthetic process [GO:0006164]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346]	MTHFD1
NM_005956		P11586	C1TC_HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]	GO:0000105; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009113; GO:0009257; GO:0016020; GO:0035999; GO:0046655; GO:0048702; GO:0048703; GO:0061053; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]	MTHFD1 MTHFC MTHFD
NM_018098	NM_018098 -> Q9H8V3-4	Q9H8V3	ECT2_HUMAN	Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)	GO:0000281; GO:0000902; GO:0005089; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0007186; GO:0015031; GO:0016604; GO:0030496; GO:0032147; GO:0032154; GO:0032467; GO:0035023; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]	ECT2
NM_001080430	NM_001080430 -> O15405-1	O15405	TOX3_HUMAN	TOX high mobility group box family member 3 (CAG trinucleotide repeat-containing gene F9 protein) (Trinucleotide repeat-containing gene 9 protein)	GO:0000981; GO:0003682; GO:0005654; GO:0005829; GO:0006915; GO:0034056; GO:0042803; GO:0042981; GO:0043524; GO:0045893; GO:0051219	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]	TOX3 CAGF9 TNRC9
NM_031966	NM_031966 -> P14635-1	P14635	CCNB1_HUMAN	G2/mitotic-specific cyclin-B1	GO:0000079; GO:0000086; GO:0000307; GO:0000922; GO:0000942; GO:0001556; GO:0001701; GO:0001933; GO:0005113; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0006367; GO:0006977; GO:0007052; GO:0007077; GO:0007080; GO:0007283; GO:0009612; GO:0010629; GO:0010971; GO:0016020; GO:0016538; GO:0019901; GO:0031145; GO:0031442; GO:0033129; GO:0035173; GO:0042246; GO:0044389; GO:0044772; GO:0045931; GO:0046680; GO:0048146; GO:0048565; GO:0051301; GO:0051726; GO:0051987; GO:0055015; GO:0060045; GO:0060623; GO:0061575; GO:0065003; GO:0071283; GO:0071398; GO:0071407; GO:0071456; GO:0090266; GO:0097125; GO:1901990; GO:1905448; GO:2000775	cell [GO:0005623]; centrosome [GO:0005813]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; histone kinase activity [GO:0035173]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to iron(III) ion [GO:0071283]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-S10 phosphorylation involved in chromosome condensation [GO:2000775]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear envelope disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; oocyte maturation [GO:0001556]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA 3'-end processing [GO:0031442]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of chromosome condensation [GO:0060623]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; response to DDT [GO:0046680]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ventricular cardiac muscle cell development [GO:0055015]	CCNB1 CCNB
NM_001080479	NM_001080479 -> Q8N1W1-6	Q8N1W1	ARG28_HUMAN	Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor) (p190-RhoGEF) (p190RhoGEF) (Rho guanine nucleotide exchange factor)	GO:0003723; GO:0005085; GO:0005089; GO:0005829; GO:0005886; GO:0030154; GO:0035023; GO:0035556; GO:0046872; GO:0048013	cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]	ARHGEF28 KIAA1998 RGNEF
NM_152573	NM_152573 -> Q8IZ41-1	Q8IZ41	RASEF_HUMAN	Ras and EF-hand domain-containing protein (Ras-related protein Rab-45)	GO:0003924; GO:0005509; GO:0005525; GO:0005829; GO:0019003; GO:0042802; GO:0048471; GO:0051260	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homooligomerization [GO:0051260]	RASEF RAB45
NM_020890	NM_020890 -> Q8TCG1-1	Q8TCG1	CIP2A_HUMAN	Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen)	GO:0005737; GO:0005829; GO:0005886; GO:0007283; GO:0016021; GO:0042803; GO:0045296; GO:2000179	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; positive regulation of neural precursor cell proliferation [GO:2000179]; spermatogenesis [GO:0007283]	CIP2A KIAA1524
NM_198468		Q6ZRQ5	MMS22_HUMAN	Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like)	GO:0000724; GO:0005654; GO:0005829; GO:0031297; GO:0043596	cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	MMS22L C6orf167
NM_006591		A0A024R5M8	A0A024R5M8_HUMAN	Polymerase (DNA-directed), delta 3, accessory subunit, isoform CRA_a	GO:0003887; GO:0005654; GO:0006260; GO:0043625	delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication [GO:0006260]	POLD3 hCG_27408
NM_006591	NM_006591 -> Q15054-1	Q15054	DPOD3_HUMAN	DNA polymerase delta subunit 3 (DNA polymerase delta subunit C) (DNA polymerase delta subunit p66) (DNA polymerase delta subunit p68)	GO:0000723; GO:0000731; GO:0003887; GO:0005654; GO:0005737; GO:0006271; GO:0006283; GO:0006296; GO:0006297; GO:0006298; GO:0016035; GO:0019985; GO:0032201; GO:0033683; GO:0042769; GO:0043625; GO:1904161	cytoplasm [GO:0005737]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; zeta DNA polymerase complex [GO:0016035]; DNA-directed DNA polymerase activity [GO:0003887]; DNA damage response, detection of DNA damage [GO:0042769]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]	POLD3 KIAA0039
NM_002737		L7RSM7	L7RSM7_HUMAN	Protein kinase C (EC 2.7.11.13)	GO:0004697; GO:0005524; GO:0005829; GO:0005886; GO:0008270; GO:0035556	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]	PRKCA
NM_002737		P17252	KPCA_HUMAN	Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13)	GO:0001525; GO:0001938; GO:0002159; GO:0004672; GO:0004674; GO:0004697; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007077; GO:0007155; GO:0007411; GO:0008270; GO:0010595; GO:0010613; GO:0018105; GO:0018107; GO:0019899; GO:0030168; GO:0030335; GO:0031666; GO:0031966; GO:0034351; GO:0035403; GO:0035408; GO:0035556; GO:0035866; GO:0038128; GO:0043488; GO:0043536; GO:0045651; GO:0045766; GO:0045780; GO:0045785; GO:0045931; GO:0048471; GO:0050796; GO:0070062; GO:0070374; GO:0070555; GO:0090330; GO:0097190; GO:0106071; GO:2000707	alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; histone kinase activity (H3-T6 specific) [GO:0035403]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; desmosome assembly [GO:0002159]; ERBB2 signaling pathway [GO:0038128]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; mitotic nuclear envelope disassembly [GO:0007077]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of mRNA stability [GO:0043488]; regulation of platelet aggregation [GO:0090330]; response to interleukin-1 [GO:0070555]	PRKCA PKCA PRKACA
NM_002737		Q7Z727	Q7Z727_HUMAN	PRKCA protein (Fragment)	GO:0035556; GO:0046872	metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]	PRKCA
NM_004163		O00194	RB27B_HUMAN	Ras-related protein Rab-27B (EC 3.6.5.2) (C25KG)	GO:0002576; GO:0003924; GO:0005525; GO:0005623; GO:0005770; GO:0005794; GO:0005795; GO:0005886; GO:0006886; GO:0016324; GO:0019003; GO:0019904; GO:0030140; GO:0030141; GO:0031088; GO:0031489; GO:0032402; GO:0032482; GO:0032585; GO:0042470; GO:0042589; GO:0045921; GO:0048488; GO:0070062; GO:0071985; GO:0098993; GO:0099641; GO:1904115	anchored component of synaptic vesicle membrane [GO:0098993]; apical plasma membrane [GO:0016324]; axon cytoplasm [GO:1904115]; cell [GO:0005623]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; secretory granule [GO:0030141]; trans-Golgi network transport vesicle [GO:0030140]; zymogen granule membrane [GO:0042589]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; anterograde axonal protein transport [GO:0099641]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; multivesicular body sorting pathway [GO:0071985]; platelet degranulation [GO:0002576]; positive regulation of exocytosis [GO:0045921]; Rab protein signal transduction [GO:0032482]; synaptic vesicle endocytosis [GO:0048488]	RAB27B
NM_032485		B4DN82	B4DN82_HUMAN	cDNA FLJ57869, highly similar to DNA replication licensing factor MCM8			
NM_032485	NM_032485 -> Q9UJA3-1	Q9UJA3	MCM8_HUMAN	DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8)	GO:0000082; GO:0000724; GO:0003678; GO:0003682; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006974; GO:0007292; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0036298; GO:0042555; GO:0048232; GO:0050821; GO:0071168; GO:0097362	chromosome [GO:0005694]; cytosol [GO:0005829]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; G1/S transition of mitotic cell cycle [GO:0000082]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]	MCM8 C20orf154
NM_003798		B3KMX6	B3KMX6_HUMAN	cDNA FLJ12864 fis, clone NT2RP2003604, highly similar to Alpha-catulin	GO:0007155; GO:0007266; GO:0045296; GO:0051015	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]	
NM_003798	NM_003798 -> Q9UBT7-1	Q9UBT7	CTNL1_HUMAN	Alpha-catulin (Alpha-catenin-related protein) (ACRP) (Catenin alpha-like protein 1)	GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266; GO:0045296; GO:0051015	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]	CTNNAL1
NM_001099286	NM_001099286 -> Q6P444-1	Q6P444	MTFR2_HUMAN	Mitochondrial fission regulator 2 (DUF729 domain-containing protein 1)	GO:0000266; GO:0005739; GO:0007005; GO:0009060	mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]	MTFR2 DUFD1 FAM54A
NM_182513		Q8NBT2	SPC24_HUMAN	Kinetochore protein Spc24 (hSpc24)	GO:0000777; GO:0005654; GO:0005730; GO:0005829; GO:0007049; GO:0031262; GO:0051301	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Ndc80 complex [GO:0031262]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301]	SPC24 SPBC24
NM_006231		Q07864	DPOE1_HUMAN	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A)	GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006270; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0032201; GO:0045004; GO:0048568; GO:0051539	epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]; telomere maintenance via semi-conservative replication [GO:0032201]	POLE POLE1
NM_031299		Q99618	CDCA3_HUMAN	Cell division cycle-associated protein 3 (Gene-rich cluster protein C8) (Trigger of mitotic entry protein 1) (TOME-1)	GO:0005829; GO:0005913; GO:0007049; GO:0016567; GO:0051301	cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]	CDCA3 C8 GRCC8 TOME1
NM_001031701	NM_001031701 -> Q86UY8-1	Q86UY8	NT5D3_HUMAN	5'-nucleotidase domain-containing protein 3 (EC 3.1.3.-) (GRP94-neighboring nucleotidase)	GO:0008253; GO:0043235; GO:0046872	receptor complex [GO:0043235]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]	NT5DC3 GNN TU12B1-TY
NM_014586		P57058	HUNK_HUMAN	Hormonally up-regulated neu tumor-associated kinase (EC 2.7.11.1) (B19) (Serine/threonine-protein kinase MAK-V)	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007165; GO:0007275; GO:0035556	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	HUNK MAKV
NM_003924		Q99453	PHX2B_HUMAN	Paired mesoderm homeobox protein 2B (Neuroblastoma Phox) (NBPhox) (PHOX2B homeodomain protein) (Paired-like homeobox 2B)	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001764; GO:0002087; GO:0003357; GO:0003358; GO:0003360; GO:0005634; GO:0005654; GO:0007399; GO:0008285; GO:0010001; GO:0010468; GO:0010971; GO:0021533; GO:0021723; GO:0021934; GO:0035914; GO:0045665; GO:0045666; GO:0045944; GO:0048483; GO:0048484; GO:0048485; GO:0048486; GO:0048839; GO:0048894; GO:0060541; GO:0061452; GO:0061549; GO:0071157; GO:0071542; GO:0071773; GO:0120162; GO:1901166	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; autonomic nervous system development [GO:0048483]; brainstem development [GO:0003360]; cell differentiation in hindbrain [GO:0021533]; cellular response to BMP stimulus [GO:0071773]; dopaminergic neuron differentiation [GO:0071542]; efferent axon development in a lateral line nerve [GO:0048894]; enteric nervous system development [GO:0048484]; glial cell differentiation [GO:0010001]; hindbrain tangential cell migration [GO:0021934]; inner ear development [GO:0048839]; medullary reticular formation development [GO:0021723]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron differentiation [GO:0003357]; parasympathetic nervous system development [GO:0048486]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory system development [GO:0060541]; retrotrapezoid nucleus neuron differentiation [GO:0061452]; skeletal muscle cell differentiation [GO:0035914]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]	PHOX2B PMX2B
NM_002592		P12004	PCNA_HUMAN	Proliferating cell nuclear antigen (PCNA) (Cyclin)	GO:0000083; GO:0000122; GO:0000307; GO:0000701; GO:0000723; GO:0000784; GO:0000785; GO:0003682; GO:0003684; GO:0005634; GO:0005652; GO:0005654; GO:0005657; GO:0005813; GO:0006272; GO:0006283; GO:0006287; GO:0006296; GO:0006297; GO:0006298; GO:0006977; GO:0007507; GO:0016032; GO:0016567; GO:0016604; GO:0019899; GO:0019985; GO:0030331; GO:0030337; GO:0030855; GO:0030894; GO:0030971; GO:0031297; GO:0032077; GO:0032139; GO:0032201; GO:0032355; GO:0032405; GO:0033683; GO:0034644; GO:0035035; GO:0042276; GO:0042769; GO:0042802; GO:0043596; GO:0043626; GO:0044849; GO:0045739; GO:0045740; GO:0046686; GO:0070062; GO:0070182; GO:0070301; GO:0070557; GO:0070987; GO:0071466; GO:0071548; GO:0097421; GO:1902065; GO:1902990	centrosome [GO:0005813]; chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage response, detection of DNA damage [GO:0042769]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epithelial cell differentiation [GO:0030855]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; protein ubiquitination [GO:0016567]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]; viral process [GO:0016032]	PCNA
NM_014900	NM_014900 -> Q53SF7-3	Q53SF7	COBL1_HUMAN	Cordon-bleu protein-like 1	GO:0003785; GO:0045296; GO:0070062	extracellular exosome [GO:0070062]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296]	COBLL1 KIAA0977
NM_004982		A0A024RAV6	A0A024RAV6_HUMAN	Potassium inwardly-rectifying channel, subfamily J, member 8, isoform CRA_a	GO:0001822; GO:0005524; GO:0005739; GO:0007507; GO:0008282; GO:0015272; GO:0017098; GO:0030016; GO:0032496; GO:0034765; GO:0042383; GO:0043330; GO:0051607; GO:1990573	inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; sarcolemma [GO:0042383]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; sulfonylurea receptor binding [GO:0017098]; defense response to virus [GO:0051607]; heart development [GO:0007507]; kidney development [GO:0001822]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]	KCNJ8 hCG_1811070
NM_004982		Q15842	KCNJ8_HUMAN	ATP-sensitive inward rectifier potassium channel 8 (Inward rectifier K(+) channel Kir6.1) (Potassium channel, inwardly rectifying subfamily J member 8) (uKATP-1)	GO:0005242; GO:0005886; GO:0006813; GO:0008076; GO:0015272; GO:0034765; GO:0098915; GO:1902282; GO:1990573	plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]	KCNJ8
NM_194298		Q7RTY1	MOT9_HUMAN	Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)	GO:0005887; GO:0008028; GO:0015293; GO:0046415	integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; urate metabolic process [GO:0046415]	SLC16A9 C10orf36 MCT9
NM_002388		A0A0S2Z4T1	A0A0S2Z4T1_HUMAN	DNA helicase (EC 3.6.4.12) (Fragment)	GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005813; GO:0006270; GO:0042555	centrosome [GO:0005813]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication initiation [GO:0006270]	MCM3
NM_002388	NM_002388 -> P25205-1	P25205	MCM3_HUMAN	DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102)	GO:0000082; GO:0000727; GO:0000784; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005658; GO:0005813; GO:0006260; GO:0006267; GO:0006270; GO:0006271; GO:0016020; GO:0042555; GO:0048471; GO:1902975	alpha DNA polymerase:primase complex [GO:0005658]; centrosome [GO:0005813]; MCM complex [GO:0042555]; membrane [GO:0016020]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	MCM3
NM_003513		P04908	H2A1B_HUMAN	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0006325; GO:0008285; GO:0046982; GO:0070062	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; negative regulation of cell population proliferation [GO:0008285]	H2AC4 H2AFM HIST1H2AB; H2AC8 H2AFA HIST1H2AE
NM_003513		Q08AJ9	Q08AJ9_HUMAN	Histone H2A	GO:0000786; GO:0003677; GO:0005634; GO:0046982	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	HIST1H2AB HIST1H2AE hCG_1640984 hCG_1787383
NM_005077		Q04724	TLE1_HUMAN	Transducin-like enhancer protein 1 (E(Sp1) homolog) (Enhancer of split groucho-like protein 1) (ESG1)	GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0007165; GO:0007275; GO:0008134; GO:0009887; GO:0010628; GO:0016055; GO:0030178; GO:0042802; GO:0043124; GO:0045892; GO:0070491; GO:0090090; GO:1904837; GO:1990907; GO:2000811	beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; animal organ morphogenesis [GO:0009887]; beta-catenin-TCF complex assembly [GO:1904837]; multicellular organism development [GO:0007275]; negative regulation of anoikis [GO:2000811]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gene expression [GO:0010628]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	TLE1
NM_005077		Q59EF7	Q59EF7_HUMAN	Transducin-like enhancer protein 1 variant (Fragment)	GO:0005634; GO:0006355	nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]	
NM_152446	NM_152446 -> Q6ZU80-2	Q6ZU80	CE128_HUMAN	Centrosomal protein of 128 kDa (Cep128)	GO:0000922; GO:0005737; GO:0005814; GO:0008104; GO:0120103	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; protein localization [GO:0008104]	CEP128 C14orf145 C14orf61
NM_152446		Q86TS1	Q86TS1_HUMAN	Centrosomal protein of 128 kDa (Full-length cDNA 5-PRIME end of clone CS0CAP003YE19 of Thymus of Homo sapiens (human)) (Fragment)			CEP128
NM_024857	NM_024857 -> Q96QE3-1	Q96QE3	ATAD5_HUMAN	ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein)	GO:0003677; GO:0005524; GO:0005634; GO:0030890; GO:0031391; GO:0033260; GO:0042100; GO:0042770; GO:0042771; GO:0045190; GO:0045740; GO:0048304; GO:0061860; GO:0090305; GO:0090618; GO:1901990; GO:1902166; GO:1902751	Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]; B cell proliferation [GO:0042100]; DNA clamp unloading [GO:0090618]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]	ATAD5 C17orf41 FRAG1
NM_003667		A0A0A8K8C7	A0A0A8K8C7_HUMAN	G protein-coupled receptor 49 (Leucine-rich repeat-containing G protein-coupled receptor 5, isoform CRA_b)	GO:0001942; GO:0004930; GO:0009994; GO:0016021; GO:0016500; GO:0042127; GO:0048839; GO:0090263; GO:2001013	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; inner ear development [GO:0048839]; oocyte differentiation [GO:0009994]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of cell population proliferation [GO:0042127]	GPR49 LGR5 hCG_23766
NM_003667	NM_003667 -> O75473-1	O75473	LGR5_HUMAN	Leucine-rich repeat-containing G-protein coupled receptor 5 (G-protein coupled receptor 49) (G-protein coupled receptor 67) (G-protein coupled receptor HG38)	GO:0001942; GO:0004888; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007190; GO:0008528; GO:0009755; GO:0009994; GO:0016500; GO:0032588; GO:0042127; GO:0048839; GO:0090263; GO:2001013	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; oocyte differentiation [GO:0009994]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of cell population proliferation [GO:0042127]	LGR5 GPR49 GPR67
NM_006486	NM_006486 -> P23142-1	P23142	FBLN1_HUMAN	Fibulin-1 (FIBL-1)	GO:0001933; GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007162; GO:0007566; GO:0008022; GO:0010628; GO:0016032; GO:0016504; GO:0030198; GO:0031012; GO:0042802; GO:0044877; GO:0048146; GO:0062023; GO:0070051; GO:0070062; GO:0070373; GO:0071953; GO:0072378; GO:1900025; GO:1904188; GO:1904237; GO:2000146; GO:2000647; GO:2001202	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor-beta secretion [GO:2001202]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; viral process [GO:0016032]	FBLN1 PP213
NM_006486		Q8NBH6	Q8NBH6_HUMAN	Fibulin-1	GO:0005178; GO:0005509; GO:0005576; GO:0016504; GO:0030198	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; extracellular matrix organization [GO:0030198]	
NM_001130963	NM_001130963 -> O14524-1	O14524	NEMP1_HUMAN	Nuclear envelope integral membrane protein 1	GO:0005635; GO:0005637; GO:0016021	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]	NEMP1 KIAA0286 TMEM194 TMEM194A
NM_006681		A0A250SH36	A0A250SH36_HUMAN	Neuromedin U, isoform CRA_b (Neuromedin U-related peptide/neuromedin U preproprotein)	GO:0001659; GO:0001696; GO:0005623; GO:0007204; GO:0007218; GO:0009648; GO:0010460; GO:0019233; GO:0031652; GO:0042755; GO:0042922; GO:0043195; GO:0044497; GO:0045187; GO:0050806; GO:0060455; GO:0097009; GO:0120061; GO:0120069; GO:1902722; GO:1903999; GO:1904058; GO:2000821	cell [GO:0005623]; terminal bouton [GO:0043195]; neuromedin U receptor binding [GO:0042922]; eating behavior [GO:0042755]; energy homeostasis [GO:0097009]; gastric acid secretion [GO:0001696]; negative regulation of eating behavior [GO:1903999]; negative regulation of gastric acid secretion [GO:0060455]; negative regulation of gastric emptying [GO:0120061]; neuropeptide signaling pathway [GO:0007218]; photoperiodism [GO:0009648]; positive regulation of blood pressure in other organism [GO:0044497]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of heat generation [GO:0031652]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of stomach fundus smooth muscle contraction [GO:0120069]; positive regulation of synaptic transmission [GO:0050806]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of grooming behavior [GO:2000821]; sensory perception of pain [GO:0019233]; temperature homeostasis [GO:0001659]	NMU hCG_20599
NM_006681		P48645	NMU_HUMAN	Neuromedin-U [Cleaved into: Neuromedin precursor-related peptide 36 (NURP36); Neuromedin precursor-related peptide 33 (NURP33); Neuromedin-U-25 (NmU-25)]	GO:0001659; GO:0001696; GO:0005102; GO:0005576; GO:0005623; GO:0007186; GO:0007204; GO:0007218; GO:0009648; GO:0010460; GO:0019233; GO:0031652; GO:0031839; GO:0031840; GO:0042755; GO:0042922; GO:0043195; GO:0044497; GO:0045187; GO:0045987; GO:0050806; GO:0060455; GO:0097009; GO:0120061; GO:0120069; GO:1902722; GO:1903999; GO:1904058; GO:2000821	cell [GO:0005623]; extracellular region [GO:0005576]; terminal bouton [GO:0043195]; neuromedin U receptor binding [GO:0042922]; signaling receptor binding [GO:0005102]; type 1 neuromedin U receptor binding [GO:0031839]; type 2 neuromedin U receptor binding [GO:0031840]; eating behavior [GO:0042755]; energy homeostasis [GO:0097009]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric acid secretion [GO:0001696]; negative regulation of eating behavior [GO:1903999]; negative regulation of gastric acid secretion [GO:0060455]; negative regulation of gastric emptying [GO:0120061]; neuropeptide signaling pathway [GO:0007218]; photoperiodism [GO:0009648]; positive regulation of blood pressure in other organism [GO:0044497]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of heat generation [GO:0031652]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of stomach fundus smooth muscle contraction [GO:0120069]; positive regulation of synaptic transmission [GO:0050806]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of grooming behavior [GO:2000821]; sensory perception of pain [GO:0019233]; temperature homeostasis [GO:0001659]	NMU
NM_018154		A0A024R7G4	A0A024R7G4_HUMAN	ASF1 anti-silencing function 1 homolog B (S. cerevisiae), isoform CRA_a	GO:0000785; GO:0001835; GO:0005654; GO:0006334; GO:0042393	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; blastocyst hatching [GO:0001835]; nucleosome assembly [GO:0006334]	ASF1B hCG_27531
NM_018154		Q9NVP2	ASF1B_HUMAN	Histone chaperone ASF1B (Anti-silencing function protein 1 homolog B) (hAsf1) (hAsf1b) (CCG1-interacting factor A-II) (CIA-II) (hCIA-II)	GO:0000790; GO:0001835; GO:0005654; GO:0006335; GO:0006336; GO:0007283; GO:0030154; GO:0032991; GO:0042393	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; blastocyst hatching [GO:0001835]; cell differentiation [GO:0030154]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; spermatogenesis [GO:0007283]	ASF1B
NM_001130064	NM_001130064 -> P17677-2	P17677	NEUM_HUMAN	Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46)	GO:0001786; GO:0005516; GO:0005737; GO:0005886; GO:0007205; GO:0007399; GO:0009611; GO:0010001; GO:0014069; GO:0016198; GO:0030054; GO:0030425; GO:0031103; GO:0031527; GO:0032584; GO:0035727; GO:0040008; GO:0042246; GO:0043204; GO:0045165; GO:0051489; GO:0098982; GO:0099150; GO:1901981	cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium membrane [GO:0031527]; GABA-ergic synapse [GO:0098982]; growth cone membrane [GO:0032584]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; calmodulin binding [GO:0005516]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylserine binding [GO:0001786]; axon choice point recognition [GO:0016198]; axon regeneration [GO:0031103]; cell fate commitment [GO:0045165]; glial cell differentiation [GO:0010001]; nervous system development [GO:0007399]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of filopodium assembly [GO:0051489]; regulation of growth [GO:0040008]; regulation of postsynaptic specialization assembly [GO:0099150]; response to wounding [GO:0009611]; tissue regeneration [GO:0042246]	GAP43
NM_003619		P56730	NETR_HUMAN	Neurotrypsin (EC 3.4.21.-) (Leydin) (Motopsin) (Serine protease 12)	GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0008236; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; exocytosis [GO:0006887]; zymogen activation [GO:0031638]	PRSS12
NM_003619		Q96I80	Q96I80_HUMAN	PRSS12 protein	GO:0005044; GO:0016020	membrane [GO:0016020]; scavenger receptor activity [GO:0005044]	
NM_003149		Q8WUK8	Q8WUK8_HUMAN	SH3 and cysteine rich domain	GO:0035556; GO:0046872	metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]	STAC
NM_003149		Q99469	STAC_HUMAN	SH3 and cysteine-rich domain-containing protein (Src homology 3 and cysteine-rich domain-containing protein)	GO:0003009; GO:0005829; GO:0007165; GO:0030315; GO:0031234; GO:0034605; GO:0035556; GO:0044325; GO:0046872; GO:1901387; GO:1903078; GO:2001259	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; T-tubule [GO:0030315]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; cellular response to heat [GO:0034605]; intracellular signal transduction [GO:0035556]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]	STAC STAC1
NM_001080539	NM_001080539 -> Q8NCX0-1	Q8NCX0	CC150_HUMAN	Coiled-coil domain-containing protein 150			CCDC150
NM_015653		Q9H4K1	RIBC2_HUMAN	RIB43A-like with coiled-coils protein 2	GO:0005634	nucleus [GO:0005634]	RIBC2 C22orf11
NM_201280	NM_201280 -> Q8TDH9-1	Q8TDH9	BL1S5_HUMAN	Biogenesis of lysosome-related organelles complex 1 subunit 5 (BLOC-1 subunit 5) (Protein Muted homolog)	GO:0005623; GO:0008089; GO:0030133; GO:0031083; GO:0031175; GO:0032402; GO:0032438; GO:0035646; GO:0048490; GO:0050942; GO:1904115	axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell [GO:0005623]; transport vesicle [GO:0030133]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosome to melanosome transport [GO:0035646]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; neuron projection development [GO:0031175]; positive regulation of pigment cell differentiation [GO:0050942]	BLOC1S5 MUTED
NM_002285	NM_002285 -> P51826-1	P51826	AFF3_HUMAN	AF4/FMR2 family member 3 (Lymphoid nuclear protein related to AF4) (Protein LAF-4)	GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0008023; GO:0016604; GO:0032783; GO:0034612; GO:0035116	cytosol [GO:0005829]; ELL-EAF complex [GO:0032783]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; embryonic hindlimb morphogenesis [GO:0035116]; response to tumor necrosis factor [GO:0034612]	AFF3 LAF4
NM_000790		A0A0S2Z3N4	A0A0S2Z3N4_HUMAN	Dopa decarboxylase isoform 1 (Fragment)	GO:0004058; GO:0006520; GO:0007623; GO:0008021; GO:0010259; GO:0015842; GO:0016597; GO:0019904; GO:0030170; GO:0030424; GO:0033076; GO:0035690; GO:0042416; GO:0042427; GO:0043025; GO:0046684; GO:0052314; GO:0071312; GO:0071363	axon [GO:0030424]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]; amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to drug [GO:0035690]; cellular response to growth factor stimulus [GO:0071363]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; serotonin biosynthetic process [GO:0042427]	DDC
NM_000790	NM_000790 -> P20711-1	P20711	DDC_HUMAN	Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC)	GO:0004058; GO:0005829; GO:0006520; GO:0007623; GO:0008021; GO:0010259; GO:0015842; GO:0016597; GO:0019899; GO:0019904; GO:0030170; GO:0030424; GO:0033076; GO:0035690; GO:0036468; GO:0042416; GO:0042423; GO:0042427; GO:0043025; GO:0046219; GO:0046684; GO:0052314; GO:0070062; GO:0071312; GO:0071363	axon [GO:0030424]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]; amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; enzyme binding [GO:0019899]; L-dopa decarboxylase activity [GO:0036468]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to drug [GO:0035690]; cellular response to growth factor stimulus [GO:0071363]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; indolalkylamine biosynthetic process [GO:0046219]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; serotonin biosynthetic process [GO:0042427]	DDC AADC
NM_000790		Q53Y41	Q53Y41_HUMAN	Dopa decarboxylase (Aromatic L-amino acid decarboxylase) (Dopa decarboxylase (Aromatic L-amino acid decarboxylase), isoform CRA_a)	GO:0006520; GO:0016831; GO:0030170	carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; cellular amino acid metabolic process [GO:0006520]	DDC hCG_1811384 tcag7.584
NM_005164		Q9UBJ2	ABCD2_HUMAN	ATP-binding cassette sub-family D member 2 (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR)	GO:0000038; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0016021; GO:0016887; GO:0032000; GO:0042626; GO:0042760; GO:0042803; GO:0043217; GO:0055085; GO:1900016; GO:1903427; GO:1990535; GO:2001280	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]	ABCD2 ALD1 ALDL1 ALDR ALDRP
NM_014344		Q86VR8	FJX1_HUMAN	Four-jointed box protein 1 (Four-jointed protein homolog)	GO:0005615; GO:0007267; GO:0010842	extracellular space [GO:0005615]; cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842]	FJX1
NM_022451		Q8WTT2	NOC3L_HUMAN	Nucleolar complex protein 3 homolog (NOC3 protein homolog) (Factor for adipocyte differentiation 24) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)	GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0016607; GO:0045444	mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; fat cell differentiation [GO:0045444]	NOC3L AD24 C10orf117 FAD24
NM_178229		Q86VI3	IQGA3_HUMAN	Ras GTPase-activating-like protein IQGAP3	GO:0000082; GO:0000187; GO:0005516; GO:0005829; GO:0005911; GO:0007265; GO:0008361; GO:0010628; GO:0010629; GO:0016328; GO:0017048; GO:0033601; GO:0043087; GO:0070371; GO:0070856; GO:0071310	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; calmodulin binding [GO:0005516]; myosin VI light chain binding [GO:0070856]; Rho GTPase binding [GO:0017048]; activation of MAPK activity [GO:0000187]; cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; Ras protein signal transduction [GO:0007265]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]	IQGAP3
NM_003104	NM_003104 -> Q00796-1	Q00796	DHSO_HUMAN	Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)	GO:0000721; GO:0003939; GO:0005615; GO:0005829; GO:0006006; GO:0006062; GO:0006970; GO:0008270; GO:0009725; GO:0016020; GO:0019640; GO:0030246; GO:0030317; GO:0031514; GO:0031667; GO:0031966; GO:0042493; GO:0042802; GO:0046370; GO:0046526; GO:0046686; GO:0046688; GO:0050255; GO:0051160; GO:0051164; GO:0051287; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; (R,R)-butanediol dehydrogenase activity [GO:0000721]; carbohydrate binding [GO:0030246]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; ribitol 2-dehydrogenase activity [GO:0050255]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; L-xylitol catabolic process [GO:0051160]; L-xylitol metabolic process [GO:0051164]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; sorbitol catabolic process [GO:0006062]	SORD
NM_020165		Q9NS91	RAD18_HUMAN	E3 ubiquitin-protein ligase RAD18 (EC 2.3.2.27) (Postreplication repair protein RAD18) (hHR18) (hRAD18) (RING finger protein 73) (RING-type E3 ubiquitin transferase RAD18)	GO:0000403; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0006301; GO:0006513; GO:0006974; GO:0009411; GO:0016567; GO:0016604; GO:0031593; GO:0031625; GO:0035861; GO:0042405; GO:0042769; GO:0042802; GO:0044877; GO:0046872; GO:0051865; GO:0051984; GO:0060548; GO:0061630; GO:0097505	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of cell death [GO:0060548]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]	RAD18 RNF73
NM_018026		A0A024R5H6	A0A024R5H6_HUMAN	Phosphofurin acidic cluster sorting protein 1, isoform CRA_a	GO:0030137; GO:0034067	COPI-coated vesicle [GO:0030137]; protein localization to Golgi apparatus [GO:0034067]	PACS1 hCG_1818391
NM_018026	NM_018026 -> Q6VY07-1	Q6VY07	PACS1_HUMAN	Phosphofurin acidic cluster sorting protein 1 (PACS-1)	GO:0005794; GO:0005829; GO:0030137; GO:0034067; GO:0044325; GO:0050690; GO:0072659	COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; ion channel binding [GO:0044325]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; regulation of defense response to virus by virus [GO:0050690]	PACS1 KIAA1175
NM_138410		A0A024R2L3	A0A024R2L3_HUMAN	CKLF-like MARVEL transmembrane domain containing 7, isoform CRA_b	GO:0002337; GO:0016021	integral component of membrane [GO:0016021]; B-1a B cell differentiation [GO:0002337]	CMTM7 hCG_20239
NM_138410	NM_138410 -> Q96FZ5-1	Q96FZ5	CKLF7_HUMAN	CKLF-like MARVEL transmembrane domain-containing protein 7 (Chemokine-like factor superfamily member 7)	GO:0002337; GO:0005125; GO:0005615; GO:0006935; GO:0016020; GO:0016021	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cytokine activity [GO:0005125]; B-1a B cell differentiation [GO:0002337]; chemotaxis [GO:0006935]	CMTM7 CKLFSF7
NM_005483	NM_005483 -> Q13111-1	Q13111	CAF1A_HUMAN	Chromatin assembly factor 1 subunit A (CAF-1 subunit A) (Chromatin assembly factor I p150 subunit) (CAF-I 150 kDa subunit) (CAF-I p150) (hp150)	GO:0000790; GO:0003682; GO:0005634; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186; GO:0042802; GO:0051082; GO:0070087	CAF-1 complex [GO:0033186]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]	CHAF1A CAF CAF1P150
NM_007317	NM_007317 -> Q14807-1	Q14807	KIF22_HUMAN	Kinesin-like protein KIF22 (Kinesin-like DNA-binding protein) (Kinesin-like protein 4)	GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0006281; GO:0006890; GO:0007018; GO:0007062; GO:0007080; GO:0008017; GO:0016607; GO:0016887; GO:0019886; GO:0051310; GO:0072686	cell [GO:0005623]; chromatin [GO:0000785]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; DNA repair [GO:0006281]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; sister chromatid cohesion [GO:0007062]	KIF22 KID KNSL4
NM_000746	NM_000746 -> P36544-1	P36544	ACHA7_HUMAN	Neuronal acetylcholine receptor subunit alpha-7	GO:0000187; GO:0001540; GO:0001666; GO:0001934; GO:0005216; GO:0005262; GO:0005623; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0007611; GO:0007613; GO:0007614; GO:0008284; GO:0015464; GO:0015643; GO:0016021; GO:0017081; GO:0022848; GO:0030054; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0044853; GO:0045202; GO:0045211; GO:0045766; GO:0050808; GO:0050877; GO:0050890; GO:0050893; GO:0051247; GO:0070374; GO:0095500; GO:0097061; GO:0098794; GO:0098815; GO:0140059; GO:1900273; GO:1901214; GO:1902004; GO:1902430; GO:1902991; GO:1904645; GO:1905144; GO:1905906; GO:1905920; GO:2000463	acetylcholine-gated channel complex [GO:0005892]; cell [GO:0005623]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; calcium channel activity [GO:0005262]; chloride channel regulator activity [GO:0017081]; ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; acetylcholine receptor signaling pathway [GO:0095500]; activation of MAPK activity [GO:0000187]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system process [GO:0050877]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of membrane potential [GO:0042391]; regulation of neuron death [GO:1901214]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]	CHRNA7 NACHRA7
NM_024945		Q9H9A7	RMI1_HUMAN	RecQ-mediated genome instability protein 1 (BLM-associated protein of 75 kDa) (BLAP75) (FAAP75)	GO:0000166; GO:0000712; GO:0000724; GO:0002023; GO:0005654; GO:0006260; GO:0009749; GO:0016604; GO:0031422; GO:0035264; GO:0042593; GO:1901796	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; RecQ family helicase-topoisomerase III complex [GO:0031422]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of signal transduction by p53 class mediator [GO:1901796]; resolution of meiotic recombination intermediates [GO:0000712]; response to glucose [GO:0009749]	RMI1 C9orf76
NM_019042		B3KRB2	B3KRB2_HUMAN	cDNA FLJ33964 fis, clone CTONG2019029, highly similar to Pseudouridylate synthase 7 homolog	GO:0001522; GO:0003723; GO:0009982	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; pseudouridine synthesis [GO:0001522]	
NM_019042		B3KY42	B3KY42_HUMAN	cDNA FLJ46788 fis, clone TRACH3028855, highly similar to Pseudouridylate synthase 7 homolog	GO:0001522; GO:0003723; GO:0009982	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; pseudouridine synthesis [GO:0001522]	
NM_019042	NM_019042 -> Q96PZ0-1	Q96PZ0	PUS7_HUMAN	Pseudouridylate synthase 7 homolog (EC 5.4.99.-)	GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380	nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]	PUS7 KIAA1897
NM_032336	NM_032336 -> Q9BRT9-1	Q9BRT9	SLD5_HUMAN	DNA replication complex GINS protein SLD5 (GINS complex subunit 4) [Cleaved into: DNA replication complex GINS protein SLD5, N-terminally processed]	GO:0000727; GO:0000811; GO:0001833; GO:0005654; GO:0005737; GO:0006271; GO:0031298; GO:0032508	cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; replication fork protection complex [GO:0031298]; DNA duplex unwinding [GO:0032508]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; inner cell mass cell proliferation [GO:0001833]	GINS4 SLD5
NM_021069	NM_021069 -> O94875-1	O94875	SRBS2_HUMAN	Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Sorbin)	GO:0003723; GO:0005200; GO:0005634; GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0008093; GO:0008307; GO:0015629; GO:0016324; GO:0030018; GO:0030027; GO:0048471; GO:0061049	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; cytoskeletal adaptor activity [GO:0008093]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]	SORBS2 ARGBP2 KIAA0777
NM_015895		A0A024QZY7	A0A024QZY7_HUMAN	Geminin, DNA replication inhibitor, isoform CRA_a	GO:0003714; GO:0005654; GO:0005829; GO:0008156; GO:0009887; GO:0045786; GO:0045892; GO:0065003; GO:0070491	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of transcription, DNA-templated [GO:0045892]; protein-containing complex assembly [GO:0065003]	GMNN hCG_37510
NM_015895		O75496	GEMI_HUMAN	Geminin	GO:0000082; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006275; GO:0008156; GO:0009887; GO:0035563; GO:0042826; GO:0045786; GO:0045892; GO:0070491; GO:0071163; GO:2000104	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-dependent DNA replication [GO:2000104]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275]	GMNN
NM_016937		P09884	DPOLA_HUMAN	DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180)	GO:0000082; GO:0000083; GO:0000166; GO:0000731; GO:0001882; GO:0003677; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006281; GO:0006303; GO:0008283; GO:0016032; GO:0016363; GO:0017076; GO:0019103; GO:0019901; GO:0032201; GO:0046872; GO:0051539; GO:1902975	alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleoside binding [GO:0001882]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]; cell population proliferation [GO:0008283]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; G1/S transition of mitotic cell cycle [GO:0000082]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; telomere maintenance via semi-conservative replication [GO:0032201]; viral process [GO:0016032]	POLA1 POLA
NM_001123375		Q71DI3	H32_HUMAN	Histone H3.2 (Histone H3/m) (Histone H3/o)	GO:0000183; GO:0000786; GO:0003677; GO:0005576; GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0007596; GO:0038111; GO:0044267; GO:0045652; GO:0045814; GO:0046982; GO:0060964; GO:0070062	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; blood coagulation [GO:0007596]; cellular protein metabolic process [GO:0044267]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; interleukin-7-mediated signaling pathway [GO:0038111]; negative regulation of gene expression, epigenetic [GO:0045814]; nucleosome assembly [GO:0006334]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]	HIST2H3A; HIST2H3C H3F2 H3FM; HIST2H3D
NM_012138		Q9NY61	AATF_HUMAN	Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1)	GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0006974; GO:0007346; GO:0019901; GO:0032929; GO:0042254; GO:0042985; GO:0043066; GO:0043522; GO:0044798; GO:0045944; GO:0048156; GO:2000378; GO:2001234	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nuclear transcription factor complex [GO:0044798]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; ribosome biogenesis [GO:0042254]	AATF CHE1 DED HSPC277
NM_153697		B7Z6Z7	B7Z6Z7_HUMAN	cDNA FLJ57209, highly similar to Ankyrin repeat domain-containing protein 44			
NM_153697	NM_153697 -> Q8N8A2-5	Q8N8A2	ANR44_HUMAN	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)			ANKRD44
NM_016426		Q9NYZ3	GTSE1_HUMAN	G2 and S phase-expressed protein 1 (GTSE-1) (Protein B99 homolog)	GO:0005654; GO:0005829; GO:0005881; GO:0006977; GO:0007017; GO:0016020; GO:0030335; GO:0046827; GO:0050821; GO:1900182; GO:1902749	cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; microtubule-based process [GO:0007017]; positive regulation of cell migration [GO:0030335]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to nucleus [GO:1900182]; protein stabilization [GO:0050821]; regulation of cell cycle G2/M phase transition [GO:1902749]	GTSE1
NM_005413		O95343	SIX3_HUMAN	Homeobox protein SIX3 (Sine oculis homeobox homolog 3)	GO:0000790; GO:0000976; GO:0000980; GO:0000981; GO:0001222; GO:0001228; GO:0001654; GO:0002070; GO:0002088; GO:0003404; GO:0003700; GO:0003713; GO:0005102; GO:0005634; GO:0005667; GO:0006606; GO:0007420; GO:0007601; GO:0009946; GO:0014016; GO:0021537; GO:0021797; GO:0021798; GO:0021846; GO:0021978; GO:0021983; GO:0030178; GO:0042127; GO:0042826; GO:0045665; GO:0045892; GO:0048512; GO:0048856; GO:0060235; GO:0061074; GO:0070306; GO:0097402; GO:1901987; GO:1902692; GO:1902742; GO:1990086; GO:2000177	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription corepressor binding [GO:0001222]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; apoptotic process involved in development [GO:1902742]; brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; circadian behavior [GO:0048512]; epithelial cell maturation [GO:0002070]; eye development [GO:0001654]; forebrain anterior/posterior pattern specification [GO:0021797]; forebrain dorsal/ventral pattern formation [GO:0021798]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lens fiber cell differentiation [GO:0070306]; lens induction in camera-type eye [GO:0060235]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; neuroblast differentiation [GO:0014016]; neuroblast migration [GO:0097402]; optic vesicle morphogenesis [GO:0003404]; pituitary gland development [GO:0021983]; protein import into nucleus [GO:0006606]; proximal/distal axis specification [GO:0009946]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell population proliferation [GO:0042127]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neural retina development [GO:0061074]; regulation of neuroblast proliferation [GO:1902692]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; visual perception [GO:0007601]	SIX3
NM_138340	NM_138340 -> Q8WU67-1	Q8WU67	ABHD3_HUMAN	Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3)	GO:0004623; GO:0005886; GO:0006656; GO:0008970; GO:0016021; GO:0016298; GO:0044255; GO:0046470; GO:0047372; GO:0052739; GO:0052740; GO:0102567; GO:0102568	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; cellular lipid metabolic process [GO:0044255]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]	ABHD3
NM_001083961	NM_001083961 -> O43379-4	O43379	WDR62_HUMAN	WD repeat-containing protein 62	GO:0000922; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0007052; GO:0007099; GO:0021987; GO:0022008; GO:0034451	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]; centriole replication [GO:0007099]; cerebral cortex development [GO:0021987]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]	WDR62 C19orf14
NM_000885	NM_000885 -> P13612-1	P13612	ITA4_HUMAN	Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d)	GO:0001968; GO:0003366; GO:0005623; GO:0005886; GO:0005925; GO:0007159; GO:0007160; GO:0007229; GO:0009986; GO:0015026; GO:0016020; GO:0030183; GO:0030198; GO:0030426; GO:0032991; GO:0033631; GO:0034113; GO:0034446; GO:0034669; GO:0035987; GO:0043025; GO:0043113; GO:0046872; GO:0046982; GO:0050776; GO:0050839; GO:0050900; GO:0050901; GO:0050904; GO:0060385; GO:0070062; GO:0071345; GO:0090074; GO:0140039; GO:1903238; GO:1904646; GO:1905564; GO:1990138; GO:1990405; GO:1990771; GO:2000353; GO:2000406	cell [GO:0005623]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integrin alpha4-beta7 complex [GO:0034669]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; cellular response to amyloid-beta [GO:1904646]; cellular response to cytokine stimulus [GO:0071345]; clathrin-dependent extracellular exosome endocytosis [GO:1990771]; diapedesis [GO:0050904]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; negative regulation of protein homodimerization activity [GO:0090074]; neuron projection extension [GO:1990138]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; receptor clustering [GO:0043113]; regulation of immune response [GO:0050776]; substrate adhesion-dependent cell spreading [GO:0034446]	ITGA4 CD49D
NM_020647		Q7Z682	Q7Z682_HUMAN	Uncharacterized protein DKFZp779I2251 (Fragment)	GO:0016021; GO:0030314	integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]	DKFZp779I2251
NM_020647		Q86VR1	Q86VR1_HUMAN	JPH1 protein (Fragment)	GO:0016021; GO:0030314	integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]	JPH1
NM_020647		Q9HDC5	JPH1_HUMAN	Junctophilin-1 (JP-1) (Junctophilin type 1)	GO:0005623; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0007517; GO:0008307; GO:0014701; GO:0015278; GO:0016021; GO:0016529; GO:0030018; GO:0030314; GO:0060314; GO:0060402	cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; calcium-release channel activity [GO:0015278]; structural constituent of muscle [GO:0008307]; calcium ion transport into cytosol [GO:0060402]; muscle organ development [GO:0007517]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]	JPH1 JP1
NM_000791		B0YJ76	B0YJ76_HUMAN	Dihydrofolate reductase (EC 1.5.1.3) (cDNA, FLJ93028, Homo sapiens dihydrofolate reductase (DHFR), mRNA)	GO:0004146; GO:0005739; GO:0046654	mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; tetrahydrofolate biosynthetic process [GO:0046654]	DYR DHFR
NM_000791	NM_000791 -> P00374-1	P00374	DYR_HUMAN	Dihydrofolate reductase (EC 1.5.1.3)	GO:0000083; GO:0000900; GO:0003729; GO:0004146; GO:0005542; GO:0005739; GO:0005829; GO:0006729; GO:0006730; GO:0008144; GO:0017148; GO:0031103; GO:0031427; GO:0046452; GO:0046653; GO:0046654; GO:0046655; GO:0050661; GO:0051000; GO:0051870; GO:0055114; GO:0070402; GO:1990825; GO:2000121	cytosol [GO:0005829]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; methotrexate binding [GO:0051870]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; oxidation-reduction process [GO:0055114]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]	DHFR
NM_004093		P52799	EFNB2_HUMAN	Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L)	GO:0001618; GO:0001945; GO:0002042; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007267; GO:0007411; GO:0008284; GO:0009653; GO:0009887; GO:0010839; GO:0010977; GO:0031295; GO:0046875; GO:0048013; GO:0048514; GO:0048845; GO:0050920; GO:0072178; GO:0098685; GO:0098978; GO:0099054; GO:0099056; GO:0099061; GO:0099072; GO:0099149; GO:1901216; GO:1903849; GO:2000727	focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; ephrin receptor binding [GO:0046875]; virus receptor activity [GO:0001618]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell signaling [GO:0007267]; ephrin receptor signaling pathway [GO:0048013]; lymph vessel development [GO:0001945]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron projection development [GO:0010977]; nephric duct morphogenesis [GO:0072178]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron death [GO:1901216]; presynapse assembly [GO:0099054]; regulation of chemotaxis [GO:0050920]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; T cell costimulation [GO:0031295]; venous blood vessel morphogenesis [GO:0048845]	EFNB2 EPLG5 HTKL LERK5
NM_005573		P20700	LMNB1_HUMAN	Lamin-B1	GO:0005198; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005654; GO:0016020; GO:0016363; GO:0031965; GO:0035722; GO:0043274; GO:1990837	lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural molecule activity [GO:0005198]; interleukin-12-mediated signaling pathway [GO:0035722]	LMNB1 LMN2 LMNB
NM_001034173		B4DTU7	B4DTU7_HUMAN	10-formyltetrahydrofolate dehydrogenase (EC 1.5.1.6)	GO:0005737; GO:0006730; GO:0009058; GO:0009258; GO:0016155; GO:0016620; GO:0016742	cytoplasm [GO:0005737]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730]	
NM_001034173	NM_001034173 -> Q3SY69-1	Q3SY69	AL1L2_HUMAN	Mitochondrial 10-formyltetrahydrofolate dehydrogenase (Mitochondrial 10-FTHFDH) (mtFDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L2)	GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0006730; GO:0009058; GO:0009258; GO:0016155; GO:0016742; GO:0046655; GO:0070062	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]	ALDH1L2
NM_022836		Q9H816	DCR1B_HUMAN	5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) (SNMIB) (hSNM1B)	GO:0000723; GO:0000781; GO:0000784; GO:0003684; GO:0005654; GO:0005737; GO:0005813; GO:0006303; GO:0007093; GO:0008409; GO:0010833; GO:0016233; GO:0016604; GO:0031627; GO:0031848; GO:0031860; GO:0035312; GO:0036297; GO:0042803; GO:0044877	centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; mitotic cell cycle checkpoint [GO:0007093]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]	DCLRE1B SNM1B
NM_015480	NM_015480 -> Q9NQS3-1	Q9NQS3	NECT3_HUMAN	Nectin-3 (CDw113) (Nectin cell adhesion molecule 3) (Poliovirus receptor-related protein 3) (CD antigen CD113)	GO:0002089; GO:0005886; GO:0005911; GO:0005913; GO:0007156; GO:0007157; GO:0007286; GO:0009566; GO:0030424; GO:0030425; GO:0034332; GO:0038023; GO:0042802; GO:0042803; GO:0043296; GO:0044291; GO:0050839; GO:0060042; GO:0061951; GO:0098686; GO:0099061; GO:1902414	apical junction complex [GO:0043296]; axon [GO:0030424]; cell-cell adherens junction [GO:0005913]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; adherens junction organization [GO:0034332]; establishment of protein localization to plasma membrane [GO:0061951]; fertilization [GO:0009566]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; retina morphogenesis in camera-type eye [GO:0060042]; spermatid development [GO:0007286]	NECTIN3 PRR3 PVRL3
NM_013296		A0A024R0F8	A0A024R0F8_HUMAN	G-protein signalling modulator 2 (AGS3-like, C. elegans), isoform CRA_a	GO:0001965; GO:0005092; GO:0005813; GO:0005829; GO:0097575	centrosome [GO:0005813]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]	GPSM2 hCG_39913
NM_013296		P81274	GPSM2_HUMAN	G-protein-signaling modulator 2 (Mosaic protein LGN)	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005623; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	cell [GO:0005623]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	GPSM2 LGN
NM_001159		Q06278	AOXA_HUMAN	Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-)	GO:0004031; GO:0004854; GO:0005506; GO:0005829; GO:0009055; GO:0009115; GO:0017144; GO:0042802; GO:0042803; GO:0042816; GO:0043546; GO:0050660; GO:0051287; GO:0051537; GO:0055114; GO:0070062; GO:0071949; GO:0102797; GO:0102798	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; vitamin B6 metabolic process [GO:0042816]; xanthine catabolic process [GO:0009115]	AOX1 AO
NM_007349	NM_007349 -> Q6ZW49-6	Q6ZW49	PAXI1_HUMAN	PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein)	GO:0000416; GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006303; GO:0006310; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035066; GO:0035097; GO:0043433; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0051568; GO:0051571; GO:0060261; GO:0060612; GO:0060717; GO:1902749; GO:2001022	chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adipose tissue development [GO:0060612]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]	PAXIP1 PAXIP1L PTIP CAGF28
NM_021066		Q99878	H2A1J_HUMAN	Histone H2A type 1-J (Histone H2A/e)	GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0006325; GO:0046982; GO:0070062	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]	H2AC14 H2AFE HIST1H2AJ
NM_006088		P68371	TBB4B_HUMAN	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	GO:0000086; GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005874; GO:0007017; GO:0010389; GO:0035578; GO:0042267; GO:0042288; GO:0043312; GO:0051082; GO:0070062; GO:0097711; GO:1903561	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; microtubule [GO:0005874]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; MHC class I protein binding [GO:0042288]; structural constituent of cytoskeleton [GO:0005200]; unfolded protein binding [GO:0051082]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; natural killer cell mediated cytotoxicity [GO:0042267]; neutrophil degranulation [GO:0043312]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	TUBB4B TUBB2C
NM_001076786		B3KWV1	B3KWV1_HUMAN	cDNA FLJ43914 fis, clone TESTI4011161, weakly similar to Proline-rich protein 12			
NM_001076786		Q2KHR3	QSER1_HUMAN	Glutamine and serine-rich protein 1			QSER1
NM_001136218		A0A024QZ97	A0A024QZ97_HUMAN	Transmembrane protein 51, isoform CRA_b	GO:0016021	integral component of membrane [GO:0016021]	TMEM51 hCG_25381
NM_001136218		Q9NW97	TMM51_HUMAN	Transmembrane protein 51	GO:0016021	integral component of membrane [GO:0016021]	TMEM51 C1orf72
NM_006502		A0A024RD62	A0A024RD62_HUMAN	Polymerase (DNA directed), eta, isoform CRA_b	GO:0003684; GO:0003887; GO:0005654; GO:0005829; GO:0006290; GO:0006301; GO:0071494	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; cellular response to UV-C [GO:0071494]; postreplication repair [GO:0006301]; pyrimidine dimer repair [GO:0006290]	POLH hCG_18996
NM_006502	NM_006502 -> Q9Y253-1	Q9Y253	POLH_HUMAN	DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)	GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0019985; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]; translesion synthesis [GO:0019985]	POLH RAD30 RAD30A XPV
NM_020733	NM_020733 -> Q9ULI3-1	Q9ULI3	HEG1_HUMAN	Protein HEG homolog 1	GO:0001570; GO:0001701; GO:0001886; GO:0001945; GO:0003017; GO:0003209; GO:0003222; GO:0003281; GO:0005509; GO:0005576; GO:0005911; GO:0007043; GO:0007507; GO:0009791; GO:0009897; GO:0016021; GO:0030324; GO:0035024; GO:0035264; GO:0048845; GO:0050878; GO:0055017; GO:0060039; GO:0090271; GO:1902414; GO:1905709; GO:2000299	cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction assembly [GO:0007043]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222]	HEG1 KIAA1237
NM_080818		B2R986	B2R986_HUMAN	HCG1774561 (Oxoglutarate receptor 1) (cDNA FLJ16066 fis, clone TRACH2006387, highly similar to 2-oxoglutarate receptor 1) (cDNA, FLJ94273, Homo sapiens G protein-coupled receptor 80 (GPR80), mRNA)	GO:0004930; GO:0005886; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	hCG_1774561
NM_080818		Q96P68	OXGR1_HUMAN	2-oxoglutarate receptor 1 (Alpha-ketoglutarate receptor 1) (G-protein coupled receptor 80) (G-protein coupled receptor 99) (P2Y purinoceptor 15) (P2Y15) (P2Y-like GPCR) (P2Y-like nucleotide receptor)	GO:0004930; GO:0005886; GO:0007186; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]	OXGR1 GPR80 GPR99 P2RY15 P2Y15
NM_024913	NM_024913 -> A4D0V7-1	A4D0V7	CPED1_HUMAN	Cadherin-like and PC-esterase domain-containing protein 1	GO:0005783	endoplasmic reticulum [GO:0005783]	CPED1 C7orf58 UNQ9432/PRO34713
NM_024734		Q6NUQ2	Q6NUQ2_HUMAN	Calmin (Calponin-like, transmembrane)	GO:0003779; GO:0016021	integral component of membrane [GO:0016021]; actin binding [GO:0003779]	CLMN
NM_024734		Q96JQ2	CLMN_HUMAN	Calmin (Calponin-like transmembrane domain protein)	GO:0005623; GO:0005640; GO:0005737; GO:0007097; GO:0008285; GO:0016021; GO:0031175; GO:0034993; GO:0051015; GO:0051647; GO:0090286	cell [GO:0005623]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear outer membrane [GO:0005640]; actin filament binding [GO:0051015]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; negative regulation of cell population proliferation [GO:0008285]; neuron projection development [GO:0031175]; nuclear migration [GO:0007097]; nucleus localization [GO:0051647]	CLMN KIAA1188
NM_001080512	NM_001080512 -> Q9H694-1	Q9H694	BICC1_HUMAN	Protein bicaudal C homolog 1 (Bic-C)	GO:0003723; GO:0005737; GO:0007368; GO:0007507; GO:0090090	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; negative regulation of canonical Wnt signaling pathway [GO:0090090]	BICC1
NM_001012267	NM_001012267 -> Q6IPU0-1	Q6IPU0	CENPP_HUMAN	Centromere protein P (CENP-P)	GO:0000775; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0034080	chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; CENP-A containing nucleosome assembly [GO:0034080]	CENPP
NM_001130415	NM_001130415 -> Q96LR9-1	Q96LR9	APLD1_HUMAN	Apolipoprotein L domain-containing protein 1 (Vascular early response gene protein)	GO:0001525; GO:0001666; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006869; GO:0008289; GO:0016021; GO:0030154; GO:0042118; GO:0042157; GO:0045601	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; endothelial cell activation [GO:0042118]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; regulation of endothelial cell differentiation [GO:0045601]; response to hypoxia [GO:0001666]	APOLD1 VERGE
NM_003389		A0A024R150	A0A024R150_HUMAN	Coronin	GO:0017053; GO:0051015	transcriptional repressor complex [GO:0017053]; actin filament binding [GO:0051015]	CORO2A hCG_29944
NM_003389		A8K9S3	A8K9S3_HUMAN	Coronin	GO:0017053; GO:0051015	transcriptional repressor complex [GO:0017053]; actin filament binding [GO:0051015]	
NM_003389		Q92828	COR2A_HUMAN	Coronin-2A (IR10) (WD repeat-containing protein 2)	GO:0017053; GO:0035556; GO:0051015	transcriptional repressor complex [GO:0017053]; actin filament binding [GO:0051015]; intracellular signal transduction [GO:0035556]	CORO2A IR10 WDR2
NM_032777		Q6YN44	Q6YN44_HUMAN	Tumor endothelial marker 5 (Fragment)			TEM5
NM_032777	NM_032777 -> Q96PE1-1	Q96PE1	AGRA2_HUMAN	Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124) (Tumor endothelial marker 5)	GO:0002040; GO:0004930; GO:0005886; GO:0007186; GO:0007417; GO:0009986; GO:0010595; GO:0016021; GO:0016055; GO:0030175; GO:0043542; GO:0045765; GO:0050920; GO:0090210; GO:0090263; GO:1900747; GO:1990909	cell surface [GO:0009986]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; G protein-coupled receptor activity [GO:0004930]; central nervous system development [GO:0007417]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]; regulation of chemotaxis [GO:0050920]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	ADGRA2 GPR124 KIAA1531 TEM5
NM_000135	NM_000135 -> O15360-1	O15360	FANCA_HUMAN	Fanconi anemia group A protein (Protein FACA)	GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0007140; GO:0008584; GO:0008585; GO:0036297; GO:0042127; GO:0043240; GO:0045589; GO:0050727; GO:0051090; GO:0065003; GO:2000348	cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]	FANCA FAA FACA FANCH
NM_213596		A6H901	A6H901_HUMAN	FOXN4 protein	GO:0003700; GO:0005634; GO:0043565	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]	FOXN4
NM_213596	NM_213596 -> Q96NZ1-1	Q96NZ1	FOXN4_HUMAN	Forkhead box protein N4	GO:0000790; GO:0000981; GO:0001158; GO:0001947; GO:0003682; GO:0003700; GO:0005634; GO:0006355; GO:0008016; GO:0010842; GO:0035881; GO:0036302; GO:0045893; GO:0060579	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; heart looping [GO:0001947]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of heart contraction [GO:0008016]; regulation of transcription, DNA-templated [GO:0006355]; retina layer formation [GO:0010842]; ventral spinal cord interneuron fate commitment [GO:0060579]	FOXN4
NM_005964	NM_005964 -> P35580-1	P35580	MYH10_HUMAN	Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)	GO:0000146; GO:0000281; GO:0001701; GO:0001725; GO:0001764; GO:0001778; GO:0003279; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005844; GO:0005903; GO:0005938; GO:0006887; GO:0006930; GO:0007097; GO:0007155; GO:0007411; GO:0007512; GO:0008283; GO:0008360; GO:0016459; GO:0016460; GO:0016887; GO:0021592; GO:0021670; GO:0021678; GO:0021680; GO:0030027; GO:0030048; GO:0030426; GO:0030496; GO:0030898; GO:0031032; GO:0031594; GO:0032154; GO:0035613; GO:0035904; GO:0042641; GO:0043025; GO:0043197; GO:0043531; GO:0048027; GO:0050714; GO:0050885; GO:0051015; GO:0055003; GO:0055015; GO:0060041; GO:0060976; GO:0070062; GO:0097513; GO:0098885; GO:0098974; GO:0098978	actomyosin [GO:0042641]; brush border [GO:0005903]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; spindle [GO:0005819]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; modification of postsynaptic actin cytoskeleton [GO:0098885]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; positive regulation of protein secretion [GO:0050714]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of cell shape [GO:0008360]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration, cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015]	MYH10
NM_016354	NM_016354 -> Q96BD0-1	Q96BD0	SO4A1_HUMAN	Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)	GO:0005886; GO:0005887; GO:0015347; GO:0015349; GO:0043252	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; sodium-independent organic anion transport [GO:0043252]	SLCO4A1 OATP1 OATP4A1 OATPE SLC21A12
NM_012338		A0A024R740	A0A024R740_HUMAN	Tetraspanin	GO:0005887; GO:0007166; GO:0010842; GO:0045765	integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]; regulation of angiogenesis [GO:0045765]; retina layer formation [GO:0010842]	TSPAN12 hCG_33045
NM_012338	NM_012338 -> O95859-1	O95859	TSN12_HUMAN	Tetraspanin-12 (Tspan-12) (Tetraspan NET-2) (Transmembrane 4 superfamily member 12)	GO:0001525; GO:0005887; GO:0007166; GO:0010842; GO:0016020; GO:0016021; GO:0016055; GO:0045765	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; angiogenesis [GO:0001525]; cell surface receptor signaling pathway [GO:0007166]; regulation of angiogenesis [GO:0045765]; retina layer formation [GO:0010842]; Wnt signaling pathway [GO:0016055]	TSPAN12 NET2 TM4SF12 UNQ774/PRO1568
NM_145231	NM_145231 -> Q9BUY7-1	Q9BUY7	EFC11_HUMAN	EF-hand calcium-binding domain-containing protein 11	GO:0005509; GO:0019722	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]	EFCAB11 C14orf143
NM_004787	NM_004787 -> O94813-1	O94813	SLIT2_HUMAN	Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product]	GO:0001657; GO:0001933; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0005095; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0007411; GO:0008045; GO:0008201; GO:0009986; GO:0010593; GO:0010596; GO:0014912; GO:0016020; GO:0021836; GO:0021972; GO:0030308; GO:0030336; GO:0030837; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0048495; GO:0048754; GO:0048846; GO:0050772; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0060412; GO:0061364; GO:0070062; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]	SLIT2 SLIL3
NM_005257	NM_005257 -> Q92908-1	Q92908	GATA6_HUMAN	Transcription factor GATA-6 (GATA-binding factor 6)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001103; GO:0001701; GO:0001889; GO:0003148; GO:0003309; GO:0003310; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006366; GO:0006644; GO:0007493; GO:0007596; GO:0008134; GO:0008270; GO:0008584; GO:0014898; GO:0019901; GO:0030855; GO:0031965; GO:0032911; GO:0032912; GO:0035239; GO:0042493; GO:0043066; GO:0043627; GO:0044212; GO:0044267; GO:0045766; GO:0045892; GO:0045893; GO:0045944; GO:0048645; GO:0051145; GO:0051891; GO:0055007; GO:0060045; GO:0060430; GO:0060486; GO:0060510; GO:0060575; GO:0060947; GO:0070848; GO:0071158; GO:0071371; GO:0071456; GO:0071773; GO:0110024	nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; animal organ formation [GO:0048645]; blood coagulation [GO:0007596]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cellular protein metabolic process [GO:0044267]; cellular response to BMP stimulus [GO:0071773]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to hypoxia [GO:0071456]; club cell differentiation [GO:0060486]; endodermal cell fate determination [GO:0007493]; epithelial cell differentiation [GO:0030855]; in utero embryonic development [GO:0001701]; intestinal epithelial cell differentiation [GO:0060575]; liver development [GO:0001889]; lung saccule development [GO:0060430]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of transforming growth factor beta2 production [GO:0032912]; outflow tract septum morphogenesis [GO:0003148]; pancreatic A cell differentiation [GO:0003310]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to growth factor [GO:0070848]; smooth muscle cell differentiation [GO:0051145]; transcription by RNA polymerase II [GO:0006366]; tube morphogenesis [GO:0035239]; type B pancreatic cell differentiation [GO:0003309]; type II pneumocyte differentiation [GO:0060510]	GATA6
NM_020188		Q9NRP2	COXM2_HUMAN	COX assembly mitochondrial protein 2 homolog	GO:0005739	mitochondrion [GO:0005739]	CMC2 C16orf61 DC13
NM_022045	NM_022045 -> Q96DY7-1	Q96DY7	MTBP_HUMAN	Mdm2-binding protein (hMTBP)	GO:0000776; GO:0000785; GO:0007050; GO:0007089; GO:0008285; GO:0031396; GO:0034501; GO:0045839	chromatin [GO:0000785]; kinetochore [GO:0000776]; cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic nuclear division [GO:0045839]; protein localization to kinetochore [GO:0034501]; regulation of protein ubiquitination [GO:0031396]; traversing start control point of mitotic cell cycle [GO:0007089]	MTBP
NM_018132		Q7L2Z9	CENPQ_HUMAN	Centromere protein Q (CENP-Q)	GO:0000776; GO:0005623; GO:0005654; GO:0005829; GO:0015629; GO:0034080; GO:0051310; GO:1905342	actin cytoskeleton [GO:0015629]; cell [GO:0005623]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; CENP-A containing nucleosome assembly [GO:0034080]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]	CENPQ C6orf139
NM_003486		Q01650	LAT1_HUMAN	Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter)	GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0009986; GO:0015171; GO:0015179; GO:0015190; GO:0015196; GO:0015804; GO:0016020; GO:0016021; GO:0016323; GO:0042605; GO:0043231; GO:0050900; GO:0070062; GO:0098591; GO:1902475; GO:1904556; GO:1990184	amino acid transport complex [GO:1990184]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; peptide antigen binding [GO:0042605]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-tryptophan transmembrane transport [GO:1904556]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]	SLC7A5 CD98LC LAT1 MPE16
NM_018376		Q71RE8	Q71RE8_HUMAN	FP944			
NM_018376		Q9BS92	NPS3B_HUMAN	Protein NipSnap homolog 3B (NipSnap3B) (SNAP1)	GO:0005739	mitochondrion [GO:0005739]	NIPSNAP3B NIPSNAP3
NM_001102562	NM_001102562 -> A6NNE9-1	A6NNE9	MARHB_HUMAN	E3 ubiquitin-protein ligase MARCH11 (EC 2.3.2.27) (Membrane-associated RING finger protein 11) (Membrane-associated RING-CH protein XI) (MARCH-XI) (RING-type E3 ubiquitin transferase MARCH11)	GO:0008270; GO:0016021; GO:0016567; GO:0016740; GO:0030659	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]	MARCH11
NM_021244	NM_021244 -> Q9NQL2-1	Q9NQL2	RRAGD_HUMAN	Ras-related GTP-binding protein D (Rag D) (RagD)	GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005813; GO:0005829; GO:0007050; GO:0009267; GO:0010506; GO:0016241; GO:0019003; GO:0032008; GO:0034448; GO:0034613; GO:0046982; GO:0051020; GO:0071230; GO:0071233; GO:1904263; GO:1990131; GO:1990253	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein heterodimerization activity [GO:0046982]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]	RRAGD
NM_005270	NM_005270 -> P10070-5	P10070	GLI2_HUMAN	Zinc finger protein GLI2 (GLI family zinc finger protein 2) (Tax helper protein)	GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001649; GO:0001701; GO:0001822; GO:0002062; GO:0002076; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0007389; GO:0007411; GO:0007418; GO:0007442; GO:0007507; GO:0008134; GO:0008270; GO:0008283; GO:0009913; GO:0009952; GO:0009954; GO:0016020; GO:0016607; GO:0021508; GO:0021513; GO:0021517; GO:0021696; GO:0021775; GO:0021776; GO:0021938; GO:0021965; GO:0021983; GO:0030324; GO:0030879; GO:0030902; GO:0031514; GO:0032331; GO:0033089; GO:0035295; GO:0042475; GO:0042733; GO:0043066; GO:0043565; GO:0045666; GO:0045740; GO:0045893; GO:0045944; GO:0048566; GO:0048589; GO:0048666; GO:0048754; GO:0060032; GO:0060513; GO:0060603; GO:0060831; GO:0071407; GO:0090103; GO:0097542; GO:0097546; GO:0098586; GO:1990841	axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell population proliferation [GO:0008283]; cellular response to organic cyclic compound [GO:0071407]; cellular response to virus [GO:0098586]; cerebellar cortex morphogenesis [GO:0021696]; chondrocyte differentiation [GO:0002062]; cochlea morphogenesis [GO:0090103]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; floor plate formation [GO:0021508]; heart development [GO:0007507]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lung development [GO:0030324]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; notochord regression [GO:0060032]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pituitary gland development [GO:0021983]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostatic bud formation [GO:0060513]; proximal/distal pattern formation [GO:0009954]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord ventral commissure morphogenesis [GO:0021965]; tube development [GO:0035295]; ventral midline development [GO:0007418]; ventral spinal cord development [GO:0021517]	GLI2 THP
NM_005270		Q1PSW9	Q1PSW9_HUMAN	GLI2 transcription factor (Zinc finger protein GLI2) (Fragment)			GLI2
NM_005270		Q59FV5	Q59FV5_HUMAN	GLI-Kruppel family member GLI2 isoform beta variant (Fragment)	GO:0003676	nucleic acid binding [GO:0003676]	
NM_001809	NM_001809 -> P49450-1	P49450	CENPA_HUMAN	Histone H3-like centromeric protein A (Centromere autoantigen A) (Centromere protein A) (CENP-A)	GO:0000132; GO:0000281; GO:0000775; GO:0000778; GO:0000780; GO:0000788; GO:0000939; GO:0003677; GO:0003682; GO:0005623; GO:0005634; GO:0005654; GO:0005829; GO:0016032; GO:0031618; GO:0034080; GO:0046982; GO:0051382; GO:0071459	cell [GO:0005623]; chromosome, centromeric region [GO:0000775]; condensed chromosome inner kinetochore [GO:0000939]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome, centromeric region [GO:0000780]; cytosol [GO:0005829]; nuclear nucleosome [GO:0000788]; nuclear pericentric heterochromatin [GO:0031618]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; CENP-A containing nucleosome assembly [GO:0034080]; establishment of mitotic spindle orientation [GO:0000132]; kinetochore assembly [GO:0051382]; mitotic cytokinesis [GO:0000281]; protein localization to chromosome, centromeric region [GO:0071459]; viral process [GO:0016032]	CENPA
NM_006371		O75718	CRTAP_HUMAN	Cartilage-associated protein	GO:0005615; GO:0005783; GO:0005788; GO:0007283; GO:0018400; GO:0032991; GO:0050821; GO:0061077; GO:1901874	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; chaperone-mediated protein folding [GO:0061077]; negative regulation of post-translational protein modification [GO:1901874]; peptidyl-proline hydroxylation to 3-hydroxy-L-proline [GO:0018400]; protein stabilization [GO:0050821]; spermatogenesis [GO:0007283]	CRTAP CASP
NM_003054	NM_003054 -> Q05940-1	Q05940	VMAT2_HUMAN	Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2)	GO:0001975; GO:0005335; GO:0005813; GO:0005886; GO:0005887; GO:0006836; GO:0007268; GO:0007269; GO:0007626; GO:0008021; GO:0008504; GO:0009791; GO:0015842; GO:0015844; GO:0015872; GO:0016020; GO:0030672; GO:0042137; GO:0043195; GO:0043231; GO:0070083; GO:0098691; GO:0098700; GO:1903427	centrosome [GO:0005813]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; chemical synaptic transmission [GO:0007268]; dopamine transport [GO:0015872]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter secretion [GO:0007269]; neurotransmitter transport [GO:0006836]; post-embryonic development [GO:0009791]; response to amphetamine [GO:0001975]; sequestering of neurotransmitter [GO:0042137]	SLC18A2 SVMT VMAT2
NM_002214	NM_002214 -> P26012-1	P26012	ITB8_HUMAN	Integrin beta-8	GO:0001570; GO:0001573; GO:0005178; GO:0005886; GO:0007155; GO:0007229; GO:0008305; GO:0009986; GO:0010628; GO:0010629; GO:0016477; GO:0030198; GO:0033627; GO:0034686; GO:0038023; GO:0045766; GO:0051216; GO:0060674; GO:0070062; GO:1901388; GO:1990430	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; extracellular matrix protein binding [GO:1990430]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; extracellular matrix organization [GO:0030198]; ganglioside metabolic process [GO:0001573]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of gene expression [GO:0010629]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; regulation of transforming growth factor beta activation [GO:1901388]; vasculogenesis [GO:0001570]	ITGB8
NM_002214		Q9BUG9	Q9BUG9_HUMAN	Integrin beta	GO:0007160; GO:0007229; GO:0008305; GO:0038023	integrin complex [GO:0008305]; signaling receptor activity [GO:0038023]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]	ITGB8 hCG_37311
NM_182920	NM_182920 -> Q9P2N4-3	Q9P2N4	ATS9_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-)	GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0006516; GO:0007275; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192]	ADAMTS9 KIAA1312
NM_002223	NM_002223 -> Q14571-1	Q14571	ITPR2_HUMAN	Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor)	GO:0001666; GO:0005220; GO:0005509; GO:0005623; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0005938; GO:0007165; GO:0015085; GO:0016020; GO:0016021; GO:0016529; GO:0030168; GO:0030659; GO:0030667; GO:0031095; GO:0033017; GO:0035091; GO:0043235; GO:0050796; GO:0051209; GO:0070679; GO:0071320; GO:0071361; GO:0097110; GO:1903779	cell [GO:0005623]; cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; scaffold protein binding [GO:0097110]; cellular response to cAMP [GO:0071320]; cellular response to ethanol [GO:0071361]; platelet activation [GO:0030168]; regulation of cardiac conduction [GO:1903779]; regulation of insulin secretion [GO:0050796]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]	ITPR2
NM_018012	NM_018012 -> Q2KJY2-1	Q2KJY2	KI26B_HUMAN	Kinesin-like protein KIF26B	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0008017; GO:0008574; GO:0022409; GO:0030010; GO:0072092	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092]	KIF26B
NM_018186		A0A024R922	A0A024R922_HUMAN	Chromosome 1 open reading frame 112, isoform CRA_a			C1orf112 hCG_38012
NM_018186		Q9NSG2	CA112_HUMAN	Uncharacterized protein C1orf112			C1orf112
NM_153026		A0A024R0W7	A0A024R0W7_HUMAN	Prickle-like 1 (Drosophila), isoform CRA_a	GO:0005634; GO:0008270; GO:0035904; GO:0060976	nucleus [GO:0005634]; zinc ion binding [GO:0008270]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]	PRICKLE1 hCG_39446
NM_153026		Q96MT3	PRIC1_HUMAN	Prickle-like protein 1 (REST/NRSF-interacting LIM domain protein 1)	GO:0001843; GO:0005634; GO:0005829; GO:0006606; GO:0008270; GO:0031398; GO:0031965; GO:0032436; GO:0035904; GO:0045892; GO:0060071; GO:0060976; GO:0090090; GO:2000691	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell myoblast differentiation [GO:2000691]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	PRICKLE1 RILP
NM_001033723		Q6ZNC4	ZN704_HUMAN	Zinc finger protein 704	GO:0001158; GO:0005634; GO:0006357; GO:0046872	nucleus [GO:0005634]; enhancer sequence-specific DNA binding [GO:0001158]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]	ZNF704
NM_032173	NM_032173 -> Q9ULT6-2	Q9ULT6	ZNRF3_HUMAN	E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING finger protein 203) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3)	GO:0004842; GO:0005109; GO:0005886; GO:0005887; GO:0006511; GO:0016055; GO:0016567; GO:0038018; GO:0046872; GO:0060173; GO:0061630; GO:0072089; GO:0090090; GO:2000051; GO:2000095	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein ubiquitination [GO:0016567]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]	ZNRF3 KIAA1133 RNF203
NM_006519		P63172	DYLT1_HUMAN	Dynein light chain Tctex-type 1 (Protein CW-1) (T-complex testis-specific protein 1 homolog)	GO:0000132; GO:0003774; GO:0005576; GO:0005623; GO:0005739; GO:0005794; GO:0005819; GO:0005868; GO:0005881; GO:0008022; GO:0008277; GO:0010976; GO:0016358; GO:0019060; GO:0030027; GO:0034774; GO:0035022; GO:0035795; GO:0042802; GO:0043025; GO:0043087; GO:0043312; GO:0043657; GO:0044295; GO:0046718; GO:0048812; GO:0050768; GO:0051301; GO:0051493; GO:0060548; GO:0061564; GO:0075521; GO:0099503; GO:1904813	axonal growth cone [GO:0044295]; cell [GO:0005623]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory granule lumen [GO:0034774]; secretory vesicle [GO:0099503]; spindle [GO:0005819]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]; axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular transport of viral protein in host cell [GO:0019060]; microtubule-dependent intracellular transport of viral material towards nucleus [GO:0075521]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087]; viral entry into host cell [GO:0046718]	DYNLT1 TCTEL1 TCTEX-1 TCTEX1
NM_000947	NM_000947 -> P49643-1	P49643	PRI2_HUMAN	DNA primase large subunit (EC 2.7.7.-) (DNA primase 58 kDa subunit) (p58)	GO:0000082; GO:0003677; GO:0003896; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0032201; GO:0046872; GO:0051539	alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201]	PRIM2 PRIM2A
NM_024096		Q9H773	DCTP1_HUMAN	dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein)	GO:0000287; GO:0005634; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143]	DCTPP1 XTP3TPA CDA03
NM_014985	NM_014985 -> O94986-3	O94986	CE152_HUMAN	Centrosomal protein of 152 kDa (Cep152)	GO:0000086; GO:0000242; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0010389; GO:0019901; GO:0051298; GO:0097711; GO:0098535; GO:0098536	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; protein kinase binding [GO:0019901]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	CEP152 KIAA0912
NM_014985		Q3B7A2	Q3B7A2_HUMAN	CEP152 protein (Fragment)	GO:0005815; GO:0007099; GO:0098535; GO:0098536	deuterosome [GO:0098536]; microtubule organizing center [GO:0005815]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]	CEP152
NM_032270		Q8TDW0	LRC8C_HUMAN	Volume-regulated anion channel subunit LRRC8C (Factor for adipocyte differentiation 158) (Leucine-rich repeat-containing protein 8C)	GO:0005225; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0015734; GO:0015810; GO:0016020; GO:0034214; GO:0034702; GO:0045444; GO:0055085; GO:0071470; GO:0098656	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular response to osmotic stress [GO:0071470]; fat cell differentiation [GO:0045444]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734]; transmembrane transport [GO:0055085]	LRRC8C AD158 FAD158
NM_005261		A0A024R9F5	A0A024R9F5_HUMAN	GTP-binding protein	GO:0003924; GO:0005525; GO:0005634; GO:0007165; GO:0016020; GO:1901842	membrane [GO:0016020]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]	GEM hCG_21652
NM_005261		P55040	GEM_HUMAN	GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR)	GO:0000278; GO:0000287; GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005623; GO:0005634; GO:0005886; GO:0006955; GO:0007165; GO:0007166; GO:0009898; GO:0019003; GO:0030496; GO:0051233; GO:0051276; GO:0051310; GO:0072686; GO:1901842	cell [GO:0005623]; cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]	GEM KIR
NM_006379	NM_006379 -> Q99985-1	Q99985	SEM3C_HUMAN	Semaphorin-3C (Semaphorin-E) (Sema E)	GO:0001755; GO:0001756; GO:0001974; GO:0003148; GO:0003215; GO:0003350; GO:0005615; GO:0005887; GO:0006955; GO:0007411; GO:0009791; GO:0021915; GO:0030215; GO:0030335; GO:0042493; GO:0045499; GO:0048843; GO:0050919; GO:0060174; GO:0060666; GO:0070062; GO:0071526; GO:0140074; GO:1905312	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; blood vessel remodeling [GO:0001974]; cardiac endothelial to mesenchymal transition [GO:0140074]; cardiac right ventricle morphogenesis [GO:0003215]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; immune response [GO:0006955]; limb bud formation [GO:0060174]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neural tube development [GO:0021915]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell migration [GO:0030335]; post-embryonic development [GO:0009791]; pulmonary myocardium development [GO:0003350]; response to drug [GO:0042493]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756]	SEMA3C SEMAE
NM_003564		A0A384MTL2	A0A384MTL2_HUMAN	Transgelin			
NM_003564	NM_003564 -> P37802-1	P37802	TAGL2_HUMAN	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	GO:0002576; GO:0005576; GO:0005829; GO:0030855; GO:0031982; GO:0045296; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epithelial cell differentiation [GO:0030855]; platelet degranulation [GO:0002576]	TAGLN2 KIAA0120 CDABP0035
NM_001098816		Q6N022	TEN4_HUMAN	Teneurin-4 (Ten-4) (Protein Odd Oz/ten-m homolog 4) (Tenascin-M4) (Ten-m4) (Teneurin transmembrane protein 4)	GO:0001702; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007157; GO:0007165; GO:0031641; GO:0031643; GO:0032289; GO:0042803; GO:0043005; GO:0046982; GO:0048666; GO:0048714; GO:0050839; GO:0060038; GO:0060912; GO:2000543	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cardiac cell fate specification [GO:0060912]; cardiac muscle cell proliferation [GO:0060038]; central nervous system myelin formation [GO:0032289]; gastrulation with mouth forming second [GO:0001702]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron development [GO:0048666]; positive regulation of gastrulation [GO:2000543]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165]	TENM4 KIAA1302 ODZ4 TNM4
NM_001814	NM_001814 -> P53634-1	P53634	CATC_HUMAN	Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]	GO:0000139; GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006888; GO:0006955; GO:0007568; GO:0008234; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043312; GO:0043621; GO:0048208; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]	CTSC CPPI
NM_024949	NM_024949 -> Q6AWC2-1	Q6AWC2	WWC2_HUMAN	Protein WWC2 (BH-3-only member B) (WW domain-containing protein 2)	GO:0000122; GO:0005829; GO:0019900; GO:0035331; GO:0046621; GO:0060090	cytosol [GO:0005829]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]	WWC2 BOMB
NM_031293	NM_031293 -> Q8TBY8-2	Q8TBY8	PMFBP_HUMAN	Polyamine-modulated factor 1-binding protein 1 (PMF-1-binding protein)	GO:0005737; GO:0007283; GO:0097224	cytoplasm [GO:0005737]; sperm connecting piece [GO:0097224]; spermatogenesis [GO:0007283]	PMFBP1
NM_006810	NM_006810 -> Q14554-1	Q14554	PDIA5_HUMAN	Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)	GO:0003756; GO:0005623; GO:0005788; GO:0005789; GO:0006457; GO:0015037; GO:0016491; GO:0036498; GO:0045454; GO:0055114	cell [GO:0005623]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; IRE1-mediated unfolded protein response [GO:0036498]; oxidation-reduction process [GO:0055114]; protein folding [GO:0006457]	PDIA5 PDIR
NM_020401	NM_020401 -> P57740-1	P57740	NU107_HUMAN	Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107)	GO:0000777; GO:0000973; GO:0005635; GO:0005643; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0008585; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031080; GO:0031965; GO:0034399; GO:0043657; GO:0051292; GO:0060964; GO:0072006; GO:0075733; GO:1900034	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; female gonad development [GO:0008585]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	NUP107
NM_030925		A0A024RDT3	A0A024RDT3_HUMAN	Calcium binding protein 39-like, isoform CRA_a			CAB39L hCG_30046
NM_030925		Q86WE6	Q86WE6_HUMAN	Sarcoma antigen NY-SAR-79 (Fragment)			
NM_030925		Q9H9S4	CB39L_HUMAN	Calcium-binding protein 39-like (Antigen MLAA-34) (MO25beta) (Mo25-like protein)	GO:0005829; GO:0007050; GO:0023014	cytosol [GO:0005829]; cell cycle arrest [GO:0007050]; signal transduction by protein phosphorylation [GO:0023014]	CAB39L
NM_012242		I1W660	I1W660_HUMAN	Dickkopf-like protein 1	GO:0000122; GO:0000904; GO:0001706; GO:0001707; GO:0001942; GO:0005576; GO:0010628; GO:0010977; GO:0030279; GO:0030326; GO:0030514; GO:0030900; GO:0032526; GO:0043066; GO:0051966; GO:0060325; GO:0061743; GO:0090082; GO:0090244; GO:0090647; GO:1902949; GO:1904958; GO:1905607	extracellular region [GO:0005576]; cell morphogenesis involved in differentiation [GO:0000904]; embryonic limb morphogenesis [GO:0030326]; endoderm formation [GO:0001706]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; hair follicle development [GO:0001942]; mesoderm formation [GO:0001707]; modulation of age-related behavioral decline [GO:0090647]; motor learning [GO:0061743]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of presynapse assembly [GO:1905607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of midbrain dopaminergic neuron differentiation [GO:1904958]; positive regulation of tau-protein kinase activity [GO:1902949]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to retinoic acid [GO:0032526]; Wnt signaling pathway involved in somitogenesis [GO:0090244]	DKK1
NM_012242		O94907	DKK1_HUMAN	Dickkopf-related protein 1 (Dickkopf-1) (Dkk-1) (hDkk-1) (SK)	GO:0000122; GO:0000904; GO:0001706; GO:0001707; GO:0001942; GO:0002090; GO:0005576; GO:0005615; GO:0005886; GO:0007611; GO:0008083; GO:0010628; GO:0010942; GO:0010977; GO:0030178; GO:0030279; GO:0030326; GO:0030514; GO:0030900; GO:0031901; GO:0032091; GO:0032526; GO:0033137; GO:0039706; GO:0042662; GO:0042663; GO:0043066; GO:0043507; GO:0045813; GO:0048019; GO:0050750; GO:0051966; GO:0060173; GO:0060325; GO:0060394; GO:0061743; GO:0090082; GO:0090090; GO:0090244; GO:0090647; GO:0098883; GO:1901216; GO:1901296; GO:1902949; GO:1904338; GO:1904723; GO:1904958; GO:1905607; GO:2000096; GO:2000726	early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; co-receptor binding [GO:0039706]; growth factor activity [GO:0008083]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; cell morphogenesis involved in differentiation [GO:0000904]; embryonic limb morphogenesis [GO:0030326]; endoderm formation [GO:0001706]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; limb development [GO:0060173]; mesoderm formation [GO:0001707]; modulation of age-related behavioral decline [GO:0090647]; motor learning [GO:0061743]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901296]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of presynapse assembly [GO:1905607]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt-Frizzled-LRP5/6 complex assembly [GO:1904723]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of midbrain dopaminergic neuron differentiation [GO:1904958]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor internalization [GO:0002090]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to retinoic acid [GO:0032526]; synapse pruning [GO:0098883]; Wnt signaling pathway involved in somitogenesis [GO:0090244]	DKK1 UNQ492/PRO1008
NM_018323		Q8TCG2	P4K2B_HUMAN	Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta) (PI4KII-BETA)	GO:0004430; GO:0005524; GO:0005768; GO:0005802; GO:0005829; GO:0005886; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0046854	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]	PI4K2B
NM_024896		Q6ZMD3	Q6ZMD3_HUMAN	cDNA FLJ23992 fis, clone HRC08583	GO:0016021	integral component of membrane [GO:0016021]	
NM_024896	NM_024896 -> Q7Z2K6-1	Q7Z2K6	ERMP1_HUMAN	Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina)	GO:0005789; GO:0006508; GO:0008237; GO:0016020; GO:0016021; GO:0046872	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]	ERMP1 FXNA KIAA1815
NM_018124		Q6PCD5	RFWD3_HUMAN	E3 ubiquitin-protein ligase RFWD3 (EC 2.3.2.27) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201)	GO:0000724; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0010212; GO:0016567; GO:0016605; GO:0031052; GO:0031297; GO:0031571; GO:0036297; GO:0046872; GO:0090734; GO:0097371; GO:2000001	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; chromosome breakage [GO:0031052]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint [GO:0031571]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212]	RFWD3 RNF201
NM_013302		O00418	EF2K_HUMAN	Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)	GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:1990416; GO:1990637	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]	EEF2K
NM_001032283		A0A024RBE7	A0A024RBE7_HUMAN	Thymopoietin, isoform CRA_c	GO:0003677; GO:0016021; GO:0031965	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]	TMPO hCG_2015322
NM_001032283	NM_001032283 -> P42167-1	P42167	LAP2B_HUMAN	Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]	GO:0003677; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005737; GO:0016020; GO:0016021; GO:0031965	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; DNA binding [GO:0003677]; lamin binding [GO:0005521]	TMPO LAP2
NM_001032283		Q59G12	Q59G12_HUMAN	Lamina-associated polypeptide 2, isoforms beta/gamma variant (Fragment)	GO:0003677; GO:0016021	integral component of membrane [GO:0016021]; DNA binding [GO:0003677]	
NM_004075		A2I2P0	A2I2P0_HUMAN	Cryptochrome 1 (Photolyase-like), isoform CRA_a (Photolyase-like cryptochrome 1) (cDNA FLJ76110, highly similar to Homo sapiens cryptochrome 1 (CRY1), mRNA)	GO:0000122; GO:0005634; GO:0005739; GO:0006094; GO:0006975; GO:0014823; GO:0016829; GO:0019901; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0035257; GO:0042593; GO:0042754; GO:0042826; GO:0043153; GO:0045721; GO:0045744; GO:0070888; GO:2000001; GO:2000323; GO:2000850	mitochondrion [GO:0005739]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; lyase activity [GO:0016829]; nuclear hormone receptor binding [GO:0035257]; protein kinase binding [GO:0019901]; circadian regulation of gene expression [GO:0032922]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]	CRY1 hCG_1811683
NM_004075		Q16526	CRY1_HUMAN	Cryptochrome-1	GO:0000122; GO:0000166; GO:0003677; GO:0003690; GO:0005634; GO:0005739; GO:0006094; GO:0006975; GO:0007623; GO:0009416; GO:0009785; GO:0009882; GO:0014823; GO:0018298; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0035257; GO:0042593; GO:0042752; GO:0042754; GO:0042826; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:0070888; GO:2000001; GO:2000323; GO:2000850	mitochondrion [GO:0005739]; nucleus [GO:0005634]; blue light photoreceptor activity [GO:0009882]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; nuclear hormone receptor binding [GO:0035257]; nucleotide binding [GO:0000166]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]	CRY1 PHLL1
NM_012137		B1AKK2	B1AKK2_HUMAN	Dimethylarginine dimethylaminohydrolase 1, isoform CRA_b (Epididymis secretory protein Li 16) (cDNA, FLJ92778, Homo sapiens dimethylarginine dimethylaminohydrolase 1 (DDAH1), mRNA)	GO:0000052; GO:0003073; GO:0006527; GO:0016403; GO:0016597; GO:0045429; GO:0045766	amino acid binding [GO:0016597]; dimethylargininase activity [GO:0016403]; arginine catabolic process [GO:0006527]; citrulline metabolic process [GO:0000052]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of systemic arterial blood pressure [GO:0003073]	DDAH1 HEL-S-16 hCG_2040048
NM_012137	NM_012137 -> O94760-1	O94760	DDAH1_HUMAN	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)	GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006525; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]	DDAH1 DDAH
NM_006240		A0A024RBZ9	A0A024RBZ9_HUMAN	Serine/threonine-protein phosphatase with EF-hands (EC 3.1.3.16)	GO:0004721; GO:0005506; GO:0005509; GO:0030145; GO:0050906	calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; phosphoprotein phosphatase activity [GO:0004721]; detection of stimulus involved in sensory perception [GO:0050906]	PPEF1 hCG_19579
NM_006240	NM_006240 -> O14829-1	O14829	PPE1_HUMAN	Serine/threonine-protein phosphatase with EF-hands 1 (PPEF-1) (EC 3.1.3.16) (Protein phosphatase with EF calcium-binding domain) (PPEF) (Serine/threonine-protein phosphatase 7) (PP7)	GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0006470; GO:0022400; GO:0030145; GO:0050906	cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; detection of stimulus involved in sensory perception [GO:0050906]; protein dephosphorylation [GO:0006470]; regulation of rhodopsin mediated signaling pathway [GO:0022400]	PPEF1 PPEF PPP7C
NM_173216	NM_173216 -> P15907-1	P15907	SIAT1_HUMAN	Beta-galactoside alpha-2,6-sialyltransferase 1 (Alpha 2,6-ST 1) (EC 2.4.99.1) (B-cell antigen CD75) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1) (ST6Gal I) (ST6GalI) (Sialyltransferase 1)	GO:0000139; GO:0003835; GO:0005576; GO:0006054; GO:0006959; GO:0008373; GO:0016021; GO:0016266; GO:0018279; GO:0032580; GO:0042803; GO:0097503	extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373]; humoral immune response [GO:0006959]; N-acetylneuraminate metabolic process [GO:0006054]; O-glycan processing [GO:0016266]; protein N-linked glycosylation via asparagine [GO:0018279]; sialylation [GO:0097503]	ST6GAL1 SIAT1
NM_199249		A0A024R4G9	A0A024R4G9_HUMAN	Chromosome 19 open reading frame 48 (Multidrug resistance-related protein, isoform CRA_a)			MGC13170 C19orf48 hCG_2008493
NM_199249		Q6RUI8	CS048_HUMAN	Uncharacterized protein C19orf48 (Multidrug resistance-related protein)			C19orf48
NM_007270		A7YQ73	A7YQ73_HUMAN	Peptidylprolyl isomerase (EC 5.2.1.8) (Fragment)	GO:0003755; GO:0005509	calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	FKBP9
NM_007270	NM_007270 -> O95302-1	O95302	FKBP9_HUMAN	Peptidyl-prolyl cis-trans isomerase FKBP9 (PPIase FKBP9) (EC 5.2.1.8) (63 kDa FK506-binding protein) (63 kDa FKBP) (FKBP-63) (FK506-binding protein 9) (FKBP-9) (Rotamase)	GO:0003755; GO:0005509; GO:0005783; GO:0006457	endoplasmic reticulum [GO:0005783]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]	FKBP9 FKBP60 FKBP63
NM_014629	NM_014629 -> O15013-5	O15013	ARHGA_HUMAN	Rho guanine nucleotide exchange factor 10	GO:0005085; GO:0005089; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0030036; GO:0035023; GO:0051298; GO:0051496; GO:0090307; GO:0090630	centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]	ARHGEF10 KIAA0294
NM_014317	NM_014317 -> Q5T2R2-1	Q5T2R2	DPS1_HUMAN	Decaprenyl-diphosphate synthase subunit 1 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 1) (Decaprenyl pyrophosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1)	GO:0000010; GO:0005759; GO:0006744; GO:0008299; GO:0046872; GO:0046982; GO:0050347; GO:1990234	mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744]	PDSS1 DPS1 TPRT
NM_005845		A8K2Q2	A8K2Q2_HUMAN	cDNA FLJ77042, highly similar to Homo sapiens ATP-binding cassette, sub-family C (CFTR/MRP), member 4, mRNA	GO:0005524; GO:0016021; GO:0016887; GO:0042626	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]	
NM_005845	NM_005845 -> O15439-1	O15439	MRP4_HUMAN	Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B)	GO:0002576; GO:0005524; GO:0005886; GO:0009986; GO:0010243; GO:0014070; GO:0015562; GO:0015662; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0042493; GO:0042626; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0098591; GO:0140115	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; ion transmembrane transporter activity, phosphorylative mechanism [GO:0015662]; xenobiotic transmembrane transporter activity [GO:0042910]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; platelet degranulation [GO:0002576]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; transmembrane transport [GO:0055085]	ABCC4 MRP4
NM_001047160		Q5SQI5	Q5SQI5_HUMAN	Epididymis secretory sperm binding protein (Neuroepithelial cell transforming gene 1, isoform CRA_b) (cDNA FLJ50843, highly similar to Neuroepithelial cell-transforming gene 1 protein)	GO:0005089; GO:0035023; GO:0035556; GO:0051451	Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; regulation of Rho protein signal transduction [GO:0035023]	NET1 hCG_19072
NM_001047160	NM_001047160 -> Q7Z628-1	Q7Z628	ARHG8_HUMAN	Neuroepithelial cell-transforming gene 1 protein (Proto-oncogene p65 Net1) (Rho guanine nucleotide exchange factor 8)	GO:0001558; GO:0005085; GO:0005089; GO:0005634; GO:0005829; GO:0007165; GO:0007186; GO:0035023; GO:0035556; GO:0043065; GO:0043547; GO:0051056; GO:0051451; GO:0070301; GO:0071479	cytosol [GO:0005829]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; regulation of cell growth [GO:0001558]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	NET1 ARHGEF8
NM_206808	NM_206808 -> Q8N0X4-1	Q8N0X4	CLYBL_HUMAN	Citramalyl-CoA lyase, mitochondrial (EC 4.1.3.25) ((3S)-malyl-CoA thioesterase) (EC 3.1.2.30) (Beta-methylmalate synthase) (EC 2.3.3.-) (Citrate lyase subunit beta-like protein) (Citrate lyase beta-like) (Malate synthase) (EC 2.3.3.9)	GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064	mitochondrion [GO:0005739]; (3S)-citramalyl-CoA lyase activity [GO:0047777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064]	CLYBL CLB
NM_152653		A0A024R2Q2	A0A024R2Q2_HUMAN	Ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast), isoform CRA_a	GO:0005524; GO:0016740	ATP binding [GO:0005524]; transferase activity [GO:0016740]	UBE2E2 hCG_1995340
NM_152653		Q96LR5	UB2E2_HUMAN	Ubiquitin-conjugating enzyme E2 E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E2) (UbcH8) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2)	GO:0004842; GO:0005524; GO:0006974; GO:0032020; GO:0042296; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:1900087	ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]	UBE2E2 UBCH8
NM_173515	NM_173515 -> Q6P9H4-1	Q6P9H4	CNKR3_HUMAN	Connector enhancer of kinase suppressor of ras 3 (Connector enhancer of KSR 3) (CNK homolog protein 3) (CNK3) (CNKSR family member 3) (Maguin-like protein)	GO:0005737; GO:0010765; GO:0016324; GO:0033137; GO:0070373; GO:2000651	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]	CNKSR3 MAGI1
NM_001316		A0A384NKW7	A0A384NKW7_HUMAN	Epididymis secretory sperm binding protein	GO:0005634; GO:0006886; GO:0008536	nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; intracellular protein transport [GO:0006886]	
NM_001316	NM_001316 -> P55060-1	P55060	XPO2_HUMAN	Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter)	GO:0005049; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006611; GO:0008536; GO:0016020; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]	CSE1L CAS XPO2
NM_017516		Q14964	RB39A_HUMAN	Ras-related protein Rab-39A (Rab-39)	GO:0000139; GO:0003924; GO:0005525; GO:0005623; GO:0005764; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0030670; GO:0032482; GO:0045335; GO:0090383; GO:0090385	cell [GO:0005623]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; Rab protein signal transduction [GO:0032482]	RAB39A RAB39
NM_004099		A0A024R882	A0A024R882_HUMAN	Stomatin, isoform CRA_a	GO:0005739; GO:0005887; GO:0042803; GO:0044829; GO:0048471; GO:0090314; GO:1901585	integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; protein homodimerization activity [GO:0042803]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of acid-sensing ion channel activity [GO:1901585]	STOM hCG_30330
NM_004099	NM_004099 -> P27105-1	P27105	STOM_HUMAN	Erythrocyte band 7 integral membrane protein (Protein 7.2b) (Stomatin)	GO:0005615; GO:0005739; GO:0005783; GO:0005856; GO:0005886; GO:0005887; GO:0016020; GO:0031982; GO:0035577; GO:0035579; GO:0042470; GO:0042803; GO:0043312; GO:0044829; GO:0045121; GO:0048471; GO:0051260; GO:0070062; GO:0070063; GO:0070821; GO:0072562; GO:0090314; GO:1901585	azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]; neutrophil degranulation [GO:0043312]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; regulation of acid-sensing ion channel activity [GO:1901585]	STOM BND7 EPB72
NM_001827		P33552	CKS2_HUMAN	Cyclin-dependent kinases regulatory subunit 2 (CKS-2)	GO:0000307; GO:0003682; GO:0006357; GO:0007127; GO:0007346; GO:0008283; GO:0019005; GO:0019901; GO:0042393; GO:0043130; GO:0044772; GO:0051301; GO:0061575	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiosis I [GO:0007127]; mitotic cell cycle phase transition [GO:0044772]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]	CKS2
NM_001031746	NM_001031746 -> Q8IW00-1	Q8IW00	VSTM4_HUMAN	V-set and transmembrane domain-containing protein 4 [Cleaved into: Peptide Lv]	GO:0005576; GO:0005886; GO:0016021	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	VSTM4 C10orf72
NM_019558	NM_019558 -> P13378-1	P13378	HXD8_HUMAN	Homeobox protein Hox-D8 (Homeobox protein Hox-4E) (Homeobox protein Hox-5.4)	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0008595; GO:0045944; GO:0048705	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior axis specification, embryo [GO:0008595]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]	HOXD8 HOX4E
NM_003940		A0A0A6YZ17	A0A0A6YZ17_HUMAN	Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12)	GO:0004843; GO:0006511; GO:0008270; GO:0016579	thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	
NM_003940	NM_003940 -> Q92995-1	Q92995	UBP13_HUMAN	Ubiquitin carboxyl-terminal hydrolase 13 (EC 3.4.19.12) (Deubiquitinating enzyme 13) (Isopeptidase T-3) (ISOT-3) (Ubiquitin thioesterase 13) (Ubiquitin-specific-processing protease 13)	GO:0004197; GO:0004843; GO:0005654; GO:0005829; GO:0006355; GO:0006511; GO:0006914; GO:0008270; GO:0008283; GO:0010506; GO:0016579; GO:0030318; GO:0031625; GO:0035523; GO:0036459; GO:0043130; GO:0044313; GO:0044389; GO:0050821; GO:0051087; GO:0070536; GO:0070628; GO:1904288; GO:1904294; GO:1904378; GO:1990380	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; melanocyte differentiation [GO:0030318]; positive regulation of ERAD pathway [GO:1904294]; protein deubiquitination [GO:0016579]; protein K29-linked deubiquitination [GO:0035523]; protein K6-linked deubiquitination [GO:0044313]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]	USP13 ISOT3
NM_005230		A0A024RBE2	A0A024RBE2_HUMAN	ELK3, ETS-domain protein (SRF accessory protein 2), isoform CRA_a	GO:0001525; GO:0003700; GO:0005654; GO:0005739; GO:0042060; GO:0043565; GO:0045892	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; angiogenesis [GO:0001525]; negative regulation of transcription, DNA-templated [GO:0045892]; wound healing [GO:0042060]	ELK3 hCG_32371
NM_005230		P41970	ELK3_HUMAN	ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2)	GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045892; GO:0045944	mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060]	ELK3 NET SAP2
NM_007027		A0AV47	A0AV47_HUMAN	Topoisomerase (DNA) II binding protein 1	GO:0016853	isomerase activity [GO:0016853]	TOPBP1
NM_007027		A7E2X7	A7E2X7_HUMAN	Topoisomerase (DNA) II binding protein 1	GO:0016853	isomerase activity [GO:0016853]	TOPBP1
NM_007027		Q05BV8	Q05BV8_HUMAN	TOPBP1 protein (Fragment)			TOPBP1
NM_007027		Q92547	TOPB1_HUMAN	DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)	GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006260; GO:0006281; GO:0006974; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0042802; GO:0043231; GO:1901796	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint [GO:0033314]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ionizing radiation [GO:0010212]	TOPBP1 KIAA0259
NM_001136002		B2RXF0	T229A_HUMAN	Transmembrane protein 229A	GO:0016021	integral component of membrane [GO:0016021]	TMEM229A
NM_016292		A0A140VJY2	A0A140VJY2_HUMAN	Testicular tissue protein Li 209	GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0006457; GO:0019901; GO:0051082; GO:1903751	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]	
NM_016292	NM_016292 -> Q12931-1	Q12931	TRAP1_HUMAN	Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)	GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0019901; GO:0051082; GO:0061077; GO:1901856; GO:1903427; GO:1903751	membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386]	TRAP1 HSP75
NM_133329	NM_133329 -> Q8TAE7-1	Q8TAE7	KCNG3_HUMAN	Potassium voltage-gated channel subfamily G member 3 (Voltage-gated potassium channel subunit Kv10.1) (Voltage-gated potassium channel subunit Kv6.3)	GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	KCNG3
NM_000436		A0A024R040	A0A024R040_HUMAN	Succinyl-CoA:3-ketoacid-coenzyme A transferase (EC 2.8.3.5)	GO:0005654; GO:0005739; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042594; GO:0042803; GO:0045471; GO:0046952; GO:0060612	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; protein homodimerization activity [GO:0042803]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	OXCT1 hCG_37537
NM_000436	NM_000436 -> P55809-1	P55809	SCOT1_HUMAN	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)	GO:0005654; GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042594; GO:0042803; GO:0045471; GO:0046950; GO:0046952; GO:0060612	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; protein homodimerization activity [GO:0042803]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	OXCT1 OXCT SCOT
NM_006191		A0A024RB85	A0A024RB85_HUMAN	Proliferation-associated 2G4, 38kDa, isoform CRA_a	GO:0005737	cytoplasm [GO:0005737]	PA2G4 hCG_2015367
NM_006191	NM_006191 -> Q9UQ80-1	Q9UQ80	PA2G4_HUMAN	Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1)	GO:0003676; GO:0003677; GO:0003700; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0016020; GO:0031625; GO:0035578; GO:0043066; GO:0043312; GO:0045597; GO:0045892; GO:0070062	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]	PA2G4 EBP1
NM_000050		P00966	ASSY_HUMAN	Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)	GO:0000050; GO:0000052; GO:0000053; GO:0001822; GO:0001889; GO:0003723; GO:0004055; GO:0005524; GO:0005634; GO:0005737; GO:0005741; GO:0005764; GO:0005783; GO:0005829; GO:0006526; GO:0006531; GO:0006953; GO:0007494; GO:0007568; GO:0007584; GO:0007623; GO:0010043; GO:0010046; GO:0015643; GO:0016597; GO:0032355; GO:0042802; GO:0043204; GO:0045429; GO:0060416; GO:0060539; GO:0070062; GO:0070852; GO:0071222; GO:0071230; GO:0071242; GO:0071320; GO:0071346; GO:0071356; GO:0071377; GO:0071400; GO:0071418; GO:0071499; GO:0071549; GO:1903038	cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perikaryon [GO:0043204]; amino acid binding [GO:0016597]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643]; acute-phase response [GO:0006953]; aging [GO:0007568]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; aspartate metabolic process [GO:0006531]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to interferon-gamma [GO:0071346]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; citrulline metabolic process [GO:0000052]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050]	ASS1 ASS
NM_000050		Q5T6L4	Q5T6L4_HUMAN	Argininosuccinate synthase 1 isoform 1 (Argininosuccinate synthetase, isoform CRA_a) (Epididymis secretory sperm binding protein) (cDNA, FLJ96050, highly similar to Homo sapiens argininosuccinate synthetase (ASS), transcript variant1, mRNA)	GO:0000050; GO:0000053; GO:0001822; GO:0001889; GO:0004055; GO:0005524; GO:0005634; GO:0005741; GO:0005764; GO:0005783; GO:0006526; GO:0006953; GO:0007494; GO:0007568; GO:0007584; GO:0007623; GO:0010043; GO:0010046; GO:0015643; GO:0032355; GO:0043204; GO:0060416; GO:0060539; GO:0070852; GO:0071222; GO:0071230; GO:0071242; GO:0071320; GO:0071346; GO:0071356; GO:0071377; GO:0071400; GO:0071418; GO:0071549	cell body fiber [GO:0070852]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perikaryon [GO:0043204]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; toxic substance binding [GO:0015643]; acute-phase response [GO:0006953]; aging [GO:0007568]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050]	ASS ASS1 hCG_31245
NM_173083	NM_173083 -> Q5TKA1-2	Q5TKA1	LIN9_HUMAN	Protein lin-9 homolog (HuLin-9) (hLin-9) (Beta subunit-associated regulator of apoptosis) (TUDOR gene similar protein) (Type I interferon receptor beta chain-associated protein) (pRB-associated protein)	GO:0000003; GO:0003677; GO:0005654; GO:0006351; GO:0007049; GO:0017053; GO:0051726; GO:0071897	nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]	LIN9 BARA TGS
NM_014363	NM_014363 -> Q9NZJ4-1	Q9NZJ4	SACS_HUMAN	Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	SACS KIAA0730
NM_003221	NM_003221 -> Q92481-1	Q92481	AP2B_HUMAN	Transcription factor AP-2-beta (AP2-beta) (Activating enhancer-binding protein 2-beta)	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001158; GO:0001228; GO:0001822; GO:0003091; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005623; GO:0005634; GO:0005654; GO:0006006; GO:0006355; GO:0006357; GO:0006366; GO:0008284; GO:0008285; GO:0010842; GO:0010960; GO:0030510; GO:0035136; GO:0035137; GO:0035810; GO:0035909; GO:0042493; GO:0042593; GO:0042803; GO:0043027; GO:0043066; GO:0043154; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0046983; GO:0048485; GO:0050796; GO:0055062; GO:0055074; GO:0055075; GO:0055078; GO:0072017; GO:0072044; GO:0072210; GO:0097070; GO:0097275; GO:0097276; GO:0097277	cell [GO:0005623]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; aorta morphogenesis [GO:0035909]; calcium ion homeostasis [GO:0055074]; cellular ammonia homeostasis [GO:0097275]; cellular creatinine homeostasis [GO:0097276]; cellular urea homeostasis [GO:0097277]; collecting duct development [GO:0072044]; distal tubule development [GO:0072017]; ductus arteriosus closure [GO:0097070]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hindlimb morphogenesis [GO:0035137]; kidney development [GO:0001822]; magnesium ion homeostasis [GO:0010960]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphate ion homeostasis [GO:0055062]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; potassium ion homeostasis [GO:0055075]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell differentiation [GO:0045595]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal water homeostasis [GO:0003091]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; skin development [GO:0043588]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]	TFAP2B
NM_003368		O94782	UBP1_HUMAN	Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1)	GO:0001501; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0006282; GO:0006511; GO:0008233; GO:0009411; GO:0016579; GO:0035520; GO:0036297; GO:0036459; GO:0042769	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; DNA damage response, detection of DNA damage [GO:0042769]; interstrand cross-link repair [GO:0036297]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; response to UV [GO:0009411]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]	USP1
NM_015183	NM_015183 -> O15021-3	O15021	MAST4_HUMAN	Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1)	GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0007010; GO:0018105; GO:0035556	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	MAST4 KIAA0303
NM_020119	NM_020119 -> Q7Z2W4-1	Q7Z2W4	ZCCHV_HUMAN	Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Inactive Poly [ADP-ribose] polymerase 13) (PARP13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP)	GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006471; GO:0009615; GO:0032727; GO:0032728; GO:0043123; GO:0045071; GO:0045087; GO:0045296; GO:0046872; GO:0051607; GO:0061014; GO:1900246	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein ADP-ribosylation [GO:0006471]; response to virus [GO:0009615]	ZC3HAV1 ZC3HDC2 PRO1677
NM_033515	NM_033515 -> Q8N392-1	Q8N392	RHG18_HUMAN	Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18)	GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0008360; GO:0016607; GO:0030833; GO:0032956; GO:0045296; GO:0051056; GO:2000145	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	ARHGAP18
NM_022750		A4D1T0	A4D1T0_HUMAN	Poly (ADP-ribose) polymerase family, member 12, isoform CRA_b (Zinc finger CCCH type domain containing 1)	GO:0003950; GO:0046872	metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]	ZC3HDC1 PARP12 hCG_1811077 tcag7.1054
NM_022750		Q9H0J9	PAR12_HUMAN	Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)	GO:0003723; GO:0003950; GO:0005634; GO:0046872; GO:0070213; GO:0140289; GO:1990404	nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; RNA binding [GO:0003723]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]	PARP12 ZC3HDC1
NM_024830		Q8NF37	PCAT1_HUMAN	Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) (Phosphonoformate immuno-associated protein 3)	GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006654; GO:0006656; GO:0008654; GO:0016020; GO:0016021; GO:0035577; GO:0036148; GO:0036151; GO:0043129; GO:0043312; GO:0045732; GO:0047159; GO:0047184; GO:0047191; GO:0047192; GO:0060041; GO:2001246	azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; calcium ion binding [GO:0005509]; negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; neutrophil degranulation [GO:0043312]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129]	LPCAT1 AYTL2 PFAAP3
NM_004390		P09668	CATH_HUMAN	Pro-cathepsin H [Cleaved into: Cathepsin H mini chain; Cathepsin H (EC 3.4.22.16); Cathepsin H heavy chain; Cathepsin H light chain]	GO:0001656; GO:0001913; GO:0002250; GO:0002764; GO:0004175; GO:0004177; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005764; GO:0005829; GO:0006508; GO:0008233; GO:0008234; GO:0008284; GO:0008656; GO:0010628; GO:0010634; GO:0010813; GO:0010815; GO:0010952; GO:0019882; GO:0030108; GO:0030335; GO:0031638; GO:0031648; GO:0032526; GO:0033619; GO:0034774; GO:0036464; GO:0043066; GO:0043129; GO:0043231; GO:0043312; GO:0044267; GO:0045766; GO:0051603; GO:0060448; GO:0062023; GO:0070062; GO:0070324; GO:0070371; GO:0097067; GO:0097208; GO:0097486; GO:1904724; GO:1904813; GO:2001235	alveolar lamellar body [GO:0097208]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; multivesicular body lumen [GO:0097486]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; HLA-A specific activating MHC class I receptor activity [GO:0030108]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; thyroid hormone binding [GO:0070324]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; bradykinin catabolic process [GO:0010815]; cellular protein metabolic process [GO:0044267]; cellular response to thyroid hormone stimulus [GO:0097067]; dichotomous subdivision of terminal units involved in lung branching [GO:0060448]; ERK1 and ERK2 cascade [GO:0070371]; immune response-regulating signaling pathway [GO:0002764]; membrane protein proteolysis [GO:0033619]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; neuropeptide catabolic process [GO:0010813]; neutrophil degranulation [GO:0043312]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidase activity [GO:0010952]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to retinoic acid [GO:0032526]; surfactant homeostasis [GO:0043129]; T cell mediated cytotoxicity [GO:0001913]; zymogen activation [GO:0031638]	CTSH CPSB
NM_003082		B2RC42	B2RC42_HUMAN	cDNA, FLJ95843, highly similar to Homo sapiens small nuclear RNA activating complex, polypeptide 1, 43kDa (SNAPC1), mRNA			
NM_003082		Q16533	SNPC1_HUMAN	snRNA-activating protein complex subunit 1 (SNAPc subunit 1) (Proximal sequence element-binding transcription factor subunit gamma) (PSE-binding factor subunit gamma) (PTF subunit gamma) (Small nuclear RNA-activating complex polypeptide 1) (snRNA-activating protein complex 43 kDa subunit) (SNAPc 43 kDa subunit)	GO:0005654; GO:0005730; GO:0019185; GO:0042795; GO:0042796; GO:0043565	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; snRNA-activating protein complex [GO:0019185]; sequence-specific DNA binding [GO:0043565]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]	SNAPC1 SNAP43
NM_022648		A1L0S7	A1L0S7_HUMAN	TNS1 protein (Fragment)			TNS1
NM_022648		Q59G71	Q59G71_HUMAN	Tensin variant (Fragment)			
NM_022648		Q86VB0	Q86VB0_HUMAN	TNS1 protein			TNS1
NM_022648	NM_022648 -> Q9HBL0-1	Q9HBL0	TENS1_HUMAN	Tensin-1	GO:0003723; GO:0003779; GO:0005737; GO:0005856; GO:0005925; GO:0007044; GO:0009986; GO:0010761	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761]	TNS1 TNS
NM_080862		Q96A44	SPSB4_HUMAN	SPRY domain-containing SOCS box protein 4 (SSB-4)	GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0035556; GO:0042752; GO:0043161; GO:0043687; GO:0048511; GO:1902916; GO:1990756	cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; intracellular signal transduction [GO:0035556]; positive regulation of protein polyubiquitination [GO:1902916]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]	SPSB4 SSB4
NM_001098272		A0A024R059	A0A024R059_HUMAN	3-hydroxy-3-methylglutaryl coenzyme A synthase (HMG-CoA synthase) (EC 2.3.3.10)	GO:0001889; GO:0004421; GO:0005829; GO:0007420; GO:0008144; GO:0008299; GO:0008584; GO:0009645; GO:0014074; GO:0016126; GO:0016853; GO:0033197; GO:0042493; GO:0042803; GO:0043177; GO:0046690; GO:0071372; GO:0071397; GO:0071404	cytosol [GO:0005829]; drug binding [GO:0008144]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isomerase activity [GO:0016853]; organic acid binding [GO:0043177]; protein homodimerization activity [GO:0042803]; brain development [GO:0007420]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; isoprenoid biosynthetic process [GO:0008299]; liver development [GO:0001889]; male gonad development [GO:0008584]; response to drug [GO:0042493]; response to low light intensity stimulus [GO:0009645]; response to purine-containing compound [GO:0014074]; response to tellurium ion [GO:0046690]; response to vitamin E [GO:0033197]; sterol biosynthetic process [GO:0016126]	HMGCS1 hCG_36936
NM_001098272		Q01581	HMCS1_HUMAN	Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)	GO:0001889; GO:0004421; GO:0005737; GO:0005829; GO:0006084; GO:0006629; GO:0006695; GO:0007420; GO:0008144; GO:0008584; GO:0009645; GO:0010142; GO:0014074; GO:0016853; GO:0019216; GO:0033197; GO:0042493; GO:0042803; GO:0043177; GO:0045540; GO:0046690; GO:0071372; GO:0071397; GO:0071404	cytoplasm [GO:0005737]; cytosol [GO:0005829]; drug binding [GO:0008144]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isomerase activity [GO:0016853]; organic acid binding [GO:0043177]; protein homodimerization activity [GO:0042803]; acetyl-CoA metabolic process [GO:0006084]; brain development [GO:0007420]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; male gonad development [GO:0008584]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to low light intensity stimulus [GO:0009645]; response to purine-containing compound [GO:0014074]; response to tellurium ion [GO:0046690]; response to vitamin E [GO:0033197]	HMGCS1 HMGCS
NM_001029858	NM_001029858 -> Q5T1Q4-1	Q5T1Q4	S35F1_HUMAN	Solute carrier family 35 member F1	GO:0016021; GO:0022857	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	SLC35F1 C6orf169
NM_015567	NM_015567 -> O94991-1	O94991	SLIK5_HUMAN	SLIT and NTRK-like protein 5 (Leucine-rich repeat-containing protein 11)	GO:0005886; GO:0007268; GO:0007409; GO:0007625; GO:0009410; GO:0016021; GO:0021756; GO:0030534; GO:0043235; GO:0043588; GO:0045202; GO:0048813; GO:0051965; GO:0072358	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; adult behavior [GO:0030534]; axonogenesis [GO:0007409]; cardiovascular system development [GO:0072358]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; grooming behavior [GO:0007625]; positive regulation of synapse assembly [GO:0051965]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; striatum development [GO:0021756]	SLITRK5 KIAA0918 LRRC11
NM_014906	NM_014906 -> Q8WY54-2	Q8WY54	PPM1E_HUMAN	Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA)	GO:0004722; GO:0004724; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006469; GO:0032991; GO:0035690; GO:0035970; GO:0046872; GO:0051496	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to drug [GO:0035690]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]	PPM1E CAMKN KIAA1072 POPX1
NM_144978	NM_144978 -> Q96M89-1	Q96M89	CC138_HUMAN	Coiled-coil domain-containing protein 138			CCDC138
NM_006721	NM_006721 -> P55263-1	P55263	ADK_HUMAN	Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase)	GO:0003723; GO:0004001; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006166; GO:0006175; GO:0009156; GO:0043101; GO:0044209; GO:0046872	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; AMP salvage [GO:0044209]; dATP biosynthetic process [GO:0006175]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; ribonucleoside monophosphate biosynthetic process [GO:0009156]	ADK
NM_003829	NM_003829 -> O75970-2	O75970	MPDZ_HUMAN	Multiple PDZ domain protein (Multi-PDZ domain protein 1)	GO:0005737; GO:0005923; GO:0007155; GO:0008022; GO:0014069; GO:0016032; GO:0016324; GO:0016327; GO:0030425; GO:0031410; GO:0043220; GO:0045211	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; viral process [GO:0016032]	MPDZ MUPP1
NM_138285	NM_138285 -> Q8NFH5-1	Q8NFH5	NUP35_HUMAN	Nucleoporin NUP35 (35 kDa nucleoporin) (Mitotic phosphoprotein 44) (MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53)	GO:0003697; GO:0005543; GO:0005635; GO:0005652; GO:0005654; GO:0005886; GO:0006110; GO:0006406; GO:0006409; GO:0006607; GO:0006999; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0042803; GO:0043657; GO:0044613; GO:0044615; GO:0060964; GO:0075733; GO:1900034; GO:1990830	host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; cellular response to leukemia inhibitory factor [GO:1990830]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	NUP35 MP44 NUP53
NM_015440	NM_015440 -> Q6UB35-1	Q6UB35	C1TM_HUMAN	Monofunctional C1-tetrahydrofolate synthase, mitochondrial (EC 6.3.4.3) (Formyltetrahydrofolate synthetase)	GO:0001843; GO:0004329; GO:0004488; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006760; GO:0009113; GO:0009257; GO:0015942; GO:0016020; GO:0035999; GO:0042803; GO:0046655; GO:0048702; GO:0048703	cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]	MTHFD1L FTHFSDC1
NM_020921		Q5XUU0	Q5XUU0_HUMAN	Ninein isoform 6	GO:0005509; GO:0005813; GO:0034454	centrosome [GO:0005813]; calcium ion binding [GO:0005509]; microtubule anchoring at centrosome [GO:0034454]	
NM_020921		Q8N4C6	NIN_HUMAN	Ninein (hNinein) (Glycogen synthase kinase 3 beta-interacting protein) (GSK3B-interacting protein)	GO:0000242; GO:0000922; GO:0005509; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005886; GO:0008104; GO:0010457; GO:0019900; GO:0021540; GO:0021957; GO:0030425; GO:0031116; GO:0034454; GO:0036449; GO:0044295; GO:0045177; GO:0048668; GO:0050772; GO:0051642; GO:0072686; GO:0090222; GO:0097431; GO:0097539; GO:0120103	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule minus-end [GO:0036449]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; centriole-centriole cohesion [GO:0010457]; centrosome localization [GO:0051642]; centrosome-templated microtubule nucleation [GO:0090222]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of axonogenesis [GO:0050772]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104]	NIN KIAA1565
NM_145016		A0A024R4Z5	A0A024R4Z5_HUMAN	Glycine-N-acyltransferase-like 2, isoform CRA_a	GO:0005739; GO:0047961	mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961]	GLYATL2 hCG_1658299
NM_145016		Q8WU03	GLYL2_HUMAN	Glycine N-acyltransferase-like protein 2 (EC 2.3.1.13) (Acyl-CoA:glycine N-acyltransferase-like protein 2)	GO:0005739; GO:0005783; GO:0042758; GO:0047961; GO:0051793; GO:1903965	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961]; long-chain fatty acid catabolic process [GO:0042758]; medium-chain fatty acid catabolic process [GO:0051793]; monounsaturated fatty acid catabolic process [GO:1903965]	GLYATL2
NM_006996		A0A024R928	A0A024R928_HUMAN	Solute carrier family 19 (Thiamine transporter), member 2, isoform CRA_a (Solute carrier family 19 member 2 isoform 2)	GO:0005886; GO:0015234; GO:0016021	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thiamine transmembrane transporter activity [GO:0015234]	SLC19A2 hCG_38014
NM_006996	NM_006996 -> O60779-1	O60779	S19A2_HUMAN	Thiamine transporter 1 (ThTr-1) (ThTr1) (Solute carrier family 19 member 2) (Thiamine carrier 1) (TC1)	GO:0005886; GO:0008517; GO:0015234; GO:0015888; GO:0016021; GO:0042723; GO:0055085; GO:0071934	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085]	SLC19A2 THT1 TRMA
NM_024766	NM_024766 -> Q7Z624-1	Q7Z624	CMKMT_HUMAN	Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60)	GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006479; GO:0007005; GO:0018025; GO:0022400; GO:0031072; GO:0032991	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; calmodulin-lysine N-methyltransferase activity [GO:0018025]; heat shock protein binding [GO:0031072]; mitochondrion organization [GO:0007005]; protein methylation [GO:0006479]; regulation of rhodopsin mediated signaling pathway [GO:0022400]	CAMKMT C2orf34 CLNMT
NM_002627	NM_002627 -> Q01813-1	Q01813	PFKAP_HUMAN	ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase)	GO:0003872; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005945; GO:0006002; GO:0006007; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0044877; GO:0045296; GO:0046872; GO:0048029; GO:0051289; GO:0061621; GO:0070062; GO:0070095; GO:1990830	6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; protein homotetramerization [GO:0051289]	PFKP PFKF
NM_002296		Q14739	LBR_HUMAN	Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase)	GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005639; GO:0005737; GO:0005789; GO:0006695; GO:0016020; GO:0016021; GO:0016126; GO:0030223; GO:0031965; GO:0050613; GO:0070087; GO:0070402	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; RNA binding [GO:0003723]; cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126]	LBR
NM_025146	NM_025146 -> Q9GZZ1-1	Q9GZZ1	NAA50_HUMAN	N-alpha-acetyltransferase 50 (hNaa50p) (EC 2.3.1.258) (N-acetyltransferase 13) (N-acetyltransferase 5) (hNAT5) (N-acetyltransferase san homolog) (hSAN) (N-epsilon-acetyltransferase 50) (EC 2.3.1.-) (NatE catalytic subunit)	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0010485; GO:0016573; GO:0031415; GO:0034087; GO:0052858; GO:0070062; GO:0071962	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]	NAA50 MAK3 NAT13 NAT5
NM_001143688	NM_001143688 -> Q8TF46-1	Q8TF46	DI3L1_HUMAN	DIS3-like exonuclease 1 (EC 3.1.13.-)	GO:0000175; GO:0000177; GO:0000178; GO:0003723; GO:0005813; GO:0005829; GO:0005886; GO:0016075; GO:0019899	centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; plasma membrane [GO:0005886]; 3'-5'-exoribonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; rRNA catabolic process [GO:0016075]	DIS3L DIS3L1 KIAA1955
NM_003091	NM_003091 -> P14678-2	P14678	RSMB_HUMAN	Small nuclear ribonucleoprotein-associated proteins B and B' (snRNP-B) (Sm protein B/B') (Sm-B/B') (SmB/B')	GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005697; GO:0005737; GO:0005829; GO:0006369; GO:0006479; GO:0007420; GO:0008334; GO:0008380; GO:0030532; GO:0034709; GO:0034719; GO:0046540; GO:0051170; GO:0070034; GO:0071004; GO:0071005; GO:0071007; GO:0071013; GO:0071204; GO:0071208; GO:1990446; GO:1990447	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone pre-mRNA 3'end processing complex [GO:0071204]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U1 snRNP binding [GO:1990446]; U2 snRNP binding [GO:1990447]; brain development [GO:0007420]; histone mRNA metabolic process [GO:0008334]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; termination of RNA polymerase II transcription [GO:0006369]	SNRPB COD SNRPB1
NM_003091		Q66K91	Q66K91_HUMAN	Small nuclear ribonucleoprotein-associated protein	GO:0003723; GO:0005654	nucleoplasm [GO:0005654]; RNA binding [GO:0003723]	SNRPB hCG_2039421
NM_024057		Q8NFH4	NUP37_HUMAN	Nucleoporin Nup37 (p37) (Nup107-160 subcomplex subunit Nup37)	GO:0000777; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0007049; GO:0007059; GO:0016032; GO:0016925; GO:0019083; GO:0031080; GO:0043657; GO:0051301; GO:0060964; GO:0075733; GO:1900034	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; host cell [GO:0043657]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	NUP37
NM_017421		Q9NZJ6	COQ3_HUMAN	Ubiquinone biosynthesis O-methyltransferase, mitochondrial (3-demethylubiquinol 3-O-methyltransferase) (EC 2.1.1.64) (Polyprenyldihydroxybenzoate methyltransferase) (EC 2.1.1.114)	GO:0004395; GO:0005739; GO:0005759; GO:0006071; GO:0006744; GO:0008171; GO:0008425; GO:0008689; GO:0010795; GO:0031314; GO:0044595; GO:0044596; GO:1990886	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity [GO:1990886]; 3-demethylubiquinone-10 3-O-methyltransferase activity [GO:0044596]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; decaprenyldihydroxybenzoate methyltransferase activity [GO:0044595]; hexaprenyldihydroxybenzoate methyltransferase activity [GO:0004395]; O-methyltransferase activity [GO:0008171]; glycerol metabolic process [GO:0006071]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744]	COQ3 UG0215E05
NM_003520		A0A024RCJ9	A0A024RCJ9_HUMAN	Histone H2B	GO:0000786; GO:0003677; GO:0005654; GO:0005829; GO:0046982	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	HIST1H2BN hCG_1743059
NM_003520		Q99877	H2B1N_HUMAN	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0016567; GO:0046982; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]; protein ubiquitination [GO:0016567]	H2BC15 H2BFD HIST1H2BN
NM_031453	NM_031453 -> Q9H098-2	Q9H098	F107B_HUMAN	Protein FAM107B			FAM107B C10orf45
NM_006092		A0A024RA73	A0A024RA73_HUMAN	Caspase recruitment domain family, member 4 (Caspase recruitment domain family, member 4, isoform CRA_b) (Nucleotide-binding oligomerization domain containing 1 isoform 1)	GO:0002606; GO:0005524; GO:0010942; GO:0032731; GO:0032755; GO:0032760; GO:0042981; GO:0043123; GO:0046330; GO:0050830; GO:0051000; GO:0070374; GO:1904417	ATP binding [GO:0005524]; defense response to Gram-positive bacterium [GO:0050830]; positive regulation of cell death [GO:0010942]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of xenophagy [GO:1904417]; regulation of apoptotic process [GO:0042981]	CARD4 NOD1 hCG_39138 tcag7.679
NM_006092	NM_006092 -> Q9Y239-1	Q9Y239	NOD1_HUMAN	Nucleotide-binding oligomerization domain-containing protein 1 (Caspase recruitment domain-containing protein 4)	GO:0000187; GO:0002606; GO:0005524; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0006952; GO:0006954; GO:0007165; GO:0007254; GO:0008656; GO:0009595; GO:0016045; GO:0016323; GO:0016324; GO:0032731; GO:0032755; GO:0032760; GO:0035556; GO:0042228; GO:0042742; GO:0042802; GO:0042803; GO:0042834; GO:0043123; GO:0043280; GO:0044877; GO:0045087; GO:0046330; GO:0050700; GO:0050830; GO:0051000; GO:0051092; GO:0070374; GO:0070423; GO:0070498; GO:0071225; GO:1901224; GO:1904417	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; identical protein binding [GO:0042802]; peptidoglycan binding [GO:0042834]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of MAPK activity [GO:0000187]; apoptotic process [GO:0006915]; cellular response to muramyl dipeptide [GO:0071225]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-8 biosynthetic process [GO:0042228]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of xenophagy [GO:1904417]; signal transduction [GO:0007165]	NOD1 CARD4
NM_003966		Q13591	SEM5A_HUMAN	Semaphorin-5A (Semaphorin-F) (Sema F)	GO:0001938; GO:0002043; GO:0005886; GO:0007155; GO:0007162; GO:0007267; GO:0007399; GO:0007413; GO:0016020; GO:0016021; GO:0021536; GO:0030215; GO:0030836; GO:0035373; GO:0043395; GO:0045545; GO:0045766; GO:0048675; GO:0048842; GO:0048843; GO:0050918; GO:0051897; GO:0060326; GO:0070062; GO:0090263; GO:0097485; GO:1990256; GO:2000352; GO:2001028	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545]; axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neuron projection guidance [GO:0097485]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; signal clustering [GO:1990256]	SEMA5A SEMAF
NM_003966		X5DR95	X5DR95_HUMAN	Semaphorin 5A isoform A (Fragment)	GO:0016021; GO:0030215	integral component of membrane [GO:0016021]; semaphorin receptor binding [GO:0030215]	SEMA5A
NM_006506	NM_006506 -> Q15283-2	Q15283	RASA2_HUMAN	Ras GTPase-activating protein 2 (GTPase-activating protein 1m) (GAP1m)	GO:0000165; GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0046580; GO:0046872; GO:0048471	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	RASA2 GAP1M RASGAP
NM_032194		Q9H7B2	RPF2_HUMAN	Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog)	GO:0000027; GO:0000463; GO:0003723; GO:0005654; GO:0005730; GO:0008097; GO:0019843; GO:0042273; GO:1901796; GO:1902570	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]	RPF2 BXDC1
NM_000251	NM_000251 -> P43246-1	P43246	MSH2_HUMAN	DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2)	GO:0000406; GO:0000784; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006310; GO:0007050; GO:0007281; GO:0008022; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0019237; GO:0019724; GO:0019899; GO:0019901; GO:0030183; GO:0031573; GO:0032137; GO:0032300; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051096; GO:0071168	membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; double-strand/single-strand DNA junction binding [GO:0000406]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; cell cycle arrest [GO:0007050]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]	MSH2
NM_007235		O43592	XPOT_HUMAN	Exportin-T (Exportin(tRNA)) (tRNA exportin)	GO:0000049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0008536; GO:0016363; GO:0071528	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; Ran GTPase binding [GO:0008536]; tRNA binding [GO:0000049]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	XPOT
NM_145290	NM_145290 -> Q8IWK6-1	Q8IWK6	AGRA3_HUMAN	Adhesion G protein-coupled receptor A3 (G-protein coupled receptor 125)	GO:0004930; GO:0007166; GO:0007186; GO:0009897; GO:0016021	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	ADGRA3 GPR125 UNQ556/PRO1113
NM_012431	NM_012431 -> O15041-1	O15041	SEM3E_HUMAN	Semaphorin-3E	GO:0001569; GO:0001755; GO:0001953; GO:0002040; GO:0005576; GO:0005615; GO:0005887; GO:0008360; GO:0016525; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0050808; GO:0050919; GO:0071526; GO:2000249	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; branching involved in blood vessel morphogenesis [GO:0001569]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell-matrix adhesion [GO:0001953]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sprouting angiogenesis [GO:0002040]; synapse organization [GO:0050808]	SEMA3E KIAA0331 SEMAH
NM_006898		P31249	HXD3_HUMAN	Homeobox protein Hox-D3 (Homeobox protein Hox-4A)	GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0006351; GO:0007160; GO:0007219; GO:0009952; GO:0010628; GO:0016235; GO:0016604; GO:0021615; GO:0030878; GO:0045666; GO:0045944; GO:0048704; GO:0051216	aggresome [GO:0016235]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; cell-matrix adhesion [GO:0007160]; embryonic skeletal system morphogenesis [GO:0048704]; glossopharyngeal nerve morphogenesis [GO:0021615]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]	HOXD3 HOX1D HOX4A
NM_020244	NM_020244 -> Q8WUD6-1	Q8WUD6	CHPT1_HUMAN	Cholinephosphotransferase 1 (hCPT1) (EC 2.7.8.2) (AAPT1-like protein) (Diacylglycerol cholinephosphotransferase 1)	GO:0000139; GO:0001558; GO:0004142; GO:0005789; GO:0005794; GO:0006629; GO:0006656; GO:0006657; GO:0006663; GO:0016020; GO:0016021; GO:0016780; GO:0019992; GO:0043231; GO:0046872	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; diacylglycerol binding [GO:0019992]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; CDP-choline pathway [GO:0006657]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; platelet activating factor biosynthetic process [GO:0006663]; regulation of cell growth [GO:0001558]	CHPT1 CPT1 MSTP022
NM_014881		Q6PJP8	DCR1A_HUMAN	DNA cross-link repair 1A protein (SNM1 homolog A) (hSNM1) (hSNM1A)	GO:0000784; GO:0001650; GO:0003684; GO:0005654; GO:0006303; GO:0007049; GO:0031848; GO:0035312; GO:0036297; GO:0051301	fibrillar center [GO:0001650]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; damaged DNA binding [GO:0003684]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]	DCLRE1A KIAA0086 SNM1 SNM1A
NM_001748	NM_001748 -> P17655-1	P17655	CAN2_HUMAN	Calpain-2 catalytic subunit (EC 3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain)	GO:0000785; GO:0001666; GO:0001824; GO:0004198; GO:0005509; GO:0005634; GO:0005737; GO:0005758; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0007520; GO:0007565; GO:0008092; GO:0008234; GO:0009897; GO:0010666; GO:0019899; GO:0022617; GO:0030425; GO:0030864; GO:0031143; GO:0032675; GO:0035458; GO:0042542; GO:0043025; GO:0045121; GO:0046982; GO:0048266; GO:0051493; GO:0051603; GO:0070062; GO:0071222; GO:0071230; GO:0097038; GO:1901216; GO:1901741; GO:2001247	chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein heterodimerization activity [GO:0046982]; behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; extracellular matrix disassembly [GO:0022617]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]	CAPN2 CANPL2
NM_001748		Q59EF6	Q59EF6_HUMAN	Calpain 2, large [catalytic] subunit variant (Fragment)	GO:0004198; GO:0005509; GO:0051493	calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; regulation of cytoskeleton organization [GO:0051493]	
NM_138801		A0A384MDW6	A0A384MDW6_HUMAN	Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase)	GO:0004034; GO:0019318; GO:0030246	aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; hexose metabolic process [GO:0019318]	
NM_138801		Q96C23	GALM_HUMAN	Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase)	GO:0004034; GO:0005737; GO:0006006; GO:0006012; GO:0030246; GO:0033499; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006]	GALM BLOCK25
NM_000254	NM_000254 -> Q99707-1	Q99707	METH_HUMAN	Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS)	GO:0000096; GO:0005829; GO:0007399; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0031103; GO:0031419; GO:0032259; GO:0042558; GO:0048678; GO:0071732	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]; sulfur amino acid metabolic process [GO:0000096]	MTR
NM_004196		Q00532	CDKL1_HUMAN	Cyclin-dependent kinase-like 1 (EC 2.7.11.22) (Protein kinase p42 KKIALRE) (Serine/threonine-protein kinase KKIALRE)	GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007507; GO:0035869; GO:0043231; GO:0070062; GO:1902017	ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; heart development [GO:0007507]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]	CDKL1
NM_005912		P32245	MC4R_HUMAN	Melanocortin receptor 4 (MC4-R)	GO:0002024; GO:0004977; GO:0004980; GO:0005634; GO:0005886; GO:0006112; GO:0007186; GO:0007188; GO:0007189; GO:0007631; GO:0016021; GO:0017046; GO:0019222; GO:0030073; GO:0031625; GO:0032868; GO:0042923; GO:0045780; GO:2000252; GO:2000821	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; diet induced thermogenesis [GO:0002024]; energy reserve metabolic process [GO:0006112]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; negative regulation of feeding behavior [GO:2000252]; positive regulation of bone resorption [GO:0045780]; regulation of grooming behavior [GO:2000821]; regulation of metabolic process [GO:0019222]; response to insulin [GO:0032868]	MC4R
NM_006281		A0A384MR07	A0A384MR07_HUMAN	Epididymis secretory sperm binding protein	GO:0004674; GO:0005524; GO:0007165	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165]	
NM_006281	NM_006281 -> Q13188-1	Q13188	STK3_HUMAN	Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)]	GO:0000287; GO:0001841; GO:0003157; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007165; GO:0007417; GO:0008285; GO:0023014; GO:0032092; GO:0032147; GO:0032991; GO:0035329; GO:0035556; GO:0042802; GO:0043065; GO:0043539; GO:0045600; GO:0046330; GO:0046621; GO:0046983; GO:0048812; GO:0050821; GO:0051091; GO:0051897; GO:0060215; GO:0060706; GO:0060800; GO:0090090; GO:0097284; GO:1902043	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]	STK3 KRS1 MST2
NM_002945		P27694	RFA1_HUMAN	Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1) (Single-stranded DNA-binding protein) [Cleaved into: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed]	GO:0000082; GO:0000723; GO:0000724; GO:0000784; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006283; GO:0006284; GO:0006289; GO:0006293; GO:0006294; GO:0006295; GO:0006296; GO:0006297; GO:0006298; GO:0006310; GO:0006974; GO:0007004; GO:0016605; GO:0019985; GO:0032201; GO:0033683; GO:0034502; GO:0036297; GO:0042276; GO:0042769; GO:0043047; GO:0043565; GO:0046872; GO:0051321; GO:0070987; GO:0090734; GO:0098505; GO:1900034; GO:1901796	DNA replication factor A complex [GO:0005662]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, detection of DNA damage [GO:0042769]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; protein localization to chromosome [GO:0034502]; regulation of cellular response to heat [GO:1900034]; regulation of signal transduction by p53 class mediator [GO:1901796]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]	RPA1 REPA1 RPA70
NM_000917	NM_000917 -> P13674-2	P13674	P4HA1_HUMAN	Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)	GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016020; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]	P4HA1 P4HA
NM_000917		Q5VSQ6	Q5VSQ6_HUMAN	Procollagen-proline, 2-oxoglutarate 4-dioxygenase (Proline 4-hydroxylase), alpha polypeptide I variant (Procollagen-proline, 2-oxoglutarate 4-dioxygenase (Proline 4-hydroxylase), alpha polypeptide I, isoform CRA_a) (Procollagen-proline, 2-oxoglutarate 4-dioxygenase (Proline 4-hydroxylase), alpha polypeptide I, isoform CRA_b) (Fragment)	GO:0004656; GO:0005506; GO:0005581; GO:0005739; GO:0005783; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0043231	collagen trimer [GO:0005581]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]	P4HA1 hCG_19276
NM_001029880		Q5VUG0	SMBT2_HUMAN	Scm-like with four MBT domains protein 2 (Scm-like with 4 MBT domains protein 2)	GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0010629; GO:0016235; GO:0016604; GO:0016607; GO:0042393; GO:0043231	aggresome [GO:0016235]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; negative regulation of gene expression [GO:0010629]; regulation of transcription, DNA-templated [GO:0006355]	SFMBT2 KIAA1617
NM_005804	NM_005804 -> O00148-1	O00148	DX39A_HUMAN	ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49)	GO:0000346; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0016887; GO:0031124; GO:0042802	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]	DDX39A DDX39
NM_006951	NM_006951 -> Q15542-1	Q15542	TAF5_HUMAN	Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100)	GO:0000790; GO:0005634; GO:0005654; GO:0005669; GO:0006325; GO:0006352; GO:0006355; GO:0006366; GO:0006367; GO:0015629; GO:0016032; GO:0016251; GO:0016573; GO:0033276; GO:0042795; GO:0042802; GO:0044212; GO:0046983; GO:1901796	actin cytoskeleton [GO:0015629]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; DNA-templated transcription, initiation [GO:0006352]; histone acetylation [GO:0016573]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]	TAF5 TAF2D
NM_030965		Q9BVH7	SIA7E_HUMAN	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E)	GO:0000139; GO:0001574; GO:0001665; GO:0006486; GO:0006688; GO:0008373; GO:0009312; GO:0016021	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	ST6GALNAC5 SIAT7E
NM_014501		Q16763	UBE2S_HUMAN	Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (E2-EPF) (Ubiquitin carrier protein S) (Ubiquitin-conjugating enzyme E2-24 kDa) (Ubiquitin-conjugating enzyme E2-EPF5) (Ubiquitin-protein ligase S)	GO:0004842; GO:0005524; GO:0005623; GO:0005654; GO:0005680; GO:0005829; GO:0006464; GO:0006511; GO:0010458; GO:0010994; GO:0010997; GO:0016567; GO:0031145; GO:0035519; GO:0044314; GO:0051301; GO:0061631; GO:0070534; GO:0070979; GO:0085020; GO:1904668	anaphase-promoting complex [GO:0005680]; cell [GO:0005623]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; cellular protein modification process [GO:0006464]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	UBE2S E2EPF OK/SW-cl.73
NM_003071		Q05BZ6	Q05BZ6_HUMAN	HLTF protein (Fragment)	GO:0003676; GO:0005524; GO:0008270; GO:0016818	ATP binding [GO:0005524]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	HLTF
NM_003071	NM_003071 -> Q14527-1	Q14527	HLTF_HUMAN	Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3)	GO:0000978; GO:0001228; GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0006355; GO:0008094; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0061630	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-dependent ATPase activity [GO:0008094]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]	HLTF HIP116A RNF80 SMARCA3 SNF2L3 ZBU1
NM_020204	NM_020204 -> Q9NQ69-1	Q9NQ69	LHX9_HUMAN	LIM/homeobox protein Lhx9 (LIM homeobox protein 9)	GO:0000790; GO:0000977; GO:0000981; GO:0003714; GO:0005634; GO:0008283; GO:0008584; GO:0008585; GO:0030182; GO:0035262; GO:0045892; GO:0045944; GO:0046872; GO:0097380	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; cell population proliferation [GO:0008283]; dorsal spinal cord interneuron anterior axon guidance [GO:0097380]; female gonad development [GO:0008585]; gonad morphogenesis [GO:0035262]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]	LHX9
NM_152540	NM_152540 -> Q8WU76-1	Q8WU76	SCFD2_HUMAN	Sec1 family domain-containing protein 2 (Syntaxin-binding protein 1-like 1)	GO:0006904; GO:0015031	protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]	SCFD2 STXBP1L1
NM_024572	NM_024572 -> Q96FL9-1	Q96FL9	GLT14_HUMAN	Polypeptide N-acetylgalactosaminyltransferase 14 (EC 2.4.1.41) (Polypeptide GalNAc transferase 14) (GalNAc-T14) (pp-GaNTase 14) (Protein-UDP acetylgalactosaminyltransferase 14) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14)	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0016266; GO:0030246; GO:0046872	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]	GALNT14 UNQ2434/PRO4994
NM_013417		P41252	SYIC_HUMAN	Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)	GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]	IARS
NM_001145199		Q8TAD7	OCC1_HUMAN	Overexpressed in colon carcinoma 1 protein (OCC-1) (AGD3)			OCC1 C12orf75
NM_005544		A0A024R499	A0A024R499_HUMAN	Insulin receptor substrate 1, isoform CRA_a	GO:0005158; GO:0005654; GO:0005829; GO:0005886; GO:0008286	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin receptor signaling pathway [GO:0008286]	IRS1 hCG_18361
NM_005544		P35568	IRS1_HUMAN	Insulin receptor substrate 1 (IRS-1)	GO:0000165; GO:0001784; GO:0005068; GO:0005070; GO:0005080; GO:0005158; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005899; GO:0005901; GO:0007165; GO:0008284; GO:0008286; GO:0010907; GO:0014065; GO:0032000; GO:0032868; GO:0032869; GO:0038111; GO:0042169; GO:0042593; GO:0043231; GO:0043434; GO:0043548; GO:0043552; GO:0045725; GO:0046326; GO:0046627; GO:0046628; GO:0046676; GO:0048009; GO:0048015; GO:0051897; GO:0071398	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-7-mediated signaling pathway [GO:0038111]; MAPK cascade [GO:0000165]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase B signaling [GO:0051897]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]	IRS1
NM_006666	NM_006666 -> Q9Y230-1	Q9Y230	RUVB2_HUMAN	RuvB-like 2 (EC 3.6.4.12) (48 kDa TATA box-binding protein-interacting protein) (48 kDa TBP-interacting protein) (51 kDa erythrocyte cytosolic protein) (ECP-51) (INO80 complex subunit J) (Repressing pontin 52) (Reptin 52) (TIP49b) (TIP60-associated protein 54-beta) (TAP54-beta)	GO:0000492; GO:0000812; GO:0000979; GO:0000980; GO:0001094; GO:0003678; GO:0003714; GO:0005524; GO:0005622; GO:0005634; GO:0005654; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0006457; GO:0008013; GO:0016020; GO:0016363; GO:0016573; GO:0017025; GO:0031011; GO:0031490; GO:0034644; GO:0035066; GO:0035267; GO:0040008; GO:0042802; GO:0042803; GO:0043139; GO:0043531; GO:0043967; GO:0043968; GO:0045944; GO:0051082; GO:0051117; GO:0070062; GO:0071169; GO:0071339; GO:0071392; GO:0071733; GO:0071899; GO:0090090; GO:0097255; GO:1904874; GO:1990904	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; intracellular [GO:0005622]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear euchromatin [GO:0005719]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein folding [GO:0006457]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733]	RUVBL2 INO80J TIP48 TIP49B CGI-46
NM_173654	NM_173654 -> Q5NDL2-3	Q5NDL2	EOGT_HUMAN	EGF domain-specific O-linked N-acetylglucosamine transferase (EC 2.4.1.255) (Extracellular O-linked N-acetylglucosamine transferase)	GO:0005788; GO:0006493; GO:0016262	endoplasmic reticulum lumen [GO:0005788]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-linked glycosylation [GO:0006493]	EOGT AER61 C3orf64 EOGT1
NM_014584		Q96HE7	ERO1A_HUMAN	ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Endoplasmic reticulum oxidoreductase alpha) (Oxidoreductin-1-L-alpha)	GO:0003756; GO:0005623; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006464; GO:0009266; GO:0010260; GO:0015035; GO:0016020; GO:0016491; GO:0016671; GO:0019471; GO:0022417; GO:0030198; GO:0030425; GO:0030968; GO:0034599; GO:0034975; GO:0034976; GO:0043231; GO:0045454; GO:0050873; GO:0051085; GO:0051209; GO:0070059; GO:0071456	cell [GO:0005623]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; 4-hydroxyproline metabolic process [GO:0019471]; animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular protein modification process [GO:0006464]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to temperature stimulus [GO:0009266]	ERO1A ERO1L UNQ434/PRO865
NM_001142645	NM_001142645 -> A6NFY4-1	A6NFY4	NEMP2_HUMAN	Nuclear envelope integral membrane protein 2	GO:0005635; GO:0005637; GO:0016021	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]	NEMP2 TMEM194B
NM_015101		Q8IYK4	GT252_HUMAN	Procollagen galactosyltransferase 2 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 2) (ColGalT 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2)	GO:0005788; GO:0050211	endoplasmic reticulum lumen [GO:0005788]; procollagen galactosyltransferase activity [GO:0050211]	COLGALT2 C1orf17 GLT25D2 KIAA0584
NM_015135		Q92621	NU205_HUMAN	Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205)	GO:0005635; GO:0005643; GO:0006110; GO:0006406; GO:0006409; GO:0006913; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0034399; GO:0043657; GO:0051292; GO:0060964; GO:0075733; GO:1900034	host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]	NUP205 C7orf14 KIAA0225
NM_017735		Q6P3X3	TTC27_HUMAN	Tetratricopeptide repeat protein 27 (TPR repeat protein 27)			TTC27
NM_022743	NM_022743 -> Q9H7B4-3	Q9H7B4	SMYD3_HUMAN	Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1)	GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0045184; GO:0045944; GO:0046872; GO:0071549	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]	SMYD3 ZMYND1 ZNFN3A1
NM_016338	NM_016338 -> Q9UI26-1	Q9UI26	IPO11_HUMAN	Importin-11 (Imp11) (Ran-binding protein 11) (RanBP11)	GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0006610; GO:0008536; GO:0061608	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]	IPO11 RANBP11
NM_030915		Q53QV2	LBH_HUMAN	Protein LBH (hLBH) (Limb bud and heart development protein homolog)	GO:0005634; GO:0005737; GO:0032991; GO:0033147; GO:0043408; GO:0045892; GO:0045893; GO:0060644; GO:1904674; GO:1904677; GO:2000103; GO:2000737	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of mammary stem cell proliferation [GO:2000103]; positive regulation of somatic stem cell division [GO:1904677]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of MAPK cascade [GO:0043408]	LBH
NM_001039844		Q8N6N7	ACBD7_HUMAN	Acyl-CoA-binding domain-containing protein 7	GO:0000062; GO:0008289	fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]	ACBD7
NM_033104		Q8WXE9	STON2_HUMAN	Stonin-2 (Stoned B)	GO:0002244; GO:0005730; GO:0005829; GO:0008021; GO:0016020; GO:0030054; GO:0030100; GO:0030136; GO:0043005; GO:0048488; GO:0061024	cell junction [GO:0030054]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; synaptic vesicle [GO:0008021]; hematopoietic progenitor cell differentiation [GO:0002244]; membrane organization [GO:0061024]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]	STON2 STN2 STNB
NM_015550	NM_015550 -> Q9H4L5-1	Q9H4L5	OSBL3_HUMAN	Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3)	GO:0005789; GO:0005829; GO:0005886; GO:0006699; GO:0006869; GO:0008289; GO:0015485; GO:0016020; GO:0031965; GO:0032433; GO:0032934; GO:0043231; GO:0097038	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; bile acid biosynthetic process [GO:0006699]; lipid transport [GO:0006869]	OSBPL3 KIAA0704 ORP3 OSBP3
NM_133367		B3KXW6	B3KXW6_HUMAN	cDNA FLJ46206 fis, clone TESTI4010721, highly similar to Membrane progestin receptor beta	GO:0016021	integral component of membrane [GO:0016021]	
NM_133367		Q8TEZ7	PAQR8_HUMAN	Membrane progestin receptor beta (mPR beta) (Lysosomal membrane protein in brain 1) (Membrane progesterone P4 receptor beta) (Membrane progesterone receptor beta) (Progesterone and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member VIII)	GO:0003707; GO:0005496; GO:0005794; GO:0005886; GO:0007275; GO:0016021; GO:0038023; GO:0048477; GO:0048545	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477]; response to steroid hormone [GO:0048545]	PAQR8 C6orf33 LMPB1 MPRB
NM_001130966	NM_001130966 -> P24557-1	P24557	THAS_HUMAN	Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1)	GO:0004497; GO:0004796; GO:0005506; GO:0005789; GO:0006690; GO:0016021; GO:0016705; GO:0019371; GO:0020037; GO:0036134	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; thromboxane-A synthase activity [GO:0004796]; cyclooxygenase pathway [GO:0019371]; icosanoid metabolic process [GO:0006690]	TBXAS1 CYP5 CYP5A1
NM_001130966		Q53F23	Q53F23_HUMAN	HCG14925, isoform CRA_a (Thromboxane A synthase 1 (Platelet, cytochrome P450, family 5, subfamily A) isoform TXS-I variant) (Thromboxane-A synthase) (Fragment)	GO:0004497; GO:0005506; GO:0016705; GO:0020037	heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]	TBXAS1 hCG_14925
NM_013261		A0A024R9Q9	A0A024R9Q9_HUMAN	Peroxisome proliferative activated receptor, gamma, coactivator 1, alpha, isoform CRA_a	GO:0000302; GO:0000422; GO:0001933; GO:0002021; GO:0002931; GO:0003713; GO:0003723; GO:0005623; GO:0005654; GO:0005719; GO:0006012; GO:0006094; GO:0007568; GO:0008209; GO:0009409; GO:0014732; GO:0014850; GO:0014878; GO:0014912; GO:0019395; GO:0021549; GO:0022626; GO:0022904; GO:0030331; GO:0030900; GO:0031490; GO:0032922; GO:0034599; GO:0035865; GO:0042594; GO:0042752; GO:0042975; GO:0043014; GO:0043025; GO:0043201; GO:0043231; GO:0043524; GO:0045820; GO:0045944; GO:0046321; GO:0048661; GO:0048662; GO:0050873; GO:0051091; GO:0051552; GO:0060612; GO:0071222; GO:0071250; GO:0071313; GO:0071332; GO:0071333; GO:0071354; GO:0071356; GO:0071372; GO:0071392; GO:0071456; GO:0071560; GO:0071871; GO:0071873; GO:0090258; GO:0097009; GO:0097067; GO:0097440; GO:0120162; GO:1901558; GO:1901857; GO:1901860; GO:1901863; GO:1904635; GO:1904637; GO:1904639; GO:1904640; GO:1990841; GO:1990843; GO:1990844; GO:1990845; GO:2000184; GO:2000272; GO:2000310; GO:2001171	apical dendrite [GO:0097440]; cell [GO:0005623]; cytosolic ribosome [GO:0022626]; interfibrillar mitochondrion [GO:1990844]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; subsarcolemmal mitochondrion [GO:1990843]; alpha-tubulin binding [GO:0043014]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; adaptive thermogenesis [GO:1990845]; adipose tissue development [GO:0060612]; aging [GO:0007568]; androgen metabolic process [GO:0008209]; autophagy of mitochondrion [GO:0000422]; brown fat cell differentiation [GO:0050873]; cellular response to caffeine [GO:0071313]; cellular response to estradiol stimulus [GO:0071392]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-6 [GO:0071354]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitrite [GO:0071250]; cellular response to oxidative stress [GO:0034599]; cellular response to potassium ion [GO:0035865]; cellular response to resveratrol [GO:1904639]; cellular response to thyroid hormone stimulus [GO:0097067]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cerebellum development [GO:0021549]; circadian regulation of gene expression [GO:0032922]; energy homeostasis [GO:0097009]; fatty acid oxidation [GO:0019395]; flavone metabolic process [GO:0051552]; forebrain development [GO:0030900]; galactose metabolic process [GO:0006012]; gluconeogenesis [GO:0006094]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of glomerular visceral epithelial cell apoptotic process [GO:1904635]; positive regulation of mitochondrial DNA metabolic process [GO:1901860]; positive regulation of muscle tissue development [GO:1901863]; positive regulation of progesterone biosynthetic process [GO:2000184]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of NMDA receptor activity [GO:2000310]; respiratory electron transport chain [GO:0022904]; response to cold [GO:0009409]; response to dietary excess [GO:0002021]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to leucine [GO:0043201]; response to metformin [GO:1901558]; response to methionine [GO:1904640]; response to muscle activity [GO:0014850]; response to norepinephrine [GO:0071873]; response to reactive oxygen species [GO:0000302]; response to starvation [GO:0042594]; skeletal muscle atrophy [GO:0014732]	PPARGC1A hCG_1811770
NM_013261	NM_013261 -> Q9UBK2-1	Q9UBK2	PRGC1_HUMAN	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1-alpha) (PPAR-gamma coactivator 1-alpha) (PPARGC-1-alpha) (Ligand effect modulator 6)	GO:0000302; GO:0000422; GO:0001659; GO:0001678; GO:0001933; GO:0002021; GO:0002931; GO:0003677; GO:0003712; GO:0003713; GO:0003723; GO:0005623; GO:0005634; GO:0005654; GO:0005719; GO:0006012; GO:0006094; GO:0006355; GO:0006367; GO:0006397; GO:0007005; GO:0007568; GO:0007586; GO:0007623; GO:0008134; GO:0008209; GO:0008380; GO:0009409; GO:0010628; GO:0010822; GO:0014732; GO:0014850; GO:0014878; GO:0014912; GO:0016605; GO:0016922; GO:0019395; GO:0021549; GO:0022626; GO:0022904; GO:0030331; GO:0030374; GO:0030521; GO:0030900; GO:0031490; GO:0031625; GO:0032922; GO:0034599; GO:0035066; GO:0035865; GO:0042594; GO:0042752; GO:0042975; GO:0043014; GO:0043025; GO:0043201; GO:0043231; GO:0043524; GO:0043565; GO:0045333; GO:0045722; GO:0045820; GO:0045893; GO:0045944; GO:0046321; GO:0048661; GO:0048662; GO:0050681; GO:0050821; GO:0050873; GO:0051091; GO:0051552; GO:0060612; GO:0065003; GO:0071222; GO:0071250; GO:0071313; GO:0071332; GO:0071333; GO:0071354; GO:0071356; GO:0071372; GO:0071392; GO:0071456; GO:0071560; GO:0071871; GO:0071873; GO:0090258; GO:0097009; GO:0097067; GO:0097440; GO:0120162; GO:1901215; GO:1901558; GO:1901857; GO:1901860; GO:1901863; GO:1904635; GO:1904637; GO:1904639; GO:1904640; GO:1990841; GO:1990843; GO:1990844; GO:1990845; GO:2000184; GO:2000272; GO:2000310; GO:2001171	apical dendrite [GO:0097440]; cell [GO:0005623]; cytosolic ribosome [GO:0022626]; interfibrillar mitochondrion [GO:1990844]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; subsarcolemmal mitochondrion [GO:1990843]; alpha-tubulin binding [GO:0043014]; androgen receptor binding [GO:0050681]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; adaptive thermogenesis [GO:1990845]; adipose tissue development [GO:0060612]; aging [GO:0007568]; androgen metabolic process [GO:0008209]; androgen receptor signaling pathway [GO:0030521]; autophagy of mitochondrion [GO:0000422]; brown fat cell differentiation [GO:0050873]; cellular glucose homeostasis [GO:0001678]; cellular respiration [GO:0045333]; cellular response to caffeine [GO:0071313]; cellular response to estradiol stimulus [GO:0071392]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-6 [GO:0071354]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitrite [GO:0071250]; cellular response to oxidative stress [GO:0034599]; cellular response to potassium ion [GO:0035865]; cellular response to resveratrol [GO:1904639]; cellular response to thyroid hormone stimulus [GO:0097067]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cerebellum development [GO:0021549]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; digestion [GO:0007586]; energy homeostasis [GO:0097009]; fatty acid oxidation [GO:0019395]; flavone metabolic process [GO:0051552]; forebrain development [GO:0030900]; galactose metabolic process [GO:0006012]; gluconeogenesis [GO:0006094]; mitochondrion organization [GO:0007005]; mRNA processing [GO:0006397]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular visceral epithelial cell apoptotic process [GO:1904635]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of mitochondrial DNA metabolic process [GO:1901860]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of muscle tissue development [GO:1901863]; positive regulation of progesterone biosynthetic process [GO:2000184]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; regulation of NMDA receptor activity [GO:2000310]; regulation of transcription, DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; response to cold [GO:0009409]; response to dietary excess [GO:0002021]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to leucine [GO:0043201]; response to metformin [GO:1901558]; response to methionine [GO:1904640]; response to muscle activity [GO:0014850]; response to norepinephrine [GO:0071873]; response to reactive oxygen species [GO:0000302]; response to starvation [GO:0042594]; RNA splicing [GO:0008380]; skeletal muscle atrophy [GO:0014732]; temperature homeostasis [GO:0001659]; transcription initiation from RNA polymerase II promoter [GO:0006367]	PPARGC1A LEM6 PGC1 PGC1A PPARGC1
NM_003875		A0A140VJK6	A0A140VJK6_HUMAN	Testicular tissue protein Li 82	GO:0003922; GO:0005524; GO:0005829; GO:0006541; GO:0016462	cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]	
NM_003875	NM_003875 -> P49915-1	P49915	GUAA_HUMAN	GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)	GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0006541; GO:0009113; GO:0009168; GO:0016462	cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	GMPS
NM_002395	NM_002395 -> P48163-1	P48163	MAOX_HUMAN	NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) (Malic enzyme 1)	GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005829; GO:0005975; GO:0006090; GO:0006108; GO:0008948; GO:0009055; GO:0009165; GO:0009725; GO:0009743; GO:0019216; GO:0030145; GO:0043531; GO:0050661; GO:0051287; GO:1902031	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxaloacetate decarboxylase activity [GO:0008948]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; nucleotide biosynthetic process [GO:0009165]; pyruvate metabolic process [GO:0006090]; regulation of lipid metabolic process [GO:0019216]; regulation of NADP metabolic process [GO:1902031]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725]	ME1
NM_002237		Q86Y85	Q86Y85_HUMAN	Potassium voltage-gated channel, subfamily G, member 1	GO:0005249; GO:0008076; GO:0034765; GO:0051260	voltage-gated potassium channel complex [GO:0008076]; voltage-gated potassium channel activity [GO:0005249]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	KCNG1
NM_002237	NM_002237 -> Q9UIX4-1	Q9UIX4	KCNG1_HUMAN	Potassium voltage-gated channel subfamily G member 1 (Voltage-gated potassium channel subunit Kv6.1) (kH2)	GO:0005249; GO:0005251; GO:0005267; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0051260; GO:0071805; GO:1902259	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259]	KCNG1
NM_006011		B2R9U8	B2R9U8_HUMAN	Alpha-2,8-sialyltransferase 8B 1 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2) (cDNA, FLJ94563, Homo sapiens sialyltransferase 8B (alpha-2, 8-sialyltransferase)(SIAT8B), mRNA)	GO:0003828; GO:0005769; GO:0005794; GO:0006486; GO:0016021; GO:0055037	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; protein glycosylation [GO:0006486]	ST8SIA2 hCG_27594
NM_006011		Q92186	SIA8B_HUMAN	Alpha-2,8-sialyltransferase 8B (EC 2.4.99.-) (Sialyltransferase 8B) (SIAT8-B) (Sialyltransferase St8Sia II) (ST8SiaII) (Sialyltransferase X) (STX)	GO:0000139; GO:0001574; GO:0003828; GO:0005769; GO:0005975; GO:0006464; GO:0006486; GO:0006491; GO:0007399; GO:0009311; GO:0016021; GO:0033691; GO:0055037	early endosome [GO:0005769]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialic acid binding [GO:0033691]; carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]	ST8SIA2 SIAT8B STX
NM_003539,NM_003542,NM_003544		B2R4R0	B2R4R0_HUMAN	Histone H4	GO:0000786; GO:0003677; GO:0005634; GO:0006352; GO:0046982	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]	HIST1H4H HIST1H4J HIST1H4L hCG_1640981
NM_003539,NM_003542,NM_003544		P62805	H4_HUMAN	Histone H4	GO:0000183; GO:0000228; GO:0000784; GO:0000786; GO:0000788; GO:0003677; GO:0003723; GO:0005576; GO:0005634; GO:0005654; GO:0006303; GO:0006334; GO:0006335; GO:0006336; GO:0006352; GO:0016020; GO:0016233; GO:0019904; GO:0032200; GO:0032991; GO:0034080; GO:0044267; GO:0045652; GO:0045653; GO:0045814; GO:0046982; GO:0051290; GO:0060964; GO:0070062	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nuclear nucleosome [GO:0000788]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; cellular protein metabolic process [GO:0044267]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin silencing at rDNA [GO:0000183]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; DNA-templated transcription, initiation [GO:0006352]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of megakaryocyte differentiation [GO:0045653]; nucleosome assembly [GO:0006334]; protein heterotetramerization [GO:0051290]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; telomere capping [GO:0016233]; telomere organization [GO:0032200]	H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4-16 HIST4H4
NM_001018111	NM_001018111 -> O00592-1	O00592	PODXL_HUMAN	Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1)	GO:0001726; GO:0005615; GO:0005730; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007162; GO:0016324; GO:0016477; GO:0022408; GO:0030027; GO:0030175; GO:0030335; GO:0031528; GO:0032534; GO:0033634; GO:0034451; GO:0036057; GO:0043231; GO:0045121; GO:0070062; GO:0072015; GO:0072175	apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; microvillus membrane [GO:0031528]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; slit diaphragm [GO:0036057]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; epithelial tube formation [GO:0072175]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; regulation of microvillus assembly [GO:0032534]	PODXL PCLP PCLP1
NM_001018111		Q96N83	Q96N83_HUMAN	Podocalyxin (Podocalyxin-like protein 1)	GO:0007155; GO:0007162; GO:0016021; GO:0016324; GO:0016477; GO:0022407; GO:0042995	apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of cell adhesion [GO:0007162]; regulation of cell-cell adhesion [GO:0022407]	
NM_181503		Q96B26	EXOS8_HUMAN	Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2) (OIP-2) (Ribosomal RNA-processing protein 43) (p9)	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006364; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043488; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]	EXOSC8 OIP2 RRP43
NM_005045	NM_005045 -> P78509-1	P78509	RELN_HUMAN	Reelin (EC 3.4.21.-)	GO:0000904; GO:0001764; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007616; GO:0008236; GO:0008306; GO:0010001; GO:0010976; GO:0014068; GO:0016358; GO:0018108; GO:0021511; GO:0021517; GO:0021766; GO:0021800; GO:0021819; GO:0030425; GO:0031012; GO:0032008; GO:0032793; GO:0038026; GO:0043005; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]	RELN
NM_002570		A2RQD9	A2RQD9_HUMAN	Proprotein convertase subtilisin/kexin type 6 (Fragment)	GO:0004252	serine-type endopeptidase activity [GO:0004252]	PCSK6
NM_002570	NM_002570 -> P29122-1	P29122	PCSK6_HUMAN	Proprotein convertase subtilisin/kexin type 6 (EC 3.4.21.-) (Paired basic amino acid cleaving enzyme 4) (Subtilisin-like proprotein convertase 4) (SPC4) (Subtilisin/kexin-like protease PACE4)	GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0007354; GO:0007368; GO:0008201; GO:0009100; GO:0009986; GO:0016020; GO:0016485; GO:0016486; GO:0030510; GO:0032455; GO:0032902; GO:0032940; GO:0048406; GO:0051004; GO:0062023; GO:0070268	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; nerve growth factor binding [GO:0048406]; serine-type endopeptidase activity [GO:0004252]; cornification [GO:0070268]; determination of left/right symmetry [GO:0007368]; glycoprotein metabolic process [GO:0009100]; nerve growth factor processing [GO:0032455]; nerve growth factor production [GO:0032902]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of BMP signaling pathway [GO:0030510]; regulation of lipoprotein lipase activity [GO:0051004]; secretion by cell [GO:0032940]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]	PCSK6 PACE4
NM_014720	NM_014720 -> Q9H2G2-1	Q9H2G2	SLK_HUMAN	STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2)	GO:0004674; GO:0005524; GO:0005737; GO:0006915; GO:0023014; GO:0030334; GO:0031122; GO:0031252; GO:0032147; GO:0042802; GO:0042803; GO:0042981; GO:0045296; GO:0046777; GO:0048471; GO:0051893; GO:0070062	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; signal transduction by protein phosphorylation [GO:0023014]	SLK KIAA0204 STK2
NM_024678	NM_024678 -> Q96I59-1	Q96I59	SYNM_HUMAN	Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS)	GO:0003676; GO:0004816; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006421	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421]	NARS2
NM_178006		A0A024RDV4	A0A024RDV4_HUMAN	START domain containing 13, isoform CRA_a	GO:0007165; GO:0008289	lipid binding [GO:0008289]; signal transduction [GO:0007165]	STARD13 hCG_32808
NM_178006	NM_178006 -> Q9Y3M8-1	Q9Y3M8	STA13_HUMAN	StAR-related lipid transfer protein 13 (46H23.2) (Deleted in liver cancer 2 protein) (DLC-2) (Rho GTPase-activating protein) (START domain-containing protein 13) (StARD13)	GO:0005096; GO:0005811; GO:0005829; GO:0007165; GO:0008289; GO:0031966; GO:0043542; GO:0051056; GO:0090051; GO:0097498	cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	STARD13 DLC2 GT650
NM_007074		A0A024R611	A0A024R611_HUMAN	Coronin	GO:0001772; GO:0001845; GO:0005769; GO:0005829; GO:0005911; GO:0006816; GO:0007015; GO:0008360; GO:0015629; GO:0030335; GO:0030424; GO:0030595; GO:0030833; GO:0031252; GO:0031339; GO:0032796; GO:0038180; GO:0042102; GO:0042802; GO:0043029; GO:0043524; GO:0048873; GO:0051015; GO:0051279; GO:0061502; GO:0071353; GO:0098978	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; leukocyte chemotaxis [GO:0030595]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagolysosome assembly [GO:0001845]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell proliferation [GO:0042102]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]	CORO1A hCG_1770704
NM_007074		P31146	COR1A_HUMAN	Coronin-1A (Coronin-like protein A) (Clipin-A) (Coronin-like protein p57) (Tryptophan aspartate-containing coat protein) (TACO)	GO:0001772; GO:0001845; GO:0001891; GO:0003723; GO:0003779; GO:0003785; GO:0005737; GO:0005769; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006816; GO:0006909; GO:0007015; GO:0008022; GO:0008092; GO:0008360; GO:0016020; GO:0016477; GO:0030027; GO:0030036; GO:0030335; GO:0030424; GO:0030595; GO:0030670; GO:0030864; GO:0031339; GO:0031589; GO:0032036; GO:0032796; GO:0032956; GO:0032991; GO:0038180; GO:0042102; GO:0042803; GO:0043029; GO:0043320; GO:0043524; GO:0043548; GO:0045087; GO:0045335; GO:0048873; GO:0050918; GO:0051015; GO:0051126; GO:0051279; GO:0061502; GO:0070062; GO:0071353; GO:0098978	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cytoskeletal protein binding [GO:0008092]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; homeostasis of number of cells within a tissue [GO:0048873]; innate immune response [GO:0045087]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; phagocytosis [GO:0006909]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of T cell proliferation [GO:0042102]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; uropod organization [GO:0032796]	CORO1A CORO1
NM_024704		A0A140VK74	A0A140VK74_HUMAN	Testis secretory sperm-binding protein Li 201a	GO:0003777; GO:0005524; GO:0007018; GO:0008017; GO:0035091	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol binding [GO:0035091]; microtubule-based movement [GO:0007018]	
NM_024704	NM_024704 -> Q96L93-1	Q96L93	KI16B_HUMAN	Kinesin-like protein KIF16B (Sorting nexin-23)	GO:0001704; GO:0001919; GO:0003777; GO:0005524; GO:0005547; GO:0005768; GO:0005769; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0017137; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0045335; GO:0071346; GO:0080025	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Rab GTPase binding [GO:0017137]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]	KIF16B C20orf23 KIAA1590 SNX23
NM_001099645		Q6P5R6	RL22L_HUMAN	60S ribosomal protein L22-like 1 (Large ribosomal subunit protein eL22-like 1)	GO:0002181; GO:0003723; GO:0003735; GO:0005840	ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]	RPL22L1
NM_032900	NM_032900 -> Q14CB8-1	Q14CB8	RHG19_HUMAN	Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19)	GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0043231; GO:0051056	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	ARHGAP19
NM_005124	NM_005124 -> P49790-1	P49790	NU153_HUMAN	Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153)	GO:0003677; GO:0005643; GO:0005654; GO:0005730; GO:0005829; GO:0006110; GO:0006406; GO:0006409; GO:0006606; GO:0008139; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031965; GO:0034399; GO:0042405; GO:0042802; GO:0043495; GO:0043657; GO:0044613; GO:0044615; GO:0046718; GO:0046832; GO:0046872; GO:0051292; GO:0060964; GO:0075732; GO:0075733; GO:1900034	cytosol [GO:0005829]; host cell [GO:0043657]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclear localization sequence binding [GO:0008139]; protein membrane anchor [GO:0043495]; structural constituent of nuclear pore [GO:0017056]; intracellular transport of virus [GO:0075733]; mRNA export from nucleus [GO:0006406]; negative regulation of RNA export from nucleus [GO:0046832]; nuclear pore complex assembly [GO:0051292]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of gene silencing by miRNA [GO:0060964]; regulation of glycolytic process [GO:0006110]; tRNA export from nucleus [GO:0006409]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732]; viral process [GO:0016032]; viral transcription [GO:0019083]	NUP153
NM_003234		A8K6Q8	A8K6Q8_HUMAN	cDNA FLJ75881, highly similar to Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA	GO:0004998; GO:0005623; GO:0005886; GO:0006879; GO:0006898; GO:0016021; GO:0033572	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferrin receptor activity [GO:0004998]; cellular iron ion homeostasis [GO:0006879]; receptor-mediated endocytosis [GO:0006898]; transferrin transport [GO:0033572]	
NM_003234		P02786	TFR1_HUMAN	Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form (sTfR)]	GO:0001618; GO:0003723; GO:0003725; GO:0004998; GO:0005576; GO:0005615; GO:0005623; GO:0005768; GO:0005769; GO:0005886; GO:0005887; GO:0005905; GO:0006826; GO:0006879; GO:0009897; GO:0009986; GO:0010008; GO:0016020; GO:0016323; GO:0030316; GO:0030665; GO:0030890; GO:0031410; GO:0031623; GO:0033572; GO:0035690; GO:0042102; GO:0042470; GO:0042802; GO:0042803; GO:0045780; GO:0045830; GO:0048471; GO:0055037; GO:0061024; GO:0070062; GO:0072562; GO:1903561; GO:1990712; GO:1990830	basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell [GO:0005623]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; virus receptor activity [GO:0001618]; cellular iron ion homeostasis [GO:0006879]; cellular response to drug [GO:0035690]; cellular response to leukemia inhibitory factor [GO:1990830]; iron ion transport [GO:0006826]; membrane organization [GO:0061024]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of isotype switching [GO:0045830]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; transferrin transport [GO:0033572]	TFRC
NM_003234		Q7Z3E0	Q7Z3E0_HUMAN	Uncharacterized protein DKFZp686O0451			DKFZp686O0451
NM_001017995		A1X283	SPD2B_HUMAN	SH3 and PX domain-containing protein 2B (Adapter protein HOFI) (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains)	GO:0001501; GO:0001654; GO:0002051; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0010628; GO:0016176; GO:0022617; GO:0030054; GO:0032266; GO:0035091; GO:0040018; GO:0042169; GO:0042995; GO:0045600; GO:0048705; GO:0051496; GO:0060348; GO:0060378; GO:0060612; GO:0070273; GO:0071800; GO:0072657; GO:0080025; GO:1904179; GO:1904888	cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; adipose tissue development [GO:0060612]; bone development [GO:0060348]; cranial skeletal system development [GO:1904888]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; osteoblast fate commitment [GO:0002051]; podosome assembly [GO:0071800]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to membrane [GO:0072657]; regulation of brood size [GO:0060378]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; superoxide metabolic process [GO:0006801]	SH3PXD2B FAD49 KIAA1295 TKS4
NM_030640		A0A024RAR2	A0A024RAR2_HUMAN	Dual specificity phosphatase 16, isoform CRA_a	GO:0004725; GO:0005654; GO:0005829; GO:0017017	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]	DUSP16 hCG_27696
NM_030640	NM_030640 -> Q9BY84-1	Q9BY84	DUS16_HUMAN	Dual specificity protein phosphatase 16 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 7) (MAP kinase phosphatase 7) (MKP-7)	GO:0000188; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0016311; GO:0016791; GO:0017017; GO:0031410; GO:0045204; GO:0045209	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; MAPK export from nucleus [GO:0045204]; MAPK phosphatase export from nucleus, leptomycin B sensitive [GO:0045209]	DUSP16 KIAA1700 MKP7
NM_022073		Q9H6Z9	EGLN3_HUMAN	Egl nine homolog 3 (EC 1.14.11.29) (HPH-1) (Hypoxia-inducible factor prolyl hydroxylase 3) (HIF-PH3) (HIF-prolyl hydroxylase 3) (HPH-3) (Prolyl hydroxylase domain-containing protein 3) (PHD3)	GO:0001666; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0016706; GO:0018126; GO:0018401; GO:0031418; GO:0031545; GO:0042127; GO:0043523; GO:0061418	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein hydroxylation [GO:0018126]; regulation of cell population proliferation [GO:0042127]; regulation of neuron apoptotic process [GO:0043523]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]	EGLN3
NM_174899	NM_174899 -> Q8NEA4-1	Q8NEA4	FBX36_HUMAN	F-box only protein 36			FBXO36 FBX36
NM_004629		O15287	FANCG_HUMAN	Fanconi anemia group G protein (Protein FACG) (DNA repair protein XRCC9)	GO:0001541; GO:0003684; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0006281; GO:0007005; GO:0007286; GO:0009314; GO:0036297; GO:0043240	cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; damaged DNA binding [GO:0003684]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; mitochondrion organization [GO:0007005]; ovarian follicle development [GO:0001541]; response to radiation [GO:0009314]; spermatid development [GO:0007286]	FANCG XRCC9
NM_004629		Q53XM5	Q53XM5_HUMAN	Fanconi anemia complementation group G isoform 1 (Fanconi anemia, complementation group G) (Fanconi anemia, complementation group G, isoform CRA_a) (cDNA, FLJ93448, Homo sapiens Fanconi anemia, complementation group G (FANCG), mRNA)	GO:0001541; GO:0005730; GO:0005829; GO:0005886; GO:0007286; GO:0009314; GO:0036297; GO:0043240	cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; interstrand cross-link repair [GO:0036297]; ovarian follicle development [GO:0001541]; response to radiation [GO:0009314]; spermatid development [GO:0007286]	FANCG hCG_20469
NM_020937	NM_020937 -> Q8IYD8-1	Q8IYD8	FANCM_HUMAN	Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog)	GO:0000712; GO:0003677; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0031297; GO:0036297; GO:0043240; GO:0071821; GO:1902527	FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]	FANCM KIAA1596
NM_001552		A0A024R1U8	A0A024R1U8_HUMAN	Insulin-like growth factor binding protein 4, isoform CRA_a	GO:0001558; GO:0005520; GO:0005615; GO:0006954; GO:0010906; GO:0043410; GO:0043568; GO:0044342	extracellular space [GO:0005615]; insulin-like growth factor binding [GO:0005520]; inflammatory response [GO:0006954]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; type B pancreatic cell proliferation [GO:0044342]	IGFBP4 hCG_1643839
NM_001552	NM_001552 -> P22692-1	P22692	IBP4_HUMAN	Insulin-like growth factor-binding protein 4 (IBP-4) (IGF-binding protein 4) (IGFBP-4)	GO:0001558; GO:0005102; GO:0005576; GO:0005615; GO:0005788; GO:0006954; GO:0007165; GO:0010906; GO:0031994; GO:0031995; GO:0043410; GO:0043567; GO:0043568; GO:0043687; GO:0044267; GO:0044342; GO:0090090	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]; cellular protein metabolic process [GO:0044267]; inflammatory response [GO:0006954]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; post-translational protein modification [GO:0043687]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342]	IGFBP4 IBP4
NM_001093729	NM_001093729 -> Q68D86-1	Q68D86	C102B_HUMAN	Coiled-coil domain-containing protein 102B			CCDC102B C18orf14
NM_152309	NM_152309 -> Q6ZUJ8-1	Q6ZUJ8	BCAP_HUMAN	Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1)	GO:0005102; GO:0005829; GO:0005886; GO:0014068; GO:0016020; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0042802; GO:0050727; GO:0051897	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]	PIK3AP1 BCAP
NM_152309		Q86YV3	Q86YV3_HUMAN	FLJ00308 protein (Fragment)			FLJ00308
NM_182503	NM_182503 -> Q7Z6V5-1	Q7Z6V5	ADAT2_HUMAN	tRNA-specific adenosine deaminase 2 (EC 3.5.4.33) (Deaminase domain-containing protein 1) (tRNA-specific adenosine-34 deaminase subunit ADAT2)	GO:0002100; GO:0005654; GO:0006400; GO:0008270; GO:0052717; GO:0052718	nucleoplasm [GO:0005654]; tRNA-specific adenosine-34 deaminase complex [GO:0052718]; tRNA-specific adenosine-34 deaminase activity [GO:0052717]; zinc ion binding [GO:0008270]; tRNA modification [GO:0006400]; tRNA wobble adenosine to inosine editing [GO:0002100]	ADAT2 DEADC1
NM_017769		Q7L622	G2E3_HUMAN	G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)	GO:0004842; GO:0005730; GO:0005794; GO:0005829; GO:0006915; GO:0007275; GO:0043231; GO:0046872	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; multicellular organism development [GO:0007275]	G2E3 KIAA1333
NM_002184	NM_002184 -> P40189-1	P40189	IL6RB_HUMAN	Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)	GO:0002675; GO:0002821; GO:0004896; GO:0004897; GO:0004921; GO:0005127; GO:0005576; GO:0005615; GO:0005886; GO:0005896; GO:0005900; GO:0005977; GO:0008284; GO:0008593; GO:0009897; GO:0010575; GO:0010613; GO:0016020; GO:0016032; GO:0019221; GO:0019838; GO:0019955; GO:0019970; GO:0030425; GO:0034097; GO:0038165; GO:0042102; GO:0042531; GO:0042802; GO:0042803; GO:0043025; GO:0043066; GO:0043235; GO:0045509; GO:0045669; GO:0048711; GO:0048861; GO:0070062; GO:0070102; GO:0070104; GO:0070106; GO:0070110; GO:0070120; GO:0070757	ciliary neurotrophic factor receptor complex [GO:0070110]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; oncostatin-M receptor complex [GO:0005900]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor activity [GO:0004897]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-27 receptor activity [GO:0045509]; protein homodimerization activity [GO:0042803]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; glycogen metabolic process [GO:0005977]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; leukemia inhibitory factor signaling pathway [GO:0048861]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of Notch signaling pathway [GO:0008593]; response to cytokine [GO:0034097]; viral process [GO:0016032]	IL6ST
NM_002184		Q17RA0	Q17RA0_HUMAN	Interleukin 6 signal transducer (Gp130, oncostatin M receptor)	GO:0004896; GO:0016021	integral component of membrane [GO:0016021]; cytokine receptor activity [GO:0004896]	IL6ST
NM_015069		B3KNG7	B3KNG7_HUMAN	cDNA FLJ14573 fis, clone NT2RM4000734, highly similar to Homo sapiens zinc finger protein 423 (ZNF423), mRNA	GO:0003676	nucleic acid binding [GO:0003676]	
NM_015069	NM_015069 -> Q2M1K9-1	Q2M1K9	ZN423_HUMAN	Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (hOAZ) (Smad- and Olf-interacting zinc finger protein)	GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0030154; GO:0030513; GO:0045892; GO:0045893; GO:0046872; GO:0120163	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]	ZNF423 KIAA0760 NPHP14 OAZ
NM_024051		A0A090N7V5	A0A090N7V5_HUMAN	Chromosome 7 open reading frame 24	GO:0003839	gamma-glutamylcyclotransferase activity [GO:0003839]	C7orf24 tcag7.1010
NM_024051	NM_024051 -> O75223-1	O75223	GGCT_HUMAN	Gamma-glutamylcyclotransferase (EC 4.3.2.9) (Cytochrome c-releasing factor 21)	GO:0001836; GO:0003839; GO:0005829; GO:0006750; GO:0042803; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]; glutathione biosynthetic process [GO:0006750]; release of cytochrome c from mitochondria [GO:0001836]	GGCT C7orf24 CRF21
NM_175861	NM_175861 -> Q8IUR5-1	Q8IUR5	TMTC1_HUMAN	Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 1)	GO:0000030; GO:0004169; GO:0005783; GO:0006396; GO:0016021; GO:0035269	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396]	TMTC1 ARG99
NM_005923	NM_005923 -> Q99683-1	Q99683	M3K5_HUMAN	Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5)	GO:0000165; GO:0000186; GO:0000287; GO:0002931; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005829; GO:0006468; GO:0007254; GO:0007257; GO:0008631; GO:0009897; GO:0010666; GO:0016032; GO:0019901; GO:0019903; GO:0019904; GO:0032991; GO:0034198; GO:0034976; GO:0038066; GO:0042060; GO:0042802; GO:0042803; GO:0043065; GO:0043280; GO:0043507; GO:0045087; GO:0045663; GO:0045893; GO:0046330; GO:0051403; GO:0070059; GO:0070301; GO:0071356; GO:0072577; GO:0097190; GO:0097300; GO:1900745; GO:1901216; GO:1902170; GO:1902911; GO:1904707; GO:1990604	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of MAPKK activity [GO:0000186]; apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; viral process [GO:0016032]; wound healing [GO:0042060]	MAP3K5 ASK1 MAPKKK5 MEKK5
NM_018242	NM_018242 -> Q96FL8-1	Q96FL8	S47A1_HUMAN	Multidrug and toxin extrusion protein 1 (MATE-1) (hMATE-1) (Solute carrier family 47 member 1)	GO:0005886; GO:0006855; GO:0015297; GO:0015695; GO:0016020; GO:0016021; GO:0022857; GO:0031982; GO:0042910; GO:0055085	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; antiporter activity [GO:0015297]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; drug transmembrane transport [GO:0006855]; organic cation transport [GO:0015695]; transmembrane transport [GO:0055085]	SLC47A1 MATE1
NM_006317	NM_006317 -> P80723-1	P80723	BASP1_HUMAN	Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22)	GO:0003714; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0007356; GO:0008406; GO:0016607; GO:0019904; GO:0021762; GO:0030054; GO:0030426; GO:0031982; GO:0044212; GO:0045892; GO:0060231; GO:0060421; GO:0060539; GO:0070062; GO:0072075; GO:0072112; GO:2001076	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; diaphragm development [GO:0060539]; glomerular visceral epithelial cell differentiation [GO:0072112]; gonad development [GO:0008406]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchyme development [GO:0072075]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of heart growth [GO:0060421]; positive regulation of metanephric ureteric bud development [GO:2001076]; substantia nigra development [GO:0021762]; thorax and anterior abdomen determination [GO:0007356]	BASP1 NAP22
NM_005620		P31949	S10AB_HUMAN	Protein S100-A11 (Calgizzarin) (Metastatic lymph node gene 70 protein) (MLN 70) (Protein S100-C) (S100 calcium-binding protein A11) [Cleaved into: Protein S100-A11, N-terminally processed]	GO:0001726; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005913; GO:0007165; GO:0008156; GO:0008285; GO:0034774; GO:0042803; GO:0043312; GO:0044548; GO:0048306; GO:0070062; GO:0098641	cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165]	S100A11 MLN70 S100C
NM_005620		V9HWH9	V9HWH9_HUMAN	Protein S100 (S100 calcium-binding protein)	GO:0005509; GO:0005737; GO:0042127; GO:0048306	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; regulation of cell population proliferation [GO:0042127]	HEL-S-43 S100A11 hCG_16921
NM_006708	NM_006708 -> Q04760-1	Q04760	LGUL_HUMAN	Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)	GO:0004462; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006090; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; pyruvate metabolic process [GO:0006090]; regulation of transcription by RNA polymerase II [GO:0006357]	GLO1
NM_006708		X5DNM4	X5DNM4_HUMAN	Lactoylglutathione lyase (EC 4.4.1.5) (Glyoxalase I) (Fragment)	GO:0004462; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]	GLO1 hCG_32350
NM_198150		Q6UWY0	ARSK_HUMAN	Arylsulfatase K (ASK) (EC 3.1.6.-) (Telethon sulfatase)	GO:0004065; GO:0005576; GO:0005788; GO:0046872	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	ARSK TSULF UNQ630/PRO1246
NM_014878		Q15397	PUM3_HUMAN	Pumilio homolog 3 (HBV X-transactivated gene 5 protein) (HBV XAg-transactivated protein 5) (Minor histocompatibility antigen HA-8) (HLA-HA8)	GO:0003677; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005783; GO:0010835	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835]	PUM3 cPERP-C KIAA0020 PUF-A XTP5
NM_194313	NM_194313 -> Q5T7B8-1	Q5T7B8	KIF24_HUMAN	Kinesin-like protein KIF24	GO:0003777; GO:0005524; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0016887; GO:0032991; GO:0042802; GO:0060271; GO:0097711	centriole [GO:0005814]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]	KIF24 C9orf48
NM_003615	NM_003615 -> Q9Y6M7-1	Q9Y6M7	S4A7_HUMAN	Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7)	GO:0005452; GO:0005623; GO:0005886; GO:0008510; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0031410; GO:0032420; GO:0045202; GO:0051453; GO:0060117	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]	SLC4A7 BT NBC2 NBC2B NBC3 NBCn1 SBC2 SLC4A6
NM_018469	NM_018469 -> Q8IWB9-2	Q8IWB9	TEX2_HUMAN	Testis-expressed protein 2 (Transmembrane protein 96)	GO:0005783; GO:0006665; GO:0006869; GO:0007165; GO:0008289; GO:0016021	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665]	TEX2 KIAA1738 TMEM96
NM_000527		A0A024R7D5	A0A024R7D5_HUMAN	Low density lipoprotein receptor (Familial hypercholesterolemia), isoform CRA_b	GO:0001540; GO:0005041; GO:0005509; GO:0005623; GO:0005764; GO:0005769; GO:0005770; GO:0006898; GO:0006909; GO:0007616; GO:0008203; GO:0009986; GO:0010628; GO:0010629; GO:0010867; GO:0010899; GO:0015914; GO:0016021; GO:0016323; GO:0030169; GO:0030229; GO:0034383; GO:0034384; GO:0036477; GO:0042159; GO:0042632; GO:0045177; GO:0048844; GO:0050729; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0090181; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; very-low-density lipoprotein particle receptor activity [GO:0030229]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; response to caloric restriction [GO:0061771]	LDLR hCG_29965
NM_000527	NM_000527 -> P01130-1	P01130	LDLR_HUMAN	Low-density lipoprotein receptor (LDL receptor)	GO:0001540; GO:0001618; GO:0002020; GO:0005041; GO:0005509; GO:0005623; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0006909; GO:0007616; GO:0008203; GO:0009897; GO:0009986; GO:0010008; GO:0010628; GO:0010629; GO:0010867; GO:0010899; GO:0015914; GO:0016020; GO:0016323; GO:0030169; GO:0030229; GO:0030299; GO:0030301; GO:0030669; GO:0032050; GO:0034362; GO:0034381; GO:0034382; GO:0034383; GO:0034384; GO:0036020; GO:0036477; GO:0042159; GO:0042632; GO:0042802; GO:0043235; GO:0045177; GO:0048844; GO:0050729; GO:0051246; GO:0051248; GO:0061024; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0071404; GO:0090118; GO:0090181; GO:0097242; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907; GO:1990666	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; membrane [GO:0016020]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; virus receptor activity [GO:0001618]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron remnant clearance [GO:0034382]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; membrane organization [GO:0061024]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771]	LDLR
NM_006255	NM_006255 -> P24723-1	P24723	KPCL_HUMAN	Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta)	GO:0004674; GO:0004697; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0010744; GO:0018105; GO:0019899; GO:0030168; GO:0034351; GO:0035556; GO:0045618; GO:0046872; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:1903078; GO:2000810	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; platelet activation [GO:0030168]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	PRKCH PKCL PRKCL
NM_016447		A0A024RA25	A0A024RA25_HUMAN	Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6), isoform CRA_c	GO:0005886	plasma membrane [GO:0005886]	MPP6 hCG_38837
NM_016447		Q9NZW5	MPP6_HUMAN	MAGUK p55 subfamily member 6 (Veli-associated MAGUK 1) (VAM-1)	GO:0005886; GO:0016020; GO:0065003; GO:0070062	extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex assembly [GO:0065003]	MPP6 VAM1
NM_001126		A0A024R5Q7	A0A024R5Q7_HUMAN	Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2)	GO:0000287; GO:0004019; GO:0005525; GO:0005829; GO:0005886; GO:0006531; GO:0014074; GO:0044208; GO:0046040; GO:0060359; GO:0071257	cytosol [GO:0005829]; plasma membrane [GO:0005886]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; 'de novo' AMP biosynthetic process [GO:0044208]; aspartate metabolic process [GO:0006531]; cellular response to electrical stimulus [GO:0071257]; IMP metabolic process [GO:0046040]; response to ammonium ion [GO:0060359]; response to purine-containing compound [GO:0014074]	ADSS ADSS2 hCG_15389
NM_001126		P30520	PURA2_HUMAN	Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2)	GO:0000287; GO:0002376; GO:0004019; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006167; GO:0006531; GO:0009168; GO:0014074; GO:0042301; GO:0044208; GO:0046040; GO:0060359; GO:0070062; GO:0071257	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; 'de novo' AMP biosynthetic process [GO:0044208]; AMP biosynthetic process [GO:0006167]; aspartate metabolic process [GO:0006531]; cellular response to electrical stimulus [GO:0071257]; immune system process [GO:0002376]; IMP metabolic process [GO:0046040]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to ammonium ion [GO:0060359]; response to purine-containing compound [GO:0014074]	ADSS2 ADSS
NM_018086		Q5HY92	FIGN_HUMAN	Fidgetin	GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005874; GO:0007049; GO:0008022; GO:0008568; GO:0010569; GO:0016363; GO:0016887; GO:0031122; GO:0051301	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; regulation of double-strand break repair via homologous recombination [GO:0010569]	FIGN
NM_001128211	NM_001128211 -> Q96RS6-2	Q96RS6	NUDC1_HUMAN	NudC domain-containing protein 1 (Chronic myelogenous leukemia tumor antigen 66) (Tumor antigen CML66)	GO:0002376; GO:0005654; GO:0005829	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; immune system process [GO:0002376]	NUDCD1 CML66
NM_018640		A0A024RAT1	A0A024RAT1_HUMAN	LIM domain only 3 (Rhombotin-like 2), isoform CRA_b	GO:0046872	metal ion binding [GO:0046872]	LMO3 hCG_24819
NM_018640	NM_018640 -> Q8TAP4-1	Q8TAP4	LMO3_HUMAN	LIM domain only protein 3 (LMO-3) (Neuronal-specific transcription factor DAT1) (Rhombotin-3)	GO:0005737; GO:0035360; GO:0045600; GO:0046872; GO:0070373; GO:2000324	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]	LMO3 RBTN3 RBTNL2 RHOM3
NM_003707		A0A384MTR5	A0A384MTR5_HUMAN	RuvB-like helicase (EC 3.6.4.12)	GO:0001094; GO:0005524; GO:0006281; GO:0006310; GO:0031011; GO:0035267; GO:0043139; GO:0043531; GO:0051117; GO:0097255; GO:1990904	Ino80 complex [GO:0031011]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; TFIID-class transcription factor complex binding [GO:0001094]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]	
NM_003707	NM_003707 -> Q9Y265-1	Q9Y265	RUVB1_HUMAN	RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein) (ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238) (NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha) (TAP54-alpha)	GO:0000492; GO:0000812; GO:0001094; GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006310; GO:0006338; GO:0006357; GO:0007049; GO:0007283; GO:0016020; GO:0016363; GO:0016573; GO:0016579; GO:0016887; GO:0017025; GO:0031011; GO:0034080; GO:0035267; GO:0040008; GO:0043139; GO:0043531; GO:0043967; GO:0043968; GO:0045296; GO:0051117; GO:0051301; GO:0070062; GO:0071339; GO:0090263; GO:0097255; GO:1904837; GO:1904874; GO:1990904	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]; 5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; beta-catenin-TCF complex assembly [GO:1904837]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; protein deubiquitination [GO:0016579]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	RUVBL1 INO80H NMP238 TIP49 TIP49A
NM_001010875		B3KSR0	B3KSR0_HUMAN	cDNA FLJ36814 fis, clone ASTRO2003316, highly similar to Homo sapiens solute carrier family 25, member 30 (SLC25A30), mRNA	GO:0006839; GO:0016021; GO:0031966	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial transport [GO:0006839]	
NM_001010875		B3KTE8	B3KTE8_HUMAN	cDNA FLJ38146 fis, clone D9OST2003594, highly similar to Homo sapiens solute carrier family 25, member 30 (SLC25A30), mRNA	GO:0006839; GO:0016021; GO:0031966	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial transport [GO:0006839]	
NM_001010875	NM_001010875 -> Q5SVS4-1	Q5SVS4	KMCP1_HUMAN	Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30)	GO:0005739; GO:0005743; GO:0006839; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial transport [GO:0006839]	SLC25A30 KMCP1
NM_014431		A0A024QZM5	A0A024QZM5_HUMAN	KIAA1274, isoform CRA_a			KIAA1274 hCG_23658
NM_014431		Q9ULE6	PALD_HUMAN	Paladin	GO:0004725; GO:0005737; GO:0005829	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein tyrosine phosphatase activity [GO:0004725]	PALD1 KIAA1274 PALD
NM_138809		Q96DG6	CMBL_HUMAN	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	GO:0005829; GO:0006805; GO:0016787; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; hydrolase activity [GO:0016787]; xenobiotic metabolic process [GO:0006805]	CMBL
NM_007018	NM_007018 -> Q7Z7A1-1	Q7Z7A1	CNTRL_HUMAN	Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110)	GO:0000086; GO:0005813; GO:0005815; GO:0005829; GO:0008092; GO:0010389; GO:0016020; GO:0051301; GO:0051493; GO:0090543; GO:0097711; GO:0120103	centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; cytoskeletal protein binding [GO:0008092]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cytoskeleton organization [GO:0051493]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	CNTRL CEP1 CEP110
NM_014325		A0A024RBI5	A0A024RBI5_HUMAN	Coronin	GO:0015629; GO:0030036; GO:0051015	actin cytoskeleton [GO:0015629]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]	CORO1C hCG_15695
NM_014325	NM_014325 -> Q9ULV4-1	Q9ULV4	COR1C_HUMAN	Coronin-1C (Coronin-3) (hCRNN4)	GO:0001755; GO:0001932; GO:0001933; GO:0005925; GO:0005938; GO:0006909; GO:0007015; GO:0007165; GO:0010008; GO:0010632; GO:0010633; GO:0010762; GO:0015629; GO:0016197; GO:0016328; GO:0016477; GO:0016600; GO:0030017; GO:0030027; GO:0032587; GO:0042383; GO:0044387; GO:0045184; GO:0045202; GO:0048365; GO:0051015; GO:0051893; GO:0051895; GO:0090148; GO:0090630; GO:0097750; GO:0140285; GO:1900024; GO:1900025; GO:1900027; GO:2000394	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202]; actin filament binding [GO:0051015]; Rac GTPase binding [GO:0048365]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165]	CORO1C CRN2 CRNN4
NM_002097	NM_002097 -> Q92664-1	Q92664	TF3A_HUMAN	Transcription factor IIIA (TFIIIA)	GO:0003677; GO:0005654; GO:0006383; GO:0008097; GO:0009303; GO:0042273; GO:0046872	nucleoplasm [GO:0005654]; 5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ribosomal large subunit biogenesis [GO:0042273]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]	GTF3A
NM_001902	NM_001902 -> P32929-1	P32929	CGL_HUMAN	Cystathionine gamma-lyase (EC 4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase)	GO:0000098; GO:0004123; GO:0005516; GO:0005737; GO:0005829; GO:0006534; GO:0016846; GO:0018272; GO:0019343; GO:0019344; GO:0019346; GO:0030170; GO:0030968; GO:0042802; GO:0043123; GO:0044524; GO:0044540; GO:0051092; GO:0051289; GO:0070062; GO:0070814; GO:0080146; GO:1904831; GO:1990830; GO:2001234	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; calmodulin binding [GO:0005516]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; identical protein binding [GO:0042802]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cellular response to leukemia inhibitory factor [GO:1990830]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; endoplasmic reticulum unfolded protein response [GO:0030968]; hydrogen sulfide biosynthetic process [GO:0070814]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of aortic smooth muscle cell differentiation [GO:1904831]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein homotetramerization [GO:0051289]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346]	CTH
NM_014412		A0A024R904	A0A024R904_HUMAN	Calcyclin binding protein, isoform CRA_a	GO:0005641; GO:0005654; GO:0005829; GO:0007568; GO:0015631; GO:0019005; GO:0019904; GO:0031625; GO:0043005; GO:0044297; GO:0044548; GO:0045740; GO:0055007; GO:0060416; GO:0060548; GO:0071277; GO:1990830	cell body [GO:0044297]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; protein domain specific binding [GO:0019904]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; aging [GO:0007568]; cardiac muscle cell differentiation [GO:0055007]; cellular response to calcium ion [GO:0071277]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell death [GO:0060548]; positive regulation of DNA replication [GO:0045740]; response to growth hormone [GO:0060416]	CACYBP hCG_2024873
NM_014412	NM_014412 -> Q9HB71-1	Q9HB71	CYBP_HUMAN	Calcyclin-binding protein (CacyBP) (hCacyBP) (S100A6-binding protein) (Siah-interacting protein)	GO:0005634; GO:0005641; GO:0005654; GO:0005829; GO:0007507; GO:0007568; GO:0015631; GO:0019005; GO:0019904; GO:0030877; GO:0031625; GO:0042803; GO:0043005; GO:0044297; GO:0044548; GO:0045740; GO:0055007; GO:0060416; GO:0060548; GO:0070062; GO:0071277; GO:1990830	beta-catenin destruction complex [GO:0030877]; cell body [GO:0044297]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; aging [GO:0007568]; cardiac muscle cell differentiation [GO:0055007]; cellular response to calcium ion [GO:0071277]; cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507]; negative regulation of cell death [GO:0060548]; positive regulation of DNA replication [GO:0045740]; response to growth hormone [GO:0060416]	CACYBP S100A6BP SIP PNAS-107
NM_020382	NM_020382 -> Q9NQR1-2	Q9NQR1	KMT5A_HUMAN	N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.43) (Lysine N-methyltransferase 5A) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8)	GO:0000122; GO:0002039; GO:0003714; GO:0005654; GO:0005694; GO:0005829; GO:0007049; GO:0016278; GO:0016279; GO:0018024; GO:0018026; GO:0042799; GO:0043516; GO:0045892; GO:0051301; GO:1901796	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]	KMT5A PRSET7 SET07 SET8 SETD8
NM_006270		A0A024QZF2	A0A024QZF2_HUMAN	Related RAS viral (R-ras) oncogene homolog, isoform CRA_a	GO:0003924; GO:0005525; GO:0007165; GO:0016020; GO:0030336	membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of cell migration [GO:0030336]; signal transduction [GO:0007165]	RRAS hCG_21124
NM_006270		P10301	RRAS_HUMAN	Ras-related protein R-Ras (p23)	GO:0002521; GO:0003924; GO:0005525; GO:0005886; GO:0005925; GO:0007265; GO:0019003; GO:0030336; GO:0044877; GO:0045766; GO:0051896; GO:0060325; GO:0070062; GO:0070372	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; face morphogenesis [GO:0060325]; leukocyte differentiation [GO:0002521]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; Ras protein signal transduction [GO:0007265]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein kinase B signaling [GO:0051896]	RRAS
NM_080491	NM_080491 -> Q9UQC2-1	Q9UQC2	GAB2_HUMAN	GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2) (pp100)	GO:0005068; GO:0005547; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008284; GO:0019221; GO:0030316; GO:0038095; GO:0043306; GO:0043325; GO:0048015	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; axon guidance [GO:0007411]; cytokine-mediated signaling pathway [GO:0019221]; Fc-epsilon receptor signaling pathway [GO:0038095]; osteoclast differentiation [GO:0030316]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mast cell degranulation [GO:0043306]	GAB2 KIAA0571
NM_178013		A0A024R6J9	A0A024R6J9_HUMAN	Proline rich membrane anchor 1, isoform CRA_a	GO:0016021	integral component of membrane [GO:0016021]	PRIMA1 hCG_1658529
NM_178013	NM_178013 -> Q86XR5-1	Q86XR5	PRIMA_HUMAN	Proline-rich membrane anchor 1 (PRiMA)	GO:0005886; GO:0016021; GO:0030054; GO:0042135; GO:0045202	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; neurotransmitter catabolic process [GO:0042135]	PRIMA1
NM_007368	NM_007368 -> Q14644-1	Q14644	RASA3_HUMAN	Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein)	GO:0000165; GO:0005096; GO:0005623; GO:0005829; GO:0007165; GO:0015278; GO:0031235; GO:0046580; GO:0046872	cell [GO:0005623]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; MAPK cascade [GO:0000165]; negative regulation of Ras protein signal transduction [GO:0046580]; signal transduction [GO:0007165]	RASA3
NM_004111	NM_004111 -> P39748-1	P39748	FEN1_HUMAN	Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1)	GO:0000287; GO:0000724; GO:0000784; GO:0003677; GO:0003684; GO:0003690; GO:0004519; GO:0004523; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006260; GO:0006281; GO:0006284; GO:0006302; GO:0007613; GO:0008309; GO:0008409; GO:0009650; GO:0016020; GO:0017108; GO:0030145; GO:0032201; GO:0032991; GO:0043137; GO:0045876; GO:0048256; GO:0090305	membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; memory [GO:0007613]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of sister chromatid cohesion [GO:0045876]; telomere maintenance via semi-conservative replication [GO:0032201]; UV protection [GO:0009650]	FEN1 RAD2
NM_004111		Q6FHX6	Q6FHX6_HUMAN	Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1)	GO:0000287; GO:0003677; GO:0005654; GO:0005730; GO:0005739; GO:0006260; GO:0006284; GO:0007613; GO:0008409; GO:0017108; GO:0043137	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; memory [GO:0007613]	FEN1 hCG_40848
NM_024322	NM_024322 -> Q9BU64-1	Q9BU64	CENPO_HUMAN	Centromere protein O (CENP-O) (Interphase centromere complex protein 36)	GO:0000778; GO:0005654; GO:0005829; GO:0016604; GO:0031511; GO:0034080	condensed nuclear chromosome kinetochore [GO:0000778]; cytosol [GO:0005829]; Mis6-Sim4 complex [GO:0031511]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; CENP-A containing nucleosome assembly [GO:0034080]	CENPO ICEN36 MCM21R
NM_015984	NM_015984 -> Q9Y5K5-1	Q9Y5K5	UCHL5_HUMAN	Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5)	GO:0000502; GO:0003723; GO:0004843; GO:0004866; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0006511; GO:0016579; GO:0031011; GO:0032435; GO:0061136; GO:0070628	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; RNA binding [GO:0003723]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511]	UCHL5 UCH37 AD-019 CGI-70
NM_014212		O43248	HXC11_HUMAN	Homeobox protein Hox-C11 (Homeobox protein Hox-3H)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001656; GO:0001759; GO:0005654; GO:0005829; GO:0007492; GO:0009952; GO:0009954; GO:0042733; GO:0045944; GO:0060272	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal joint morphogenesis [GO:0060272]; endoderm development [GO:0007492]; metanephros development [GO:0001656]; organ induction [GO:0001759]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]	HOXC11 HOX3H
NM_001084		O60568	PLOD3_HUMAN	Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]	GO:0001701; GO:0001886; GO:0005506; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005794; GO:0005802; GO:0006493; GO:0008104; GO:0008475; GO:0017185; GO:0021915; GO:0030199; GO:0031418; GO:0032870; GO:0032963; GO:0033823; GO:0042311; GO:0046947; GO:0048730; GO:0050211; GO:0060425; GO:0062023; GO:0070062; GO:0070831	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]	PLOD3
NM_001084		Q9UG85	Q9UG85_HUMAN	Uncharacterized protein DKFZp564O1822 (Fragment)	GO:0005506; GO:0008475; GO:0031418	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	DKFZp564O1822
NM_052852		Q4G180	Q4G180_HUMAN	ZNF486 protein (Fragment)	GO:0003676; GO:0006355; GO:0046872	metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]	ZNF486
NM_052852		Q96H40	ZN486_HUMAN	Zinc finger protein 486 (KRAB domain only protein 2)	GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0070062	extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]	ZNF486 KRBO2
NM_004272		Q5U5K4	Q5U5K4_HUMAN	Homer homolog 1 (Drosophila)			HOMER1
NM_004272	NM_004272 -> Q86YM7-1	Q86YM7	HOME1_HUMAN	Homer protein homolog 1 (Homer-1)	GO:0003009; GO:0005737; GO:0005829; GO:0005886; GO:0007206; GO:0007216; GO:0007268; GO:0009967; GO:0014069; GO:0030018; GO:0030054; GO:0030424; GO:0030425; GO:0035256; GO:0035591; GO:0043005; GO:0043034; GO:0043197; GO:0044309; GO:0044325; GO:0045177; GO:0045211; GO:0048148; GO:0048741; GO:0048875; GO:0051262; GO:0051592; GO:0051928; GO:0051966; GO:0090279; GO:0098962; GO:0098978; GO:0099524; GO:1902950; GO:2001256; GO:2001257	apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Z disc [GO:0030018]; G protein-coupled glutamate receptor binding [GO:0035256]; ion channel binding [GO:0044325]; signaling adaptor activity [GO:0035591]; behavioral response to cocaine [GO:0048148]; chemical homeostasis within a tissue [GO:0048875]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of signal transduction [GO:0009967]; protein tetramerization [GO:0051262]; regulation of calcium ion import [GO:0090279]; regulation of cation channel activity [GO:2001257]; regulation of dendritic spine maintenance [GO:1902950]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of store-operated calcium entry [GO:2001256]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to calcium ion [GO:0051592]; skeletal muscle contraction [GO:0003009]; skeletal muscle fiber development [GO:0048741]	HOMER1 SYN47
NM_025049	NM_025049 -> Q9H611-1	Q9H611	PIF1_HUMAN	ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) (PIF1/RRM3 DNA helicase-like protein)	GO:0000002; GO:0000287; GO:0000723; GO:0000784; GO:0005524; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0010521; GO:0017116; GO:0032204; GO:0032211; GO:0032508; GO:0033678; GO:0042162; GO:0043139; GO:0051880; GO:0051974	mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance [GO:0000723]	PIF1 C15orf20
NM_002202		P61371	ISL1_HUMAN	Insulin gene enhancer protein ISL-1 (Islet-1)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001102; GO:0001158; GO:0001228; GO:0001755; GO:0003139; GO:0003148; GO:0003151; GO:0003203; GO:0003215; GO:0003266; GO:0003713; GO:0005634; GO:0005737; GO:0007409; GO:0007507; GO:0008284; GO:0010575; GO:0010718; GO:0016922; GO:0021520; GO:0021522; GO:0021524; GO:0021559; GO:0021983; GO:0030331; GO:0031016; GO:0031103; GO:0031290; GO:0032024; GO:0032725; GO:0032729; GO:0032730; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0033147; GO:0035066; GO:0042531; GO:0043388; GO:0043425; GO:0043524; GO:0045597; GO:0045665; GO:0045766; GO:0045944; GO:0046872; GO:0048665; GO:0048762; GO:0048880; GO:0048936; GO:0050680; GO:0050728; GO:0055010; GO:0060037; GO:0060379; GO:0060384; GO:0060413; GO:0060913; GO:0071385; GO:0071657; GO:0090074; GO:0090090; GO:1901258; GO:1990841	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; mesenchymal cell differentiation [GO:0048762]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage colony-stimulating factor production [GO:1901258]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron differentiation [GO:0021522]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]	ISL1
NM_025196		Q9HAV7	GRPE1_HUMAN	GrpE protein homolog 1, mitochondrial (HMGE) (Mt-GrpE#1)	GO:0000774; GO:0001405; GO:0005654; GO:0005739; GO:0005759; GO:0006457; GO:0030150; GO:0042803; GO:0051082; GO:0051087	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; PAM complex, Tim23 associated import motor [GO:0001405]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]	GRPEL1 GREPEL1
NM_004664		O14910	LIN7A_HUMAN	Protein lin-7 homolog A (Lin-7A) (hLin-7) (Mammalian lin-seven protein 1) (MALS-1) (Tax interaction protein 33) (TIP-33) (Vertebrate lin-7 homolog 1) (Veli-1)	GO:0005623; GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0014069; GO:0015031; GO:0016323; GO:0045199; GO:0045202; GO:0045211; GO:0048489; GO:0048839; GO:0065003; GO:0070062; GO:0097016; GO:0097025; GO:0098793; GO:1903361	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell [GO:0005623]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; exocytosis [GO:0006887]; inner ear development [GO:0048839]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; synaptic vesicle transport [GO:0048489]	LIN7A MALS1 VELI1
NM_014272		Q9UFZ4	Q9UFZ4_HUMAN	Uncharacterized protein DKFZp434H204 (Fragment)	GO:0008233	peptidase activity [GO:0008233]	DKFZp434H204
NM_014272		Q9UKP4	ATS7_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) (COMPase)	GO:0004222; GO:0005576; GO:0005788; GO:0008237; GO:0009986; GO:0032331; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of chondrocyte differentiation [GO:0032331]; proteolysis involved in cellular protein catabolic process [GO:0051603]	ADAMTS7
NM_014165		Q9P032	NDUF4_HUMAN	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 (Hormone-regulated proliferation-associated protein of 20 kDa)	GO:0005516; GO:0005739; GO:0005743; GO:0031966; GO:0032981	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; calmodulin binding [GO:0005516]; mitochondrial respiratory chain complex I assembly [GO:0032981]	NDUFAF4 C6orf66 HRPAP20 HSPC125 My013
NM_052928		Q8IYR2	SMYD4_HUMAN	SET and MYND domain-containing protein 4 (EC 2.1.1.-)	GO:0008168; GO:0046872	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	SMYD4 KIAA1936
NM_000302		A0A024R4H0	A0A024R4H0_HUMAN	Procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1, isoform CRA_a	GO:0005506; GO:0008475; GO:0031418; GO:1902494	catalytic complex [GO:1902494]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	PLOD1 hCG_25059
NM_000302	NM_000302 -> Q02809-1	Q02809	PLOD1_HUMAN	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)	GO:0001666; GO:0005506; GO:0005789; GO:0006464; GO:0008475; GO:0008544; GO:0017185; GO:0030199; GO:0030867; GO:0031418; GO:0032963; GO:0042803; GO:0046947; GO:0055114; GO:0070062; GO:1902494	catalytic complex [GO:1902494]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; protein homodimerization activity [GO:0042803]; cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; epidermis development [GO:0008544]; hydroxylysine biosynthetic process [GO:0046947]; oxidation-reduction process [GO:0055114]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666]	PLOD1 LLH PLOD
NM_000795		A0A024R3C5	A0A024R3C5_HUMAN	Dopamine receptor D2, isoform CRA_c	GO:0001591; GO:0001659; GO:0001666; GO:0001669; GO:0001933; GO:0001975; GO:0001976; GO:0002027; GO:0002028; GO:0002031; GO:0002052; GO:0002092; GO:0004930; GO:0005623; GO:0006914; GO:0007195; GO:0007270; GO:0007409; GO:0007416; GO:0007608; GO:0007616; GO:0007625; GO:0007628; GO:0008104; GO:0008285; GO:0008542; GO:0010039; GO:0014069; GO:0014854; GO:0016055; GO:0016328; GO:0021756; GO:0021769; GO:0021853; GO:0021984; GO:0030139; GO:0030336; GO:0030432; GO:0030672; GO:0031223; GO:0032147; GO:0032228; GO:0032922; GO:0033602; GO:0035094; GO:0035240; GO:0035255; GO:0035810; GO:0035815; GO:0036126; GO:0040018; GO:0042321; GO:0042417; GO:0042756; GO:0042803; GO:0043197; GO:0043204; GO:0043266; GO:0043278; GO:0043473; GO:0043666; GO:0043679; GO:0045745; GO:0045776; GO:0045824; GO:0045944; GO:0046676; GO:0046717; GO:0046982; GO:0048148; GO:0048149; GO:0048169; GO:0048678; GO:0048755; GO:0051481; GO:0051586; GO:0051823; GO:0051898; GO:0051967; GO:0060124; GO:0060134; GO:0060158; GO:0060160; GO:0060548; GO:0070374; GO:0090325; GO:0098691; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099170; GO:1900273; GO:1901386; GO:2000300	acrosomal vesicle [GO:0001669]; axon terminus [GO:0043679]; cell [GO:0005623]; dendritic spine [GO:0043197]; dopaminergic synapse [GO:0098691]; endocytic vesicle [GO:0030139]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; lateral plasma membrane [GO:0016328]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; sperm flagellum [GO:0036126]; synaptic vesicle membrane [GO:0030672]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; G protein-coupled receptor activity [GO:0004930]; ionotropic glutamate receptor binding [GO:0035255]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; acid secretion [GO:0046717]; activation of protein kinase activity [GO:0032147]; adenohypophysis development [GO:0021984]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adult walking behavior [GO:0007628]; auditory behavior [GO:0031223]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; branching morphogenesis of a nerve [GO:0048755]; cerebral cortex GABAergic interneuron migration [GO:0021853]; circadian regulation of gene expression [GO:0032922]; dopamine metabolic process [GO:0042417]; drinking behavior [GO:0042756]; G protein-coupled receptor internalization [GO:0002031]; grooming behavior [GO:0007625]; long-term memory [GO:0007616]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell death [GO:0060548]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of innate immune response [GO:0045824]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron-neuron synaptic transmission [GO:0007270]; orbitofrontal cortex development [GO:0021769]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; pigmentation [GO:0043473]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of receptor internalization [GO:0002092]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; prepulse inhibition [GO:0060134]; protein localization [GO:0008104]; regulation of heart rate [GO:0002027]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of potassium ion transport [GO:0043266]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to axon injury [GO:0048678]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to iron ion [GO:0010039]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; temperature homeostasis [GO:0001659]; visual learning [GO:0008542]; Wnt signaling pathway [GO:0016055]	DRD2 hCG_39593
NM_000795	NM_000795 -> P14416-1	P14416	DRD2_HUMAN	D(2) dopamine receptor (Dopamine D2 receptor)	GO:0001591; GO:0001659; GO:0001666; GO:0001669; GO:0001933; GO:0001963; GO:0001975; GO:0001976; GO:0002027; GO:0002028; GO:0002031; GO:0002052; GO:0002092; GO:0004935; GO:0005623; GO:0005886; GO:0005887; GO:0005929; GO:0006874; GO:0006914; GO:0007186; GO:0007188; GO:0007194; GO:0007195; GO:0007270; GO:0007409; GO:0007416; GO:0007608; GO:0007616; GO:0007625; GO:0007626; GO:0007628; GO:0008104; GO:0008144; GO:0008285; GO:0008306; GO:0008542; GO:0009416; GO:0009636; GO:0010039; GO:0014059; GO:0014069; GO:0014854; GO:0015459; GO:0016055; GO:0016328; GO:0021756; GO:0021769; GO:0021853; GO:0021984; GO:0030139; GO:0030336; GO:0030424; GO:0030425; GO:0030432; GO:0030672; GO:0031223; GO:0032147; GO:0032228; GO:0032467; GO:0032922; GO:0033602; GO:0034776; GO:0035094; GO:0035240; GO:0035255; GO:0035556; GO:0035810; GO:0035815; GO:0036126; GO:0040018; GO:0042220; GO:0042321; GO:0042417; GO:0042493; GO:0042756; GO:0042802; GO:0042803; GO:0043197; GO:0043204; GO:0043266; GO:0043278; GO:0043473; GO:0043666; GO:0043679; GO:0045202; GO:0045745; GO:0045776; GO:0045824; GO:0045944; GO:0046676; GO:0046982; GO:0048148; GO:0048149; GO:0048169; GO:0048678; GO:0048755; GO:0050482; GO:0050709; GO:0051209; GO:0051481; GO:0051482; GO:0051584; GO:0051586; GO:0051823; GO:0051898; GO:0051967; GO:0060079; GO:0060124; GO:0060134; GO:0060158; GO:0060160; GO:0060170; GO:0060548; GO:0070374; GO:0071880; GO:0090325; GO:0097730; GO:0098691; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099170; GO:1900168; GO:1900273; GO:1901386; GO:2000300	acrosomal vesicle [GO:0001669]; axon [GO:0030424]; axon terminus [GO:0043679]; cell [GO:0005623]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dopaminergic synapse [GO:0098691]; endocytic vesicle [GO:0030139]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; lateral plasma membrane [GO:0016328]; non-motile cilium [GO:0097730]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; sperm flagellum [GO:0036126]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; adrenergic receptor activity [GO:0004935]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; activation of protein kinase activity [GO:0032147]; adenohypophysis development [GO:0021984]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adult walking behavior [GO:0007628]; arachidonic acid secretion [GO:0050482]; associative learning [GO:0008306]; auditory behavior [GO:0031223]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; branching morphogenesis of a nerve [GO:0048755]; cellular calcium ion homeostasis [GO:0006874]; cerebral cortex GABAergic interneuron migration [GO:0021853]; circadian regulation of gene expression [GO:0032922]; dopamine metabolic process [GO:0042417]; drinking behavior [GO:0042756]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell death [GO:0060548]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of innate immune response [GO:0045824]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein secretion [GO:0050709]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron-neuron synaptic transmission [GO:0007270]; orbitofrontal cortex development [GO:0021769]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; pigmentation [GO:0043473]; positive regulation of cytokinesis [GO:0032467]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glial cell-derived neurotrophic factor secretion [GO:1900168]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of receptor internalization [GO:0002092]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; prepulse inhibition [GO:0060134]; protein localization [GO:0008104]; regulation of dopamine secretion [GO:0014059]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of heart rate [GO:0002027]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of potassium ion transport [GO:0043266]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic vesicle exocytosis [GO:2000300]; release of sequestered calcium ion into cytosol [GO:0051209]; response to amphetamine [GO:0001975]; response to axon injury [GO:0048678]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to histamine [GO:0034776]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to iron ion [GO:0010039]; response to light stimulus [GO:0009416]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to toxic substance [GO:0009636]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; temperature homeostasis [GO:0001659]; visual learning [GO:0008542]; Wnt signaling pathway [GO:0016055]	DRD2
NM_020651		Q53T26	Q53T26_HUMAN	E3 ubiquitin-protein ligase pellino homolog (EC 2.3.2.27)	GO:0001819; GO:0005634; GO:0008063; GO:0008592; GO:0030890; GO:0031398; GO:0032088; GO:0032496; GO:0034141; GO:0034145; GO:0042130; GO:0043123; GO:0043331; GO:0060546; GO:0061630; GO:0070936	nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; protein K48-linked ubiquitination [GO:0070936]; regulation of Toll signaling pathway [GO:0008592]; response to dsRNA [GO:0043331]; response to lipopolysaccharide [GO:0032496]; Toll signaling pathway [GO:0008063]	PELI1 hCG_22381
NM_020651		Q96FA3	PELI1_HUMAN	E3 ubiquitin-protein ligase pellino homolog 1 (Pellino-1) (EC 2.3.2.27) (Pellino-related intracellular-signaling molecule) (RING-type E3 ubiquitin transferase pellino homolog 1)	GO:0000209; GO:0001819; GO:0005634; GO:0005829; GO:0008063; GO:0008592; GO:0030890; GO:0031398; GO:0032088; GO:0032496; GO:0034141; GO:0034145; GO:0034450; GO:0042130; GO:0043123; GO:0043161; GO:0043331; GO:0060546; GO:0061630; GO:0070498; GO:0070534; GO:0070936	cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592]; response to dsRNA [GO:0043331]; response to lipopolysaccharide [GO:0032496]; Toll signaling pathway [GO:0008063]	PELI1 PRISM
NM_021100		Q53FP3	Q53FP3_HUMAN	NFS1 nitrogen fixation 1 isoform a variant (Fragment)	GO:0030170; GO:0031071; GO:0044571	cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]	
NM_021100	NM_021100 -> Q9Y697-1	Q9Y697	NFS1_HUMAN	Cysteine desulfurase, mitochondrial (EC 2.8.1.7)	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006777; GO:0016226; GO:0018283; GO:0030170; GO:0031071; GO:0032324; GO:0042803; GO:0044281; GO:0044571; GO:0046872; GO:0051536	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; small molecule metabolic process [GO:0044281]	NFS1 NIFS HUSSY-08
NM_032343		Q9BRQ6	MIC25_HUMAN	MICOS complex subunit MIC25 (Coiled-coil-helix cristae morphology protein 1) (Coiled-coil-helix-coiled-coil-helix domain-containing protein 6)	GO:0005739; GO:0005743; GO:0005829; GO:0006974; GO:0042407; GO:0061617	cytosol [GO:0005829]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cellular response to DNA damage stimulus [GO:0006974]; cristae formation [GO:0042407]	CHCHD6 CHCM1 MIC25
NM_018841		Q9UBI6	GBG12_HUMAN	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0003924; GO:0005834; GO:0005884; GO:0005886; GO:0007165; GO:0007186; GO:0021987; GO:0030165; GO:0031680; GO:0031681; GO:0032496; GO:0042301; GO:0070062	actin filament [GO:0005884]; extracellular exosome [GO:0070062]; G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; phosphate ion binding [GO:0042301]; cerebral cortex development [GO:0021987]; G protein-coupled receptor signaling pathway [GO:0007186]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]	GNG12
NM_025076	NM_025076 -> Q8NBZ7-1	Q8NBZ7	UXS1_HUMAN	UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1)	GO:0005737; GO:0016021; GO:0032580; GO:0033320; GO:0042803; GO:0048040; GO:0051262; GO:0070062; GO:0070403	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; UDP-glucuronate decarboxylase activity [GO:0048040]; protein tetramerization [GO:0051262]; UDP-D-xylose biosynthetic process [GO:0033320]	UXS1 UNQ2538/PRO6079
NM_138341	NM_138341 -> Q8NCL8-1	Q8NCL8	TM116_HUMAN	Transmembrane protein 116	GO:0016021	integral component of membrane [GO:0016021]	TMEM116
NM_018837	NM_018837 -> Q8IWU5-1	Q8IWU5	SULF2_HUMAN	Extracellular sulfatase Sulf-2 (hSulf-2) (EC 3.1.6.-)	GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009611; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0090263; GO:0097421; GO:2000345	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; liver regeneration [GO:0097421]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of hepatocyte proliferation [GO:2000345]; response to wounding [GO:0009611]	SULF2 KIAA1247 UNQ559/PRO1120
NM_144593	NM_144593 -> Q8TAI7-1	Q8TAI7	REBL1_HUMAN	GTPase RhebL1 (Ras homolog enriched in brain like-1 c) (RhebL1c) (Ras homolog enriched in brain-like protein 1) (Rheb-like protein 1) (Rheb2)	GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0007264; GO:0012505; GO:0019003; GO:0031929; GO:0046872; GO:0051092	cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; small GTPase mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929]	RHEBL1
NM_021205		A0A024R3Q7	A0A024R3Q7_HUMAN	Ras homolog gene family, member U, isoform CRA_a	GO:0000082; GO:0003924; GO:0005525; GO:0008360; GO:0016601; GO:0030036	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; G1/S transition of mitotic cell cycle [GO:0000082]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]	RHOU hCG_14873
NM_021205	NM_021205 -> Q7L0Q8-1	Q7L0Q8	RHOU_HUMAN	Rho-related GTP-binding protein RhoU (CDC42-like GTPase 1) (GTP-binding protein-like 1) (Rho GTPase-like protein ARHU) (Ryu GTPase) (Wnt-1 responsive Cdc42 homolog 1) (WRCH-1)	GO:0000082; GO:0000139; GO:0002102; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006897; GO:0007010; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0016601; GO:0019221; GO:0019901; GO:0030031; GO:0030036; GO:0032488; GO:0032956; GO:0042995; GO:0046872; GO:0051056; GO:1903955	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; cell projection assembly [GO:0030031]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	RHOU ARHU CDC42L1 G28K WRCH1 SB128
NM_005099	NM_005099 -> O75173-1	O75173	ATS4_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAM-TS 4) (ADAM-TS4) (ADAMTS-4) (EC 3.4.24.82) (ADMP-1) (Aggrecanase-1)	GO:0001501; GO:0002020; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0016607; GO:0022617; GO:0046872; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]	ADAMTS4 KIAA0688 UNQ769/PRO1563
NM_003338		A0A024QZJ2	A0A024QZJ2_HUMAN	Ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast), isoform CRA_c	GO:0000209; GO:0005524; GO:0061631; GO:1902916	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; positive regulation of protein polyubiquitination [GO:1902916]; protein polyubiquitination [GO:0000209]	UBE2D1 hCG_40954
NM_003338		P51668	UB2D1_HUMAN	Ubiquitin-conjugating enzyme E2 D1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D1) (Stimulator of Fe transport) (SFT) (UBC4/5 homolog) (UbcH5) (Ubiquitin carrier protein D1) (Ubiquitin-conjugating enzyme E2(17)KB 1) (Ubiquitin-conjugating enzyme E2-17 kDa 1) (Ubiquitin-protein ligase D1)	GO:0000122; GO:0000151; GO:0000209; GO:0002756; GO:0004842; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0006625; GO:0016567; GO:0016579; GO:0030509; GO:0031145; GO:0031398; GO:0031625; GO:0032991; GO:0035666; GO:0061631; GO:0070936; GO:1901990; GO:1902916	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; BMP signaling pathway [GO:0030509]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; protein deubiquitination [GO:0016579]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein targeting to peroxisome [GO:0006625]; protein ubiquitination [GO:0016567]; regulation of mitotic cell cycle phase transition [GO:1901990]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; ubiquitin-dependent protein catabolic process [GO:0006511]	UBE2D1 SFT UBC5A UBCH5 UBCH5A
NM_005932		Q99797	MIPEP_HUMAN	Mitochondrial intermediate peptidase (MIP) (EC 3.4.24.59)	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006518; GO:0006627; GO:0046872	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508]	MIPEP MIP
NM_020365		Q9HA31	Q9HA31_HUMAN	Eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa, isoform CRA_e (cDNA FLJ12337 fis, clone MAMMA1002236, highly similar to TRANSLATION INITIATION FACTOR EIF-2B GAMMA SUBUNIT) (eIF2B3 protein)	GO:0003743	translation initiation factor activity [GO:0003743]	EIF2B3 hCG_18606
NM_020365	NM_020365 -> Q9NR50-1	Q9NR50	EI2BG_HUMAN	Translation initiation factor eIF-2B subunit gamma (eIF-2B GDP-GTP exchange factor subunit gamma)	GO:0003743; GO:0005085; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014003; GO:0016779; GO:0021766; GO:0043434; GO:0050852	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; hippocampus development [GO:0021766]; oligodendrocyte development [GO:0014003]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]	EIF2B3
NM_022459		Q9C0E2	XPO4_HUMAN	Exportin-4 (Exp4)	GO:0005049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0046827	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]	XPO4 KIAA1721
NM_004749	NM_004749 -> Q969Z0-1	Q969Z0	FAKD4_HUMAN	FAST kinase domain-containing protein 4 (Cell cycle progression restoration protein 2) (Cell cycle progression protein 2) (Protein TBRG4) (Transforming growth factor beta regulator 4)	GO:0003723; GO:0004672; GO:0005739; GO:0005759; GO:0007050; GO:0008284; GO:0016071; GO:0044528; GO:0090615	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; cell cycle arrest [GO:0007050]; mitochondrial mRNA processing [GO:0090615]; mRNA metabolic process [GO:0016071]; positive regulation of cell population proliferation [GO:0008284]; regulation of mitochondrial mRNA stability [GO:0044528]	TBRG4 CPR2 FASTKD4 KIAA0948
NM_080546		A0A024R151	A0A024R151_HUMAN	Solute carrier family 44, member 1, isoform CRA_a	GO:0005654; GO:0005739; GO:0015220; GO:0016021	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; choline transmembrane transporter activity [GO:0015220]	SLC44A1 hCG_29051
NM_080546	NM_080546 -> Q8WWI5-1	Q8WWI5	CTL1_HUMAN	Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92)	GO:0005654; GO:0005739; GO:0005741; GO:0005886; GO:0006656; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0042426; GO:0055085; GO:0070062	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; choline catabolic process [GO:0042426]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]	SLC44A1 CD92 CDW92 CTL1
NM_012425	NM_012425 -> Q15404-1	Q15404	RSU1_HUMAN	Ras suppressor protein 1 (RSP-1) (Rsu-1)	GO:0005829; GO:0005925; GO:0007165; GO:0010811; GO:0043547; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	RSU1 RSP1
NM_003514,NM_003509		A4FTV9	A4FTV9_HUMAN	Histone H2A	GO:0000786; GO:0003677; GO:0005634; GO:0046982	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	HIST1H2AK HIST1H2AG HIST1H2AI HIST1H2AL HIST1H2AM hCG_1640463 hCG_1640467 hCG_1641458 hCG_1643754 hCG_1743060
NM_003514,NM_003509		P0C0S8	H2A1_HUMAN	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0006325; GO:0019899; GO:0046982; GO:0070062	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]	H2AC11 H2AFP HIST1H2AG; H2AC13 H2AFC HIST1H2AI; H2AC15 H2AFD HIST1H2AK; H2AC16 H2AFI HIST1H2AL; H2AC17 H2AFN HIST1H2AM
NM_032222		Q4G0A6	MINY4_HUMAN	Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (EC 3.4.19.12) (Probable deubiquitinating enzyme MINDY-4)	GO:0016807; GO:0036459; GO:1990380	cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]	MINDY4 C7orf67 FAM188B
NM_173662	NM_173662 -> Q8N4F7-1	Q8N4F7	RN175_HUMAN	RING finger protein 175	GO:0000139; GO:0005789; GO:0016021; GO:0030433; GO:0046872; GO:0061630	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-dependent ERAD pathway [GO:0030433]	RNF175
NM_007005	NM_007005 -> Q04727-1	Q04727	TLE4_HUMAN	Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4)	GO:0000122; GO:0000981; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0070491; GO:0090090; GO:1904837; GO:1990830; GO:1990907	beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055]	TLE4 GRG4 KIAA1261
NM_014749	NM_014749 -> Q9BVV6-2	Q9BVV6	TALD3_HUMAN	Protein TALPID3	GO:0001917; GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0060271; GO:0070201	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; cilium assembly [GO:0060271]; regulation of establishment of protein localization [GO:0070201]; smoothened signaling pathway [GO:0007224]	KIAA0586 TALPID3
NM_004435		E5KNL5	E5KNL5_HUMAN	Endonuclease (EC 3.1.30.-)	GO:0001701; GO:0003676; GO:0004519; GO:0004536; GO:0005623; GO:0005634; GO:0005739; GO:0005829; GO:0006309; GO:0007568; GO:0009612; GO:0032355; GO:0034612; GO:0036475; GO:0043204; GO:0046677; GO:0046872; GO:0071277; GO:0071333; GO:0071456; GO:1901300; GO:1902512	cell [GO:0005623]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; deoxyribonuclease activity [GO:0004536]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; aging [GO:0007568]; apoptotic DNA fragmentation [GO:0006309]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; in utero embryonic development [GO:0001701]; neuron death in response to oxidative stress [GO:0036475]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]	
NM_004435		Q14249	NUCG_HUMAN	Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-)	GO:0000014; GO:0000737; GO:0001701; GO:0003676; GO:0004519; GO:0004521; GO:0005623; GO:0005634; GO:0005739; GO:0005743; GO:0005829; GO:0006309; GO:0006310; GO:0007568; GO:0009612; GO:0032355; GO:0034612; GO:0036475; GO:0043204; GO:0046677; GO:0046872; GO:0071277; GO:0071333; GO:0071456; GO:1901300; GO:1902512	cell [GO:0005623]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; aging [GO:0007568]; apoptotic DNA fragmentation [GO:0006309]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA recombination [GO:0006310]; in utero embryonic development [GO:0001701]; neuron death in response to oxidative stress [GO:0036475]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]	ENDOG
NM_018233	NM_018233 -> Q8N543-1	Q8N543	OGFD1_HUMAN	Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (Termination and polyadenylation 1 homolog) (uS12 prolyl 3-hydroxylase)	GO:0005506; GO:0005654; GO:0005737; GO:0005829; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0019511; GO:0031418; GO:0031543; GO:0031544; GO:0034063	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell population proliferation [GO:0008283]; peptidyl-proline hydroxylation [GO:0019511]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]	OGFOD1 KIAA1612 TPA1
NM_007062		A0A024RBH5	A0A024RBH5_HUMAN	PWP1 homolog (S. cerevisiae), isoform CRA_a	GO:0005730; GO:0005794; GO:0033140; GO:0034773; GO:1990889; GO:2000738	Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; H4K20me3 modified histone binding [GO:1990889]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]	PWP1 hCG_16508
NM_007062	NM_007062 -> Q13610-1	Q13610	PWP1_HUMAN	Periodic tryptophan protein 1 homolog (Keratinocyte protein IEF SSP 9502)	GO:0005634; GO:0005694; GO:0005730; GO:0005794; GO:0006351; GO:0033140; GO:0034773; GO:0042254; GO:1901838; GO:1990889; GO:2000738	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; H4K20me3 modified histone binding [GO:1990889]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; ribosome biogenesis [GO:0042254]; transcription, DNA-templated [GO:0006351]	PWP1
NM_014498		O00461	GOLI4_HUMAN	Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)	GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0010008; GO:0016020; GO:0016021; GO:0030133; GO:0030139; GO:0032580	cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]	GOLIM4 GIMPC GOLPH4 GPP130
NM_004529		A0A0S2Z448	A0A0S2Z448_HUMAN	Myeloid/lymphoid or mixed-lineage leukemia translocated to 3 isoform 1 (Fragment)	GO:0005654; GO:0005829; GO:0006355; GO:0007379; GO:0009952	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anterior/posterior pattern specification [GO:0009952]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]	MLLT3
NM_004529	NM_004529 -> P42568-1	P42568	AF9_HUMAN	Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3)	GO:0000981; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006366; GO:0006368; GO:0007379; GO:0008023; GO:0009952; GO:0042393; GO:0045893; GO:0070062; GO:0070577; GO:0090090; GO:0140030; GO:2000096	chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; anterior/posterior pattern specification [GO:0009952]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; segment specification [GO:0007379]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]	MLLT3 AF9 YEATS3
NM_032523	NM_032523 -> Q9BZF3-1	Q9BZF3	OSBL6_HUMAN	Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6)	GO:0005789; GO:0005829; GO:0005886; GO:0006699; GO:0006869; GO:0008289; GO:0015485; GO:0016020; GO:0031965; GO:0032934; GO:0043231; GO:0097038	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; bile acid biosynthetic process [GO:0006699]; lipid transport [GO:0006869]	OSBPL6 ORP6
NM_021214	NM_021214 -> Q6PCB6-1	Q6PCB6	AB17C_HUMAN	Alpha/beta hydrolase domain-containing protein 17C (Abhydrolase domain-containing protein 17C) (EC 3.1.2.22)	GO:0002084; GO:0008474; GO:0014069; GO:0018345; GO:0030054; GO:0043197; GO:0045211; GO:0055038; GO:0098978; GO:0099175; GO:1902817; GO:1905668	cell junction [GO:0030054]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]; negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; protein palmitoylation [GO:0018345]; regulation of postsynapse organization [GO:0099175]	ABHD17C FAM108C1
NM_013272	NM_013272 -> Q9UIG8-1	Q9UIG8	SO3A1_HUMAN	Solute carrier organic anion transporter family member 3A1 (OATP3A1) (Organic anion transporter polypeptide-related protein 3) (OATP-RP3) (OATPRP3) (Organic anion-transporting polypeptide D) (OATP-D) (PGE1 transporter) (Sodium-independent organic anion transporter D) (Solute carrier family 21 member 11)	GO:0005886; GO:0005887; GO:0015347; GO:0015732; GO:0043252	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]	SLCO3A1 OATP3A1 OATPD SLC21A11
NM_024638	NM_024638 -> Q9H974-1	Q9H974	QTRT2_HUMAN	Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1)	GO:0005737; GO:0005739; GO:0005741; GO:0006400; GO:0008479; GO:0032991; GO:0042803; GO:0046872; GO:0046982; GO:0101030	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	QTRT2 QTRTD1
NM_003523,NM_003522,NM_003518,NM_003526		B2R4S9	B2R4S9_HUMAN	Histone H2B	GO:0000786; GO:0002227; GO:0003677; GO:0005615; GO:0005654; GO:0005829; GO:0019731; GO:0046982; GO:0050830; GO:0061844	cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]	HIST1H2BC HIST1H2BE HIST1H2BF HIST1H2BG HIST1H2BI hCG_1640484 hCG_1640985 hCG_1641780 hCG_1787353 hCG_1787365
NM_003523,NM_003522,NM_003518,NM_003526		P62807	H2B1C_HUMAN	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	GO:0000786; GO:0002227; GO:0003677; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0016567; GO:0019731; GO:0042802; GO:0046982; GO:0050830; GO:0061844; GO:0070062	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; nucleosome assembly [GO:0006334]; protein ubiquitination [GO:0016567]	H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI
NM_152422	NM_152422 -> A2A3K4-2	A2A3K4	PTPC1_HUMAN	Protein tyrosine phosphatase domain-containing protein 1 (EC 3.1.3.-)	GO:0004725; GO:0005654; GO:0005737; GO:0008138; GO:0060271	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cilium assembly [GO:0060271]	PTPDC1 PTP9Q22
NM_002291		P07942	LAMB1_HUMAN	Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)	GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005788; GO:0007155; GO:0009887; GO:0009888; GO:0016477; GO:0021812; GO:0030198; GO:0030335; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043256; GO:0043257; GO:0043259; GO:0043687; GO:0044267; GO:0048471; GO:0050679; GO:0062023; GO:0070062; GO:0070831	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	LAMB1
NM_002291		Q8TAS6	Q8TAS6_HUMAN	LAMB1 protein (Fragment)			LAMB1
NM_172240		A0MNP0	A0MNP0_HUMAN	CDW9/WDR51B (WD repeat domain 51B, isoform CRA_b)			WDR51B hCG_27606
NM_172240	NM_172240 -> Q8TC44-1	Q8TC44	POC1B_HUMAN	POC1 centriolar protein homolog B (Pix1) (Proteome of centriole protein 1B) (WD repeat-containing protein 51B)	GO:0000922; GO:0001895; GO:0005737; GO:0005813; GO:0005814; GO:0008283; GO:0036064; GO:0060271	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; cell population proliferation [GO:0008283]; cilium assembly [GO:0060271]; retina homeostasis [GO:0001895]	POC1B WDR51B
NM_015954		Q9Y315	DEOC_HUMAN	Deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase)	GO:0004139; GO:0005576; GO:0005654; GO:0005829; GO:0006098; GO:0009264; GO:0016052; GO:0034774; GO:0043312; GO:0046121; GO:0046386; GO:1904813	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; deoxyribose-phosphate aldolase activity [GO:0004139]; carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098]	DERA CGI-26
NM_180989		Q86V85	GP180_HUMAN	Integral membrane protein GPR180 (Intimal thickness-related receptor)	GO:0007186; GO:0016021; GO:0019236	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]	GPR180 ITR
NM_020752		Q5T848	GP158_HUMAN	Probable G-protein coupled receptor 158	GO:0004930; GO:0005886; GO:0016021; GO:0072659	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein localization to plasma membrane [GO:0072659]	GPR158 KIAA1136
NM_002488	NM_002488 -> O43678-1	O43678	NDUA2_HUMAN	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8) (CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit)	GO:0001835; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0031966; GO:0032981	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; blastocyst hatching [GO:0001835]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]	NDUFA2
NM_147182	NM_147182 -> Q6PIL6-3	Q6PIL6	KCIP4_HUMAN	Kv channel-interacting protein 4 (KChIP4) (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4)	GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0008076; GO:0015459; GO:0061337; GO:0072659; GO:1901379	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; cardiac conduction [GO:0061337]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]	KCNIP4 CALP KCHIP4
NM_021129		Q15181	IPYR_HUMAN	Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase)	GO:0000287; GO:0004427; GO:0005737; GO:0005829; GO:0006418; GO:0006796; GO:0070062; GO:0071344	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; tRNA aminoacylation for protein translation [GO:0006418]	PPA1 IOPPP PP
NM_021129		V9HWB5	V9HWB5_HUMAN	Epididymis secretory sperm binding protein Li 66p (Pyrophosphatase (Inorganic) 1, isoform CRA_a)	GO:0000287; GO:0004427; GO:0005737; GO:0006796	cytoplasm [GO:0005737]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphate-containing compound metabolic process [GO:0006796]	HEL-S-66p PPA1 hCG_2024809
NM_005766		A0A2X0TVY0	A0A2X0TVY0_HUMAN	FARP1 (FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (Chondrocyte-derived)) (Fragment)	GO:0005089; GO:0005856; GO:0008092; GO:0035023	cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023]	FARP1 hCG_1811328
NM_005766	NM_005766 -> Q9Y4F1-1	Q9Y4F1	FARP1_HUMAN	FERM, ARHGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (FERM, RhoGEF and pleckstrin domain-containing protein 1) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)	GO:0005089; GO:0005829; GO:0005856; GO:0007416; GO:0008092; GO:0010923; GO:0030054; GO:0030175; GO:0030425; GO:0030676; GO:0031234; GO:0035023; GO:0043197; GO:0048813	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; filopodium [GO:0030175]; cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; dendrite morphogenesis [GO:0048813]; negative regulation of phosphatase activity [GO:0010923]; regulation of Rho protein signal transduction [GO:0035023]; synapse assembly [GO:0007416]	FARP1 CDEP PLEKHC2
NM_182960	NM_182960 -> Q8N945-1	Q8N945	PRLD2_HUMAN	PRELI domain-containing protein 2	GO:0005758; GO:0015914; GO:1990050	mitochondrial intermembrane space [GO:0005758]; phosphatidic acid transfer activity [GO:1990050]; phospholipid transport [GO:0015914]	PRELID2
NM_031271		Q9BXT5	TEX15_HUMAN	Testis-expressed protein 15 (Cancer/testis antigen 42) (CT42)	GO:0005634; GO:0005737; GO:0006281; GO:0007129; GO:0007140; GO:0007283; GO:0010569; GO:0030154	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; DNA repair [GO:0006281]; male meiotic nuclear division [GO:0007140]; regulation of double-strand break repair via homologous recombination [GO:0010569]; spermatogenesis [GO:0007283]; synapsis [GO:0007129]	TEX15
NM_004060	NM_004060 -> P51959-1	P51959	CCNG1_HUMAN	Cyclin-G1 (Cyclin-G)	GO:0000079; GO:0000307; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0016538; GO:0019901; GO:0044772; GO:0051301	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	CCNG1 CCNG CYCG1
NM_003045		A0A024RDQ9	A0A024RDQ9_HUMAN	Solute carrier family 7 (Cationic amino acid transporter, y+ system), member 1, isoform CRA_a	GO:0015181; GO:0016021	integral component of membrane [GO:0016021]; arginine transmembrane transporter activity [GO:0015181]	SLC7A1 hCG_27802
NM_003045		P30825	CTR1_HUMAN	High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter)	GO:0000064; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015181; GO:0015189; GO:0016020; GO:0032991; GO:0097638; GO:1903352	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; amino acid transmembrane transporter activity [GO:0015171]; arginine transmembrane transporter activity [GO:0015181]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]	SLC7A1 ATRC1 ERR REC1L
NM_018947		G4XXL9	G4XXL9_HUMAN	Cytochrome c (Cytochrome c, somatic, isoform CRA_a)	GO:0005739; GO:0009055; GO:0020037; GO:0046872; GO:0070469	mitochondrion [GO:0005739]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	CYCS hCG_2009955
NM_018947		P99999	CYC_HUMAN	Cytochrome c	GO:0000159; GO:0005634; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006122; GO:0006123; GO:0006470; GO:0006915; GO:0007005; GO:0008635; GO:0020037; GO:0034599; GO:0045155; GO:0045333; GO:0046872; GO:0070469	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; respirasome [GO:0070469]; electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity [GO:0045155]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; cellular respiration [GO:0045333]; cellular response to oxidative stress [GO:0034599]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrion organization [GO:0007005]; protein dephosphorylation [GO:0006470]	CYCS CYC
NM_032180	NM_032180 -> Q3B820-1	Q3B820	F161A_HUMAN	Protein FAM161A	GO:0000235; GO:0001917; GO:0005813; GO:0005876; GO:0007601; GO:0008017; GO:0032391; GO:0036064; GO:0042802; GO:0044782; GO:0050896; GO:0060271; GO:0072686; GO:0097431; GO:1901985	astral microtubule [GO:0000235]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; spindle microtubule [GO:0005876]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; positive regulation of protein acetylation [GO:1901985]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	FAM161A
NM_001103	NM_001103 -> P35609-1	P35609	ACTN2_HUMAN	Alpha-actinin-2 (Alpha-actinin skeletal muscle isoform 2) (F-actin cross-linking protein)	GO:0000165; GO:0002576; GO:0005178; GO:0005509; GO:0005546; GO:0005576; GO:0005829; GO:0005856; GO:0005884; GO:0005925; GO:0007155; GO:0008092; GO:0008307; GO:0019904; GO:0030018; GO:0030035; GO:0030049; GO:0030175; GO:0030274; GO:0030375; GO:0030864; GO:0031093; GO:0031143; GO:0031432; GO:0042391; GO:0042802; GO:0042803; GO:0042981; GO:0043197; GO:0043267; GO:0043268; GO:0044325; GO:0045214; GO:0046983; GO:0048041; GO:0051015; GO:0051289; GO:0051373; GO:0051695; GO:0055013; GO:0070062; GO:0070080; GO:0072659; GO:0086097; GO:0098839; GO:0098978; GO:0099092; GO:1901017; GO:1901018; GO:2000009; GO:2000310; GO:2001137; GO:2001259	actin filament [GO:0005884]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; platelet alpha granule lumen [GO:0031093]; postsynaptic density membrane [GO:0098839]; postsynaptic density, intracellular component [GO:0099092]; pseudopodium [GO:0031143]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; FATZ binding [GO:0051373]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; LIM domain binding [GO:0030274]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; thyroid hormone receptor coactivator activity [GO:0030375]; titin binding [GO:0031432]; titin Z domain binding [GO:0070080]; actin filament uncapping [GO:0051695]; cardiac muscle cell development [GO:0055013]; cell adhesion [GO:0007155]; focal adhesion assembly [GO:0048041]; MAPK cascade [GO:0000165]; microspike assembly [GO:0030035]; muscle filament sliding [GO:0030049]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of protein localization to cell surface [GO:2000009]; phospholipase C-activating angiotensin-activated signaling pathway [GO:0086097]; platelet degranulation [GO:0002576]; positive regulation of cation channel activity [GO:2001259]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein homotetramerization [GO:0051289]; protein localization to plasma membrane [GO:0072659]; regulation of apoptotic process [GO:0042981]; regulation of membrane potential [GO:0042391]; regulation of NMDA receptor activity [GO:2000310]; sarcomere organization [GO:0045214]	ACTN2
NM_139281		Q8NI36	WDR36_HUMAN	WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP)	GO:0001895; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0007601; GO:0030516; GO:0032040; GO:0034388; GO:0050896	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; regulation of axon extension [GO:0030516]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; rRNA processing [GO:0006364]; visual perception [GO:0007601]	WDR36
NM_004562	NM_004562 -> O60260-1	O60260	PRKN_HUMAN	E3 ubiquitin-protein ligase parkin (Parkin) (EC 2.3.2.31) (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2) (Parkinson disease protein 2)	GO:0000122; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0000976; GO:0001227; GO:0001664; GO:0001933; GO:0001964; GO:0003779; GO:0004842; GO:0005623; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007417; GO:0007612; GO:0008013; GO:0008270; GO:0008344; GO:0010498; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010906; GO:0010994; GO:0014059; GO:0015631; GO:0016235; GO:0016236; GO:0016567; GO:0016579; GO:0016607; GO:0017124; GO:0019899; GO:0019900; GO:0019901; GO:0030165; GO:0030544; GO:0031072; GO:0031396; GO:0031624; GO:0031625; GO:0031647; GO:0031648; GO:0032092; GO:0032232; GO:0032368; GO:0032436; GO:0033132; GO:0034620; GO:0034976; GO:0035249; GO:0035519; GO:0036503; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043123; GO:0043130; GO:0043161; GO:0043274; GO:0043388; GO:0043524; GO:0044257; GO:0044267; GO:0044314; GO:0044828; GO:0044877; GO:0045732; GO:0045944; GO:0046329; GO:0046676; GO:0048471; GO:0050821; GO:0051087; GO:0051582; GO:0051583; GO:0051865; GO:0051881; GO:0055069; GO:0060548; GO:0060828; GO:0061630; GO:0061734; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0071287; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0097237; GO:0097413; GO:0097602; GO:0098779; GO:0098793; GO:0099074; GO:1900407; GO:1901215; GO:1901800; GO:1902236; GO:1902254; GO:1902283; GO:1902530; GO:1902803; GO:1903202; GO:1903214; GO:1903265; GO:1903351; GO:1903377; GO:1903382; GO:1903542; GO:1903599; GO:1903861; GO:1904049; GO:1905281; GO:1905366; GO:1905477; GO:1990381; GO:1990444; GO:1990452; GO:2000377; GO:2000378	aggresome [GO:0016235]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular protein metabolic process [GO:0044267]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; cellular response to unfolded protein [GO:0034620]; central nervous system development [GO:0007417]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; ERAD pathway [GO:0036503]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid transport [GO:0032368]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]	PRKN PARK2
NM_004562		X5DR79	X5DR79_HUMAN	RBR-type E3 ubiquitin transferase (EC 2.3.2.31) (Fragment)	GO:0000423; GO:0001964; GO:0005739; GO:0005829; GO:0007612; GO:0008344; GO:0016607; GO:0031648; GO:0032436; GO:0032991; GO:0034976; GO:0035249; GO:0042415; GO:0042417; GO:0043005; GO:0044257; GO:0046872; GO:0046928; GO:0051583; GO:0051881; GO:0061630; GO:0070585; GO:0097237; GO:0098793; GO:1902530; GO:1903377; GO:1903382; GO:1903861	cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; adult locomotory behavior [GO:0008344]; cellular protein catabolic process [GO:0044257]; cellular response to toxic substance [GO:0097237]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; learning [GO:0007612]; mitophagy [GO:0000423]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; norepinephrine metabolic process [GO:0042415]; positive regulation of dendrite extension [GO:1903861]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein linear polyubiquitination [GO:1902530]; protein destabilization [GO:0031648]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neurotransmitter secretion [GO:0046928]; response to endoplasmic reticulum stress [GO:0034976]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]	PARK2
NM_152295	NM_152295 -> P26639-1	P26639	SYTC_HUMAN	Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)	GO:0000049; GO:0004829; GO:0005524; GO:0005737; GO:0005829; GO:0006412; GO:0006418; GO:0006435; GO:0015629; GO:0042803; GO:0070062	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; threonyl-tRNA aminoacylation [GO:0006435]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]	TARS1 TARS
NM_024628		A0AV02	S12A8_HUMAN	Solute carrier family 12 member 8 (Cation-chloride cotransporter 9)	GO:0005623; GO:0006884; GO:0015379; GO:0016021; GO:0055064; GO:0055075; GO:1902476; GO:1990573	cell [GO:0005623]; integral component of membrane [GO:0016021]; potassium:chloride symporter activity [GO:0015379]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	SLC12A8 CCC9
NM_014161		Q9H0U6	RM18_HUMAN	39S ribosomal protein L18, mitochondrial (L18mt) (MRP-L18) (Mitochondrial large ribosomal subunit protein uL18m)	GO:0003735; GO:0005615; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0008097; GO:0035928; GO:0070125; GO:0070126	extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; rRNA import into mitochondrion [GO:0035928]; translation [GO:0006412]	MRPL18 HSPC071
NM_001037132		Q14CA1	Q14CA1_HUMAN	NRCAM protein	GO:0016021	integral component of membrane [GO:0016021]	NRCAM
NM_001037132	NM_001037132 -> Q92823-1	Q92823	NRCAM_HUMAN	Neuronal cell adhesion molecule (Nr-CAM) (Neuronal surface protein Bravo) (hBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related)	GO:0001525; GO:0001764; GO:0005576; GO:0005886; GO:0005887; GO:0007409; GO:0007413; GO:0007416; GO:0007417; GO:0008104; GO:0009897; GO:0019227; GO:0030506; GO:0030516; GO:0031290; GO:0043005; GO:0043194; GO:0045162; GO:0045666; GO:0086080; GO:0098609; GO:0098978; GO:0099061; GO:0099175	axon initial segment [GO:0043194]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ankyrin binding [GO:0030506]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; angiogenesis [GO:0001525]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; clustering of voltage-gated sodium channels [GO:0045162]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of postsynapse organization [GO:0099175]; retinal ganglion cell axon guidance [GO:0031290]; synapse assembly [GO:0007416]	NRCAM KIAA0343
NM_178169	NM_178169 -> Q86WH2-1	Q86WH2	RASF3_HUMAN	Ras association domain-containing protein 3	GO:0005829; GO:0005874; GO:0005886; GO:0007165; GO:0042802; GO:0042981	cytosol [GO:0005829]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]	RASSF3
NM_001098426	NM_001098426 -> Q92925-1	Q92925	SMRD2_HUMAN	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B) (BAF60B)	GO:0000790; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0016514; GO:0032991; GO:0043044	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]	SMARCD2 BAF60B PRO2451
NM_020864	NM_020864 -> Q9P242-1	Q9P242	NYAP2_HUMAN	Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2	GO:0014065; GO:0048812	neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065]	NYAP2 KIAA1486
NM_001013627	NM_001013627 -> Q5HYW2-1	Q5HYW2	NHSL2_HUMAN	NHS-like protein 2	GO:0030154	cell differentiation [GO:0030154]	NHSL2
NM_058187	NM_058187 -> P58658-1	P58658	EVA1C_HUMAN	Protein eva-1 homolog C (Protein FAM176C) (SUE21)	GO:0008201; GO:0016021; GO:0030246	integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201]	EVA1C C21orf63 C21orf64 FAM176C PRED34 UNQ2504/PRO5993
NM_003146		A0A024R4Z6	A0A024R4Z6_HUMAN	FACT complex subunit SSRP1	GO:0003677; GO:0003682; GO:0005634; GO:0005694; GO:0006260; GO:0006281	chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260]	SSRP1 hCG_39757
NM_003146		Q08945	SSRP1_HUMAN	FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160)	GO:0000790; GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006260; GO:0006281; GO:0006366; GO:0006368; GO:0031491; GO:0035101; GO:0042393; GO:1901796	FACT complex [GO:0035101]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]	SSRP1 FACT80
NM_033390	NM_033390 -> Q9C0D7-1	Q9C0D7	ZC12C_HUMAN	Probable ribonuclease ZC3H12C (EC 3.1.-.-) (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C)	GO:0004519; GO:0046872	endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]	ZC3H12C KIAA1726 MCPIP3
NM_002079		A0A140VK69	A0A140VK69_HUMAN	Aspartate aminotransferase (EC 2.6.1.1)	GO:0004069; GO:0004609; GO:0005623; GO:0005654; GO:0005764; GO:0005829; GO:0006107; GO:0006114; GO:0006532; GO:0007219; GO:0009743; GO:0019550; GO:0019551; GO:0030170; GO:0030511; GO:0031406; GO:0032966; GO:0035902; GO:0043679; GO:0046686; GO:0047801; GO:0051481; GO:0051902; GO:0055089; GO:0060290; GO:0071260; GO:1990267	axon terminus [GO:0043679]; cell [GO:0005623]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; carboxylic acid binding [GO:0031406]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]; aspartate biosynthetic process [GO:0006532]; cellular response to mechanical stimulus [GO:0071260]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glycerol biosynthetic process [GO:0006114]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of mitochondrial depolarization [GO:0051902]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to cadmium ion [GO:0046686]; response to carbohydrate [GO:0009743]; response to immobilization stress [GO:0035902]; response to transition metal nanoparticle [GO:1990267]; transdifferentiation [GO:0060290]	
NM_002079	NM_002079 -> P17174-1	P17174	AATC_HUMAN	Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)	GO:0004069; GO:0004609; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006094; GO:0006103; GO:0006107; GO:0006114; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007219; GO:0008652; GO:0009743; GO:0019550; GO:0019551; GO:0030170; GO:0030511; GO:0031406; GO:0032869; GO:0032966; GO:0035902; GO:0043679; GO:0046686; GO:0047801; GO:0051384; GO:0051481; GO:0051902; GO:0055089; GO:0060290; GO:0070062; GO:0071260; GO:1990267	axon terminus [GO:0043679]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; carboxylic acid binding [GO:0031406]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of mitochondrial depolarization [GO:0051902]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to cadmium ion [GO:0046686]; response to carbohydrate [GO:0009743]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to transition metal nanoparticle [GO:1990267]; transdifferentiation [GO:0060290]	GOT1
NM_017802		B3KPE2	B3KPE2_HUMAN	cDNA FLJ31671 fis, clone NT2RI2004985, highly similar to HEAT repeat-containing protein 2			
NM_017802	NM_017802 -> Q86Y56-1	Q86Y56	DAAF5_HUMAN	Dynein assembly factor 5, axonemal (HEAT repeat-containing protein 2)	GO:0003341; GO:0005737; GO:0036158; GO:0036159; GO:0045505	cytoplasm [GO:0005737]; dynein intermediate chain binding [GO:0045505]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]	DNAAF5 HEATR2
NM_006802		Q12874	SF3A3_HUMAN	Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61)	GO:0000375; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0006397; GO:0008270; GO:0016607; GO:0071005; GO:0071013; GO:1903241	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]	SF3A3 SAP61
NM_021814		A0A024RD35	A0A024RD35_HUMAN	Elongation of very long chain fatty acids protein 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5)	GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0016021; GO:0019367; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]	ELOVL5 hCG_2001424
NM_021814	NM_021814 -> Q9NYP7-1	Q9NYP7	ELOV5_HUMAN	Elongation of very long chain fatty acids protein 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Fatty acid elongase 1) (hELO1) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5)	GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0016020; GO:0019367; GO:0030148; GO:0030176; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0036109; GO:0042761; GO:0043025; GO:0043651; GO:0045723; GO:0097447; GO:0102336; GO:0102337; GO:0102338; GO:0102756	dendrite [GO:0030425]; dendritic tree [GO:0097447]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; alpha-linolenic acid metabolic process [GO:0036109]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of fatty acid biosynthetic process [GO:0045723]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]	ELOVL5 ELOVL2 PRO0530
NM_016396		A0A024R5Q8	A0A024R5Q8_HUMAN	CTD (Carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2, isoform CRA_a	GO:0004721; GO:0005654; GO:0030514; GO:0046827	nucleoplasm [GO:0005654]; phosphoprotein phosphatase activity [GO:0004721]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein export from nucleus [GO:0046827]	CTDSPL2 hCG_37787
NM_016396	NM_016396 -> Q05D32-1	Q05D32	CTSL2_HUMAN	CTD small phosphatase-like protein 2 (CTDSP-like 2) (EC 3.1.3.-)	GO:0004721; GO:0005654; GO:0030514; GO:0046827	nucleoplasm [GO:0005654]; phosphoprotein phosphatase activity [GO:0004721]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein export from nucleus [GO:0046827]	CTDSPL2 HSPC058 HSPC129
NM_004094		P05198	IF2A_HUMAN	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)	GO:0003723; GO:0003743; GO:0005634; GO:0005829; GO:0005844; GO:0005850; GO:0005851; GO:0006413; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034063; GO:0034198; GO:0034599; GO:0034605; GO:0034644; GO:0034976; GO:0036499; GO:0043022; GO:0043614; GO:0044207; GO:0045202; GO:0046777; GO:0055085; GO:0070062; GO:0097451; GO:1901216; GO:1905098; GO:1990737; GO:2000676	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; transmembrane transport [GO:0055085]	EIF2S1 EIF2A
NM_004094		Q53XC0	Q53XC0_HUMAN	Eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa, isoform CRA_a (Full-length cDNA clone CS0DL010YH08 of B cells (Ramos cell line) of Homo sapiens (human)) (cDNA, FLJ92791, Homo sapiens eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa (EIF2S1), mRNA)	GO:0003743; GO:0005634; GO:0005737; GO:0005829; GO:0005850; GO:0007568; GO:0010494; GO:0032057; GO:0034063; GO:0034198; GO:0034599; GO:0034605; GO:0034644; GO:0044207; GO:0045202; GO:0046777; GO:0097451; GO:1901216; GO:1905098; GO:1990737; GO:2000676	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; glial limiting end-foot [GO:0097451]; nucleus [GO:0005634]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]	EIF2S1 hCG_21909
NM_004793	NM_004793 -> P36776-1	P36776	LONM_HUMAN	Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)	GO:0000002; GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016020; GO:0032042; GO:0034599; GO:0042645; GO:0043531; GO:0043565; GO:0051131; GO:0051260; GO:0051603; GO:0051880; GO:0070182; GO:0070407	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	LONP1 PRSS15
NM_019619	NM_019619 -> Q8TEW0-1	Q8TEW0	PARD3_HUMAN	Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha)	GO:0000226; GO:0005546; GO:0005547; GO:0005623; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005913; GO:0005923; GO:0005938; GO:0006612; GO:0007049; GO:0007155; GO:0007163; GO:0007179; GO:0007205; GO:0007409; GO:0008104; GO:0008356; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032991; GO:0033269; GO:0035091; GO:0036464; GO:0042802; GO:0043025; GO:0043296; GO:0044295; GO:0045197; GO:0051660; GO:0060341; GO:0065003; GO:0070830; GO:0090162	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell [GO:0005623]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179]	PARD3 PAR3 PAR3A
NM_004227	NM_004227 -> O43739-2	O43739	CYH3_HUMAN	Cytohesin-3 (ARF nucleotide-binding site opener 3) (Protein ARNO3) (General receptor of phosphoinositides 1) (Grp1) (PH, SEC7 and coiled-coil domain-containing protein 3)	GO:0000139; GO:0001726; GO:0005086; GO:0005547; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0031234; GO:0032012; GO:0045785; GO:0048193; GO:0090162	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; establishment of epithelial cell polarity [GO:0090162]; Golgi vesicle transport [GO:0048193]; positive regulation of cell adhesion [GO:0045785]; regulation of ARF protein signal transduction [GO:0032012]	CYTH3 ARNO3 GRP1 PSCD3
NM_004457		A0A024R497	A0A024R497_HUMAN	Acyl-CoA synthetase long-chain family member 3, isoform CRA_a	GO:0004467; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016021; GO:0047676	integral component of membrane [GO:0016021]; arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid-CoA ligase activity [GO:0004467]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]	ACSL3 hCG_21017
NM_004457		O95573	ACSL3_HUMAN	Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3)	GO:0001676; GO:0003996; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006633; GO:0007420; GO:0007584; GO:0014070; GO:0016020; GO:0016021; GO:0019901; GO:0019904; GO:0034379; GO:0035338; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0102391; GO:2001247	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; acyl-CoA ligase activity [GO:0003996]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; very-low-density lipoprotein particle assembly [GO:0034379]	ACSL3 ACS3 FACL3 LACS3
NM_003115		A0A140VKC0	A0A140VKC0_HUMAN	Testis tissue sperm-binding protein Li 37a	GO:0005654; GO:0005829; GO:0005886; GO:0070569	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; uridylyltransferase activity [GO:0070569]	
NM_003115	NM_003115 -> Q16222-2	Q16222	UAP1_HUMAN	UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83) (AGX-1); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (AGX-2)]	GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006048; GO:0030246; GO:0042802	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	UAP1 SPAG2
NM_000214	NM_000214 -> P78504-1	P78504	JAG1_HUMAN	Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339)	GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005887; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045746; GO:0045747; GO:0045944; GO:0060411; GO:0061073; GO:0061156; GO:0061309; GO:0061314; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456]	JAG1 JAGL1
NM_000214		Q99740	Q99740_HUMAN	Soluble protein Jagged (Fragment)	GO:0005112; GO:0005509; GO:0007219	calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; Notch signaling pathway [GO:0007219]	
NM_006750		A0A024R732	A0A024R732_HUMAN	Syntrophin, beta 2 (Dystrophin-associated protein A1, 59kDa, basic component 2), isoform CRA_a	GO:0005198; GO:0045202	synapse [GO:0045202]; structural molecule activity [GO:0005198]	SNTB2 hCG_28200
NM_006750	NM_006750 -> Q13425-1	Q13425	SNTB2_HUMAN	Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL)	GO:0003723; GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005874; GO:0005925; GO:0016010; GO:0016020; GO:0030658; GO:0032991; GO:0045202	cytoplasm [GO:0005737]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]	SNTB2 D16S2531E SNT2B2 SNTL
NM_058165		Q96PD6	MOGT1_HUMAN	2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Diacylglycerol O-acyltransferase candidate 2) (hDC2) (Diacylglycerol acyltransferase 2-like protein 1) (Monoacylglycerol O-acyltransferase 1)	GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006651; GO:0016021; GO:0019432	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]	MOGAT1 DC2 DGAT2L1
NM_152834	NM_152834 -> Q96B42-1	Q96B42	TMM18_HUMAN	Transmembrane protein 18	GO:0003677; GO:0005737; GO:0016021; GO:0016477; GO:0031965	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; cell migration [GO:0016477]	TMEM18
NM_005761		O60486	PLXC1_HUMAN	Plexin-C1 (Virus-encoded semaphorin protein receptor) (CD antigen CD232)	GO:0002116; GO:0005102; GO:0005886; GO:0005887; GO:0007155; GO:0007162; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0043087; GO:0050772; GO:1902287	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	PLXNC1 VESPR
NM_001510	NM_001510 -> O43424-1	O43424	GRID2_HUMAN	Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)	GO:0004970; GO:0005886; GO:0005887; GO:0007157; GO:0007215; GO:0008066; GO:0008328; GO:0010975; GO:0021707; GO:0030054; GO:0030165; GO:0034613; GO:0035249; GO:0043197; GO:0043523; GO:0045202; GO:0045211; GO:0050804; GO:0051965; GO:0060079; GO:0060134; GO:0097110; GO:0098688; GO:0098839; GO:0098978; GO:0099061; GO:0099151; GO:1900454; GO:1904315; GO:1904861	cell junction [GO:0030054]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; ionotropic glutamate receptor complex [GO:0008328]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular protein localization [GO:0034613]; cerebellar granule cell differentiation [GO:0021707]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; glutamate receptor signaling pathway [GO:0007215]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; prepulse inhibition [GO:0060134]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; regulation of postsynaptic density assembly [GO:0099151]; synaptic transmission, glutamatergic [GO:0035249]	GRID2 GLURD2
NM_000859		A0A024RAP2	A0A024RAP2_HUMAN	3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)	GO:0004420; GO:0005789; GO:0006695; GO:0006743; GO:0007568; GO:0007584; GO:0008299; GO:0008542; GO:0010664; GO:0010666; GO:0015936; GO:0016021; GO:0032874; GO:0042177; GO:0042282; GO:0042803; GO:0043407; GO:0045445; GO:0045471; GO:0048643; GO:0048661; GO:0050661; GO:0051721; GO:0061045; GO:0061179; GO:0070374; GO:0097756; GO:1900222	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; aging [GO:0007568]; cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; myoblast differentiation [GO:0045445]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of wound healing [GO:0061045]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress-activated MAPK cascade [GO:0032874]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; ubiquinone metabolic process [GO:0006743]; visual learning [GO:0008542]	HMGCR hCG_1757337
NM_000859	NM_000859 -> P04035-1	P04035	HMDH_HUMAN	3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)	GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0006743; GO:0007568; GO:0007584; GO:0008299; GO:0008542; GO:0010664; GO:0010666; GO:0015936; GO:0016021; GO:0016126; GO:0019216; GO:0032874; GO:0042177; GO:0042282; GO:0042803; GO:0043407; GO:0045445; GO:0045471; GO:0045540; GO:0048643; GO:0048661; GO:0050662; GO:0050709; GO:0051262; GO:0051721; GO:0061045; GO:0061179; GO:0070374; GO:0070402; GO:0097756; GO:1900222	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; coenzyme binding [GO:0050662]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; aging [GO:0007568]; cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; myoblast differentiation [GO:0045445]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of wound healing [GO:0061045]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein tetramerization [GO:0051262]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of lipid metabolic process [GO:0019216]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; sterol biosynthetic process [GO:0016126]; ubiquinone metabolic process [GO:0006743]; visual learning [GO:0008542]	HMGCR
NM_004850		A0A2P9DU05	A0A2P9DU05_HUMAN	Rho-associated protein kinase (EC 2.7.11.1)	GO:0004674; GO:0005524; GO:0005856; GO:0006939; GO:0007266; GO:0010825; GO:0017048; GO:0030036; GO:0032956; GO:0046872	cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; positive regulation of centrosome duplication [GO:0010825]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; smooth muscle contraction [GO:0006939]	ROCK2
NM_004850		O75116	ROCK2_HUMAN	Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)	GO:0000281; GO:0001934; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007186; GO:0007249; GO:0007266; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0017049; GO:0018105; GO:0018107; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031644; GO:0032723; GO:0032956; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048010; GO:0048013; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051246; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP-Rho binding [GO:0017049]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of blood vessel diameter [GO:0097746]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral RNA genome replication [GO:0039694]	ROCK2 KIAA0619
NM_004850		Q14DU5	Q14DU5_HUMAN	ROCK2 protein (Rho-associated protein kinase 2)	GO:0017048; GO:0035556; GO:0046872	metal ion binding [GO:0046872]; Rho GTPase binding [GO:0017048]; intracellular signal transduction [GO:0035556]	ROCK2
NM_001127257		A0A024R3W5	A0A024R3W5_HUMAN	Solute carrier family 39 (Zinc transporter), member 10, isoform CRA_a	GO:0002903; GO:0005385; GO:0005623; GO:0005886; GO:0006882; GO:0016021; GO:0030890; GO:0050861; GO:0071578; GO:1903615	cell [GO:0005623]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578]	SLC39A10 hCG_21193
NM_001127257		Q05C42	Q05C42_HUMAN	SLC39A10 protein (Fragment)			SLC39A10
NM_001127257	NM_001127257 -> Q9ULF5-1	Q9ULF5	S39AA_HUMAN	Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10)	GO:0002903; GO:0005385; GO:0005623; GO:0005887; GO:0006882; GO:0030890; GO:0050861; GO:0071578; GO:1903615	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578]	SLC39A10 KIAA1265 ZIP10
NM_000143		A0A0S2Z4C3	A0A0S2Z4C3_HUMAN	Epididymis secretory sperm binding protein (Fumarate hydratase isoform 1) (Fragment)	GO:0004333; GO:0005739; GO:0006099; GO:0006106; GO:0006108; GO:0045239; GO:0048873; GO:0120162	mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; positive regulation of cold-induced thermogenesis [GO:0120162]; tricarboxylic acid cycle [GO:0006099]	FH
NM_000143	NM_000143 -> P07954-1	P07954	FUMH_HUMAN	Fumarate hydratase, mitochondrial (Fumarase) (HsFH) (EC 4.2.1.2)	GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0035861; GO:0042393; GO:0045239; GO:0048873; GO:0070062; GO:0120162; GO:2001034	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]	FH
NM_014777		Q14146	URB2_HUMAN	Unhealthy ribosome biogenesis protein 2 homolog	GO:0005730; GO:0016235; GO:0030496; GO:0042254	aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254]	URB2 KIAA0133
NM_005993	NM_005993 -> Q9BTW9-1	Q9BTW9	TBCD_HUMAN	Tubulin-specific chaperone D (Beta-tubulin cofactor D) (tfcD) (SSD-1) (Tubulin-folding cofactor D)	GO:0000226; GO:0000278; GO:0005096; GO:0005737; GO:0005813; GO:0005874; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0051087; GO:0070830	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	TBCD KIAA0988 SSD1 TFCD PP1096
NM_005384		A0A024R241	A0A024R241_HUMAN	Nuclear factor interleukin-3-regulated protein	GO:0000978; GO:0003700; GO:0005634; GO:0006366; GO:0006955; GO:0007623; GO:0045892; GO:0045893; GO:0071353	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]	NFIL3 hCG_30387
NM_005384		Q16649	NFIL3_HUMAN	Nuclear factor interleukin-3-regulated protein (E4 promoter-binding protein 4) (Interleukin-3 promoter transcriptional activator) (Interleukin-3-binding protein 1) (Transcriptional activator NF-IL3A)	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0006355; GO:0006366; GO:0006955; GO:0007623; GO:0045892; GO:0045893; GO:0071353	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]	NFIL3 E4BP4 IL3BP1
NM_015974	NM_015974 -> Q9Y2S2-1	Q9Y2S2	CRYL1_HUMAN	Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH)	GO:0003857; GO:0005829; GO:0006631; GO:0019640; GO:0042803; GO:0050104; GO:0070062; GO:0070403	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]	CRYL1 CRY
NM_015974		V9HWG2	V9HWG2_HUMAN	Epididymis luminal protein 30 (Testicular tissue protein Li 44)	GO:0003857; GO:0006631; GO:0070403	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid metabolic process [GO:0006631]	HEL30
NM_017653	NM_017653 -> Q7RTS9-1	Q7RTS9	DYM_HUMAN	Dymeclin (Dyggve-Melchior-Clausen syndrome protein)	GO:0005737; GO:0005794; GO:0007030; GO:0016020; GO:0019899; GO:0060348	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; enzyme binding [GO:0019899]; bone development [GO:0060348]; Golgi organization [GO:0007030]	DYM
NM_001080509		A1L157	TSN11_HUMAN	Tetraspanin-11 (Tspan-11)	GO:0005887; GO:0016477	integral component of plasma membrane [GO:0005887]; cell migration [GO:0016477]	TSPAN11
NM_032852		A0A384MTY5	A0A384MTY5_HUMAN	Cysteine protease (EC 3.4.22.-)	GO:0004197; GO:0005737; GO:0006914; GO:0015031	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; autophagy [GO:0006914]; protein transport [GO:0015031]	
NM_032852		Q96DT6	ATG4C_HUMAN	Cysteine protease ATG4C (EC 3.4.22.-) (AUT-like 3 cysteine endopeptidase) (Autophagin-3) (Autophagy-related cysteine endopeptidase 3) (Autophagy-related protein 4 homolog C)	GO:0004197; GO:0005737; GO:0006914; GO:0015031	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; autophagy [GO:0006914]; protein transport [GO:0015031]	ATG4C APG4C AUTL1 AUTL3
NM_000965		F1D8S6	F1D8S6_HUMAN	Retinoic acid receptor beta variant 1 (Retinoic acid receptor, beta, isoform CRA_a)	GO:0000122; GO:0001657; GO:0002068; GO:0003148; GO:0003417; GO:0003707; GO:0004879; GO:0005654; GO:0008144; GO:0008270; GO:0008285; GO:0021756; GO:0031641; GO:0032331; GO:0035116; GO:0035264; GO:0043065; GO:0043066; GO:0043565; GO:0044877; GO:0045666; GO:0045944; GO:0046965; GO:0048048; GO:0048384; GO:0055012	nucleoplasm [GO:0005654]; drug binding [GO:0008144]; nuclear receptor activity [GO:0004879]; protein-containing complex binding [GO:0044877]; retinoid X receptor binding [GO:0046965]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; embryonic eye morphogenesis [GO:0048048]; embryonic hindlimb morphogenesis [GO:0035116]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myelination [GO:0031641]; retinoic acid receptor signaling pathway [GO:0048384]; striatum development [GO:0021756]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]	NR1B2 RARB hCG_26863
NM_000965	NM_000965 -> P10826-2	P10826	RARB_HUMAN	Retinoic acid receptor beta (RAR-beta) (HBV-activated protein) (Nuclear receptor subfamily 1 group B member 2) (RAR-epsilon)	GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001657; GO:0001889; GO:0002068; GO:0003148; GO:0003417; GO:0003677; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006367; GO:0007165; GO:0007275; GO:0008134; GO:0008144; GO:0008270; GO:0008285; GO:0009755; GO:0021756; GO:0030154; GO:0030374; GO:0031641; GO:0032331; GO:0032526; GO:0033993; GO:0035116; GO:0035264; GO:0038023; GO:0043065; GO:0043066; GO:0044877; GO:0045666; GO:0045944; GO:0046965; GO:0048048; GO:0048384; GO:0048566; GO:0048732; GO:0055012; GO:0060349; GO:0060429; GO:0071300; GO:0090575	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; drug binding [GO:0008144]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; embryonic digestive tract development [GO:0048566]; embryonic eye morphogenesis [GO:0048048]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; gland development [GO:0048732]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hormone-mediated signaling pathway [GO:0009755]; liver development [GO:0001889]; multicellular organism development [GO:0007275]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myelination [GO:0031641]; response to lipid [GO:0033993]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; striatum development [GO:0021756]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]	RARB HAP NR1B2
NM_000965		Q86UC5	Q86UC5_HUMAN	RARB protein (Fragment)	GO:0003707; GO:0004879; GO:0005634; GO:0008270; GO:0043565; GO:0048384	nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; retinoic acid receptor signaling pathway [GO:0048384]	RARB
NM_003106		A0A0U3FYV6	A0A0U3FYV6_HUMAN	SRY (Sex determining region Y)-box 2 (Transcription factor SOX-2)	GO:0000976; GO:0001228; GO:0005654; GO:0021984; GO:0022409; GO:0042246; GO:0045597	nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; adenohypophysis development [GO:0021984]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-cell adhesion [GO:0022409]; tissue regeneration [GO:0042246]	SOX2 hCG_2021649
NM_003106		P48431	SOX2_HUMAN	Transcription factor SOX-2	GO:0000122; GO:0000790; GO:0000976; GO:0000981; GO:0001228; GO:0001649; GO:0001654; GO:0001714; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006325; GO:0006355; GO:0007050; GO:0009611; GO:0010468; GO:0019221; GO:0021781; GO:0021983; GO:0021984; GO:0022409; GO:0030154; GO:0030900; GO:0035019; GO:0035198; GO:0042246; GO:0043281; GO:0043410; GO:0043565; GO:0044212; GO:0044798; GO:0045165; GO:0045597; GO:0045665; GO:0045893; GO:0045944; GO:0048839; GO:0050680; GO:0070848; GO:0090090; GO:0097150	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; miRNA binding [GO:0035198]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; adenohypophysis development [GO:0021984]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chromatin organization [GO:0006325]; cytokine-mediated signaling pathway [GO:0019221]; endodermal cell fate specification [GO:0001714]; eye development [GO:0001654]; forebrain development [GO:0030900]; glial cell fate commitment [GO:0021781]; inner ear development [GO:0048839]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; response to growth factor [GO:0070848]; response to wounding [GO:0009611]; somatic stem cell population maintenance [GO:0035019]; tissue regeneration [GO:0042246]	SOX2
NM_005529		P98160	PGBM_HUMAN	Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]	GO:0001523; GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0030198; GO:0043202; GO:0044267; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072358; GO:0098797; GO:1905907	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523]; tissue development [GO:0009888]	HSPG2
NM_015292		A0A024RB17	A0A024RB17_HUMAN	Family with sequence similarity 62 (C2 domain containing), member A, isoform CRA_b	GO:0005783; GO:0006869; GO:0008289; GO:0016021; GO:0061817	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]	FAM62A hCG_25002
NM_015292	NM_015292 -> Q9BSJ8-1	Q9BSJ8	ESYT1_HUMAN	Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein)	GO:0005509; GO:0005544; GO:0005783; GO:0005789; GO:0006687; GO:0006869; GO:0008429; GO:0016020; GO:0030176; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0061817	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; glycosphingolipid metabolic process [GO:0006687]; lipid transport [GO:0006869]	ESYT1 FAM62A KIAA0747 MBC2
NM_020777		Q96PQ0	SORC2_HUMAN	VPS10 domain-containing receptor SorCS2 [Cleaved into: SorCS2 122 kDa chain; SorCS2 104 kDa chain; SorCS2 18 kDa chain]	GO:0005887; GO:0006886; GO:0007218; GO:0008188; GO:0014069; GO:0016020; GO:0016021; GO:0030054; GO:0030659; GO:0031901; GO:0043197; GO:0043204; GO:0045211; GO:0055038; GO:0060292	cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome membrane [GO:0055038]; neuropeptide receptor activity [GO:0008188]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; neuropeptide signaling pathway [GO:0007218]	SORCS2 KIAA1329
NM_004905		P30041	PRDX6_HUMAN	Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12)	GO:0004602; GO:0005576; GO:0005615; GO:0005623; GO:0005634; GO:0005737; GO:0005829; GO:0006979; GO:0016020; GO:0031625; GO:0034599; GO:0035578; GO:0042744; GO:0042803; GO:0043312; GO:0045296; GO:0045454; GO:0046475; GO:0047499; GO:0048026; GO:0048471; GO:0051920; GO:0070062; GO:0098869; GO:0102567; GO:0102568	azurophil granule lumen [GO:0035578]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; cellular response to oxidative stress [GO:0034599]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; neutrophil degranulation [GO:0043312]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]	PRDX6 AOP2 KIAA0106
NM_004905		V9HWC7	V9HWC7_HUMAN	Epididymis secretory sperm binding protein Li 128m (Peroxiredoxin 6, isoform CRA_a)	GO:0004602; GO:0005623; GO:0042744; GO:0045454; GO:0051920	cell [GO:0005623]; glutathione peroxidase activity [GO:0004602]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]; hydrogen peroxide catabolic process [GO:0042744]	HEL-S-128m PRDX6 hCG_22109
NM_001031713		A0A384NPW7	A0A384NPW7_HUMAN	Chromosome 6 open reading frame 79, isoform CRA_a (Epididymis secretory sperm binding protein)	GO:0006851; GO:0016021	integral component of membrane [GO:0016021]; mitochondrial calcium ion transmembrane transport [GO:0006851]	C6orf79 hCG_37418
NM_001031713	NM_001031713 -> Q96AQ8-1	Q96AQ8	MCUR1_HUMAN	Mitochondrial calcium uniporter regulator 1 (MCU regulator 1) (Coiled-coil domain-containing protein 90A, mitochondrial)	GO:0005739; GO:0006851; GO:0031305; GO:0036444; GO:0051561; GO:0070509	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]	MCUR1 C6orf79 CCDC90A
NM_017943		A0A024R653	A0A024R653_HUMAN	F-box protein 34, isoform CRA_a			FBXO34 hCG_1660225
NM_017943		Q9NWN3	FBX34_HUMAN	F-box only protein 34			FBXO34 FBX34
NM_054027	NM_054027 -> Q9HCJ1-1	Q9HCJ1	ANKH_HUMAN	Progressive ankylosis protein homolog (ANK)	GO:0001501; GO:0005315; GO:0005886; GO:0005887; GO:0007626; GO:0015114; GO:0016021; GO:0019867; GO:0030500; GO:0030504; GO:0055085	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; outer membrane [GO:0019867]; plasma membrane [GO:0005886]; inorganic diphosphate transmembrane transporter activity [GO:0030504]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transporter activity [GO:0015114]; locomotory behavior [GO:0007626]; regulation of bone mineralization [GO:0030500]; skeletal system development [GO:0001501]; transmembrane transport [GO:0055085]	ANKH KIAA1581 UNQ241/PRO274
NM_000932	NM_000932 -> Q01970-1	Q01970	PLCB3_HUMAN	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3)	GO:0003073; GO:0004435; GO:0004629; GO:0005509; GO:0005516; GO:0005623; GO:0005654; GO:0005829; GO:0007186; GO:0007223; GO:0016020; GO:0016042; GO:0032959; GO:0032991; GO:0043647; GO:0045296; GO:0048015; GO:0051209; GO:0099524	cell [GO:0005623]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of systemic arterial blood pressure [GO:0003073]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	PLCB3
NM_005689	NM_005689 -> Q9NP58-1	Q9NP58	ABCB6_HUMAN	ATP-binding cassette sub-family B member 6, mitochondrial (Mitochondrial ABC transporter 3) (Mt-ABC transporter 3) (P-glycoprotein-related protein) (Ubiquitously-expressed mammalian ABC half transporter)	GO:0000139; GO:0005524; GO:0005623; GO:0005654; GO:0005739; GO:0005740; GO:0005741; GO:0005768; GO:0005774; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006779; GO:0006879; GO:0007420; GO:0010008; GO:0015439; GO:0015562; GO:0015886; GO:0016021; GO:0016887; GO:0020037; GO:0031307; GO:0042626; GO:0043190; GO:0043588; GO:0055085; GO:0070062	ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell [GO:0005623]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled heme transmembrane transporter activity [GO:0015439]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; heme binding [GO:0020037]; brain development [GO:0007420]; cellular iron ion homeostasis [GO:0006879]; heme transport [GO:0015886]; porphyrin-containing compound biosynthetic process [GO:0006779]; skin development [GO:0043588]; transmembrane transport [GO:0055085]	ABCB6 MTABC3 PRP UMAT
NM_020650		Q96D15	RCN3_HUMAN	Reticulocalbin-3 (EF-hand calcium-binding protein RLP49)	GO:0005509; GO:0005783; GO:0005788; GO:0009306; GO:0010952; GO:0015031; GO:0032964; GO:0036503; GO:0043129; GO:0051896; GO:0055091; GO:0060428	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; collagen biosynthetic process [GO:0032964]; ERAD pathway [GO:0036503]; lung epithelium development [GO:0060428]; phospholipid homeostasis [GO:0055091]; positive regulation of peptidase activity [GO:0010952]; protein secretion [GO:0009306]; protein transport [GO:0015031]; regulation of protein kinase B signaling [GO:0051896]; surfactant homeostasis [GO:0043129]	RCN3 UNQ239/PRO272
NM_178834	NM_178834 -> Q6UX15-2	Q6UX15	LAYN_HUMAN	Layilin	GO:0001726; GO:0005540; GO:0005925; GO:0009986; GO:0016021; GO:0030246	cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; ruffle [GO:0001726]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]	LAYN UNQ208/PRO234
NM_003709		A0A024R3X8	A0A024R3X8_HUMAN	Kruppel-like factor 7 (Ubiquitous), isoform CRA_a	GO:0003677; GO:0003700; GO:0007411; GO:0045893; GO:0048813	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; axon guidance [GO:0007411]; dendrite morphogenesis [GO:0048813]; positive regulation of transcription, DNA-templated [GO:0045893]	KLF7 hCG_16523
NM_003709	NM_003709 -> O75840-1	O75840	KLF7_HUMAN	Krueppel-like factor 7 (Ubiquitous krueppel-like factor)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0003713; GO:0005634; GO:0006357; GO:0007409; GO:0007411; GO:0008270; GO:0042593; GO:0045604; GO:0045944; GO:0048813; GO:0061179; GO:1904178	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]	KLF7 UKLF
NM_022779	NM_022779 -> Q9H8H2-1	Q9H8H2	DDX31_HUMAN	Probable ATP-dependent RNA helicase DDX31 (EC 3.6.4.13) (DEAD box protein 31) (Helicain)	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005794; GO:0042254; GO:0043231	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ribosome biogenesis [GO:0042254]	DDX31
NM_013396	NM_013396 -> Q9UHP3-2	Q9UHP3	UBP25_HUMAN	Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (USP on chromosome 21) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25)	GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006464; GO:0006508; GO:0006511; GO:0008233; GO:0016579; GO:0019783; GO:0031625; GO:0036459; GO:0043130; GO:0051117; GO:0070536; GO:0071108; GO:1904293	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATPase binding [GO:0051117]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein-specific protease activity [GO:0019783]; cellular protein modification process [GO:0006464]; negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; ubiquitin-dependent protein catabolic process [GO:0006511]	USP25 USP21
NM_001018072	NM_001018072 -> A6QL63-1	A6QL63	BTBDB_HUMAN	Ankyrin repeat and BTB/POZ domain-containing protein BTBD11 (BTB/POZ domain-containing protein 11)	GO:0016021; GO:0046982; GO:0060395	integral component of membrane [GO:0016021]; protein heterodimerization activity [GO:0046982]; SMAD protein signal transduction [GO:0060395]	BTBD11
NM_001018072		B3KVD0	B3KVD0_HUMAN	cDNA FLJ16416 fis, clone BRACE3001066, highly similar to Homo sapiens BTB (POZ) domain containing 11 (BTBD11), transcript variant 3, mRNA			
NM_001018072		B3KXB0	B3KXB0_HUMAN	cDNA FLJ45068 fis, clone BRAWH3025157, highly similar to Homo sapiens BTB (POZ) domain containing 11 (BTBD11), transcript variant 3, mRNA			
NM_173674	NM_173674 -> Q8N8Z6-2	Q8N8Z6	DCBD1_HUMAN	Discoidin, CUB and LCCL domain-containing protein 1	GO:0016021	integral component of membrane [GO:0016021]	DCBLD1
NM_014285	NM_014285 -> Q13868-1	Q13868	EXOS2_HUMAN	Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4)	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0008312; GO:0030307; GO:0034427; GO:0034475; GO:0043488; GO:0043928; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]	EXOSC2 RRP4
NM_006432		A0A024R6C0	A0A024R6C0_HUMAN	Epididymis secretory sperm binding protein (Niemann-Pick disease, type C2, isoform CRA_a)	GO:0032367	intracellular cholesterol transport [GO:0032367]	NPC2 hCG_21712
NM_006432	NM_006432 -> P61916-1	P61916	NPC2_HUMAN	NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1) (He1) (Niemann-Pick disease type C2 protein)	GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0009615; GO:0015485; GO:0015914; GO:0015918; GO:0019747; GO:0019899; GO:0030301; GO:0032366; GO:0032367; GO:0032934; GO:0033344; GO:0034383; GO:0035578; GO:0042632; GO:0043202; GO:0043312; GO:0046836; GO:0070062; GO:0120020	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycolipid transport [GO:0046836]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; low-density lipoprotein particle clearance [GO:0034383]; neutrophil degranulation [GO:0043312]; phospholipid transport [GO:0015914]; regulation of isoprenoid metabolic process [GO:0019747]; response to virus [GO:0009615]; sterol transport [GO:0015918]	NPC2 HE1
NM_182557	NM_182557 -> Q86UU0-1	Q86UU0	BCL9L_HUMAN	B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2)	GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0008013; GO:0010718; GO:0022604; GO:0030512; GO:0035019; GO:0035914; GO:0045944; GO:0060070; GO:1904837; GO:1990907	beta-catenin-TCF complex [GO:1990907]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; beta-catenin-TCF complex assembly [GO:1904837]; canonical Wnt signaling pathway [GO:0060070]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell morphogenesis [GO:0022604]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell population maintenance [GO:0035019]	BCL9L DLNB11
NM_032291	NM_032291 -> Q9BQI5-1	Q9BQI5	SGIP1_HUMAN	SH3-containing GRB2-like protein 3-interacting protein 1 (Endophilin-3-interacting protein)	GO:0002021; GO:0005543; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0008017; GO:0008092; GO:0017124; GO:0030122; GO:0030136; GO:0048260; GO:0048268; GO:0061024; GO:0072583; GO:0097009; GO:2000253	AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; SH3 domain binding [GO:0017124]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; energy homeostasis [GO:0097009]; membrane organization [GO:0061024]; positive regulation of feeding behavior [GO:2000253]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to dietary excess [GO:0002021]	SGIP1
NM_004100	NM_004100 -> O95677-1	O95677	EYA4_HUMAN	Eyes absent homolog 4 (EC 3.1.3.48)	GO:0004725; GO:0005634; GO:0005737; GO:0006281; GO:0007275; GO:0007601; GO:0007605; GO:0009653; GO:0016576; GO:0045739; GO:0046872; GO:0048856; GO:2001240	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; multicellular organism development [GO:0007275]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	EYA4
NM_004100		Q96CJ7	Q96CJ7_HUMAN	Eyes absent homolog (EC 3.1.3.48) (Fragment)	GO:0004725; GO:0007275; GO:0007605; GO:0046872	metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; multicellular organism development [GO:0007275]; sensory perception of sound [GO:0007605]	EYA4
NM_003512		A0A024R017	A0A024R017_HUMAN	Histone H2A	GO:0000786; GO:0003677; GO:0005634; GO:0046982	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	HIST1H2AC hCG_19120
NM_003512		Q93077	H2A1C_HUMAN	Histone H2A type 1-C (Histone H2A/l)	GO:0000786; GO:0000790; GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0008285; GO:0046982; GO:0070062	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325]; negative regulation of cell population proliferation [GO:0008285]	HIST1H2AC H2AFL
NM_014396	NM_014396 -> P49754-1	P49754	VPS41_HUMAN	Vacuolar protein sorting-associated protein 41 homolog (S53)	GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006886; GO:0006914; GO:0008017; GO:0008333; GO:0010008; GO:0015630; GO:0016020; GO:0030123; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0035542; GO:0042144; GO:0042802; GO:0043621; GO:0045055; GO:0046872; GO:0048193; GO:1902774	AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulated exocytosis [GO:0045055]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]	VPS41
NM_012281		A4D0V9	A4D0V9_HUMAN	Potassium voltage-gated channel, Shal-related subfamily, member 2	GO:0005250; GO:0008076; GO:0019228; GO:0019233; GO:0034765; GO:0043025; GO:0043197; GO:0045475; GO:0051260; GO:0098978; GO:0098982; GO:0099060; GO:1905030	dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; locomotor rhythm [GO:0045475]; neuronal action potential [GO:0019228]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]	KCND2 hCG_2039708 tcag7.101
NM_012281		Q9NZV8	KCND2_HUMAN	Potassium voltage-gated channel subfamily D member 2 (Voltage-gated potassium channel subunit Kv4.2)	GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0005887; GO:0007268; GO:0008076; GO:0014069; GO:0016021; GO:0019228; GO:0019233; GO:0030054; GO:0030425; GO:0031226; GO:0032809; GO:0034765; GO:0043197; GO:0043204; GO:0044853; GO:0045211; GO:0045475; GO:0046872; GO:0051260; GO:0061337; GO:0071456; GO:0071805; GO:0098978; GO:0098982; GO:0099060; GO:1905030	cell junction [GO:0030054]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cardiac conduction [GO:0061337]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; locomotor rhythm [GO:0045475]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]	KCND2 KIAA1044
NM_022828		Q9H6S0	YTDC2_HUMAN	3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (YTH domain-containing protein 2) (hYTHDC2)	GO:0003723; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0007286; GO:0008186; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA-dependent ATPase activity [GO:0008186]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]	YTHDC2
NM_024616		Q5BVD1	TTMP_HUMAN	TPA-induced transmembrane protein	GO:0005789; GO:0016021	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	TTMP C3orf52
NM_015074	NM_015074 -> O60333-2	O60333	KIF1B_HUMAN	Kinesin-like protein KIF1B (Klp)	GO:0003777; GO:0005524; GO:0005739; GO:0005871; GO:0005874; GO:0005875; GO:0006915; GO:0007018; GO:0007270; GO:0007274; GO:0008017; GO:0008021; GO:0008089; GO:0008574; GO:0010628; GO:0016192; GO:0016887; GO:0019894; GO:0019900; GO:0030054; GO:0030424; GO:0030425; GO:0030659; GO:0030705; GO:0031410; GO:0032418; GO:0043005; GO:0047497; GO:0097110; GO:1904115; GO:1904647; GO:1990048; GO:1990049; GO:1990090; GO:1990778	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; scaffold protein binding [GO:0097110]; anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; apoptotic process [GO:0006915]; cellular response to nerve growth factor stimulus [GO:1990090]; cytoskeleton-dependent intracellular transport [GO:0030705]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; mitochondrion transport along microtubule [GO:0047497]; neuromuscular synaptic transmission [GO:0007274]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of gene expression [GO:0010628]; protein localization to cell periphery [GO:1990778]; response to rotenone [GO:1904647]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192]	KIF1B KIAA0591 KIAA1448
NM_014488		A8K5R1	A8K5R1_HUMAN	RAB30, member RAS oncogene family, isoform CRA_a (cDNA FLJ78283, highly similar to Homo sapiens RAB30, member RAS oncogene family (RAB30), mRNA) (cDNA, FLJ92634, Homo sapiens RAB30, member RAS oncogene family (RAB30), mRNA)	GO:0003924; GO:0005525; GO:0032482; GO:0043231	intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rab protein signal transduction [GO:0032482]	RAB30 hCG_27287
NM_014488	NM_014488 -> Q15771-1	Q15771	RAB30_HUMAN	Ras-related protein Rab-30	GO:0000139; GO:0003924; GO:0005525; GO:0005795; GO:0005801; GO:0005802; GO:0006886; GO:0007030; GO:0031985; GO:0032482; GO:0043231	cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]	RAB30
NM_006380		A0A024QZ47	A0A024QZ47_HUMAN	Amyloid beta protein (Cytoplasmic tail) binding protein 2, isoform CRA_a	GO:0006886	intracellular protein transport [GO:0006886]	APPBP2 hCG_32179
NM_006380		Q92624	APBP2_HUMAN	Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2) (Protein interacting with APP tail 1)	GO:0003777; GO:0005634; GO:0005737; GO:0005874; GO:0005875; GO:0006886; GO:0030659; GO:0046907	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; microtubule motor activity [GO:0003777]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]	APPBP2 KIAA0228 PAT1
NM_002892		A0A024R657	A0A024R657_HUMAN	AT rich interactive domain 4A (RBP1-like), isoform CRA_c	GO:0003677; GO:0005654; GO:0005829; GO:0005886; GO:0006349; GO:0007283; GO:0034773; GO:0036124; GO:0045944; GO:0048821; GO:0080182; GO:0097368	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; erythrocyte development [GO:0048821]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; spermatogenesis [GO:0007283]	ARID4A hCG_20985
NM_002892	NM_002892 -> P29374-1	P29374	ARI4A_HUMAN	AT-rich interactive domain-containing protein 4A (ARID domain-containing protein 4A) (Retinoblastoma-binding protein 1) (RBBP-1)	GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006349; GO:0006357; GO:0007283; GO:0017053; GO:0034773; GO:0036124; GO:0044212; GO:0045892; GO:0045944; GO:0048821; GO:0080182; GO:0097368	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; transcription regulatory region DNA binding [GO:0044212]; erythrocyte development [GO:0048821]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	ARID4A RBBP1 RBP1
NM_002892		Q05CG0	Q05CG0_HUMAN	ARID4A protein (Fragment)	GO:0003677; GO:0005634	nucleus [GO:0005634]; DNA binding [GO:0003677]	ARID4A
NM_005160		A0A024R1D8	A0A024R1D8_HUMAN	G protein-coupled receptor kinase (EC 2.7.11.-)	GO:0004703; GO:0005524; GO:0007165	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; signal transduction [GO:0007165]	ADRBK2 hCG_40095
NM_005160		P35626	ARBK2_HUMAN	Beta-adrenergic receptor kinase 2 (Beta-ARK-2) (EC 2.7.11.15) (G-protein-coupled receptor kinase 3)	GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0007165; GO:0007186; GO:0031623; GO:0047696	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; G protein-coupled receptor signaling pathway [GO:0007186]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]	GRK3 ADRBK2 BARK2
NM_005160		Q8N433	Q8N433_HUMAN	G protein-coupled receptor kinase (EC 2.7.11.-)	GO:0004703; GO:0005524; GO:0007165	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; signal transduction [GO:0007165]	GRK3
NM_181711	NM_181711 -> Q7Z6J2-1	Q7Z6J2	GRASP_HUMAN	General receptor for phosphoinositides 1-associated scaffold protein (GRP1-associated scaffold protein)	GO:0005886; GO:0007165; GO:0008104; GO:0014069; GO:0030054; GO:0030165; GO:0030306; GO:0042802; GO:0045211; GO:0048471; GO:0098685; GO:0098978; GO:0099152	cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685]; ADP-ribosylation factor binding [GO:0030306]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein localization [GO:0008104]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]	GRASP
NM_001145348	NM_001145348 -> Q8N371-3	Q8N371	KDM8_HUMAN	Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.-) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8)	GO:0000086; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0016706; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0051864; GO:0070544	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]	KDM8 JMJD5
NM_053064		P59768	GBG2_HUMAN	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (G gamma-I)	GO:0003924; GO:0005834; GO:0005886; GO:0006457; GO:0007186; GO:0007191; GO:0007223; GO:0008283; GO:0016020; GO:0030168; GO:0031680; GO:0031681; GO:0070062; GO:0071380; GO:0071870	extracellular exosome [GO:0070062]; G-protein beta/gamma-subunit complex [GO:0031680]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; cell population proliferation [GO:0008283]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]; platelet activation [GO:0030168]; protein folding [GO:0006457]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	GNG2
NM_001142800	NM_001142800 -> Q5T1H1-1	Q5T1H1	EYS_HUMAN	Protein eyes shut homolog (Epidermal growth factor-like protein 10) (EGF-like protein 10) (Epidermal growth factor-like protein 11) (EGF-like protein 11) (Protein spacemaker homolog)	GO:0001750; GO:0005509; GO:0005737; GO:0005815; GO:0033165; GO:0043403; GO:0050908; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; interphotoreceptor matrix [GO:0033165]; microtubule organizing center [GO:0005815]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; detection of light stimulus involved in visual perception [GO:0050908]; skeletal muscle tissue regeneration [GO:0043403]	EYS C6orf178 C6orf179 C6orf180 EGFL10 EGFL11 SPAM UNQ9424/PRO34591
NM_203282	NM_203282 -> O75437-1	O75437	ZN254_HUMAN	Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)	GO:0000122; GO:0000981; GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]	ZNF254 BMZF5 ZNF539 ZNF91L
NM_001013659	NM_001013659 -> Q6ZN11-1	Q6ZN11	ZN793_HUMAN	Zinc finger protein 793	GO:0003677; GO:0005634; GO:0006355; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]	ZNF793
NM_003437		P52737	ZN136_HUMAN	Zinc finger protein 136	GO:0000122; GO:0003677; GO:0003714; GO:0005634; GO:0006366; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366]	ZNF136
NM_005113	NM_005113 -> Q8TBA6-1	Q8TBA6	GOGA5_HUMAN	Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein)	GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0016021; GO:0017137; GO:0030133; GO:0031985; GO:0042803; GO:0048193	cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]	GOLGA5 RETII RFG5 PIG31
NM_194286		A7MD48	SRRM4_HUMAN	Serine/arginine repetitive matrix protein 4 (Medulloblastoma antigen MU-MB-2.76) (Neural-specific serine/arginine repetitive splicing factor of 100 kDa) (Neural-specific SR-related protein of 100 kDa) (nSR100)	GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0007399; GO:0007605; GO:0008380; GO:0030154; GO:0042551; GO:0043484	nucleus [GO:0005634]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sensory perception of sound [GO:0007605]	SRRM4 KIAA1853
NM_194286		V5T9A0	V5T9A0_HUMAN	Serine/arginine repetitive matrix 4	GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0007399; GO:0007605; GO:0030154	nucleus [GO:0005634]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; sensory perception of sound [GO:0007605]	SRRM4
NM_003957		A0A140VJF6	A0A140VJF6_HUMAN	BR serine/threonine kinase 2, isoform CRA_a (Testicular tissue protein Li 30)	GO:0004672; GO:0005524	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]	BRSK2 hCG_1778319
NM_003957	NM_003957 -> Q8IWQ3-3	Q8IWQ3	BRSK2_HUMAN	Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A)	GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0018105; GO:0019901; GO:0030010; GO:0030182; GO:0031532; GO:0035556; GO:0036503; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0150034; GO:1904152; GO:2000807	centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cell division [GO:0051301]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of ATPase activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]	BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12
NM_173511	NM_173511 -> Q6P1L5-1	Q6P1L5	F117B_HUMAN	Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein)			FAM117B ALS2CR13
NM_173511		Q7Z3M2	Q7Z3M2_HUMAN	Uncharacterized protein DKFZp686H01244			DKFZp686H01244
NM_021135	NM_021135 -> Q15349-1	Q15349	KS6A2_HUMAN	Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3)	GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0008285; GO:0035556; GO:0043065; GO:0045786	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	RPS6KA2 MAPKAPK1C RSK3
NM_018717		Q96JK9	MAML3_HUMAN	Mastermind-like protein 3 (Mam-3)	GO:0003713; GO:0005634; GO:0005654; GO:0006367; GO:0007219; GO:0007221; GO:0016607; GO:0045747; GO:0045944	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; transcription initiation from RNA polymerase II promoter [GO:0006367]	MAML3 KIAA1816
NM_018717		Q9NPV6	Q9NPV6_HUMAN	Uncharacterized protein DKFZp762E1511 (Fragment)			DKFZp762E1511
NM_001079537	NM_001079537 -> Q86SZ2-1	Q86SZ2	TPC6B_HUMAN	Trafficking protein particle complex subunit 6B (TRAPP complex subunit 6B)	GO:0000139; GO:0005783; GO:0005801; GO:0005802; GO:0005829; GO:0006888; GO:0007399; GO:0043087; GO:0048208	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]	TRAPPC6B
NM_032826	NM_032826 -> Q969S0-1	Q969S0	S35B4_HUMAN	UDP-xylose and UDP-N-acetylglucosamine transporter (Solute carrier family 35 member B4) (YEA4 homolog)	GO:0000139; GO:0005462; GO:0005464; GO:0005783; GO:0005794; GO:0006111; GO:0008643; GO:0015790; GO:0022857; GO:0030173; GO:0030176; GO:1990569	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]; regulation of gluconeogenesis [GO:0006111]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790]	SLC35B4 YEA4 PSEC0055
NM_032312		Q9BSR8	YIPF4_HUMAN	Protein YIPF4 (YIP1 family member 4)	GO:0005783; GO:0005794; GO:0005886; GO:0016021; GO:0043231	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	YIPF4 Nbla11189
NM_020911		A0A024R7A6	A0A024R7A6_HUMAN	Plexin A4, B, isoform CRA_b	GO:0016021; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021793; GO:0021960; GO:0048485; GO:0048841; GO:0050923; GO:1902287	integral component of membrane [GO:0016021]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]	PLXNA4B hCG_2014152
NM_020911	NM_020911 -> Q9HCM2-1	Q9HCM2	PLXA4_HUMAN	Plexin-A4	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021793; GO:0021960; GO:0030334; GO:0043087; GO:0048485; GO:0048841; GO:0050772; GO:0050923; GO:0071526; GO:1902287	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]	PLXNA4 KIAA1550 PLXNA4A PLXNA4B UNQ2820/PRO34003
NM_014293		O95502	NPTXR_HUMAN	Neuronal pentraxin receptor	GO:0016021; GO:0046872; GO:0098962; GO:0098978	glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]	NPTXR
NM_003655		A0A0S2Z5B2	A0A0S2Z5B2_HUMAN	Chromobox homolog 4 (Pc class homolog, Drosophila), isoform CRA_a (Chromobox-like protein 4 isoform 2) (Fragment)	GO:0000122; GO:0003682; GO:0003727; GO:0005654; GO:0016604; GO:0016925; GO:0032183; GO:0035064; GO:0044212; GO:0051219	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; phosphoprotein binding [GO:0051219]; single-stranded RNA binding [GO:0003727]; SUMO binding [GO:0032183]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein sumoylation [GO:0016925]	CBX4 hCG_28566
NM_003655	NM_003655 -> O00257-1	O00257	CBX4_HUMAN	E3 SUMO-protein ligase CBX4 (EC 2.3.2.-) (Chromobox protein homolog 4) (Polycomb 2 homolog) (Pc2) (hPc2)	GO:0000122; GO:0003682; GO:0003714; GO:0003727; GO:0005634; GO:0005654; GO:0006325; GO:0016604; GO:0016607; GO:0019789; GO:0019899; GO:0031519; GO:0032183; GO:0035064; GO:0035102; GO:0043066; GO:0044212; GO:0045892; GO:0051219	nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; phosphoprotein binding [GO:0051219]; single-stranded RNA binding [GO:0003727]; SUMO binding [GO:0032183]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]	CBX4
NM_025231		Q9H4T2	ZSC16_HUMAN	Zinc finger and SCAN domain-containing protein 16 (Zinc finger protein 392) (Zinc finger protein 435)	GO:0003677; GO:0003700; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	ZSCAN16 ZNF392 ZNF435
NM_014653	NM_014653 -> Q2TBF2-1	Q2TBF2	WSCD2_HUMAN	WSC domain-containing protein 2	GO:0016021	integral component of membrane [GO:0016021]	WSCD2 KIAA0789
NM_175929	NM_175929 -> Q92915-2	Q92915	FGF14_HUMAN	Fibroblast growth factor 14 (FGF-14) (Fibroblast growth factor homologous factor 4) (FHF-4)	GO:0005576; GO:0005634; GO:0007165; GO:0007254; GO:0007267; GO:0007399; GO:0008083; GO:0008201; GO:0048167; GO:0060078; GO:1901843; GO:1903421	extracellular region [GO:0005576]; nucleus [GO:0005634]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; cell-cell signaling [GO:0007267]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle recycling [GO:1903421]; signal transduction [GO:0007165]	FGF14 FHF4
NM_032726	NM_032726 -> Q9BRC7-1	Q9BRC7	PLCD4_HUMAN	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (hPLCD4) (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4)	GO:0001965; GO:0004435; GO:0005085; GO:0005509; GO:0005623; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0007340; GO:0016042; GO:0031965; GO:0032959; GO:0043647; GO:0046488; GO:0048015; GO:0051209	cell [GO:0005623]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phospholipase C activity [GO:0004435]; acrosome reaction [GO:0007340]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; release of sequestered calcium ion into cytosol [GO:0051209]; small GTPase mediated signal transduction [GO:0007264]	PLCD4
NM_152749,NM_020725	NM_020725 -> Q9ULK2-1,NM_152749 -> Q9ULK2-2	Q9ULK2	AT7L1_HUMAN	Ataxin-7-like protein 1 (Ataxin-7-like protein 4)			ATXN7L1 ATXN7L4 KIAA1218
NM_001017969	NM_001017969 -> Q5HYC2-1	Q5HYC2	K2026_HUMAN	Uncharacterized protein KIAA2026			KIAA2026
NM_012082	NM_012082 -> Q8WW38-1	Q8WW38	FOG2_HUMAN	Zinc finger protein ZFPM2 (Friend of GATA protein 2) (FOG-2) (Friend of GATA 2) (hFOG-2) (Zinc finger protein 89B) (Zinc finger protein multitype 2)	GO:0000122; GO:0000790; GO:0000981; GO:0001085; GO:0001570; GO:0001701; GO:0003148; GO:0003221; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007506; GO:0007507; GO:0007596; GO:0008134; GO:0008270; GO:0030324; GO:0045599; GO:0045892; GO:0045944; GO:0048568; GO:0060045; GO:0060412; GO:0060548; GO:2000020; GO:2000195	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; blood coagulation [GO:0007596]; embryonic organ development [GO:0048568]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of female gonad development [GO:2000195]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]	ZFPM2 FOG2 ZNF89B
NM_012082		Q9NPQ0	Q9NPQ0_HUMAN	FOG2, frind of GATA2 (Fragment)	GO:0001085; GO:0006357	RNA polymerase II transcription factor binding [GO:0001085]; regulation of transcription by RNA polymerase II [GO:0006357]	
NM_001024843		A0A024R1N5	A0A024R1N5_HUMAN	Trinucleotide repeat containing 6B, isoform CRA_a	GO:0003676; GO:0035278	nucleic acid binding [GO:0003676]; miRNA mediated inhibition of translation [GO:0035278]	TNRC6B hCG_41115
NM_001024843	NM_001024843 -> Q9UPQ9-2	Q9UPQ9	TNR6B_HUMAN	Trinucleotide repeat-containing gene 6B protein	GO:0000932; GO:0003723; GO:0005654; GO:0005829; GO:0007223; GO:0010628; GO:0010629; GO:0031047; GO:0035194; GO:0035195; GO:0035278; GO:0045652; GO:0060213; GO:1900153	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; gene silencing by RNA [GO:0031047]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	TNRC6B KIAA1093
NM_006143		Q15760	GPR19_HUMAN	Probable G-protein coupled receptor 19 (GPR-NGA)	GO:0004930; GO:0005887; GO:0005929; GO:0007186	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]	GPR19
NM_006143		Q6IBH2	Q6IBH2_HUMAN	G protein-coupled receptor 19 (GPR19 protein) (HCG2039474, isoform CRA_a) (cDNA FLJ90248 fis, clone NT2RM2001939, highly similar to Probable G-protein coupled receptor 19)	GO:0004930; GO:0016021	integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]	GPR19 hCG_2039474
NM_003316	NM_003316 -> P53804-1	P53804	TTC3_HUMAN	E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3)	GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006511; GO:0046872; GO:0070936	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]	TTC3 DCRR1 RNF105 TPRD
NM_006181		O00634	NET3_HUMAN	Netrin-3 (Netrin-2-like protein)	GO:0005102; GO:0005604; GO:0005794; GO:0007411; GO:0008045; GO:0009887; GO:0009888; GO:0016358	basement membrane [GO:0005604]; Golgi apparatus [GO:0005794]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888]	NTN3 NTN2L
NM_022783	NM_022783 -> Q8TB45-1	Q8TB45	DPTOR_HUMAN	DEP domain-containing mTOR-interacting protein (DEP domain-containing protein 6)	GO:0005622; GO:0006469; GO:0032007; GO:0035556; GO:0045792; GO:2001236	intracellular [GO:0005622]; intracellular signal transduction [GO:0035556]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]	DEPTOR DEPDC6
NM_001127715	NM_001127715 -> Q5T5C0-1	Q5T5C0	STXB5_HUMAN	Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1)	GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0008021; GO:0015031; GO:0017075; GO:0017137; GO:0017157; GO:0019905; GO:0030054; GO:0030659; GO:0031201; GO:0031594; GO:0045159; GO:0045921; GO:0098685; GO:0098888; GO:0099504; GO:0099523	acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of presynaptic membrane [GO:0098888]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; synaptic vesicle cycle [GO:0099504]	STXBP5 LLGL3
NM_024532		B4DYB5	B4DYB5_HUMAN	cDNA FLJ53372, highly similar to Sperm-associated antigen 16 protein			
NM_024532		Q4G1A2	Q4G1A2_HUMAN	SPAG16 protein			SPAG16
NM_024532	NM_024532 -> Q8N0X2-1	Q8N0X2	SPG16_HUMAN	Sperm-associated antigen 16 protein (Pf20 protein homolog)	GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:1990716	axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288]	SPAG16 PF20
NM_020856		Q63HK5	TSH3_HUMAN	Teashirt homolog 3 (Zinc finger protein 537)	GO:0000790; GO:0000981; GO:0002087; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0007275; GO:0030426; GO:0045892; GO:0046872; GO:0051968; GO:0060291	growth cone [GO:0030426]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; long-term synaptic potentiation [GO:0060291]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]	TSHZ3 KIAA1474 TSH3 ZNF537
NM_005486	NM_005486 -> O75674-1	O75674	TM1L1_HUMAN	TOM1-like protein 1 (Src-activating and signaling molecule protein) (Target of Myb-like protein 1)	GO:0005737; GO:0005764; GO:0005768; GO:0005795; GO:0005829; GO:0006886; GO:0007165; GO:0010008; GO:0017124; GO:0019901; GO:0030276; GO:0030295; GO:0031954; GO:0032147; GO:0043130; GO:0043162; GO:0045839; GO:0070062	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; lysosome [GO:0005764]; clathrin binding [GO:0030276]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130]; activation of protein kinase activity [GO:0032147]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; positive regulation of protein autophosphorylation [GO:0031954]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	TOM1L1 SRCASM
NM_152356		Q8N8L2	ZN491_HUMAN	Zinc finger protein 491	GO:0003700; GO:0005634; GO:0043565; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]	ZNF491
NM_002825		A0A024R778	A0A024R778_HUMAN	Pleiotrophin (Heparin binding growth factor 8, neurite growth-promoting factor 1), isoform CRA_a	GO:0001889; GO:0002232; GO:0002690; GO:0005604; GO:0007406; GO:0007507; GO:0007612; GO:0007613; GO:0008083; GO:0008201; GO:0008360; GO:0009986; GO:0010811; GO:0010996; GO:0014823; GO:0016020; GO:0016525; GO:0021510; GO:0021549; GO:0021794; GO:0030282; GO:0030324; GO:0030336; GO:0030501; GO:0031104; GO:0031594; GO:0031641; GO:0032355; GO:0032570; GO:0034644; GO:0035373; GO:0036120; GO:0038085; GO:0042246; GO:0043065; GO:0044849; GO:0045446; GO:0045545; GO:0045837; GO:0046697; GO:0048471; GO:0048477; GO:0048680; GO:0050680; GO:0060221; GO:0060253; GO:0060291; GO:0071305; GO:0071456; GO:0072201; GO:0098793; GO:0098794; GO:0140059; GO:1900006; GO:1900272; GO:1903706; GO:1904373; GO:1904389; GO:1904391; GO:1904395; GO:1904397; GO:1904399; GO:1990089; GO:2000036; GO:2000347; GO:2000738	basement membrane [GO:0005604]; cell surface [GO:0009986]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; chondroitin sulfate proteoglycan binding [GO:0035373]; growth factor activity [GO:0008083]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; syndecan binding [GO:0045545]; vascular endothelial growth factor binding [GO:0038085]; bone mineralization [GO:0030282]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to UV [GO:0034644]; cellular response to vitamin D [GO:0071305]; cerebellum development [GO:0021549]; decidualization [GO:0046697]; dendrite arborization [GO:0140059]; dendrite regeneration [GO:0031104]; endothelial cell differentiation [GO:0045446]; estrous cycle [GO:0044849]; heart development [GO:0007507]; learning [GO:0007612]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; lung development [GO:0030324]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of membrane potential [GO:0045837]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuromuscular junction development [GO:1904397]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axon regeneration [GO:0048680]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dendrite development [GO:1900006]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of stem cell differentiation [GO:2000738]; regulation of cell shape [GO:0008360]; regulation of hemopoiesis [GO:1903706]; regulation of myelination [GO:0031641]; regulation of stem cell population maintenance [GO:2000036]; response to activity [GO:0014823]; response to auditory stimulus [GO:0010996]; response to ciliary neurotrophic factor [GO:1904391]; response to estradiol [GO:0032355]; response to kainic acid [GO:1904373]; response to nerve growth factor [GO:1990089]; response to progesterone [GO:0032570]; retinal rod cell differentiation [GO:0060221]; rod bipolar cell differentiation [GO:1904389]; spinal cord development [GO:0021510]; thalamus development [GO:0021794]; tissue regeneration [GO:0042246]	PTN hCG_18946
NM_002825		P21246	PTN_HUMAN	Pleiotrophin (PTN) (Heparin-binding brain mitogen) (HBBM) (Heparin-binding growth factor 8) (HBGF-8) (Heparin-binding growth-associated molecule) (HB-GAM) (Heparin-binding neurite outgrowth-promoting factor) (HBNF) (Heparin-binding neurite outgrowth-promoting factor 1) (HBNF-1) (Osteoblast-specific factor 1) (OSF-1)	GO:0001889; GO:0002232; GO:0002690; GO:0004864; GO:0005178; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0005886; GO:0007185; GO:0007229; GO:0007399; GO:0007406; GO:0007507; GO:0007612; GO:0007613; GO:0008083; GO:0008201; GO:0008284; GO:0008360; GO:0009986; GO:0010594; GO:0010811; GO:0010976; GO:0010996; GO:0014823; GO:0016525; GO:0019901; GO:0021510; GO:0021549; GO:0021794; GO:0030282; GO:0030324; GO:0030336; GO:0030501; GO:0031104; GO:0031594; GO:0031641; GO:0032355; GO:0032570; GO:0032991; GO:0034644; GO:0035373; GO:0035374; GO:0036120; GO:0038085; GO:0042246; GO:0043065; GO:0043113; GO:0043932; GO:0044849; GO:0045446; GO:0045545; GO:0045778; GO:0045837; GO:0046697; GO:0048167; GO:0048471; GO:0048477; GO:0048680; GO:0048714; GO:0050680; GO:0051781; GO:0060221; GO:0060253; GO:0060291; GO:0071305; GO:0071456; GO:0072201; GO:0098793; GO:0098794; GO:0140059; GO:1900006; GO:1900272; GO:1903706; GO:1904373; GO:1904389; GO:1904391; GO:1904395; GO:1904397; GO:1904399; GO:1990089; GO:2000036; GO:2000347; GO:2000738	basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; chondroitin sulfate binding [GO:0035374]; chondroitin sulfate proteoglycan binding [GO:0035373]; growth factor activity [GO:0008083]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein phosphatase inhibitor activity [GO:0004864]; syndecan binding [GO:0045545]; vascular endothelial growth factor binding [GO:0038085]; bone mineralization [GO:0030282]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to UV [GO:0034644]; cellular response to vitamin D [GO:0071305]; cerebellum development [GO:0021549]; decidualization [GO:0046697]; dendrite arborization [GO:0140059]; dendrite regeneration [GO:0031104]; endothelial cell differentiation [GO:0045446]; estrous cycle [GO:0044849]; heart development [GO:0007507]; integrin-mediated signaling pathway [GO:0007229]; learning [GO:0007612]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; lung development [GO:0030324]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of membrane potential [GO:0045837]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuromuscular junction development [GO:1904397]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; ossification involved in bone remodeling [GO:0043932]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axon regeneration [GO:0048680]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dendrite development [GO:1900006]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of ossification [GO:0045778]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of stem cell differentiation [GO:2000738]; receptor clustering [GO:0043113]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; regulation of hemopoiesis [GO:1903706]; regulation of myelination [GO:0031641]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; response to activity [GO:0014823]; response to auditory stimulus [GO:0010996]; response to ciliary neurotrophic factor [GO:1904391]; response to estradiol [GO:0032355]; response to kainic acid [GO:1904373]; response to nerve growth factor [GO:1990089]; response to progesterone [GO:0032570]; retinal rod cell differentiation [GO:0060221]; rod bipolar cell differentiation [GO:1904389]; spinal cord development [GO:0021510]; thalamus development [GO:0021794]; tissue regeneration [GO:0042246]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	PTN HBNF1 NEGF1
NM_033064		A0A0S2Z5T8	A0A0S2Z5T8_HUMAN	Ataxia cerebellar Cayman type isoform 1 (Ataxia, cerebellar, Cayman type (Caytaxin)) (Fragment)	GO:0016021; GO:0030424; GO:0030425; GO:0031175; GO:0031966; GO:0044306; GO:0045202; GO:0048311; GO:0048471	axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; mitochondrion distribution [GO:0048311]; neuron projection development [GO:0031175]	ATCAY hCG_23529
NM_033064	NM_033064 -> Q86WG3-1	Q86WG3	ATCAY_HUMAN	Caytaxin (Ataxia cayman type protein) (BNIP-2-homology) (BNIP-H)	GO:0004309; GO:0005737; GO:0006798; GO:0006915; GO:0019894; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0031966; GO:0032880; GO:0043005; GO:0044306; GO:0045202; GO:0048311; GO:0048471; GO:2000212	axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; exopolyphosphatase activity [GO:0004309]; kinesin binding [GO:0019894]; apoptotic process [GO:0006915]; mitochondrion distribution [GO:0048311]; negative regulation of glutamate metabolic process [GO:2000212]; neuron projection development [GO:0031175]; polyphosphate catabolic process [GO:0006798]; regulation of protein localization [GO:0032880]	ATCAY KIAA1872
NM_024721	NM_024721 -> Q86UP3-5	Q86UP3	ZFHX4_HUMAN	Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0005634; GO:0008270; GO:0044212; GO:0045893	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]	ZFHX4
NM_004717		O75912	DGKI_HUMAN	Diacylglycerol kinase iota (DAG kinase iota) (EC 2.7.1.107) (Diglyceride kinase iota) (DGK-iota)	GO:0003951; GO:0004143; GO:0005095; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007205; GO:0007269; GO:0008021; GO:0017016; GO:0030168; GO:0032045; GO:0032991; GO:0035556; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0046339; GO:0046486; GO:0046579; GO:0046834; GO:0046872; GO:0046959; GO:0048471; GO:0051966; GO:0060076; GO:0060079; GO:0098685; GO:0098891; GO:0098978; GO:0099147; GO:1900452; GO:2000300	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extrinsic component of postsynaptic density membrane [GO:0099147]; extrinsic component of presynaptic active zone membrane [GO:0098891]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; GTPase inhibitor activity [GO:0005095]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; Ras GTPase binding [GO:0017016]; diacylglycerol metabolic process [GO:0046339]; excitatory postsynaptic potential [GO:0060079]; glycerolipid metabolic process [GO:0046486]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; neurotransmitter secretion [GO:0007269]; platelet activation [GO:0030168]; positive regulation of Ras protein signal transduction [GO:0046579]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]	DGKI
NM_153426	NM_153426 -> Q99697-1	Q99697	PITX2_HUMAN	Pituitary homeobox 2 (ALL1-responsive protein ARP1) (Homeobox protein PITX2) (Paired-like homeodomain transcription factor 2) (RIEG bicoid-related homeobox transcription factor) (Solurshin)	GO:0000122; GO:0000790; GO:0000976; GO:0000978; GO:0000981; GO:0001085; GO:0001102; GO:0001227; GO:0003253; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007368; GO:0008134; GO:0009653; GO:0035315; GO:0035993; GO:0042476; GO:0042802; GO:0042803; GO:0043010; GO:0043021; GO:0043565; GO:0045944; GO:0048536; GO:0051219; GO:0060126; GO:0060127; GO:0061072; GO:0061325; GO:0070986	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell proliferation involved in outflow tract morphogenesis [GO:0061325]; deltoid tuberosity development [GO:0035993]; determination of left/right symmetry [GO:0007368]; hair cell differentiation [GO:0035315]; iris morphogenesis [GO:0061072]; left/right axis specification [GO:0070986]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prolactin secreting cell differentiation [GO:0060127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatotropin secreting cell differentiation [GO:0060126]; spleen development [GO:0048536]	PITX2 ARP1 RGS RIEG RIEG1
NM_012264		A0A024R1S0	A0A024R1S0_HUMAN	Chromosome 22 open reading frame 5, isoform CRA_a	GO:0016021	integral component of membrane [GO:0016021]	C22orf5 hCG_41692
NM_012264		Q9Y519	T184B_HUMAN	Transmembrane protein 184B (Putative MAPK-activating protein FM08)	GO:0016021	integral component of membrane [GO:0016021]	TMEM184B C22orf5 PSEC0108
NM_025209	NM_025209 -> Q9H2F5-1	Q9H2F5	EPC1_HUMAN	Enhancer of polycomb homolog 1	GO:0000122; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0016604; GO:0031965; GO:0032777; GO:0035267; GO:0035886; GO:0040008; GO:0043967; GO:0043968; GO:0045814; GO:0045892; GO:0045893; GO:0045944; GO:0070317	NuA4 histone acetyltransferase complex [GO:0035267]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; vascular smooth muscle cell differentiation [GO:0035886]	EPC1
NM_003901		O95470	SGPL1_HUMAN	Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)	GO:0001553; GO:0001570; GO:0001667; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006665; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0016831; GO:0030097; GO:0030148; GO:0030149; GO:0030170; GO:0030176; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; vasculogenesis [GO:0001570]	SGPL1 KIAA1252
NM_020714		Q9ULM2	ZN490_HUMAN	Zinc finger protein 490	GO:0003677; GO:0005634; GO:0006355; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]	ZNF490 KIAA1198
NM_004218	NM_004218 -> Q15907-1	Q15907	RB11B_HUMAN	Ras-related protein Rab-11B (GTP-binding protein YPT3)	GO:0001881; GO:0003924; GO:0005525; GO:0005623; GO:0005768; GO:0005829; GO:0006886; GO:0006887; GO:0008021; GO:0019003; GO:0030054; GO:0030670; GO:0031489; GO:0032402; GO:0032482; GO:0033572; GO:0035773; GO:0043687; GO:0044070; GO:0045054; GO:0045055; GO:0045296; GO:0045335; GO:0055037; GO:0055038; GO:0070062; GO:0071468; GO:0090150; GO:0098993; GO:0150093; GO:1990126; GO:2000008; GO:2001135	anchored component of synaptic vesicle membrane [GO:0098993]; cell [GO:0005623]; cell junction [GO:0030054]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; cadherin binding [GO:0045296]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; amyloid-beta clearance by transcytosis [GO:0150093]; cellular response to acidic pH [GO:0071468]; constitutive secretory pathway [GO:0045054]; establishment of protein localization to membrane [GO:0090150]; exocytosis [GO:0006887]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; post-translational protein modification [GO:0043687]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulated exocytosis [GO:0045055]; regulation of anion transport [GO:0044070]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to plasma membrane [GO:1990126]; transferrin transport [GO:0033572]	RAB11B YPT3
NM_004987	NM_004987 -> P48059-1	P48059	LIMS1_HUMAN	LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48)	GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007569; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0033209; GO:0034329; GO:0043547; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051894; GO:0071560; GO:0098609; GO:1900026; GO:1901224; GO:2001046	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	LIMS1 PINCH PINCH1
NM_015009	NM_015009 -> Q9UPQ7-1	Q9UPQ7	PZRN3_HUMAN	E3 ubiquitin-protein ligase PDZRN3 (EC 2.3.2.27) (Ligand of Numb protein X 3) (PDZ domain-containing RING finger protein 3) (RING-type E3 ubiquitin transferase PDZRN3) (Semaphorin cytoplasmic domain-associated protein 3) (Protein SEMACAP3)	GO:0004842; GO:0005737; GO:0007528; GO:0008270; GO:0016567; GO:0030054; GO:0031594; GO:0061630	cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]	PDZRN3 KIAA1095 LNX3 SEMCAP3
NM_015358		Q14149	MORC3_HUMAN	MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3)	GO:0003723; GO:0005654; GO:0006468; GO:0007569; GO:0008270; GO:0009791; GO:0016032; GO:0016363; GO:0016605; GO:0018105; GO:0048147; GO:0050821; GO:0051457	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; peptidyl-serine phosphorylation [GO:0018105]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; viral process [GO:0016032]	MORC3 KIAA0136 NXP2 ZCWCC3
NM_015358		Q4VBZ9	Q4VBZ9_HUMAN	MORC family CW-type zinc finger 3	GO:0008270	zinc ion binding [GO:0008270]	MORC3
NM_177401		Q504T8	MIDN_HUMAN	Midnolin (Midbrain nucleolar protein)	GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0019900; GO:0033132; GO:0046676	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; kinase binding [GO:0019900]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]	MIDN
NM_002254		A2RU78	A2RU78_HUMAN	Kinesin-like protein	GO:0003777; GO:0005524; GO:0005874; GO:0008017; GO:0072384	microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; organelle transport along microtubule [GO:0072384]	KIF3C hCG_21381
NM_002254		O14782	KIF3C_HUMAN	Kinesin-like protein KIF3C	GO:0003774; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0006890; GO:0007018; GO:0008017; GO:0016887; GO:0019886; GO:0035735; GO:0072384; GO:0097542	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; organelle transport along microtubule [GO:0072384]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]	KIF3C
NM_032504	NM_032504 -> Q8N2C7-1	Q8N2C7	UNC80_HUMAN	Protein unc-80 homolog	GO:0005261; GO:0005886; GO:0030424; GO:0034220; GO:0034703; GO:0055080	axon [GO:0030424]; cation channel complex [GO:0034703]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; ion transmembrane transport [GO:0034220]	UNC80 C2orf21 KIAA1843
NM_015938		Q96D46	NMD3_HUMAN	60S ribosomal export protein NMD3 (hNMD3)	GO:0000055; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0016020; GO:0030674; GO:0032092; GO:0043023; GO:1902680; GO:1904751	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein binding, bridging [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055]	NMD3 CGI-07
NM_001010895		Q5T890	ER6L2_HUMAN	DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) (DNA repair and recombination protein RAD26-like)	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005815; GO:0019901; GO:0032991; GO:0034614; GO:0036297	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein kinase binding [GO:0019901]; cellular response to reactive oxygen species [GO:0034614]; interstrand cross-link repair [GO:0036297]	ERCC6L2 C9orf102 RAD26L
NM_176815		Q86XF0	DYR2_HUMAN	Dihydrofolate reductase 2, mitochondrial (Dihydrofolate reductase, mitochondrial) (EC 1.5.1.3) (Dihydrofolate reductase-like protein 1)	GO:0003729; GO:0004146; GO:0005739; GO:0005743; GO:0005759; GO:0006730; GO:0046105; GO:0046452; GO:0046653; GO:0046654; GO:0046655; GO:0050661	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]; thymidine biosynthetic process [GO:0046105]	DHFR2 DHFRL1 DHFRP4
NM_023072		Q9H7M6	ZSWM4_HUMAN	Zinc finger SWIM domain-containing protein 4	GO:0008270; GO:0031462; GO:1902667	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	ZSWIM4
NM_023072		Q9HA55	Q9HA55_HUMAN	cDNA FLJ12221 fis, clone MAMMA1001091			
NM_006262		B3KWQ6	B3KWQ6_HUMAN	cDNA FLJ43599 fis, clone SMINT2017781, highly similar to PERIPHERIN	GO:0005198; GO:0045098; GO:0045104	type III intermediate filament [GO:0045098]; structural molecule activity [GO:0005198]; intermediate filament cytoskeleton organization [GO:0045104]	
NM_006262	NM_006262 -> P41219-1	P41219	PERI_HUMAN	Peripherin (Neurofilament 4)	GO:0005198; GO:0005882; GO:0016020; GO:0045098; GO:0045104; GO:0070062	extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; type III intermediate filament [GO:0045098]; structural molecule activity [GO:0005198]; intermediate filament cytoskeleton organization [GO:0045104]	PRPH NEF4 PRPH1
NM_032124	NM_032124 -> Q9H0R4-1	Q9H0R4	HDHD2_HUMAN	Haloacid dehalogenase-like hydrolase domain-containing protein 2	GO:0016311; GO:0016791; GO:0019899; GO:0046872; GO:0070062	extracellular exosome [GO:0070062]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]	HDHD2
NM_032124		V9HW73	V9HW73_HUMAN	Epididymis secretory protein Li 301 (Epididymis secretory sperm binding protein)	GO:0016791	phosphatase activity [GO:0016791]	HEL-S-301
NM_152556		Q1RMZ1	SAMTR_HUMAN	S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog) (EC 2.1.1.-)	GO:0005730; GO:0016433; GO:0034198; GO:1904047; GO:1904262	nucleolus [GO:0005730]; rRNA (adenine) methyltransferase activity [GO:0016433]; S-adenosyl-L-methionine binding [GO:1904047]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]	BMT2 C7orf60 SAMTOR
NM_000945		P63098	CANB1_HUMAN	Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1)	GO:0004723; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005829; GO:0005955; GO:0007223; GO:0016018; GO:0019902; GO:0019904; GO:0033173; GO:0038095; GO:0042383; GO:0045944; GO:1900740	calcineurin complex [GO:0005955]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; cyclosporin A binding [GO:0016018]; phosphatase binding [GO:0019902]; protein domain specific binding [GO:0019904]; calcineurin-NFAT signaling cascade [GO:0033173]; Fc-epsilon receptor signaling pathway [GO:0038095]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	PPP3R1 CNA2 CNB
NM_003081	NM_003081 -> P60880-2	P60880	SNP25_HUMAN	Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein)	GO:0001504; GO:0001917; GO:0005249; GO:0005484; GO:0005737; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006906; GO:0007268; GO:0007269; GO:0007626; GO:0008021; GO:0008306; GO:0010975; GO:0014047; GO:0016020; GO:0016079; GO:0016081; GO:0016082; GO:0017075; GO:0019905; GO:0030054; GO:0030426; GO:0031201; GO:0031234; GO:0031629; GO:0035579; GO:0036477; GO:0042734; GO:0043005; GO:0043312; GO:0048306; GO:0048471; GO:0050796; GO:0060291; GO:0070032; GO:0070821; GO:0098794; GO:0098967; GO:0098978; GO:0099590	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic membrane [GO:0042734]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; specific granule membrane [GO:0035579]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; calcium-dependent protein binding [GO:0048306]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; voltage-gated potassium channel activity [GO:0005249]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; exocytosis [GO:0006887]; glutamate secretion [GO:0014047]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter secretion [GO:0007269]; neurotransmitter uptake [GO:0001504]; neutrophil degranulation [GO:0043312]; regulation of insulin secretion [GO:0050796]; regulation of neuron projection development [GO:0010975]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]	SNAP25 SNAP
NM_025212		J9JIF5	J9JIF5_HUMAN	CXXC-type zinc finger protein 4	GO:0003677; GO:0008270	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	CXXC4
NM_014238	NM_014238 -> Q8IVT5-4	Q8IVT5	KSR1_HUMAN	Kinase suppressor of Ras 1 (EC 2.7.11.1)	GO:0000165; GO:0000185; GO:0004674; GO:0005078; GO:0005524; GO:0005783; GO:0005789; GO:0005829; GO:0007265; GO:0008022; GO:0016020; GO:0019933; GO:0031434; GO:0032587; GO:0032991; GO:0042127; GO:0043405; GO:0043410; GO:0046872; GO:0046982; GO:0051087; GO:0051879; GO:0071889	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKKK activity [GO:0000185]; cAMP-mediated signaling [GO:0019933]; MAPK cascade [GO:0000165]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]	KSR1 KSR
NM_014801	NM_014801 -> A6NKB5-1	A6NKB5	PCX2_HUMAN	Pecanex-like protein 2 (Pecanex homolog protein 2)	GO:0016021	integral component of membrane [GO:0016021]	PCNX2 KIAA0435 PCNXL2
NM_014801		B3KNZ5	B3KNZ5_HUMAN	cDNA FLJ30812 fis, clone FEBRA2001492, highly similar to Mus musculus pecanex-like 2 (Drosophila) (Pcnxl2), transcript variant 2, mRNA	GO:0016021	integral component of membrane [GO:0016021]	
NM_032638	NM_032638 -> P23769-1	P23769	GATA2_HUMAN	Endothelial transcription factor GATA-2 (GATA-binding protein 2)	GO:0000122; GO:0000978; GO:0000980; GO:0000981; GO:0001158; GO:0001228; GO:0001655; GO:0001709; GO:0001764; GO:0001892; GO:0003682; GO:0003700; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006909; GO:0007204; GO:0007596; GO:0008134; GO:0008270; GO:0010628; GO:0010629; GO:0010725; GO:0021514; GO:0021533; GO:0021902; GO:0021954; GO:0021983; GO:0032991; GO:0033993; GO:0035019; GO:0035065; GO:0035854; GO:0042472; GO:0043306; GO:0045599; GO:0045648; GO:0045650; GO:0045654; GO:0045666; GO:0045746; GO:0045766; GO:0045944; GO:0048469; GO:0048873; GO:0050766; GO:0060100; GO:0060216; GO:0060872; GO:0070345; GO:0070742; GO:0090050; GO:0090102; GO:0097154; GO:1902036; GO:1902895; GO:1903589; GO:2000178; GO:2000352; GO:2000977	cell [GO:0005623]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; blood coagulation [GO:0007596]; cell differentiation in hindbrain [GO:0021533]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; cochlea development [GO:0090102]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; definitive hemopoiesis [GO:0060216]; embryonic placenta development [GO:0001892]; eosinophil fate commitment [GO:0035854]; GABAergic neuron differentiation [GO:0097154]; homeostasis of number of cells within a tissue [GO:0048873]; inner ear morphogenesis [GO:0042472]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; phagocytosis [GO:0006909]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of forebrain neuron differentiation [GO:2000977]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of histone acetylation [GO:0035065]; regulation of primitive erythrocyte differentiation [GO:0010725]; response to lipid [GO:0033993]; semicircular canal development [GO:0060872]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; urogenital system development [GO:0001655]; ventral spinal cord interneuron differentiation [GO:0021514]	GATA2
NM_005909		P46821	MAP1B_HUMAN	Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1]	GO:0000226; GO:0001578; GO:0001750; GO:0001764; GO:0003779; GO:0005198; GO:0005543; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0007026; GO:0007409; GO:0007416; GO:0008017; GO:0009612; GO:0009743; GO:0009987; GO:0010035; GO:0014012; GO:0014069; GO:0015631; GO:0016358; GO:0017085; GO:0021700; GO:0030054; GO:0030424; GO:0030425; GO:0030426; GO:0031114; GO:0031116; GO:0032355; GO:0032387; GO:0033189; GO:0036477; GO:0042493; GO:0042995; GO:0043025; GO:0043196; GO:0043197; GO:0043204; GO:0044877; GO:0045202; GO:0045773; GO:0047497; GO:0048471; GO:0048675; GO:0051915; GO:0061162; GO:0071363; GO:0071375; GO:0097440; GO:0097441; GO:0097457	apical dendrite [GO:0097440]; axon [GO:0030424]; basal dendrite [GO:0097441]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; hippocampal mossy fiber [GO:0097457]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; varicosity [GO:0043196]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular process [GO:0009987]; cellular response to growth factor stimulus [GO:0071363]; cellular response to peptide hormone stimulus [GO:0071375]; dendrite development [GO:0016358]; developmental maturation [GO:0021700]; establishment of monopolar cell polarity [GO:0061162]; induction of synaptic plasticity by chemical substance [GO:0051915]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of intracellular transport [GO:0032387]; negative regulation of microtubule depolymerization [GO:0007026]; neuron migration [GO:0001764]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axon extension [GO:0045773]; positive regulation of microtubule polymerization [GO:0031116]; regulation of microtubule depolymerization [GO:0031114]; response to carbohydrate [GO:0009743]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to insecticide [GO:0017085]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; synapse assembly [GO:0007416]	MAP1B
NM_005909		Q6PJD3	Q6PJD3_HUMAN	MAP1B protein (Fragment)	GO:0000226; GO:0005874; GO:0007399; GO:0008017	microtubule [GO:0005874]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]	MAP1B
NM_005909		Q86X89	Q86X89_HUMAN	MAP1B protein (Fragment)	GO:0000226; GO:0005874; GO:0007399; GO:0008017	microtubule [GO:0005874]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]	MAP1B
NM_005252	NM_005252 -> P01100-1	P01100	FOS_HUMAN	Proto-oncogene c-Fos (Cellular oncogene fos) (G0/G1 switch regulatory protein 7)	GO:0000790; GO:0000978; GO:0000979; GO:0000981; GO:0001102; GO:0001228; GO:0001661; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006306; GO:0006357; GO:0006366; GO:0006954; GO:0007179; GO:0007399; GO:0007565; GO:0007568; GO:0008134; GO:0009409; GO:0009416; GO:0009629; GO:0009636; GO:0016020; GO:0019221; GO:0030431; GO:0031668; GO:0032496; GO:0032570; GO:0032870; GO:0032993; GO:0034614; GO:0035902; GO:0035914; GO:0035976; GO:0035994; GO:0038095; GO:0043005; GO:0044212; GO:0045672; GO:0045893; GO:0045944; GO:0046982; GO:0051090; GO:0051412; GO:0051591; GO:0060395; GO:0070412; GO:0071276; GO:0071277; GO:1901216; GO:1902895	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription factor AP-1 complex [GO:0035976]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; conditioned taste aversion [GO:0001661]; cytokine-mediated signaling pathway [GO:0019221]; DNA methylation [GO:0006306]; Fc-epsilon receptor signaling pathway [GO:0038095]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; nervous system development [GO:0007399]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to corticosterone [GO:0051412]; response to gravity [GO:0009629]; response to immobilization stress [GO:0035902]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; skeletal muscle cell differentiation [GO:0035914]; sleep [GO:0030431]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]	FOS G0S7
NM_005252		Q6FG41	Q6FG41_HUMAN	FOS protein (V-fos FBJ murine osteosarcoma viral oncogene homolog, isoform CRA_a) (cDNA FLJ76842, highly similar to Homo sapiens v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS), mRNA)	GO:0000978; GO:0001228; GO:0001661; GO:0003682; GO:0005654; GO:0005667; GO:0006366; GO:0007399; GO:0007565; GO:0007568; GO:0008134; GO:0009409; GO:0009416; GO:0009629; GO:0009636; GO:0016020; GO:0030431; GO:0031668; GO:0032496; GO:0032570; GO:0032870; GO:0034097; GO:0035902; GO:0035914; GO:0035994; GO:0043005; GO:0045672; GO:0046982; GO:0051412; GO:0051591; GO:0071277; GO:1901216; GO:1902895	membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]; aging [GO:0007568]; cellular response to calcium ion [GO:0071277]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; conditioned taste aversion [GO:0001661]; female pregnancy [GO:0007565]; nervous system development [GO:0007399]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to gravity [GO:0009629]; response to immobilization stress [GO:0035902]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; skeletal muscle cell differentiation [GO:0035914]; sleep [GO:0030431]; transcription by RNA polymerase II [GO:0006366]	FOS hCG_22355
NM_015678		B3KXQ8	B3KXQ8_HUMAN	cDNA FLJ45892 fis, clone OCBBF3023175, highly similar to Protein neurobeachin			
NM_015678	NM_015678 -> Q8NFP9-1	Q8NFP9	NBEA_HUMAN	Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B)	GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0019901	cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; protein kinase binding [GO:0019901]; protein localization [GO:0008104]	NBEA BCL8B KIAA1544 LYST2
NM_006299		A0A024RCK9	A0A024RCK9_HUMAN	Zinc finger protein 193, isoform CRA_a	GO:0003676; GO:0003700; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	ZNF193 hCG_31428
NM_006299	NM_006299 -> O15535-1	O15535	ZSC9_HUMAN	Zinc finger and SCAN domain-containing protein 9 (Cell proliferation-inducing gene 12 protein) (PRD51) (Zinc finger protein 193)	GO:0003677; GO:0003700; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]	ZSCAN9 ZNF193 PIG12
NM_016941	NM_016941 -> Q9NYJ7-1	Q9NYJ7	DLL3_HUMAN	Delta-like protein 3 (Drosophila Delta homolog 3) (Delta3)	GO:0001501; GO:0001756; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0007386; GO:0016021; GO:0045746; GO:0048339; GO:0050768	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; compartment pattern specification [GO:0007386]; negative regulation of neurogenesis [GO:0050768]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; paraxial mesoderm development [GO:0048339]; skeletal system development [GO:0001501]; somitogenesis [GO:0001756]	DLL3
NM_001029997		B4DM69	B4DM69_HUMAN	cDNA FLJ52631, highly similar to Zinc finger protein 181	GO:0003676	nucleic acid binding [GO:0003676]	
NM_001029997	NM_001029997 -> Q2M3W8-1	Q2M3W8	ZN181_HUMAN	Zinc finger protein 181 (HHZ181)	GO:0000981; GO:0003677; GO:0005634; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]	ZNF181
NM_052936	NM_052936 -> Q8WYN0-1	Q8WYN0	ATG4A_HUMAN	Cysteine protease ATG4A (EC 3.4.22.-) (AUT-like 2 cysteine endopeptidase) (Autophagin-2) (Autophagy-related cysteine endopeptidase 2) (Autophagy-related protein 4 homolog A) (hAPG4A)	GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; autophagy [GO:0006914]; protein transport [GO:0015031]; proteolysis [GO:0006508]	ATG4A APG4A AUTL2
NM_017643	NM_017643 -> Q05BQ5-1	Q05BQ5	MBTD1_HUMAN	MBT domain-containing protein 1	GO:0005634; GO:0006325; GO:0006355; GO:0008270; GO:0035064; GO:0048706	nucleus [GO:0005634]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; embryonic skeletal system development [GO:0048706]; regulation of transcription, DNA-templated [GO:0006355]	MBTD1
NM_015441	NM_015441 -> Q68BL8-1	Q68BL8	OLM2B_HUMAN	Olfactomedin-like protein 2B (Photomedin-2)	GO:0005576	extracellular region [GO:0005576]	OLFML2B
NM_005422		O75443	TECTA_HUMAN	Alpha-tectorin	GO:0005201; GO:0005576; GO:0005886; GO:0007160; GO:0007605; GO:0031225; GO:0062023; GO:0070062	anchored component of membrane [GO:0031225]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]	TECTA
NM_032242		Q9UIW2	PLXA1_HUMAN	Plexin-A1 (Semaphorin receptor NOV)	GO:0002116; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007162; GO:0007275; GO:0008360; GO:0014910; GO:0017154; GO:0030334; GO:0038023; GO:0043087; GO:0050772; GO:0060666; GO:0070062; GO:1902287; GO:1990138	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; multicellular organism development [GO:0007275]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	PLXNA1 NOV PLXN1
NM_018100		B2CKC5	B2CKC5_HUMAN	EF-hand domain (C-terminal) containing 1, isoform CRA_a (EF-hand domain containing 1)	GO:0005509	calcium ion binding [GO:0005509]	EFHC1 hCG_21196
NM_018100	NM_018100 -> Q5JVL4-1	Q5JVL4	EFHC1_HUMAN	EF-hand domain-containing protein 1 (Myoclonin-1)	GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005930; GO:0007052; GO:0008022; GO:0021795; GO:0043014; GO:0043025; GO:0051302; GO:0060285; GO:0072686	axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302]	EFHC1
NM_001024593	NM_001024593 -> Q4VC12-1	Q4VC12	MSS51_HUMAN	Putative protein MSS51 homolog, mitochondrial (Zinc finger MYND domain-containing protein 17)	GO:0046872	metal ion binding [GO:0046872]	MSS51 ZMYND17
NM_001142550	NM_001142550 -> O94967-4	O94967	WDR47_HUMAN	WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin)	GO:0005737; GO:0005874; GO:0007275	cytoplasm [GO:0005737]; microtubule [GO:0005874]; multicellular organism development [GO:0007275]	WDR47 KIAA0893
NM_014970	NM_014970 -> Q92845-1	Q92845	KIFA3_HUMAN	Kinesin-associated protein 3 (KAP-3) (KAP3) (Smg GDS-associated protein)	GO:0000794; GO:0005623; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0006890; GO:0007017; GO:0007018; GO:0007165; GO:0008285; GO:0015630; GO:0016939; GO:0019886; GO:0019894; GO:0019903; GO:0032391; GO:0035735; GO:0036064; GO:0043066; GO:0046587; GO:0065003; GO:0072383; GO:0097542; GO:0120170; GO:1990075	axoneme [GO:0005930]; cell [GO:0005623]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein-containing complex assembly [GO:0065003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]	KIFAP3 KIF3AP SMAP
NM_025055	NM_025055 -> Q8N5R6-6	Q8N5R6	CCD33_HUMAN	Coiled-coil domain-containing protein 33 (Cancer/testis antigen 61) (CT61)			CCDC33
NM_017599	NM_017599 -> Q9HBM0-1	Q9HBM0	VEZA_HUMAN	Vezatin	GO:0001669; GO:0002142; GO:0005654; GO:0005829; GO:0005912; GO:0016021; GO:0017022; GO:0060171; GO:0098609	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]	VEZT
NM_138415		A0A0S2Z6R3	A0A0S2Z6R3_HUMAN	PHD finger protein 21B isoform 1 (Fragment)	GO:0046872	metal ion binding [GO:0046872]	PHF21B
NM_138415	NM_138415 -> Q96EK2-1	Q96EK2	PF21B_HUMAN	PHD finger protein 21B	GO:0046872	metal ion binding [GO:0046872]	PHF21B KIAA1661
NM_018697		B3KTN5	B3KTN5_HUMAN	cDNA FLJ38538 fis, clone HCHON2001407, highly similar to LanC-like protein 2	GO:0003824	catalytic activity [GO:0003824]	
NM_018697		Q9NS86	LANC2_HUMAN	LanC-like protein 2 (Testis-specific adriamycin sensitivity protein)	GO:0003824; GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0009789; GO:0010314; GO:0030864; GO:0032266; GO:0045892; GO:0070273	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; catalytic activity [GO:0003824]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]	LANCL2 GPR69B TASP
NM_182948	NM_182948 -> P22694-2	P22694	KAPCB_HUMAN	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	GO:0000287; GO:0001843; GO:0002223; GO:0003091; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007596; GO:0010737; GO:0031625; GO:0034199; GO:0034237; GO:0034380; GO:0045171; GO:0048471; GO:0051447; GO:0070062; GO:0070613; GO:0071377; GO:0097338; GO:0097546; GO:1901621	cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; blood coagulation [GO:0007596]; cellular response to glucagon stimulus [GO:0071377]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; response to clozapine [GO:0097338]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]	PRKACB
NM_001008781	NM_001008781 -> Q8TDW7-3	Q8TDW7	FAT3_HUMAN	Protocadherin Fat 3 (hFat3) (Cadherin family member 15) (FAT tumor suppressor homolog 3)	GO:0005509; GO:0005886; GO:0007156; GO:0007275; GO:0016021; GO:0098609	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]	FAT3 CDHF15 KIAA1989
NM_001039350		A7E2E4	A7E2E4_HUMAN	Dipeptidyl-peptidase 6	GO:0008236; GO:0016021	integral component of membrane [GO:0016021]; serine-type peptidase activity [GO:0008236]	DPP6
NM_001039350		E9PF59	E9PF59_HUMAN	Dipeptidyl aminopeptidase-like protein 6	GO:0008236; GO:0016021	integral component of membrane [GO:0016021]; serine-type peptidase activity [GO:0008236]	DPP6
NM_001128620	NM_001128620 -> Q13153-2	Q13153	PAK1_HUMAN	Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)	GO:0001666; GO:0001726; GO:0001934; GO:0002223; GO:0004672; GO:0004674; GO:0005518; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0006338; GO:0006468; GO:0006887; GO:0006915; GO:0006974; GO:0008284; GO:0010763; GO:0014704; GO:0019901; GO:0021549; GO:0023014; GO:0030010; GO:0030018; GO:0030027; GO:0030335; GO:0030424; GO:0030425; GO:0031116; GO:0031295; GO:0031532; GO:0031965; GO:0032147; GO:0032587; GO:0032869; GO:0032991; GO:0033138; GO:0033148; GO:0038095; GO:0038096; GO:0042060; GO:0042802; GO:0043507; GO:0045773; GO:0046628; GO:0046777; GO:0048012; GO:0048013; GO:0048754; GO:0048812; GO:0050770; GO:0050852; GO:0051496; GO:0060244; GO:0061052; GO:0071437; GO:0090314; GO:1904707; GO:1904754	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Z disc [GO:0030018]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; response to hypoxia [GO:0001666]; signal transduction by protein phosphorylation [GO:0023014]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; wound healing [GO:0042060]	PAK1
NM_001024660	NM_001024660 -> O60229-1	O60229	KALRN_HUMAN	Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)	GO:0004674; GO:0005085; GO:0005089; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007165; GO:0007186; GO:0007399; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0015629; GO:0016192; GO:0035023; GO:0035176; GO:0035556; GO:0042711; GO:0043065; GO:0043547; GO:0046872; GO:0046959; GO:0048013; GO:0051056; GO:0060125; GO:0060137; GO:0061003; GO:0070062	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192]	KALRN DUET DUO HAPIP TRAD
NM_001512		A0A024RD58	A0A024RD58_HUMAN	Glutathione S-transferase A4, isoform CRA_b	GO:0004364	glutathione transferase activity [GO:0004364]	GSTA4 hCG_21940
NM_001512	NM_001512 -> O15217-1	O15217	GSTA4_HUMAN	Glutathione S-transferase A4 (EC 2.5.1.18) (GST class-alpha member 4) (Glutathione S-transferase A4-4)	GO:0004364; GO:0005829; GO:0006749; GO:0006805; GO:0042802; GO:0042803; GO:1901687	cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805]	GSTA4
NM_016231		A0A024QZ12	A0A024QZ12_HUMAN	Mitogen-activated protein kinase (EC 2.7.11.24)	GO:0000287; GO:0004707; GO:0005524; GO:0005634; GO:0006355; GO:0018107; GO:0030178; GO:0042169; GO:0042501; GO:0046777	nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; SH2 domain binding [GO:0042169]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of transcription, DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]	NLK hCG_31804
NM_016231		Q9UBE8	NLK_HUMAN	Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1)	GO:0000287; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0007179; GO:0007223; GO:0008134; GO:0010468; GO:0018107; GO:0030178; GO:0031625; GO:0035556; GO:0042169; GO:0042501; GO:0046777; GO:0050821	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SH2 domain binding [GO:0042169]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; intracellular signal transduction [GO:0035556]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	NLK LAK1
NM_180991		Q6ZQN7	SO4C1_HUMAN	Solute carrier organic anion transporter family member 4C1 (OATP-H) (Organic anion transporter M1) (OATP-M1) (Solute carrier family 21 member 20)	GO:0005886; GO:0005887; GO:0007275; GO:0007283; GO:0015347; GO:0016323; GO:0030154; GO:0035577; GO:0035579; GO:0043252; GO:0043312; GO:0070062	azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]	SLCO4C1 OATP4C1 OATPX SLC21A20
NM_018318		A0A024RAW6	A0A024RAW6_HUMAN	Uncharacterized protein	GO:0005654; GO:0005794; GO:0042802; GO:0048193	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; Golgi vesicle transport [GO:0048193]	DKFZP779L1558 hCG_37266
NM_018318		Q05D28	Q05D28_HUMAN	CCDC91 protein (Fragment)	GO:0048193	Golgi vesicle transport [GO:0048193]	CCDC91
NM_018318	NM_018318 -> Q7Z6B0-1	Q7Z6B0	CCD91_HUMAN	Coiled-coil domain-containing protein 91 (GGA-binding partner) (p56 accessory protein)	GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0015031; GO:0016020; GO:0042802; GO:0090160	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]	CCDC91 GGABP HSD8
NM_133369	NM_133369 -> Q6ZN44-1	Q6ZN44	UNC5A_HUMAN	Netrin receptor UNC5A (Protein unc-5 homolog 1) (Protein unc-5 homolog A)	GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0016021; GO:0031175; GO:0031226; GO:0032589; GO:0032809; GO:0033564; GO:0038007; GO:0045121	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; neuron projection membrane [GO:0032589]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; netrin-activated signaling pathway [GO:0038007]; neuron projection development [GO:0031175]	UNC5A KIAA1976 UNC5H1
NM_173822		B3KUG1	B3KUG1_HUMAN	cDNA FLJ39792 fis, clone SPLEN2003396, weakly similar to Down-regulated by CTNNB1 protein A			
NM_173822		Q8IXS8	F126B_HUMAN	Protein FAM126B	GO:0005622; GO:0005829; GO:0005886; GO:0046854; GO:0072659	cytosol [GO:0005829]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]	FAM126B
NM_153813		Q8IX07	FOG1_HUMAN	Zinc finger protein ZFPM1 (Friend of GATA protein 1) (FOG-1) (Friend of GATA 1) (Zinc finger protein 89A) (Zinc finger protein multitype 1)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001085; GO:0001102; GO:0001227; GO:0002295; GO:0003151; GO:0003181; GO:0003192; GO:0003195; GO:0005634; GO:0005654; GO:0005667; GO:0007507; GO:0007596; GO:0008134; GO:0010724; GO:0017053; GO:0030218; GO:0030219; GO:0030220; GO:0030851; GO:0032091; GO:0032642; GO:0035162; GO:0035855; GO:0045078; GO:0045403; GO:0045599; GO:0045652; GO:0046872; GO:0055008; GO:0060318; GO:0060319; GO:0060377; GO:0060412; GO:0060413; GO:0071733	nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; blood coagulation [GO:0007596]; cardiac muscle tissue morphogenesis [GO:0055008]; definitive erythrocyte differentiation [GO:0060318]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; heart development [GO:0007507]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; mitral valve formation [GO:0003192]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-4 biosynthetic process [GO:0045403]; negative regulation of mast cell differentiation [GO:0060377]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of interferon-gamma biosynthetic process [GO:0045078]; primitive erythrocyte differentiation [GO:0060319]; regulation of chemokine production [GO:0032642]; regulation of definitive erythrocyte differentiation [GO:0010724]; regulation of megakaryocyte differentiation [GO:0045652]; T-helper cell lineage commitment [GO:0002295]; transcriptional activation by promoter-enhancer looping [GO:0071733]; tricuspid valve formation [GO:0003195]; ventricular septum morphogenesis [GO:0060412]	ZFPM1 FOG1 ZFN89A
NM_003469		P13521	SCG2_HUMAN	Secretogranin-2 (Chromogranin-C) (Secretogranin II) (SgII) [Cleaved into: Secretoneurin (SN); Manserin]	GO:0000165; GO:0001525; GO:0001937; GO:0001938; GO:0005125; GO:0005615; GO:0005788; GO:0006954; GO:0009306; GO:0030141; GO:0035556; GO:0042056; GO:0043542; GO:0043687; GO:0044267; GO:0048245; GO:0050918; GO:0050930; GO:0098992; GO:2000352; GO:2001237	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; secretory granule [GO:0030141]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; angiogenesis [GO:0001525]; cellular protein metabolic process [GO:0044267]; endothelial cell migration [GO:0043542]; eosinophil chemotaxis [GO:0048245]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell proliferation [GO:0001938]; post-translational protein modification [GO:0043687]; protein secretion [GO:0009306]	SCG2 CHGC
NM_016053		Q9Y3C0	WASC3_HUMAN	WASH complex subunit 3 (Coiled-coil domain-containing protein 53)	GO:0005769; GO:0006887; GO:0015031; GO:0030041; GO:0071203	early endosome [GO:0005769]; WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; exocytosis [GO:0006887]; protein transport [GO:0015031]	WASHC3 AD-016 CCDC53 CGI-116 x0009
NM_001025266		A6NLC5	CC070_HUMAN	UPF0524 protein C3orf70			C3orf70
NM_015018		B2RWN9	B2RWN9_HUMAN	DOPEY1 protein	GO:0005829; GO:0006895	cytosol [GO:0005829]; Golgi to endosome transport [GO:0006895]	DOPEY1
NM_015018		Q5JWR5	DOP1_HUMAN	Protein dopey-1	GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031	cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	DOP1A DOPEY1 KIAA1117
NM_001109662		F8VWT9	F8VWT9_HUMAN	Probable E3 ubiquitin-protein ligase HECTD4	GO:0004842	ubiquitin-protein transferase activity [GO:0004842]	HECTD4
NM_004571	NM_004571 -> P55347-1	P55347	PKNX1_HUMAN	Homeobox protein PKNOX1 (Homeobox protein PREP-1) (PBX/knotted homeobox 1)	GO:0000790; GO:0000981; GO:0001525; GO:0003682; GO:0003700; GO:0005667; GO:0005737; GO:0006366; GO:0030217; GO:0030218; GO:0043010; GO:0043565; GO:0045944; GO:0046982	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; angiogenesis [GO:0001525]; camera-type eye development [GO:0043010]; erythrocyte differentiation [GO:0030218]; positive regulation of transcription by RNA polymerase II [GO:0045944]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]	PKNOX1 PREP1
NM_004571		Q6PKH2	Q6PKH2_HUMAN	PKNOX1 protein (Fragment)	GO:0003677; GO:0005634; GO:0006355	nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]	PKNOX1
NM_004571		Q96I87	Q96I87_HUMAN	Homeobox-containing protein PKNOX1 (PBX/knotted 1 homeobox 1) (PBX/knotted 1 homeobox 1, isoform CRA_b)	GO:0000981; GO:0001525; GO:0003682; GO:0005634; GO:0005667; GO:0005829; GO:0030217; GO:0030218; GO:0043010; GO:0043565; GO:0045944; GO:0046982	cytosol [GO:0005829]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; angiogenesis [GO:0001525]; camera-type eye development [GO:0043010]; erythrocyte differentiation [GO:0030218]; positive regulation of transcription by RNA polymerase II [GO:0045944]; T cell differentiation [GO:0030217]	PKNOX1 hCG_2043122
NM_002372		Q16706	MA2A1_HUMAN	Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)	GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062	cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]	MAN2A1 MANA2
NM_001081		O60494	CUBN_HUMAN	Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008144; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0034384; GO:0038023; GO:0038024; GO:0042359; GO:0042803; GO:0042953; GO:0043202; GO:0070062	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; high-density lipoprotein particle clearance [GO:0034384]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]; vitamin D metabolic process [GO:0042359]	CUBN IFCR
NM_000740		A0A024R3S2	A0A024R3S2_HUMAN	Muscarinic acetylcholine receptor	GO:0005886; GO:0006939; GO:0016907; GO:0030054; GO:0030425; GO:0042166; GO:0043679; GO:0046541; GO:0098978; GO:0099056; GO:0099061; GO:1904695	axon terminus [GO:0043679]; cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; acetylcholine binding [GO:0042166]; G protein-coupled acetylcholine receptor activity [GO:0016907]; positive regulation of vascular smooth muscle contraction [GO:1904695]; saliva secretion [GO:0046541]; smooth muscle contraction [GO:0006939]	CHRM3 hCG_1641761
NM_000740		P20309	ACM3_HUMAN	Muscarinic acetylcholine receptor M3	GO:0003056; GO:0004435; GO:0004930; GO:0004993; GO:0005886; GO:0005887; GO:0006464; GO:0006939; GO:0007165; GO:0007186; GO:0007187; GO:0007197; GO:0007213; GO:0007268; GO:0007399; GO:0016323; GO:0016907; GO:0030054; GO:0030425; GO:0030594; GO:0038023; GO:0042166; GO:0043679; GO:0046541; GO:0098978; GO:0099056; GO:0099061; GO:1904695	axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; acetylcholine binding [GO:0042166]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; phosphatidylinositol phospholipase C activity [GO:0004435]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; cellular protein modification process [GO:0006464]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; positive regulation of vascular smooth muscle contraction [GO:1904695]; regulation of vascular smooth muscle contraction [GO:0003056]; saliva secretion [GO:0046541]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]	CHRM3
NM_178502		A0A024RB96	A0A024RB96_HUMAN	Deltex 3 homolog (Drosophila), isoform CRA_b	GO:0007219; GO:0016567	Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]	DTX3 hCG_39663
NM_178502	NM_178502 -> Q8N9I9-1	Q8N9I9	DTX3_HUMAN	Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING finger protein 154) (RING-type E3 ubiquitin transferase DTX3)	GO:0005737; GO:0007219; GO:0016567; GO:0016740; GO:0046872	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]	DTX3 RNF154
NM_001130438	NM_001130438 -> Q13813-2	Q13813	SPTN1_HUMAN	Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)	GO:0000165; GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0006888; GO:0007411; GO:0008091; GO:0015630; GO:0016020; GO:0035580; GO:0043231; GO:0043312; GO:0045296; GO:0051693; GO:0070062; GO:1903561; GO:1904724	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; MAPK cascade [GO:0000165]; neutrophil degranulation [GO:0043312]	SPTAN1 NEAS SPTA2
NM_001146220		B2RBM0	B2RBM0_HUMAN	cDNA, FLJ95584, highly similar to Homo sapiens zinc finger protein 226 (ZNF226), mRNA	GO:0003676; GO:0006355	nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]	
NM_001146220	NM_001146220 -> Q9NYT6-2	Q9NYT6	ZN226_HUMAN	Zinc finger protein 226	GO:0003677; GO:0005634; GO:0006355; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]	ZNF226
NM_014747	NM_014747 -> Q9UJD0-1	Q9UJD0	RIMS3_HUMAN	Regulating synaptic membrane exocytosis protein 3 (Nim3) (RIM3 gamma) (Rab-3-interacting molecule 3) (RIM 3)	GO:0017137; GO:0017156; GO:0030054; GO:0042391; GO:0042734; GO:0044325; GO:0045202; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0098831; GO:2000300	cell junction [GO:0030054]; cytoskeleton of presynaptic active zone [GO:0048788]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; ion channel binding [GO:0044325]; Rab GTPase binding [GO:0017137]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; positive regulation of synaptic transmission [GO:0050806]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]	RIMS3 KIAA0237
NM_001137550,NM_001137552	NM_001137552 -> Q32MZ4-1,NM_001137550 -> Q32MZ4-4	Q32MZ4	LRRF1_HUMAN	Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein)	GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0003725; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006357; GO:0032481; GO:0042803; GO:0045296; GO:0045892; GO:0051092	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I interferon production [GO:0032481]; regulation of transcription by RNA polymerase II [GO:0006357]	LRRFIP1 GCF2 TRIP
NM_004443		P54753	EPHB3_HUMAN	Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6)	GO:0001525; GO:0001655; GO:0004714; GO:0005003; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0007413; GO:0008046; GO:0016477; GO:0021952; GO:0022038; GO:0022407; GO:0030425; GO:0031290; GO:0034446; GO:0043087; GO:0043235; GO:0046777; GO:0048013; GO:0048538; GO:0048546; GO:0050770; GO:0051965; GO:0060021; GO:0060996; GO:0060997	cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; ephrin receptor activity [GO:0005003]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; central nervous system projection neuron axonogenesis [GO:0021952]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; digestive tract morphogenesis [GO:0048546]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of axonogenesis [GO:0050770]; regulation of cell-cell adhesion [GO:0022407]; regulation of GTPase activity [GO:0043087]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; substrate adhesion-dependent cell spreading [GO:0034446]; thymus development [GO:0048538]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]	EPHB3 ETK2 HEK2 TYRO6
NM_001023560		A0A024RCN4	A0A024RCN4_HUMAN	Zinc finger and SCAN domain-containing protein 26 (Zinc finger protein 187, isoform CRA_a)	GO:0003676; GO:0003700; GO:0005654; GO:0005829; GO:0046872	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	ZSCAN26 ZNF187 hCG_31430
NM_001023560		B3KTR1	B3KTR1_HUMAN	cDNA FLJ38629 fis, clone HHDPC1000163, highly similar to Homo sapiens zinc finger protein 187 (ZNF187), transcript variant 3, mRNA	GO:0003677	DNA binding [GO:0003677]	
NM_001023560		Q16670	ZSC26_HUMAN	Zinc finger and SCAN domain-containing protein 26 (Protein SRE-ZBP) (Zinc finger protein 187)	GO:0003676; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0046872	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]	ZSCAN26 ZNF187
NM_015879		O43173	SIA8C_HUMAN	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase (EC 2.4.99.-) (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sialyltransferase 8C) (SIAT8-C) (Sialyltransferase St8Sia III) (ST8SiaIII)	GO:0000139; GO:0001574; GO:0003828; GO:0006486; GO:0006491; GO:0006688; GO:0008373; GO:0009100; GO:0009311; GO:0016021; GO:0033691; GO:0042802; GO:1990743	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; identical protein binding [GO:0042802]; sialic acid binding [GO:0033691]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]	ST8SIA3 SIAT8C
NM_015879		Q59GW3	Q59GW3_HUMAN	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 variant (Fragment)	GO:0005794; GO:0006486; GO:0008373; GO:0016021	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; sialyltransferase activity [GO:0008373]; protein glycosylation [GO:0006486]	
NM_001964		P18146	EGR1_HUMAN	Early growth response protein 1 (EGR-1) (AT225) (Nerve growth factor-induced protein A) (NGFI-A) (Transcription factor ETR103) (Transcription factor Zif268) (Zinc finger protein 225) (Zinc finger protein Krox-24)	GO:0000122; GO:0000790; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0001666; GO:0002931; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0008270; GO:0009749; GO:0010385; GO:0010628; GO:0030217; GO:0030509; GO:0032868; GO:0032922; GO:0033233; GO:0035035; GO:0035914; GO:0042981; GO:0043565; GO:0044729; GO:0044849; GO:0045080; GO:0045475; GO:0045893; GO:0045944; GO:0046886; GO:0050725; GO:0060086; GO:0060337; GO:0061418; GO:0070498; GO:0071480; GO:0071504; GO:0071506; GO:0072110; GO:0072303; GO:0090090; GO:0098759; GO:1901216; GO:1902949; GO:1990841; GO:2000182	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; histone acetyltransferase binding [GO:0035035]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; BMP signaling pathway [GO:0030509]; cellular response to gamma radiation [GO:0071480]; cellular response to heparin [GO:0071504]; cellular response to interleukin-8 [GO:0098759]; cellular response to mycophenolic acid [GO:0071506]; circadian regulation of gene expression [GO:0032922]; circadian temperature homeostasis [GO:0060086]; estrous cycle [GO:0044849]; glomerular mesangial cell proliferation [GO:0072110]; interleukin-1-mediated signaling pathway [GO:0070498]; locomotor rhythm [GO:0045475]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular metanephric mesangial cell proliferation [GO:0072303]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of interleukin-1 beta biosynthetic process [GO:0050725]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of protein sumoylation [GO:0033233]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to ischemia [GO:0002931]; skeletal muscle cell differentiation [GO:0035914]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]; type I interferon signaling pathway [GO:0060337]	EGR1 KROX24 ZNF225
NM_001964		Q546S1	Q546S1_HUMAN	Early growth response protein	GO:0000122; GO:0000977; GO:0001228; GO:0002931; GO:0005654; GO:0009749; GO:0030217; GO:0030509; GO:0032868; GO:0032922; GO:0035914; GO:0042981; GO:0044849; GO:0045080; GO:0045475; GO:0046872; GO:0046886; GO:0050725; GO:0060086; GO:0061418; GO:0071480; GO:0090090; GO:1901216; GO:1902949; GO:2000182	nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; BMP signaling pathway [GO:0030509]; cellular response to gamma radiation [GO:0071480]; circadian regulation of gene expression [GO:0032922]; circadian temperature homeostasis [GO:0060086]; estrous cycle [GO:0044849]; locomotor rhythm [GO:0045475]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of interleukin-1 beta biosynthetic process [GO:0050725]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; regulation of apoptotic process [GO:0042981]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to ischemia [GO:0002931]; skeletal muscle cell differentiation [GO:0035914]; T cell differentiation [GO:0030217]	EGR1 hCG_18777
NM_001400		P21453	S1PR1_HUMAN	Sphingosine 1-phosphate receptor 1 (S1P receptor 1) (S1P1) (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1) (S1P receptor Edg-1) (CD antigen CD363)	GO:0001525; GO:0001664; GO:0001955; GO:0003245; GO:0003376; GO:0004930; GO:0005623; GO:0005654; GO:0005768; GO:0005886; GO:0006935; GO:0007155; GO:0007186; GO:0007193; GO:0007420; GO:0009897; GO:0016021; GO:0016477; GO:0019221; GO:0019226; GO:0030032; GO:0030155; GO:0030182; GO:0030335; GO:0030500; GO:0030595; GO:0031226; GO:0031532; GO:0038036; GO:0043231; GO:0043547; GO:0045121; GO:0045124; GO:0045446; GO:0045944; GO:0046625; GO:0048661; GO:0050927; GO:0051482; GO:0051497; GO:0061384; GO:0072678	cell [GO:0005623]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; sphingolipid binding [GO:0046625]; sphingosine-1-phosphate receptor activity [GO:0038036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; endothelial cell differentiation [GO:0045446]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; negative regulation of stress fiber assembly [GO:0051497]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678]; transmission of nerve impulse [GO:0019226]	S1PR1 CHEDG1 EDG1
NM_016056		Q9HC24	LFG4_HUMAN	Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein)	GO:0000139; GO:0005795; GO:0006915; GO:0016021; GO:0043066; GO:0050848	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848]	TMBIM4 GAAP LFG4 CGI-119
NM_001797	NM_001797 -> P55287-1	P55287	CAD11_HUMAN	Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin)	GO:0000902; GO:0001501; GO:0001503; GO:0005509; GO:0005737; GO:0005886; GO:0005913; GO:0007043; GO:0007155; GO:0007156; GO:0008092; GO:0009986; GO:0016021; GO:0016339; GO:0016342; GO:0021957; GO:0034332; GO:0042803; GO:0044331; GO:0045296; GO:0050804; GO:0070062; GO:0098609; GO:0098685; GO:0098978	catenin complex [GO:0016342]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; protein homodimerization activity [GO:0042803]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; corticospinal tract morphogenesis [GO:0021957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; ossification [GO:0001503]; skeletal system development [GO:0001501]	CDH11
NM_001004196	NM_001004196 -> P41217-3	P41217	OX2G_HUMAN	OX-2 membrane glycoprotein (CD antigen CD200)	GO:0002695; GO:0005886; GO:0005887; GO:0008285; GO:0009986; GO:0016020; GO:0030424; GO:0032088; GO:0032793; GO:0034113; GO:0043005; GO:0043025; GO:0043031; GO:0044297; GO:0050776; GO:0071636; GO:0086080; GO:0098609; GO:0140081; GO:0150072; GO:0150074; GO:0150077; GO:0150079; GO:1900165; GO:1901215; GO:1904465; GO:1905522; GO:2000405	axon [GO:0030424]; cell body [GO:0044297]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; glycosylated region protein binding [GO:0140081]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; cell-cell adhesion [GO:0098609]; heterotypic cell-cell adhesion [GO:0034113]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of leukocyte activation [GO:0002695]; negative regulation of macrophage activation [GO:0043031]; negative regulation of macrophage migration [GO:1905522]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell migration [GO:2000405]; positive regulation of arginase activity [GO:0150072]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of protein-glutamine gamma-glutamyltransferase activity [GO:0150074]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of immune response [GO:0050776]; regulation of neuroinflammatory response [GO:0150077]	CD200 MOX1 MOX2 My033
NM_017652	NM_017652 -> Q9NXT0-1	Q9NXT0	ZN586_HUMAN	Zinc finger protein 586	GO:0003677; GO:0005634; GO:0045892; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]	ZNF586
NM_001859		A0A024R824	A0A024R824_HUMAN	Solute carrier family 31 (Copper transporters), member 1, isoform CRA_a	GO:0005375; GO:0005623; GO:0005770; GO:0005886; GO:0006855; GO:0006878; GO:0016021; GO:0043025; GO:0055037; GO:0072719; GO:0098705	cell [GO:0005623]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import across plasma membrane [GO:0098705]; drug transmembrane transport [GO:0006855]	SLC31A1 hCG_1784803
NM_001859		O15431	COPT1_HUMAN	High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1)	GO:0005375; GO:0005623; GO:0005770; GO:0005886; GO:0005887; GO:0006825; GO:0006855; GO:0006878; GO:0042802; GO:0043025; GO:0055037; GO:0072719; GO:0098705	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; cellular copper ion homeostasis [GO:0006878]; cellular response to cisplatin [GO:0072719]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; drug transmembrane transport [GO:0006855]	SLC31A1 COPT1 CTR1
NM_003489		A8K171	A8K171_HUMAN	cDNA FLJ77253, highly similar to Homo sapiens nuclear receptor interacting protein 1 (NRIP1), mRNA	GO:0003712; GO:0005102; GO:0005634; GO:0006357	nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	
NM_003489		P48552	NRIP1_HUMAN	Nuclear receptor-interacting protein 1 (Nuclear factor RIP140) (Receptor-interacting protein 140)	GO:0000118; GO:0000122; GO:0000790; GO:0000978; GO:0001543; GO:0001650; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007623; GO:0016607; GO:0019915; GO:0030331; GO:0030521; GO:0032922; GO:0035257; GO:0035259; GO:0042826; GO:0045893; GO:0045944; GO:0046965; GO:0050681; GO:0071392	cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; histone deacetylase binding [GO:0042826]; nuclear hormone receptor binding [GO:0035257]; retinoid X receptor binding [GO:0046965]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; androgen receptor signaling pathway [GO:0030521]; cellular response to estradiol stimulus [GO:0071392]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; lipid storage [GO:0019915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle rupture [GO:0001543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]	NRIP1
NM_013320	NM_013320 -> Q9Y5Z7-1	Q9Y5Z7	HCFC2_HUMAN	Host cell factor 2 (HCF-2) (C2 factor)	GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0016032; GO:0016604; GO:0071339	cytoplasm [GO:0005737]; cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription coactivator activity [GO:0003713]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]	HCFC2
NM_000720	NM_000720 -> Q01668-2	Q01668	CAC1D_HUMAN	Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3)	GO:0005245; GO:0005262; GO:0005886; GO:0005891; GO:0006816; GO:0007188; GO:0007605; GO:0008331; GO:0030018; GO:0030506; GO:0045762; GO:0046872; GO:0050796; GO:0051393; GO:0051928; GO:0060372; GO:0061337; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086046; GO:0086059; GO:0086091; GO:0098683; GO:0099059; GO:0099635; GO:1901016; GO:1901379; GO:1990454	cochlear hair cell ribbon synapse [GO:0098683]; integral component of presynaptic active zone membrane [GO:0099059]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; ankyrin binding [GO:0030506]; calcium channel activity [GO:0005262]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of insulin secretion [GO:0050796]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; sensory perception of sound [GO:0007605]	CACNA1D CACH3 CACN4 CACNL1A2 CCHL1A2
NM_000720		Q59GD8	Q59GD8_HUMAN	Calcium channel, voltage-dependent, L type, alpha 1D subunit variant (Voltage-dependent L-type calcium channel subunit alpha-1D) (Fragment)	GO:0005245; GO:0005891; GO:0034765	voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]	CACNA1D
NM_020133	NM_020133 -> Q9NRZ5-1	Q9NRZ5	PLCD_HUMAN	1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta)	GO:0003841; GO:0005741; GO:0005783; GO:0005789; GO:0006654; GO:0008654; GO:0016021; GO:0016024; GO:0016746	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; transferase activity, transferring acyl groups [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]	AGPAT4 UNQ499/PRO1016
NM_001098482	NM_001098482 -> Q6UUV9-2	Q6UUV9	CRTC1_HUMAN	CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1) (Transducer of regulated cAMP response element-binding protein 1) (TORC-1) (Transducer of CREB protein 1)	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007613; GO:0008140; GO:0014069; GO:0016032; GO:0016604; GO:0030425; GO:0032793; GO:0043025; GO:0043153; GO:0045944; GO:0048511; GO:0051289; GO:0097009; GO:0098978; GO:0099527; GO:1900006; GO:1900273; GO:1902631	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cAMP response element binding protein binding [GO:0008140]; energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511]; viral process [GO:0016032]	CRTC1 KIAA0616 MECT1 TORC1 WAMTP1
NM_001030060		Q5TGI4	SAMD5_HUMAN	Sterile alpha motif domain-containing protein 5 (SAM domain-containing protein 5)	GO:0005737	cytoplasm [GO:0005737]	SAMD5 SAMDC1
NM_018145		A0A024R9P6	A0A024R9P6_HUMAN	Family with sequence similarity 82, member C, isoform CRA_a	GO:0005739; GO:0016021; GO:0045171	integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; mitochondrion [GO:0005739]	FAM82C hCG_38969
NM_018145	NM_018145 -> Q96TC7-1	Q96TC7	RMD3_HUMAN	Regulator of microtubule dynamics protein 3 (RMD-3) (hRMD-3) (Cerebral protein 10) (Protein FAM82A2) (Protein FAM82C) (Protein tyrosine phosphatase-interacting protein 51) (TCPTP-interacting protein 51)	GO:0000922; GO:0005623; GO:0005634; GO:0005739; GO:0005741; GO:0005874; GO:0006874; GO:0006915; GO:0016021; GO:0030154; GO:0045171	cell [GO:0005623]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole [GO:0000922]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874]	RMDN3 FAM82A2 FAM82C PTPIP51 hucep-10 UNQ3122/PRO10274
NM_021160		A0A1U9X777	A0A1U9X777_HUMAN	ABHD16A	GO:0004620; GO:0006660; GO:0016021; GO:0047372; GO:0052651; GO:1905344	integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344]	
NM_021160	NM_021160 -> O95870-1	O95870	ABHGA_HUMAN	Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5) (hBAT5) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23) (Protein G5)	GO:0004620; GO:0006660; GO:0016021; GO:0047372; GO:0052651; GO:1905344	integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344]	ABHD16A BAT5 G5 NG26 PP199
NM_014819	NM_014819 -> O43164-1	O43164	PJA2_HUMAN	E3 ubiquitin-protein ligase Praja-2 (Praja2) (EC 2.3.2.27) (RING finger protein 131) (RING-type E3 ubiquitin transferase Praja-2)	GO:0000139; GO:0004842; GO:0005737; GO:0005789; GO:0005886; GO:0006954; GO:0007616; GO:0010738; GO:0014069; GO:0016567; GO:0030054; GO:0034137; GO:0034236; GO:0034237; GO:0035329; GO:0043030; GO:0045087; GO:0045111; GO:0045211; GO:0046330; GO:0046872; GO:0061630; GO:1900745	cell junction [GO:0030054]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; metal ion binding [GO:0046872]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; hippo signaling [GO:0035329]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; protein ubiquitination [GO:0016567]; regulation of macrophage activation [GO:0043030]; regulation of protein kinase A signaling [GO:0010738]	PJA2 KIAA0438 RNF131
NM_178835		B3KSR1	B3KSR1_HUMAN	cDNA FLJ36817 fis, clone ASTRO2004032	GO:0003676	nucleic acid binding [GO:0003676]	
NM_178835	NM_178835 -> Q17R98-2	Q17R98	ZN827_HUMAN	Zinc finger protein 827	GO:0000979; GO:0005634; GO:0010468; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; regulation of gene expression [GO:0010468]	ZNF827
NM_006738	NM_006738 -> Q12802-2	Q12802	AKP13_HUMAN	A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47)	GO:0004691; GO:0005078; GO:0005089; GO:0005634; GO:0005829; GO:0005884; GO:0005938; GO:0007186; GO:0007507; GO:0016020; GO:0017048; GO:0035025; GO:0043065; GO:0043123; GO:0043406; GO:0046872; GO:0048471; GO:0051018; GO:0051056; GO:0051168; GO:0055007; GO:0060090; GO:0060297; GO:0060348; GO:0061049; GO:0071875; GO:0086023; GO:1900169	actin filament [GO:0005884]; cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056]	AKAP13 BRX HT31 LBC
NM_015892	NM_015892 -> Q7LFX5-1	Q7LFX5	CHSTF_HUMAN	Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST)	GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]	CHST15 BRAG GALNAC4S6ST KIAA0598
NM_015037	NM_015037 -> A7E2V4-4	A7E2V4	ZSWM8_HUMAN	Zinc finger SWIM domain-containing protein 8	GO:0008270; GO:0031462; GO:1902667	Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; regulation of axon guidance [GO:1902667]	ZSWIM8 KIAA0913
NM_001025252	NM_001025252 -> P55327-1	P55327	TPD52_HUMAN	Tumor protein D52 (Protein N8)	GO:0005509; GO:0005737; GO:0005783; GO:0009653; GO:0030183; GO:0042803; GO:0046903; GO:0046982; GO:0048471	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; anatomical structure morphogenesis [GO:0009653]; B cell differentiation [GO:0030183]; secretion [GO:0046903]	TPD52
NM_198185		A0A087X1V8	A0A087X1V8_HUMAN	Ovochymase-2	GO:0004252	serine-type endopeptidase activity [GO:0004252]	OVCH2
NM_001010883	NM_001010883 -> Q5T8I3-1	Q5T8I3	F102B_HUMAN	Protein FAM102B			FAM102B
NM_001024596	NM_001024596 -> Q68DY9-1	Q68DY9	ZN772_HUMAN	Zinc finger protein 772	GO:0003677; GO:0005634; GO:0006355; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]	ZNF772
NM_014648	NM_014648 -> Q86Y13-1	Q86Y13	DZIP3_HUMAN	E3 ubiquitin-protein ligase DZIP3 (EC 2.3.2.27) (DAZ-interacting protein 3) (RING-type E3 ubiquitin transferase DZIP3) (RNA-binding ubiquitin ligase of 138 kDa) (hRUL138)	GO:0000209; GO:0003723; GO:0004842; GO:0005737; GO:0019902; GO:0031593; GO:0046872; GO:0061630	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]	DZIP3 KIAA0675
NM_001039570	NM_001039570 -> Q96MU8-3	Q96MU8	KREM1_HUMAN	Kremen protein 1 (Dickkopf receptor) (Kringle domain-containing transmembrane protein 1) (Kringle-containing protein marking the eye and the nose)	GO:0005886; GO:0006915; GO:0007154; GO:0016020; GO:0016021; GO:0016055; GO:0030279; GO:0043025; GO:0048681; GO:0060173; GO:0060828; GO:0090090	integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; apoptotic process [GO:0006915]; cell communication [GO:0007154]; limb development [GO:0060173]; negative regulation of axon regeneration [GO:0048681]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]	KREMEN1 KREMEN KRM1
NM_001229	NM_001229 -> P55211-1	P55211	CASP9_HUMAN	Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10]	GO:0001822; GO:0002931; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0007568; GO:0008047; GO:0008233; GO:0008630; GO:0008635; GO:0017124; GO:0019901; GO:0030220; GO:0032025; GO:0032355; GO:0032496; GO:0032991; GO:0034349; GO:0034644; GO:0042770; GO:0042802; GO:0043065; GO:0043293; GO:0043525; GO:0046677; GO:0071549; GO:0071887; GO:0097153; GO:0097192; GO:0097199; GO:2001020	apoptosome [GO:0043293]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770]	CASP9 MCH6
NM_014701	NM_014701 -> Q93073-2	Q93073	SBP2L_HUMAN	Selenocysteine insertion sequence-binding protein 2-like (SECIS-binding protein 2-like)	GO:0001514; GO:0003723; GO:0003730; GO:0035368; GO:0043021; GO:1990904	ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514]	SECISBP2L KIAA0256
NM_015204		Q9UPZ6	THS7A_HUMAN	Thrombospondin type-1 domain-containing protein 7A [Cleaved into: Thrombospondin type-1 domain-containing protein 7A, soluble form]	GO:0001525; GO:0005576; GO:0005886; GO:0016021; GO:0030154; GO:0031532; GO:0042995	cell projection [GO:0042995]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]	THSD7A KIAA0960
NM_003873		O14786	NRP1_HUMAN	Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304)	GO:0001525; GO:0001569; GO:0001764; GO:0001938; GO:0002040; GO:0002042; GO:0002116; GO:0003148; GO:0005021; GO:0005096; GO:0005615; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0005925; GO:0006930; GO:0007165; GO:0007229; GO:0007267; GO:0007411; GO:0007413; GO:0008201; GO:0009611; GO:0009887; GO:0009986; GO:0010595; GO:0014911; GO:0015026; GO:0017154; GO:0019838; GO:0019901; GO:0019955; GO:0021612; GO:0021637; GO:0021649; GO:0021675; GO:0021785; GO:0021828; GO:0030424; GO:0030426; GO:0031290; GO:0031410; GO:0031532; GO:0032489; GO:0034446; GO:0035729; GO:0035767; GO:0035924; GO:0036486; GO:0038085; GO:0038189; GO:0038190; GO:0042327; GO:0043005; GO:0043025; GO:0043235; GO:0043524; GO:0043542; GO:0046872; GO:0048008; GO:0048010; GO:0048012; GO:0048842; GO:0048843; GO:0048844; GO:0048846; GO:0050731; GO:0050918; GO:0051491; GO:0051496; GO:0051894; GO:0060301; GO:0060385; GO:0060627; GO:0060666; GO:0060978; GO:0060982; GO:0061299; GO:0061441; GO:0061549; GO:0061551; GO:0070374; GO:0071526; GO:0071679; GO:0090050; GO:0090259; GO:0097102; GO:0097374; GO:0097443; GO:0097475; GO:0097490; GO:0097491; GO:0098978; GO:0099055; GO:0099173; GO:0150018; GO:0150020; GO:1900026; GO:1901166; GO:1901998; GO:1902285; GO:1902287; GO:1902336; GO:1902378; GO:1902946; GO:1903375; GO:1904835; GO:1905040; GO:2000251; GO:2001237	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; neurofilament [GO:0005883]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; semaphorin receptor complex [GO:0002116]; sorting endosome [GO:0097443]; coreceptor activity [GO:0015026]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; GTPase activator activity [GO:0005096]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; artery morphogenesis [GO:0048844]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; basal dendrite development [GO:0150018]; branching involved in blood vessel morphogenesis [GO:0001569]; branchiomotor neuron axon guidance [GO:0021785]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell signaling [GO:0007267]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; dorsal root ganglion morphogenesis [GO:1904835]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; endothelial tip cell fate specification [GO:0097102]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; integrin-mediated signaling pathway [GO:0007229]; motor neuron migration [GO:0097475]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; neuropilin signaling pathway [GO:0038189]; otic placode development [GO:1905040]; outflow tract septum morphogenesis [GO:0003148]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytokine activity [GO:0060301]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphorylation [GO:0042327]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynapse organization [GO:0099173]; protein localization to early endosome [GO:1902946]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of vesicle-mediated transport [GO:0060627]; renal artery morphogenesis [GO:0061441]; response to wounding [GO:0009611]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal ganglion cell axon guidance [GO:0031290]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; toxin transport [GO:1901998]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; VEGF-activated neuropilin signaling pathway [GO:0038190]; VEGF-activated neuropilin signaling pathway involved in axon guidance [GO:1902378]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]	NRP1 NRP VEGF165R
NM_003873		Q59F20	Q59F20_HUMAN	Neuropilin-1 variant (Fragment)	GO:0001525; GO:0005021; GO:0007411; GO:0009887; GO:0016021; GO:0017154; GO:0019838; GO:0035767; GO:0046872; GO:0048010	integral component of membrane [GO:0016021]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; endothelial cell chemotaxis [GO:0035767]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	
NM_003873		Q68DN3	Q68DN3_HUMAN	Neuropilin	GO:0001525; GO:0005021; GO:0007411; GO:0009887; GO:0016021; GO:0017154; GO:0019838; GO:0035767; GO:0046872; GO:0048010	integral component of membrane [GO:0016021]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; endothelial cell chemotaxis [GO:0035767]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	DKFZp781F1414
NM_003873		Q6AWA9	Q6AWA9_HUMAN	Uncharacterized protein DKFZp686A03134 (Fragment)			DKFZp686A03134
NM_001101372		A6NGN9	IGLO5_HUMAN	IgLON family member 5	GO:0005576	extracellular region [GO:0005576]	IGLON5
NM_006178		A0A384MTI6	A0A384MTI6_HUMAN	Epididymis secretory sperm binding protein	GO:0005524; GO:0006813; GO:0017075; GO:0019901; GO:0035494; GO:0042623	ATP binding [GO:0005524]; ATPase activity, coupled [GO:0042623]; protein kinase binding [GO:0019901]; syntaxin-1 binding [GO:0017075]; potassium ion transport [GO:0006813]; SNARE complex disassembly [GO:0035494]	
NM_006178	NM_006178 -> P46459-1	P46459	NSF_HUMAN	Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)	GO:0000139; GO:0000149; GO:0001921; GO:0005524; GO:0005765; GO:0005795; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0006887; GO:0006888; GO:0006890; GO:0014069; GO:0016192; GO:0016887; GO:0017075; GO:0017137; GO:0017157; GO:0019901; GO:0030165; GO:0035255; GO:0035494; GO:0042623; GO:0043001; GO:0043198; GO:0044877; GO:0045026; GO:0045732; GO:0046872; GO:0048208; GO:0048211	cytosol [GO:0005829]; dendritic shaft [GO:0043198]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; plasma membrane fusion [GO:0045026]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; regulation of exocytosis [GO:0017157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex disassembly [GO:0035494]; vesicle-mediated transport [GO:0016192]	NSF
NM_032146	NM_032146 -> Q9H0F7-1	Q9H0F7	ARL6_HUMAN	ADP-ribosylation factor-like protein 6 (Bardet-Biedl syndrome 3 protein)	GO:0003924; GO:0005525; GO:0005543; GO:0005623; GO:0005737; GO:0005829; GO:0005879; GO:0005886; GO:0005929; GO:0005930; GO:0006612; GO:0006886; GO:0007368; GO:0007420; GO:0007601; GO:0008589; GO:0010842; GO:0016020; GO:0016055; GO:0016192; GO:0030117; GO:0032402; GO:0045444; GO:0046872; GO:0051258; GO:0060271; GO:0061512; GO:0070062; GO:0097499; GO:1903445	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; cell [GO:0005623]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane coat [GO:0030117]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; brain development [GO:0007420]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; fat cell differentiation [GO:0045444]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of smoothened signaling pathway [GO:0008589]; retina layer formation [GO:0010842]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]	ARL6 BBS3
NM_001731		P62324	BTG1_HUMAN	Protein BTG1 (B-cell translocation gene 1 protein)	GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006979; GO:0007283; GO:0008285; GO:0016477; GO:0019899; GO:0019900; GO:0030308; GO:0043434; GO:0045603; GO:0045663; GO:0045766; GO:0045930; GO:2000271	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; transcription coregulator activity [GO:0003712]; cell migration [GO:0016477]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of myoblast differentiation [GO:0045663]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; spermatogenesis [GO:0007283]	BTG1
NM_001731		Q6IBC8	Q6IBC8_HUMAN	B-cell translocation gene 1, anti-proliferative (B-cell translocation gene 1, anti-proliferative, isoform CRA_b) (BTG1) (BTG1 protein) (cDNA, FLJ93822, Homo sapiens B-cell translocation gene 1, anti-proliferative(BTG1), mRNA)	GO:0005634; GO:0006979; GO:0007283; GO:0008285; GO:0043434	nucleus [GO:0005634]; negative regulation of cell population proliferation [GO:0008285]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; spermatogenesis [GO:0007283]	BTG1 hCG_21188
NM_002971		A0A024R2H1	A0A024R2H1_HUMAN	DNA-binding protein SATB (Special AT-rich sequence-binding protein)	GO:0003677; GO:0005634; GO:0006338	nucleus [GO:0005634]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]	SATB1 hCG_26781
NM_002971	NM_002971 -> Q01826-1	Q01826	SATB1_HUMAN	DNA-binding protein SATB1 (Special AT-rich sequence-binding protein 1)	GO:0000122; GO:0000790; GO:0000977; GO:0000981; GO:0001227; GO:0003682; GO:0003690; GO:0005634; GO:0005654; GO:0005720; GO:0006325; GO:0006338; GO:0008544; GO:0016032; GO:0016363; GO:0016571; GO:0016604; GO:0016605; GO:0043367; GO:0043374; GO:0050798; GO:0060004	nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nuclear heterochromatin [GO:0005720]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; activated T cell proliferation [GO:0050798]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; CD8-positive, alpha-beta T cell differentiation [GO:0043374]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; epidermis development [GO:0008544]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; reflex [GO:0060004]; viral process [GO:0016032]	SATB1
NM_032221	NM_032221 -> Q8TD26-1	Q8TD26	CHD6_HUMAN	Chromodomain-helicase-DNA-binding protein 6 (CHD-6) (EC 3.6.4.12) (ATP-dependent helicase CHD6) (Radiation-induced gene B protein)	GO:0001221; GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0006325; GO:0008094; GO:0016032; GO:0036091	nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; transcription cofactor binding [GO:0001221]; chromatin organization [GO:0006325]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; viral process [GO:0016032]	CHD6 CHD5 KIAA1335 RIGB
NM_139245	NM_139245 -> Q5SGD2-1	Q5SGD2	PPM1L_HUMAN	Protein phosphatase 1L (EC 3.1.3.16) (Protein phosphatase 1-like) (Protein phosphatase 2C isoform epsilon) (PP2C-epsilon)	GO:0000165; GO:0004722; GO:0004724; GO:0005789; GO:0007178; GO:0016021; GO:0030148; GO:0046872; GO:0070062	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; MAPK cascade [GO:0000165]; sphingolipid biosynthetic process [GO:0030148]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]	PPM1L PP2CE
NM_003747	NM_003747 -> O95271-1	O95271	TNKS1_HUMAN	Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1)	GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0000784; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031670; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]	TNKS PARP5A PARPL TIN1 TINF1 TNKS1
NM_015097	NM_015097 -> O75122-3	O75122	CLAP2_HUMAN	CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2)	GO:0000226; GO:0000777; GO:0002162; GO:0005623; GO:0005737; GO:0005794; GO:0005802; GO:0005815; GO:0005828; GO:0005829; GO:0005874; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051497; GO:0051895; GO:0072659; GO:0090091; GO:1903690; GO:1903754; GO:1904261; GO:1990782	axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell [GO:0005623]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782]; cell division [GO:0051301]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903]	CLASP2 KIAA0627
NM_000553		Q14191	WRN_HUMAN	Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2)	GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0001302; GO:0003677; GO:0003678; GO:0003682; GO:0004386; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006284; GO:0006302; GO:0006310; GO:0006974; GO:0006979; GO:0007420; GO:0007568; GO:0007569; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0010259; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0042981; GO:0043005; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090656; GO:0098530; GO:1901796; GO:1902570; GO:1905773	centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; regulation of signal transduction by p53 class mediator [GO:1901796]; replication fork processing [GO:0031297]; replicative cell aging [GO:0001302]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]	WRN RECQ3 RECQL2
NM_001040260	NM_001040260 -> Q8N568-1	Q8N568	DCLK2_HUMAN	Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2)	GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005874; GO:0018105; GO:0021766; GO:0021860; GO:0035556; GO:1900181	cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; pyramidal neuron development [GO:0021860]	DCLK2 DCAMKL2 DCDC3B DCK2
NM_001142353	NM_001142353 -> P16298-4	P16298	PP2BB_HUMAN	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta)	GO:0001915; GO:0001946; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005955; GO:0006468; GO:0006470; GO:0007165; GO:0007223; GO:0007507; GO:0007612; GO:0007613; GO:0008144; GO:0016311; GO:0017156; GO:0019899; GO:0030018; GO:0030217; GO:0030315; GO:0030346; GO:0031987; GO:0033173; GO:0033192; GO:0034097; GO:0035690; GO:0035774; GO:0038095; GO:0042098; GO:0042110; GO:0043029; GO:0045893; GO:0045944; GO:0046983; GO:0048167; GO:0048675; GO:0050796; GO:0097720; GO:0098978; GO:1900242	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]; axon extension [GO:0048675]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to drug [GO:0035690]; dephosphorylation [GO:0016311]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	PPP3CB CALNA2 CALNB CNA2
NM_138962	NM_138962 -> Q96DH6-1	Q96DH6	MSI2H_HUMAN	RNA-binding protein Musashi homolog 2 (Musashi-2)	GO:0003723; GO:0005634; GO:0005737; GO:0005844; GO:0008266; GO:0048864; GO:1990904	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; stem cell development [GO:0048864]	MSI2
NM_153605	NM_153605 -> Q68DQ2-3	Q68DQ2	CRBG3_HUMAN	Very large A-kinase anchor protein (vlAKAP) (Beta/gamma crystallin domain-containing protein 3)	GO:0002088; GO:0005212; GO:0007601; GO:0030246; GO:0032991; GO:0051018	protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]; protein kinase A binding [GO:0051018]; structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601]	CRYBG3
NM_032812	NM_032812 -> Q6UX71-1	Q6UX71	PXDC2_HUMAN	Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)	GO:0016021	integral component of membrane [GO:0016021]	PLXDC2 TEM7R UNQ2514/PRO6003
NM_017799		B3KN73	B3KN73_HUMAN	cDNA FLJ13823 fis, clone THYRO1000502			
NM_017799	NM_017799 -> Q9NX78-1	Q9NX78	TM260_HUMAN	Transmembrane protein 260	GO:0016021	integral component of membrane [GO:0016021]	TMEM260 C14orf101
NM_005467	NM_005467 -> Q9Y3Q0-1	Q9Y3Q0	NALD2_HUMAN	N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)	GO:0004180; GO:0005886; GO:0006508; GO:0008236; GO:0008237; GO:0008239; GO:0008652; GO:0016021; GO:0016805; GO:0042135; GO:0046872; GO:0050129	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]; cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]	NAALAD2
NM_000362		P35625	TIMP3_HUMAN	Metalloproteinase inhibitor 3 (Protein MIG-5) (Tissue inhibitor of metalloproteinases 3) (TIMP-3)	GO:0002020; GO:0002576; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0007601; GO:0008191; GO:0009725; GO:0010033; GO:0010951; GO:0031012; GO:0031089; GO:0034097; GO:0046872; GO:0051045; GO:0062023; GO:0070373; GO:0071310; GO:1903984; GO:1904684	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; platelet dense granule lumen [GO:0031089]; metal ion binding [GO:0046872]; metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]; cellular response to organic substance [GO:0071310]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metalloendopeptidase activity [GO:1904684]; platelet degranulation [GO:0002576]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to organic substance [GO:0010033]; visual perception [GO:0007601]	TIMP3
NM_138796		Q96L03	SPT17_HUMAN	Spermatogenesis-associated protein 17	GO:0005516; GO:0005737	cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]	SPATA17
NM_173632		B2RN90	B2RN90_HUMAN	Zinc finger protein 776	GO:0003676	nucleic acid binding [GO:0003676]	ZNF776
NM_173632		B4DSC6	B4DSC6_HUMAN	cDNA FLJ55588, moderately similar to Zinc finger protein 418	GO:0003676; GO:0006355; GO:0046872	metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]	
NM_173632		Q68DI1	ZN776_HUMAN	Zinc finger protein 776	GO:0003677; GO:0005634; GO:0045892; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]	ZNF776
NM_012326	NM_012326 -> Q9UPY8-1	Q9UPY8	MARE3_HUMAN	Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3) (EBF3) (End-binding protein 3) (EB3) (RP3)	GO:0005737; GO:0005815; GO:0005874; GO:0005881; GO:0008017; GO:0008022; GO:0008104; GO:0015630; GO:0019901; GO:0030496; GO:0031110; GO:0031113; GO:0035371; GO:0035372; GO:0042802; GO:0045737; GO:0045860; GO:0045893; GO:0048471; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:1903033; GO:1904825; GO:1905721	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]	MAPRE3
NM_001001415		Q86V71	ZN429_HUMAN	Zinc finger protein 429	GO:0003677; GO:0005634; GO:0006355; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]	ZNF429
NM_144650	NM_144650 -> Q8IWW8-1	Q8IWW8	HOT_HUMAN	Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT) (EC 1.1.99.24) (Alcohol dehydrogenase iron-containing protein 1) (ADHFe1) (Fe-containing alcohol dehydrogenase)	GO:0004022; GO:0005739; GO:0005759; GO:0006103; GO:0006539; GO:0046872; GO:0047988	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; 2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]	ADHFE1 HMFT2263
NM_001394	NM_001394 -> Q13115-1	Q13115	DUS4_HUMAN	Dual specificity protein phosphatase 4 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2) (MAP kinase phosphatase 2) (MKP-2)	GO:0000188; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0008138; GO:0008330; GO:0016311; GO:0016791; GO:0017017; GO:0035335; GO:0035970; GO:0070373; GO:1990439	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]	DUSP4 MKP2 VH2
NM_018177		B2ZZ87	B2ZZ87_HUMAN	Nedd4 binding protein 2			N4BP2
NM_018177	NM_018177 -> Q86UW6-1	Q86UW6	N4BP2_HUMAN	NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein)	GO:0004519; GO:0005524; GO:0005829; GO:0046404	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; endonuclease activity [GO:0004519]	N4BP2 B3BP KIAA1413
NM_013361		Q9UK11	ZN223_HUMAN	Zinc finger protein 223	GO:0003677; GO:0005634; GO:0006355; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]	ZNF223
NM_004952	NM_004952 -> P52797-1	P52797	EFNA3_HUMAN	Ephrin-A3 (EFL-2) (EHK1 ligand) (EHK1-L) (EPH-related receptor tyrosine kinase ligand 3) (LERK-3)	GO:0005005; GO:0005886; GO:0007267; GO:0007411; GO:0016525; GO:0031225; GO:0031226; GO:0046875; GO:0048013; GO:1902961	anchored component of membrane [GO:0031225]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of angiogenesis [GO:0016525]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]	EFNA3 EFL2 EPLG3 LERK3
NM_173485	NM_173485 -> Q9NRE2-1	Q9NRE2	TSH2_HUMAN	Teashirt homolog 2 (Ovarian cancer-related protein 10-2) (OVC10-2) (Zinc finger protein 218)	GO:0000790; GO:0000981; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007275; GO:0046872	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]	TSHZ2 C20orf17 TSH2 ZNF218
NM_001165		Q13489	BIRC3_HUMAN	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Apoptosis inhibitor 2) (API2) (Cellular inhibitor of apoptosis 2) (C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1) (hIAP-1) (hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1)	GO:0002756; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0007283; GO:0010803; GO:0016579; GO:0016740; GO:0031398; GO:0032991; GO:0033209; GO:0034121; GO:0035666; GO:0038061; GO:0039535; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043154; GO:0045088; GO:0045121; GO:0046872; GO:0050727; GO:0051291; GO:0060544; GO:0060546; GO:0061630; GO:0070424; GO:1990001; GO:2000116	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; regulation of apoptotic process [GO:0042981]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; spermatogenesis [GO:0007283]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	BIRC3 API2 MIHC RNF49
NM_005981		Q12999	TSN31_HUMAN	Tetraspanin-31 (Tspan-31) (Sarcoma-amplified sequence)	GO:0005887; GO:0008284; GO:0016020	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; positive regulation of cell population proliferation [GO:0008284]	TSPAN31 SAS
NM_020747		B3KPE6	B3KPE6_HUMAN	Zinc finger protein 608 (cDNA FLJ31685 fis, clone NT2RI2005368, highly similar to Homo sapiens zinc finger protein 608 (ZNF608), mRNA) (Fragment)	GO:0003676	nucleic acid binding [GO:0003676]	ZNF608
NM_020747	NM_020747 -> Q9ULD9-1	Q9ULD9	ZN608_HUMAN	Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36)	GO:0000122; GO:0003676; GO:0046872	metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription by RNA polymerase II [GO:0000122]	ZNF608 KIAA1281
NM_001166	NM_001166 -> Q13490-1	Q13490	BIRC2_HUMAN	Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2)	GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0002756; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0010803; GO:0016579; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0035666; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043154; GO:0043161; GO:0045088; GO:0045121; GO:0045471; GO:0045595; GO:0047485; GO:0050727; GO:0051087; GO:0051291; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:1990001; GO:2000116; GO:2000377	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	BIRC2 API1 MIHB RNF48
NM_023940		Q9BPW5	RSLBB_HUMAN	Ras-like protein family member 11B	GO:0003924; GO:0005160; GO:0005525; GO:0007165; GO:0016020; GO:0030512	membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; transforming growth factor beta receptor binding [GO:0005160]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; signal transduction [GO:0007165]	RASL11B
NM_018013		A7XYQ1	SOBP_HUMAN	Sine oculis-binding protein homolog (Jackson circler protein 1)	GO:0005634; GO:0007605; GO:0007626; GO:0032184; GO:0042472; GO:0046872; GO:0050890; GO:0090102	nucleus [GO:0005634]; metal ion binding [GO:0046872]; SUMO polymer binding [GO:0032184]; cochlea development [GO:0090102]; cognition [GO:0050890]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605]	SOBP JXC1
NM_018013		Q24K27	Q24K27_HUMAN	SOBP protein (Fragment)			SOBP
NM_005994		A0A024QZ86	A0A024QZ86_HUMAN	T-box 2, isoform CRA_a	GO:0000122; GO:0003148; GO:0003203; GO:0003256; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0007219; GO:0007521; GO:0007569; GO:0035909; GO:0036302; GO:0042733; GO:0048596; GO:0048738; GO:0060021; GO:0060045; GO:0060465; GO:0060560; GO:0060596; GO:1901208; GO:1901211	nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; cardiac muscle tissue development [GO:0048738]; cell aging [GO:0007569]; developmental growth involved in morphogenesis [GO:0060560]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; endocardial cushion morphogenesis [GO:0003203]; mammary placode formation [GO:0060596]; muscle cell fate determination [GO:0007521]; negative regulation of cardiac chamber formation [GO:1901211]; negative regulation of heart looping [GO:1901208]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; outflow tract septum morphogenesis [GO:0003148]; pharynx development [GO:0060465]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; roof of mouth development [GO:0060021]	TBX2 hCG_32216
NM_005994		Q13207	TBX2_HUMAN	T-box transcription factor TBX2 (T-box protein 2)	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001102; GO:0001227; GO:0001228; GO:0001708; GO:0001947; GO:0003148; GO:0003151; GO:0003203; GO:0003205; GO:0003256; GO:0003677; GO:0005634; GO:0005667; GO:0007219; GO:0007417; GO:0007521; GO:0007569; GO:0008016; GO:0008284; GO:0035050; GO:0035909; GO:0036302; GO:0042733; GO:0043565; GO:0045892; GO:0045944; GO:0048596; GO:0048738; GO:0060021; GO:0060045; GO:0060465; GO:0060560; GO:0060596; GO:0090398; GO:1901208; GO:1901211	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; cardiac chamber development [GO:0003205]; cardiac muscle tissue development [GO:0048738]; cell aging [GO:0007569]; cell fate specification [GO:0001708]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; developmental growth involved in morphogenesis [GO:0060560]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endocardial cushion morphogenesis [GO:0003203]; heart looping [GO:0001947]; mammary placode formation [GO:0060596]; muscle cell fate determination [GO:0007521]; negative regulation of cardiac chamber formation [GO:1901211]; negative regulation of heart looping [GO:1901208]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharynx development [GO:0060465]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; roof of mouth development [GO:0060021]	TBX2
NM_003884		Q92831	KAT2B_HUMAN	Histone acetyltransferase KAT2B (EC 2.3.1.48) (Histone acetyltransferase PCAF) (Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor) (P/CAF) (Spermidine acetyltransferase KAT2B) (EC 2.3.1.57)	GO:0000125; GO:0000776; GO:0000977; GO:0003682; GO:0003712; GO:0003713; GO:0004145; GO:0004402; GO:0004468; GO:0004861; GO:0005634; GO:0005654; GO:0005671; GO:0005813; GO:0006338; GO:0006367; GO:0006473; GO:0007050; GO:0007219; GO:0007221; GO:0007507; GO:0008134; GO:0008285; GO:0010835; GO:0016032; GO:0016407; GO:0016579; GO:0018076; GO:0018393; GO:0018394; GO:0019901; GO:0031672; GO:0031674; GO:0032869; GO:0032991; GO:0035948; GO:0042641; GO:0042826; GO:0043966; GO:0043970; GO:0045652; GO:0045747; GO:0045815; GO:0045944; GO:0046600; GO:0048511; GO:0060173; GO:0061733	A band [GO:0031672]; actomyosin [GO:0042641]; Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; I band [GO:0031674]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCAF complex [GO:0000125]; protein-containing complex [GO:0032991]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; diamine N-acetyltransferase activity [GO:0004145]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein kinase binding [GO:0019901]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; cellular response to insulin stimulus [GO:0032869]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3 acetylation [GO:0043966]; histone H3-K9 acetylation [GO:0043970]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centriole replication [GO:0046600]; Notch signaling pathway [GO:0007219]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter [GO:0035948]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; protein acetylation [GO:0006473]; protein deubiquitination [GO:0016579]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of protein ADP-ribosylation [GO:0010835]; rhythmic process [GO:0048511]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]	KAT2B PCAF
NM_178011	NM_178011 -> Q86VH5-1	Q86VH5	LRRT3_HUMAN	Leucine-rich repeat transmembrane neuronal protein 3	GO:0005615; GO:0030054; GO:0031012; GO:0051965; GO:0098978; GO:0099054; GO:0099061; GO:1902004	cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]	LRRTM3 UNQ803/PRO1693
NM_016247		F1T0J3	F1T0J3_HUMAN	Interphotoreceptor matrix proteoglycan 2	GO:0005201; GO:0005540; GO:0007601; GO:0008201; GO:0016021; GO:0033165	integral component of membrane [GO:0016021]; interphotoreceptor matrix [GO:0033165]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540]; visual perception [GO:0007601]	IMPG2
NM_016247		Q9BZV3	IMPG2_HUMAN	Interphotoreceptor matrix proteoglycan 2 (Interphotoreceptor matrix proteoglycan of 200 kDa) (IPM 200) (Sialoprotein associated with cones and rods proteoglycan) (Spacrcan)	GO:0005201; GO:0005540; GO:0007601; GO:0008201; GO:0016021; GO:0031012; GO:0033165; GO:0042995; GO:0043235	cell projection [GO:0042995]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; interphotoreceptor matrix [GO:0033165]; receptor complex [GO:0043235]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540]; visual perception [GO:0007601]	IMPG2 IPM200
NM_021150	NM_021150 -> Q9Y3R0-3	Q9Y3R0	GRIP1_HUMAN	Glutamate receptor-interacting protein 1 (GRIP-1)	GO:0003713; GO:0005789; GO:0005829; GO:0005886; GO:0008013; GO:0008022; GO:0014069; GO:0016358; GO:0030054; GO:0030159; GO:0030425; GO:0030521; GO:0031410; GO:0035259; GO:0035556; GO:0043005; GO:0043204; GO:0045121; GO:0045211; GO:0045893; GO:0050681; GO:0098887; GO:0098978; GO:0099003; GO:0150012	cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; androgen receptor binding [GO:0050681]; beta-catenin binding [GO:0008013]; glucocorticoid receptor binding [GO:0035259]; protein C-terminus binding [GO:0008022]; receptor signaling complex adaptor activity [GO:0030159]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; dendrite development [GO:0016358]; intracellular signal transduction [GO:0035556]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription, DNA-templated [GO:0045893]; vesicle-mediated transport in synapse [GO:0099003]	GRIP1
NM_000550		P17643	TYRP1_HUMAN	5,6-dihydroxyindole-2-carboxylic acid oxidase (DHICA oxidase) (EC 1.14.18.-) (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1) (TRP) (TRP-1) (TRP1)	GO:0004503; GO:0005737; GO:0010008; GO:0016021; GO:0016491; GO:0030318; GO:0030669; GO:0032438; GO:0033162; GO:0042438; GO:0042470; GO:0042803; GO:0043438; GO:0043473; GO:0046872; GO:0046982; GO:0048023; GO:0097708	clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; metal ion binding [GO:0046872]; monophenol monooxygenase activity [GO:0004503]; oxidoreductase activity [GO:0016491]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; acetoacetic acid metabolic process [GO:0043438]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome organization [GO:0032438]; pigmentation [GO:0043473]; positive regulation of melanin biosynthetic process [GO:0048023]	TYRP1 CAS2 TYRP TYRRP
NM_016518		Q9P0Z9	SOX_HUMAN	Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase)	GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0006625; GO:0008115; GO:0033514; GO:0046653; GO:0050031; GO:0055114	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554]; oxidation-reduction process [GO:0055114]; protein targeting to peroxisome [GO:0006625]; tetrahydrofolate metabolic process [GO:0046653]	PIPOX LPIPOX PSO
NM_012330		B2RWN8	B2RWN8_HUMAN	Histone acetyltransferase (EC 2.3.1.48)	GO:0000786; GO:0003677; GO:0004402; GO:0005634; GO:0006334; GO:0006355; GO:0046872	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; nucleosome assembly [GO:0006334]; regulation of transcription, DNA-templated [GO:0006355]	MYST4
NM_012330	NM_012330 -> Q8WYB5-1	Q8WYB5	KAT6B_HUMAN	Histone acetyltransferase KAT6B (EC 2.3.1.48) (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Monocytic leukemia zinc finger protein-related factor)	GO:0000123; GO:0000786; GO:0000790; GO:0003677; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006355; GO:0008134; GO:0016407; GO:0016573; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0070776; GO:1990830	histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; cellular response to leukemia inhibitory factor [GO:1990830]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]	KAT6B KIAA0383 MORF MOZ2 MYST4
NM_178831		Q8NAP1	CAST3_HUMAN	Putative protein CASTOR 3 (STAG3 opposite strand transcript protein)	GO:0005829; GO:1902531; GO:1903577; GO:1904262	cytosol [GO:0005829]; cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531]	CASTOR3 GATS STAG3OS
NM_152721		Q6PKX4	DOK6_HUMAN	Docking protein 6 (Downstream of tyrosine kinase 6)	GO:0005829; GO:0007411	cytosol [GO:0005829]; axon guidance [GO:0007411]	DOK6 DOK5L
NM_000313		A0A0S2Z4K3	A0A0S2Z4K3_HUMAN	Protein S isoform 1 (Fragment)	GO:0005509; GO:0005576; GO:0030195	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; negative regulation of blood coagulation [GO:0030195]	PROS1
NM_000313		P07225	PROS_HUMAN	Vitamin K-dependent protein S	GO:0000139; GO:0002576; GO:0004866; GO:0005509; GO:0005576; GO:0005615; GO:0005789; GO:0005796; GO:0005886; GO:0006888; GO:0007596; GO:0030449; GO:0031093; GO:0042730; GO:0050900; GO:0070062; GO:0072562	blood microparticle [GO:0072562]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; endopeptidase inhibitor activity [GO:0004866]; blood coagulation [GO:0007596]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibrinolysis [GO:0042730]; leukocyte migration [GO:0050900]; platelet degranulation [GO:0002576]; regulation of complement activation [GO:0030449]	PROS1 PROS
NM_022072		Q9H649	NSUN3_HUMAN	tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 3)	GO:0000049; GO:0002127; GO:0005739; GO:0005759; GO:0005762; GO:0008168; GO:0016428; GO:0031167; GO:0070129	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; regulation of mitochondrial translation [GO:0070129]; rRNA methylation [GO:0031167]; tRNA wobble base cytosine methylation [GO:0002127]	NSUN3 MSTP077 UG0651E06
NM_003917		O75843	AP1G2_HUMAN	AP-1 complex subunit gamma-like 2 (Gamma2-adaptin) (G2ad)	GO:0000139; GO:0005794; GO:0005798; GO:0006886; GO:0010008; GO:0016020; GO:0016032; GO:0016192; GO:0030121; GO:0030133	AP-1 adaptor complex [GO:0030121]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; transport vesicle [GO:0030133]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]; viral process [GO:0016032]	AP1G2
NM_014845		Q92562	FIG4_HUMAN	Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3)	GO:0000139; GO:0004438; GO:0005783; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0048666; GO:0055037	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]	FIG4 KIAA0274 SAC3
NM_014751	NM_014751 -> O43312-1	O43312	MTSS1_HUMAN	Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein)	GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	MTSS1 KIAA0429 MIM
NM_001860		O15432	COPT2_HUMAN	Probable low affinity copper uptake protein 2 (Copper transporter 2) (hCTR2) (Solute carrier family 31 member 2)	GO:0005375; GO:0005623; GO:0005770; GO:0005886; GO:0005887; GO:0006825; GO:0006878; GO:0055037; GO:1902311	cell [GO:0005623]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; cellular copper ion homeostasis [GO:0006878]; copper ion transport [GO:0006825]; regulation of copper ion transmembrane transport [GO:1902311]	SLC31A2 COPT2 CTR2
NM_001860		Q53X94	Q53X94_HUMAN	SLC31A2 protein (Solute carrier family 31 (Copper transporters), member 2) (Fragment)	GO:0005375; GO:0005623; GO:0005770; GO:0006878; GO:0016021; GO:0055037; GO:1902311	cell [GO:0005623]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; cellular copper ion homeostasis [GO:0006878]; regulation of copper ion transmembrane transport [GO:1902311]	SLC31A2 hCG_29184
NM_153252	NM_153252 -> Q6RI45-1	Q6RI45	BRWD3_HUMAN	Bromodomain and WD repeat-containing protein 3	GO:0005634; GO:0006357; GO:0007010; GO:0008360	nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]	BRWD3
NM_019073		A0A140VJV1	A0A140VJV1_HUMAN	Spermatogenesis associated 6, isoform CRA_a (Testicular tissue protein Li 178)	GO:0007283; GO:0032027; GO:0044458; GO:0097224	sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283]	SPATA6 hCG_1639865
NM_019073	NM_019073 -> Q9NWH7-1	Q9NWH7	SPAT6_HUMAN	Spermatogenesis-associated protein 6	GO:0005576; GO:0007275; GO:0007283; GO:0030154; GO:0032027; GO:0044458; GO:0097224	extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]	SPATA6
NM_003806		O00198	HRK_HUMAN	Activator of apoptosis harakiri (BH3-interacting domain-containing protein 3) (Neuronal death protein DP5)	GO:0005739; GO:0006915; GO:0016021; GO:0031334; GO:0043065; GO:0090200	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]	HRK BID3
NM_024948	NM_024948 -> Q9H8M7-1	Q9H8M7	MINY3_HUMAN	Ubiquitin carboxyl-terminal hydrolase MINDY-3 (EC 3.4.19.12) (Dermal papilla-derived protein 5) (Deubiquitinating enzyme MINDY-3) (Protein CARP)	GO:0005654; GO:0006915; GO:0016807; GO:0031965; GO:0036459; GO:1990380	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; cysteine-type carboxypeptidase activity [GO:0016807]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; apoptotic process [GO:0006915]	MINDY3 C10orf97 CARP DERP5 FAM188A MSTP126 My042
NM_024874	NM_024874 -> Q8IZA0-1	Q8IZA0	K319L_HUMAN	Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR)	GO:0000139; GO:0005730; GO:0005794; GO:0005886; GO:0016021; GO:0031410	cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	KIAA0319L AAVR KIAA1837 PP791
NM_007207	NM_007207 -> Q9Y6W6-1	Q9Y6W6	DUS10_HUMAN	Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 5) (MAP kinase phosphatase 5) (MKP-5)	GO:0000188; GO:0002819; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006470; GO:0008138; GO:0008330; GO:0008432; GO:0010633; GO:0016311; GO:0016607; GO:0016791; GO:0017017; GO:0030336; GO:0032496; GO:0033549; GO:0035970; GO:0043508; GO:0044387; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0048715; GO:0050680; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042; GO:1990264	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; inactivation of MAPK activity [GO:0000188]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein dephosphorylation [GO:0006470]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]	DUSP10 MKP5
NM_152519	NM_152519 -> A0AUZ9-1	A0AUZ9	KAL1L_HUMAN	KAT8 regulatory NSL complex subunit 1-like protein (MSL1v2)	GO:0035035; GO:0043981; GO:0043982; GO:0043984; GO:0044545	NSL complex [GO:0044545]; histone acetyltransferase binding [GO:0035035]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]	KANSL1L C2orf67
NM_020859		B3KY47	B3KY47_HUMAN	cDNA FLJ46841 fis, clone UTERU3000670, highly similar to Homo sapiens shroom (SHRM), mRNA	GO:0000902; GO:0001843; GO:0002064; GO:0051015	actin filament binding [GO:0051015]; cell morphogenesis [GO:0000902]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]	
NM_020859	NM_020859 -> Q8TF72-1	Q8TF72	SHRM3_HUMAN	Protein Shroom3 (Shroom-related protein) (hShrmL)	GO:0000902; GO:0001843; GO:0002064; GO:0005856; GO:0005874; GO:0005912; GO:0007015; GO:0007389; GO:0008360; GO:0016324; GO:0030036; GO:0030864; GO:0043296; GO:0043482; GO:0045176; GO:0051015	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]	SHROOM3 KIAA1481 SHRML MSTP013
NM_138328	NM_138328 -> P58872-1	P58872	RHBL3_HUMAN	Rhomboid-related protein 3 (EC 3.4.21.105) (Ventrhoid transmembrane protein)	GO:0004252; GO:0005509; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]	RHBDL3 RHBDL4 VRHO
NM_004535	NM_004535 -> Q01538-1	Q01538	MYT1_HUMAN	Myelin transcription factor 1 (MyT1) (Myelin transcription factor I) (MyTI) (PLPB1) (Proteolipid protein-binding protein)	GO:0000790; GO:0000977; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0007399; GO:0008270; GO:0030154	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]	MYT1 KIAA0835 KIAA1050 MTF1 MYTI PLPB1
NM_020808	NM_020808 -> Q9P2F8-1	Q9P2F8	SI1L2_HUMAN	Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2)	GO:0005096; GO:0051056	GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]	SIPA1L2 KIAA1389
NM_183376		A0A024RC80	A0A024RC80_HUMAN	Arrestin domain containing 4, isoform CRA_a	GO:0005886; GO:0015031; GO:0043231; GO:0140112; GO:1903561; GO:1990756	extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; extracellular vesicle biogenesis [GO:0140112]; protein transport [GO:0015031]	ARRDC4 hCG_21308
NM_183376		A8K2F6	A8K2F6_HUMAN	cDNA FLJ75621, highly similar to Homo sapiens arrestin domain containing 4 (ARRDC4), mRNA			
NM_183376		Q8NCT1	ARRD4_HUMAN	Arrestin domain-containing protein 4	GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0016567; GO:0043231; GO:0051443; GO:0140112; GO:1903561; GO:1990756	early endosome [GO:0005769]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein binding, bridging involved in substrate recognition for ubiquitination [GO:1990756]; extracellular vesicle biogenesis [GO:0140112]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]	ARRDC4
NM_007077	NM_007077 -> Q9Y587-2	Q9Y587	AP4S1_HUMAN	AP-4 complex subunit sigma-1 (AP-4 adaptor complex subunit sigma-1) (Adaptor-related protein complex 4 subunit sigma-1) (Sigma-1 subunit of AP-4) (Sigma-4-adaptin) (Sigma4-adaptin)	GO:0006605; GO:0008104; GO:0016192; GO:0030124; GO:0031904; GO:0032588; GO:0043231	AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network membrane [GO:0032588]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	AP4S1
NM_004308		Q07960	RHG01_HUMAN	Rho GTPase-activating protein 1 (CDC42 GTPase-activating protein) (GTPase-activating protein rhoGAP) (Rho-related small GTPase protein activator) (Rho-type GTPase-activating protein 1) (p50-RhoGAP)	GO:0005070; GO:0005096; GO:0005737; GO:0005829; GO:0007264; GO:0007266; GO:0010008; GO:0016197; GO:0017124; GO:0017137; GO:0033572; GO:0045296; GO:0048471; GO:0051056; GO:0070062; GO:2001136	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; endosomal transport [GO:0016197]; negative regulation of endocytic recycling [GO:2001136]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]; transferrin transport [GO:0033572]	ARHGAP1 CDC42GAP RHOGAP1
NM_138295	NM_138295 -> Q8TDX9-1	Q8TDX9	PK1L1_HUMAN	Polycystic kidney disease protein 1-like 1 (PC1-like 1 protein) (Polycystin-1L1)	GO:0003127; GO:0005262; GO:0005929; GO:0016020; GO:0034704; GO:0050982; GO:0060170; GO:0070986; GO:0097730; GO:0098609	calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; calcium channel activity [GO:0005262]; cell-cell adhesion [GO:0098609]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986]	PKD1L1 UNQ5785/PRO19563
NM_130773		Q8WYK1	CNTP5_HUMAN	Contactin-associated protein-like 5 (Cell recognition molecule Caspr5)	GO:0007155; GO:0016021	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]	CNTNAP5 CASPR5
NM_001080424	NM_001080424 -> O15054-1	O15054	KDM6B_HUMAN	Lysine-specific demethylase 6B (EC 1.14.11.-) (JmjC domain-containing protein 3) (Jumonji domain-containing protein 3) (Lysine demethylase 6B)	GO:0000790; GO:0000978; GO:0002437; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0008013; GO:0014823; GO:0021766; GO:0031490; GO:0043565; GO:0044666; GO:0045165; GO:0045446; GO:0045944; GO:0046872; GO:0048333; GO:0051213; GO:0055007; GO:0060992; GO:0070301; GO:0071557; GO:0071558; GO:0120162	MLL3/4 complex [GO:0044666]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cardiac muscle cell differentiation [GO:0055007]; cell fate commitment [GO:0045165]; cellular response to hydrogen peroxide [GO:0070301]; chromatin remodeling [GO:0006338]; endothelial cell differentiation [GO:0045446]; hippocampus development [GO:0021766]; histone H3-K27 demethylation [GO:0071557]; inflammatory response to antigenic stimulus [GO:0002437]; mesodermal cell differentiation [GO:0048333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to activity [GO:0014823]; response to fungicide [GO:0060992]	KDM6B JMJD3 KIAA0346
NM_153487	NM_153487 -> Q8NFP4-1	Q8NFP4	MDGA1_HUMAN	MAM domain-containing glycosylphosphatidylinositol anchor protein 1 (GPI and MAM protein) (GPIM) (Glycosylphosphatidylinositol-MAM) (MAM domain-containing protein 3)	GO:0001764; GO:0005576; GO:0005615; GO:0005794; GO:0005886; GO:0007420; GO:0021527; GO:0046658; GO:0098982; GO:0099179; GO:1905606	anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; brain development [GO:0007420]; neuron migration [GO:0001764]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]; spinal cord association neuron differentiation [GO:0021527]	MDGA1 MAMDC3
NM_013313		O60688	YPEL1_HUMAN	Protein yippee-like 1	GO:0005634; GO:0046872	nucleus [GO:0005634]; metal ion binding [GO:0046872]	YPEL1 FKSG3
NM_002088	NM_002088 -> Q16478-1	Q16478	GRIK5_HUMAN	Glutamate receptor ionotropic, kainate 5 (GluK5) (Excitatory amino acid receptor 2) (EAA2) (Glutamate receptor KA-2) (KA2)	GO:0005623; GO:0005654; GO:0005783; GO:0005886; GO:0006621; GO:0008066; GO:0015277; GO:0017124; GO:0030054; GO:0030165; GO:0030425; GO:0031630; GO:0032983; GO:0035249; GO:0042734; GO:0042802; GO:0043113; GO:0043195; GO:0043204; GO:0043525; GO:0045211; GO:0050804; GO:0051649; GO:0060079; GO:0071333; GO:0098686; GO:0098839; GO:0098978; GO:0099056; GO:0099061; GO:1904315	cell [GO:0005623]; cell junction [GO:0030054]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; PDZ domain binding [GO:0030165]; SH3 domain binding [GO:0017124]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to glucose stimulus [GO:0071333]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; protein retention in ER lumen [GO:0006621]; receptor clustering [GO:0043113]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; synaptic transmission, glutamatergic [GO:0035249]	GRIK5 GRIK2
NM_022096		Q9NU02	ANKE1_HUMAN	Ankyrin repeat and EF-hand domain-containing protein 1 (Ankyrin repeat domain-containing protein 5)	GO:0005509	calcium ion binding [GO:0005509]	ANKEF1 ANKRD5
NM_020755		Q9NRX5	SERC1_HUMAN	Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2)	GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0016021; GO:0019899; GO:0030674; GO:0044091; GO:1904219; GO:1904222	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; protein binding, bridging [GO:0030674]; membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]	SERINC1 KIAA1253 TDE1L TDE2 UNQ396/PRO732
NM_003485		Q15743	OGR1_HUMAN	Ovarian cancer G-protein coupled receptor 1 (OGR-1) (G-protein coupled receptor 68) (GPR12A) (Sphingosylphosphorylcholine receptor)	GO:0004930; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0035774; GO:0045656; GO:0071467; GO:2001206	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cellular response to pH [GO:0071467]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of monocyte differentiation [GO:0045656]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of osteoclast development [GO:2001206]	GPR68 OGR1
NM_005222	NM_005222 -> P56179-3	P56179	DLX6_HUMAN	Homeobox protein DLX-6	GO:0000790; GO:0000978; GO:0000981; GO:0001501; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0030154; GO:0030326; GO:0030855; GO:0042472; GO:0043565; GO:0045944; GO:0048646; GO:0050679; GO:0060021; GO:0060322	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure formation involved in morphogenesis [GO:0048646]; cell differentiation [GO:0030154]; embryonic limb morphogenesis [GO:0030326]; epithelial cell differentiation [GO:0030855]; head development [GO:0060322]; inner ear morphogenesis [GO:0042472]; nervous system development [GO:0007399]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	DLX6
NM_178568		Q86UN2	R4RL1_HUMAN	Reticulon-4 receptor-like 1 (Nogo receptor-like 2) (Nogo-66 receptor homolog 2) (Nogo-66 receptor-related protein 3) (NgR3)	GO:0005576; GO:0005615; GO:0005886; GO:0008201; GO:0009897; GO:0009986; GO:0010977; GO:0022038; GO:0031012; GO:0031103; GO:0035374; GO:0038023; GO:0042995; GO:0043204; GO:0045121; GO:0046658; GO:0048681; GO:0070062	anchored component of plasma membrane [GO:0046658]; cell projection [GO:0042995]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; signaling receptor activity [GO:0038023]; axon regeneration [GO:0031103]; corpus callosum development [GO:0022038]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977]	RTN4RL1 NGRH2 NGRL2
NM_001024948	NM_001024948 -> Q5T0N5-4	Q5T0N5	FBP1L_HUMAN	Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1)	GO:0005623; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0031410; GO:0045296; GO:0051020; GO:0051491; GO:0060271; GO:0061024; GO:0072583; GO:0097320	cell [GO:0005623]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase binding [GO:0051020]; lipid binding [GO:0008289]; autophagy [GO:0006914]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; membrane organization [GO:0061024]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050]	FNBP1L C1orf39 TOCA1
NM_173076		B3KVV3	B3KVV3_HUMAN	cDNA FLJ41584 fis, clone CTONG2020445, highly similar to ATP-binding cassette sub-family A member 12	GO:0005524; GO:0006869; GO:0016021; GO:0016887; GO:0042626	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transport [GO:0006869]	
NM_173076	NM_173076 -> Q86UK0-1	Q86UK0	ABCAC_HUMAN	ATP-binding cassette sub-family A member 12 (ATP-binding cassette transporter 12) (ATP-binding cassette 12)	GO:0005102; GO:0005319; GO:0005524; GO:0005623; GO:0005737; GO:0005829; GO:0005886; GO:0006869; GO:0010875; GO:0016021; GO:0016887; GO:0019725; GO:0031424; GO:0032940; GO:0033700; GO:0034040; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0043231; GO:0045055; GO:0048286; GO:0055085; GO:0055088; GO:0061436; GO:0072659; GO:0097209; GO:2000010	cell [GO:0005623]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]; cellular homeostasis [GO:0019725]; ceramide transport [GO:0035627]; establishment of skin barrier [GO:0061436]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129]; transmembrane transport [GO:0055085]	ABCA12 ABC12
NM_001005404		Q96QA6	YPEL2_HUMAN	Protein yippee-like 2	GO:0005730; GO:0046872	nucleolus [GO:0005730]; metal ion binding [GO:0046872]	YPEL2 FKSG4
NM_001297	NM_001297 -> Q14028-1	Q14028	CNGB1_HUMAN	Cyclic nucleotide-gated cation channel beta-1 (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP)	GO:0000139; GO:0001750; GO:0001895; GO:0005222; GO:0005223; GO:0005623; GO:0005886; GO:0006812; GO:0007601; GO:0007608; GO:0015276; GO:0016056; GO:0017071; GO:0022400; GO:0030552; GO:0030553; GO:0030660; GO:0033365; GO:0035845; GO:0043195; GO:0045494; GO:0050908; GO:0051290; GO:0051480; GO:0060170; GO:1902495	cell [GO:0005623]; ciliary membrane [GO:0060170]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; transmembrane transporter complex [GO:1902495]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; cation transport [GO:0006812]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; protein heterotetramerization [GO:0051290]; protein localization to organelle [GO:0033365]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; retina homeostasis [GO:0001895]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]	CNGB1 CNCG2 CNCG3L CNCG4 RCNC2
NM_015393		Q6UWI2	PARM1_HUMAN	Prostate androgen-regulated mucin-like protein 1 (PARM-1)	GO:0000139; GO:0005654; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0016021; GO:0043231; GO:0051973	cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; positive regulation of telomerase activity [GO:0051973]	PARM1 UNQ1879/PRO4322
NM_003419		Q14585	ZN345_HUMAN	Zinc finger protein 345 (Zinc finger protein HZF10)	GO:0000122; GO:0003677; GO:0005634; GO:0006359; GO:0006366; GO:0006383; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]	ZNF345
NM_020716	NM_020716 -> Q3KR37-1	Q3KR37	ASTRB_HUMAN	Protein Aster-B (GRAM domain-containing protein 1B)	GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]	GRAMD1B KIAA1201 UNQ3032/PRO9834
NM_001009984		Q0IIP3	Q0IIP3_HUMAN	C20orf194 protein			C20orf194
NM_001009984		Q5TEA3	CT194_HUMAN	Uncharacterized protein C20orf194			C20orf194
NM_181523		A0A2X0SFG1	A0A2X0SFG1_HUMAN	PIK3R1 (Fragment)	GO:0001678; GO:0001953; GO:0005623; GO:0005634; GO:0005801; GO:0005829; GO:0005911; GO:0006468; GO:0006606; GO:0008134; GO:0008286; GO:0008625; GO:0008630; GO:0030183; GO:0030335; GO:0032760; GO:0032991; GO:0034644; GO:0034976; GO:0036312; GO:0042307; GO:0043066; GO:0043560; GO:0045671; GO:0045944; GO:0046626; GO:0046982; GO:0051492; GO:1903076; GO:1990578	cell [GO:0005623]; cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; protein-containing complex [GO:0032991]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of cell migration [GO:0030335]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]	PIK3R1
NM_181523	NM_181523 -> P27986-1	P27986	P85A_HUMAN	Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)	GO:0001678; GO:0001784; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005168; GO:0005623; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0006606; GO:0006661; GO:0007173; GO:0007186; GO:0007411; GO:0008134; GO:0008286; GO:0008625; GO:0008630; GO:0014065; GO:0014068; GO:0016020; GO:0016032; GO:0019221; GO:0019903; GO:0030168; GO:0030183; GO:0030335; GO:0031295; GO:0032760; GO:0032869; GO:0033120; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0038095; GO:0038096; GO:0038128; GO:0042307; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048010; GO:0048015; GO:0050821; GO:0050852; GO:0050900; GO:0051492; GO:0051897; GO:0060396; GO:1900103; GO:1903078; GO:1990578	cell [GO:0005623]; cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transcription factor binding [GO:0008134]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; axon guidance [GO:0007411]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone receptor signaling pathway [GO:0060396]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; leukocyte migration [GO:0050900]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of glucose import [GO:0046326]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral process [GO:0016032]	PIK3R1 GRB1
NM_017644	NM_017644 -> Q6TFL4-1	Q6TFL4	KLH24_HUMAN	Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1)	GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312	adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]	KLHL24 DRE1
NM_001009565	NM_001009565 -> Q5MAI5-2	Q5MAI5	CDKL4_HUMAN	Cyclin-dependent kinase-like 4 (EC 2.7.11.22)	GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein phosphorylation [GO:0006468]	CDKL4
NM_001080475	NM_001080475 -> Q6ZWE6-1	Q6ZWE6	PKHM3_HUMAN	Pleckstrin homology domain-containing family M member 3 (PH domain-containing family M member 3) (Differentiation associated protein)	GO:0005737; GO:0005794; GO:0005886; GO:0045445; GO:0046872	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; myoblast differentiation [GO:0045445]	PLEKHM3 DAPR PLEKHM1L
NM_017794		B3KNV9	B3KNV9_HUMAN	cDNA FLJ30554 fis, clone BRAWH2003693			
NM_017794		Q5VW36	FOCAD_HUMAN	Focadhesin	GO:0005925; GO:0016021	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]	FOCAD KIAA1797
NM_004316		P50553	ASCL1_HUMAN	Achaete-scute homolog 1 (ASH-1) (hASH1) (Class A basic helix-loop-helix protein 46) (bHLHa46)	GO:0000122; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001764; GO:0003358; GO:0003359; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0007219; GO:0007346; GO:0007400; GO:0007405; GO:0007423; GO:0007507; GO:0008134; GO:0010226; GO:0010468; GO:0014003; GO:0021527; GO:0021530; GO:0021750; GO:0021892; GO:0021902; GO:0021954; GO:0021987; GO:0022008; GO:0030182; GO:0030856; GO:0032526; GO:0042803; GO:0043025; GO:0043066; GO:0043425; GO:0043525; GO:0045665; GO:0045666; GO:0045747; GO:0045787; GO:0045892; GO:0045944; GO:0048469; GO:0048485; GO:0048663; GO:0048665; GO:0048666; GO:0050767; GO:0050883; GO:0051593; GO:0060163; GO:0060165; GO:0060166; GO:0060487; GO:0060579; GO:0061100; GO:0061102; GO:0061103; GO:0061104; GO:0061549; GO:0070849; GO:0070888; GO:0071259; GO:0090575; GO:2000179	neuronal cell body [GO:0043025]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; regulation of transcription by RNA polymerase II [GO:0006357]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to lithium ion [GO:0010226]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]	ASCL1 ASH1 BHLHA46 HASH1
NM_020768		A8K8W2	A8K8W2_HUMAN	cDNA FLJ77188, highly similar to Homo sapiens potassium channel tetramerisation domain containing 16 (KCTD16), mRNA	GO:0051260	protein homooligomerization [GO:0051260]	
NM_020768		Q68DU8	KCD16_HUMAN	BTB/POZ domain-containing protein KCTD16 (Potassium channel tetramerization domain-containing protein 16)	GO:0008277; GO:0030054; GO:0042734; GO:0042995; GO:0043235; GO:0045211; GO:0051260	cell junction [GO:0030054]; cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	KCTD16 KIAA1317
NM_020775		B4DWM4	B4DWM4_HUMAN	cDNA FLJ56163, moderately similar to Mus musculus sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, mRNA	GO:0016021	integral component of membrane [GO:0016021]	
NM_020775	NM_020775 -> Q6UXG2-1	Q6UXG2	K1324_HUMAN	UPF0577 protein KIAA1324 (Estrogen-induced gene 121 protein)	GO:0000045; GO:0003723; GO:0005765; GO:0005794; GO:0005886; GO:0005887; GO:0009267; GO:0031902; GO:0044090; GO:0070062; GO:2000786	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of vacuole organization [GO:0044090]	KIAA1324 EIG121 UNQ2426/PRO4985
NM_002297		A0A024R8D7	A0A024R8D7_HUMAN	Lipocalin 1 (Tear prealbumin), isoform CRA_a	GO:0036094	small molecule binding [GO:0036094]	LCN1 hCG_1818001
NM_002297		P31025	LCN1_HUMAN	Lipocalin-1 (Tear lipocalin) (Tlc) (Tear prealbumin) (TP) (von Ebner gland protein) (VEG protein)	GO:0001895; GO:0004869; GO:0005102; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0015909; GO:0031404; GO:0036094; GO:0050896; GO:0050909	extracellular region [GO:0005576]; extracellular space [GO:0005615]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; signaling receptor binding [GO:0005102]; small molecule binding [GO:0036094]; zinc ion binding [GO:0008270]; long-chain fatty acid transport [GO:0015909]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; sensory perception of taste [GO:0050909]	LCN1 VEGP
NM_001144757		A0A024R9I1	A0A024R9I1_HUMAN	Secretory granule, neuroendocrine protein 1 (7B2 protein), isoform CRA_a	GO:0004857; GO:0006886; GO:0007218; GO:0016486; GO:0030141; GO:0046883	secretory granule [GO:0030141]; enzyme inhibitor activity [GO:0004857]; intracellular protein transport [GO:0006886]; neuropeptide signaling pathway [GO:0007218]; peptide hormone processing [GO:0016486]; regulation of hormone secretion [GO:0046883]	SGNE1 hCG_1811965
NM_001144757	NM_001144757 -> P05408-1	P05408	7B2_HUMAN	Neuroendocrine protein 7B2 (Pituitary polypeptide) (Secretogranin V) (Secretogranin-5) (Secretory granule endocrine protein I) [Cleaved into: N-terminal peptide; C-terminal peptide]	GO:0004857; GO:0005525; GO:0005576; GO:0006886; GO:0007218; GO:0016486; GO:0030141; GO:0046883; GO:0051082	extracellular region [GO:0005576]; secretory granule [GO:0030141]; enzyme inhibitor activity [GO:0004857]; GTP binding [GO:0005525]; unfolded protein binding [GO:0051082]; intracellular protein transport [GO:0006886]; neuropeptide signaling pathway [GO:0007218]; peptide hormone processing [GO:0016486]; regulation of hormone secretion [GO:0046883]	SCG5 SGNE1
NM_144778	NM_144778 -> Q5VZF2-2	Q5VZF2	MBNL2_HUMAN	Muscleblind-like protein 2 (Muscleblind-like protein 1) (Muscleblind-like protein-like) (Muscleblind-like protein-like 39)	GO:0000381; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0008380; GO:0043484; GO:0046872	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	MBNL2 MBLL MBLL39 MLP1
NM_012306	NM_012306 -> Q9BWQ8-1	Q9BWQ8	LFG2_HUMAN	Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2) (Neural membrane protein 35) (Transmembrane BAX inhibitor motif-containing protein 2)	GO:0002931; GO:0005783; GO:0005794; GO:0006915; GO:0016021; GO:0021549; GO:0021680; GO:0021681; GO:0021702; GO:0030054; GO:0043066; GO:0043523; GO:0043524; GO:0045121; GO:0045211; GO:1902042	cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; postsynaptic membrane [GO:0045211]; apoptotic process [GO:0006915]; cerebellar granular layer development [GO:0021681]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum development [GO:0021549]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; response to ischemia [GO:0002931]	FAIM2 KIAA0950 LFG LFG2 NMP35 TMBIM2
NM_021260	NM_021260 -> Q9HBF4-1	Q9HBF4	ZFYV1_HUMAN	Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1)	GO:0000407; GO:0005545; GO:0005547; GO:0005776; GO:0005783; GO:0005795; GO:0008270; GO:0009267; GO:0010923; GO:0016236; GO:0043325; GO:0044233; GO:0048471; GO:0097629; GO:1990462	autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; extrinsic component of omegasome membrane [GO:0097629]; Golgi stack [GO:0005795]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923]	ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436
NM_006157		K9UUD5	K9UUD5_HUMAN	NELL-1 protein short isoform	GO:0005509	calcium ion binding [GO:0005509]	NELL1
NM_006157	NM_006157 -> Q92832-1	Q92832	NELL1_HUMAN	Protein kinase C-binding protein NELL1 (NEL-like protein 1) (Nel-related protein 1)	GO:0005080; GO:0005509; GO:0005576; GO:0005635; GO:0005737; GO:0007399; GO:0008201; GO:0010468; GO:0030154; GO:0030501; GO:0033689; GO:0045669; GO:0048471; GO:1903363	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080]; cell differentiation [GO:0030154]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of osteoblast proliferation [GO:0033689]; nervous system development [GO:0007399]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]	NELL1 NRP1
NM_018040	NM_018040 -> Q9NW75-1	Q9NW75	GPTC2_HUMAN	G patch domain-containing protein 2	GO:0003676; GO:0005730; GO:0010923; GO:0016607	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; negative regulation of phosphatase activity [GO:0010923]	GPATCH2 GPATC2
NM_198503		A9LNM6	A9LNM6_HUMAN	Sodium activated potassium channel	GO:0016021; GO:0070089; GO:0097623	integral component of membrane [GO:0016021]; chloride-activated potassium channel activity [GO:0070089]; potassium ion export across plasma membrane [GO:0097623]	KCNT2
NM_198503	NM_198503 -> Q6UVM3-1	Q6UVM3	KCNT2_HUMAN	Potassium channel subfamily T member 2 (Sequence like an intermediate conductance potassium channel subunit) (Sodium and chloride-activated ATP-sensitive potassium channel Slo2.1)	GO:0005228; GO:0005524; GO:0005886; GO:0015271; GO:0016021; GO:0070089; GO:0097623	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; chloride-activated potassium channel activity [GO:0070089]; intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271]; potassium ion export across plasma membrane [GO:0097623]	KCNT2 SLICK
NM_019005		A0A024RA24	A0A024RA24_HUMAN	zinc_ribbon_16 domain-containing protein	GO:0005654; GO:0005829; GO:0030054	cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	FLJ20323 hCG_19531
NM_019005	NM_019005 -> Q9NXC5-1	Q9NXC5	MIO_HUMAN	GATOR complex protein MIOS (Missing oocyte meiosis regulator homolog)	GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0030054; GO:0032008; GO:0034198; GO:0034629; GO:0061700	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]	MIOS
NM_020923		N0DVB2	N0DVB2_HUMAN	Zinc finger DBF-type containing 2 vesion 1	GO:0003676; GO:0008270	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	ZDBF2
NM_020923		Q9HCK1	ZDBF2_HUMAN	DBF4-type zinc finger-containing protein 2	GO:0003676; GO:0008270	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	ZDBF2 KIAA1571
NM_018113		A0A024R0Y9	A0A024R0Y9_HUMAN	Limb region 1 homolog (Mouse)-like, isoform CRA_e (Limb region 1-like protein-like isoform 1)	GO:0005789; GO:0016021; GO:0030217; GO:0042098; GO:0060218; GO:0070231; GO:0090090	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]	LMBR1L hCG_2010766
NM_018113	NM_018113 -> Q6UX01-1	Q6UX01	LMBRL_HUMAN	Protein LMBR1L (Limb region 1 protein homolog-like) (Lipocalin-1-interacting membrane receptor) (LIMR)	GO:0004888; GO:0005789; GO:0005886; GO:0005887; GO:0006898; GO:0007165; GO:0016055; GO:0030217; GO:0042098; GO:0060218; GO:0070231; GO:0090090	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; Wnt signaling pathway [GO:0016055]	LMBR1L KIAA1174 LIMR UNQ458/PRO783
NM_003861	NM_003861 -> Q96JK2-1	Q96JK2	DCAF5_HUMAN	DDB1- and CUL4-associated factor 5 (Breakpoint cluster region protein 2) (BCRP2) (WD repeat-containing protein 22)	GO:0005654; GO:0016567; GO:0043687; GO:0080008	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]	DCAF5 BCRG2 KIAA1824 WDR22
NM_002976		Q01118	SCN7A_HUMAN	Sodium channel protein type 7 subunit alpha (Putative voltage-gated sodium channel subunit alpha Nax) (Sodium channel protein cardiac and skeletal muscle subunit alpha) (Sodium channel protein type VII subunit alpha)	GO:0001518; GO:0005244; GO:0005248; GO:0005886; GO:0006814; GO:0006936; GO:0009617; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0055078; GO:0086010; GO:0097386	axon [GO:0030424]; glial cell projection [GO:0097386]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; response to bacterium [GO:0009617]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	SCN7A SCN6A
NM_006439		Q9Y586	MB212_HUMAN	Protein mab-21-like 2	GO:0001654; GO:0005634; GO:0005737; GO:0007399; GO:0008284; GO:0010172; GO:0043010	cytoplasm [GO:0005737]; nucleus [GO:0005634]; camera-type eye development [GO:0043010]; embryonic body morphogenesis [GO:0010172]; eye development [GO:0001654]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]	MAB21L2
NM_000081	NM_000081 -> Q99698-1	Q99698	LYST_HUMAN	Lysosomal-trafficking regulator (Beige homolog)	GO:0005737; GO:0007040; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; pigmentation [GO:0043473]; protein transport [GO:0015031]	LYST CHS CHS1
NM_138426		Q86VQ1	GLCI1_HUMAN	Glucocorticoid-induced transcript 1 protein	GO:0005737	cytoplasm [GO:0005737]	GLCCI1
NM_006336		A0A024R8B0	A0A024R8B0_HUMAN	Zyg-11 homolog B (C. elegans)-like, isoform CRA_b			ZYG11BL hCG_1788209
NM_006336		Q7Z7L7	ZER1_HUMAN	Protein zer-1 homolog (Hzyg) (Zyg-11 homolog B-like protein) (Zyg11b-like protein)	GO:0006515; GO:0031462; GO:0032436	Cul2-RING ubiquitin ligase complex [GO:0031462]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	ZER1 C9orf60 ZYG ZYG11BL
NM_015078		Q86YR7	MF2L2_HUMAN	Probable guanine nucleotide exchange factor MCF2L2 (Dbs-related Rho family guanine nucleotide exchange factor) (MCF2-transforming sequence-like protein 2)	GO:0005089; GO:0035023	Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023]	MCF2L2 DRG KIAA0861
NM_015642	NM_015642 -> Q9HC78-2	Q9HC78	ZBT20_HUMAN	Zinc finger and BTB domain-containing protein 20 (Dendritic-derived BTB/POZ zinc finger protein) (Zinc finger protein 288)	GO:0000977; GO:0001227; GO:0003677; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0016604; GO:0032728; GO:0032755; GO:0032760; GO:0044212; GO:0045821; GO:0046872; GO:0046889; GO:0055088; GO:0071333	cell [GO:0005623]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of tumor necrosis factor production [GO:0032760]	ZBTB20 DPZF ZNF288
NM_001010897		Q8N6R1	SERP2_HUMAN	Stress-associated endoplasmic reticulum protein 2 (Ribosome-associated membrane protein RAMP4-2)	GO:0005789; GO:0006486; GO:0015031; GO:0016021; GO:0030968	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]	SERP2 C13orf21
NM_019600	NM_019600 -> Q32MH5-1	Q32MH5	F214A_HUMAN	Protein FAM214A			FAM214A KIAA1370
NM_033502		Q05GC8	Q05GC8_HUMAN	Breast cancer anti-estrogen resistance 2 (Transcriptional-regulating factor 1)	GO:0001650; GO:0003677; GO:0005654; GO:0005829	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]	TRERF1 BCAR2
NM_033502	NM_033502 -> Q96PN7-1	Q96PN7	TREF1_HUMAN	Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132)	GO:0000118; GO:0000981; GO:0001650; GO:0003700; GO:0003712; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006694; GO:0006707; GO:0007275; GO:0008134; GO:0008301; GO:0030374; GO:0042592; GO:0044212; GO:0045893; GO:0046872; GO:0046885	cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cholesterol catabolic process [GO:0006707]; homeostatic process [GO:0042592]; multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hormone biosynthetic process [GO:0046885]; steroid biosynthetic process [GO:0006694]	TRERF1 BCAR2 RAPA TREP132
NM_000809		P48169	GBRA4_HUMAN	Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4)	GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007417; GO:0008503; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:0099060; GO:1902476; GO:1902711; GO:1904315; GO:2001023	cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of response to drug [GO:2001023]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]	GABRA4
NM_000809		X5D7F5	X5D7F5_HUMAN	Gamma-aminobutyric acid A receptor alpha 4 isoform A (Fragment)	GO:0004890; GO:0006821; GO:0007214; GO:0007417; GO:0098982; GO:0099060; GO:1904315; GO:2001023	GABA-ergic synapse [GO:0098982]; integral component of postsynaptic specialization membrane [GO:0099060]; GABA-A receptor activity [GO:0004890]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; central nervous system development [GO:0007417]; chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of response to drug [GO:2001023]	GABRA4
NM_144633	NM_144633 -> Q96L42-1	Q96L42	KCNH8_HUMAN	Potassium voltage-gated channel subfamily H member 8 (ELK1) (hElk1) (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (ELK3) (Voltage-gated potassium channel subunit Kv12.1)	GO:0005249; GO:0005886; GO:0005887; GO:0034765; GO:0042391; GO:0071805	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	KCNH8
NM_001128615	NM_001128615 -> Q9NR81-2	Q9NR81	ARHG3_HUMAN	Rho guanine nucleotide exchange factor 3 (Exchange factor found in platelets and leukemic and neuronal tissues) (XPLN)	GO:0005089; GO:0005622; GO:0005829; GO:0007186; GO:0007266; GO:0035023; GO:0043065; GO:0051056	cytosol [GO:0005829]; intracellular [GO:0005622]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	ARHGEF3
NM_018328	NM_018328 -> Q9P267-1	Q9P267	MBD5_HUMAN	Methyl-CpG-binding domain protein 5 (Methyl-CpG-binding protein MBD5)	GO:0003682; GO:0005634; GO:0005654; GO:0007399; GO:0010369; GO:0016579; GO:0030496; GO:0040014; GO:0042593; GO:0050795; GO:0060399; GO:0070062	chromocenter [GO:0010369]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; glucose homeostasis [GO:0042593]; nervous system development [GO:0007399]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; protein deubiquitination [GO:0016579]; regulation of behavior [GO:0050795]; regulation of multicellular organism growth [GO:0040014]	MBD5 KIAA1461
NM_000110	NM_000110 -> Q12882-1	Q12882	DPYD_HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase)	GO:0002058; GO:0005737; GO:0005829; GO:0006145; GO:0006208; GO:0006210; GO:0006212; GO:0006214; GO:0017113; GO:0019483; GO:0042803; GO:0046135; GO:0046872; GO:0050660; GO:0050661; GO:0051536; GO:0051539	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]; beta-alanine biosynthetic process [GO:0019483]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; pyrimidine nucleoside catabolic process [GO:0046135]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]	DPYD
NM_152486		Q96NU1	SAM11_HUMAN	Sterile alpha motif domain-containing protein 11 (SAM domain-containing protein 11)	GO:0005634	nucleus [GO:0005634]	SAMD11
NM_002515	NM_002515 -> P51513-4	P51513	NOVA1_HUMAN	RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Onconeural ventral antigen 1) (Paraneoplastic Ri antigen) (Ventral neuron-specific protein 1)	GO:0000398; GO:0003723; GO:0003730; GO:0005654; GO:0005730; GO:0006396; GO:0007268; GO:0007626; GO:0008380; GO:0043231; GO:0045202; GO:0051252; GO:0120163	intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; chemical synaptic transmission [GO:0007268]; locomotory behavior [GO:0007626]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of RNA metabolic process [GO:0051252]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]	NOVA1
NM_004416		Q86Y01	DTX1_HUMAN	E3 ubiquitin-protein ligase DTX1 (EC 2.3.2.27) (Protein deltex-1) (Deltex1) (hDTX1) (RING-type E3 ubiquitin transferase DTX1)	GO:0003713; GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0006366; GO:0007166; GO:0007219; GO:0008270; GO:0008593; GO:0010001; GO:0016567; GO:0016604; GO:0016740; GO:0017124; GO:0031625; GO:0045581; GO:0045665; GO:1990830	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; cellular response to leukemia inhibitory factor [GO:1990830]; glial cell differentiation [GO:0010001]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of T cell differentiation [GO:0045581]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]	DTX1
NM_006301		A0A024RAY5	A0A024RAY5_HUMAN	Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25)	GO:0004709; GO:0005524; GO:0007254; GO:0046777	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; JNK cascade [GO:0007254]; protein autophosphorylation [GO:0046777]	MAP3K12 hCG_23343
NM_006301	NM_006301 -> Q12852-1	Q12852	M3K12_HUMAN	Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25) (Dual leucine zipper bearing kinase) (DLK) (Leucine-zipper protein kinase) (ZPK) (MAPK-upstream kinase) (MUK) (Mixed lineage kinase)	GO:0004672; GO:0004674; GO:0004706; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0007256; GO:0007257; GO:0016020; GO:0016572; GO:0018105; GO:0018107; GO:0019901; GO:0030426; GO:0035556; GO:0042803; GO:0045893; GO:0046777; GO:0070374; GO:2000672	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of JNKK activity [GO:0007256]; activation of JUN kinase activity [GO:0007257]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	MAP3K12 ZPK
NM_173519	NM_173519 -> Q8IUQ0-1	Q8IUQ0	CLVS1_HUMAN	Clavesin-1 (Cellular retinaldehyde-binding protein-like) (Retinaldehyde-binding protein 1-like 1) (clathrin vesicle-associated Sec14 protein 1)	GO:0005768; GO:0005802; GO:0007040; GO:0030136; GO:0031901; GO:0032588; GO:0080025	clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; lysosome organization [GO:0007040]	CLVS1 CRALBPL RLBP1L1
NM_014991		A0A024RDI0	A0A024RDI0_HUMAN	WD repeat and FYVE domain containing 3, isoform CRA_a	GO:0003831; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0046872; GO:0097635	cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]	WDFY3 hCG_15053
NM_014991	NM_014991 -> Q8IZQ1-1	Q8IZQ1	WDFY3_HUMAN	WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)	GO:0003831; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0007275; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]; multicellular organism development [GO:0007275]	WDFY3 KIAA0993
NM_001130136		Q6UXK2	ISLR2_HUMAN	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (Leucine-rich repeat domain and immunoglobulin domain-containing axon extension protein)	GO:0005886; GO:0009986; GO:0016021; GO:0045773	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; positive regulation of axon extension [GO:0045773]	ISLR2 KIAA1465 LINX UNQ1885/PRO4329
NM_003344		A4D1L5	A4D1L5_HUMAN	Ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast) (Ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast), isoform CRA_b) (Ubiquitin-conjugating enzyme E2H isoform 1) (Ubiquitin-conjugating enzyme E2H isoform A)	GO:0005524; GO:0043161; GO:0061631	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	UBE2H hCG_18056 tcag7.352
NM_003344	NM_003344 -> P62256-1	P62256	UBE2H_HUMAN	Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UbcH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H)	GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0016567; GO:0043161; GO:0061631; GO:0070936; GO:0070979	cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	UBE2H
NM_018945		Q9NP56	PDE7B_HUMAN	cAMP-specific 3',5'-cyclic phosphodiesterase 7B (EC 3.1.4.53)	GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0007186; GO:0007268; GO:0045202; GO:0046872	cytosol [GO:0005829]; synapse [GO:0045202]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	PDE7B
NM_004613	NM_004613 -> P21980-1	P21980	TGM2_HUMAN	Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Tissue transglutaminase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase H) (TGase H) (Transglutaminase-2) (TGase-2)	GO:0001974; GO:0003810; GO:0005525; GO:0005623; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005925; GO:0018149; GO:0018153; GO:0019904; GO:0031226; GO:0032471; GO:0043065; GO:0043123; GO:0043277; GO:0045785; GO:0046872; GO:0048661; GO:0050729; GO:0051260; GO:0051482; GO:0051561; GO:0060445; GO:0060662; GO:0062023; GO:0070062	cell [GO:0005623]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intrinsic component of plasma membrane [GO:0031226]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; apoptotic cell clearance [GO:0043277]; blood vessel remodeling [GO:0001974]; branching involved in salivary gland morphogenesis [GO:0060445]; isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [GO:0018153]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein homooligomerization [GO:0051260]; salivary gland cavitation [GO:0060662]	TGM2
NM_004613		V9HWG3	V9HWG3_HUMAN	Epididymis secretory protein Li 45	GO:0001974; GO:0003810; GO:0005525; GO:0005623; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0018153; GO:0019904; GO:0032471; GO:0043065; GO:0043123; GO:0045785; GO:0046872; GO:0048661; GO:0050729; GO:0051260; GO:0051482; GO:0051561; GO:0060445; GO:0060662	cell [GO:0005623]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; blood vessel remodeling [GO:0001974]; branching involved in salivary gland morphogenesis [GO:0060445]; isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [GO:0018153]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein homooligomerization [GO:0051260]; salivary gland cavitation [GO:0060662]	HEL-S-45
NM_002338		B7Z661	B7Z661_HUMAN	cDNA FLJ54658, highly similar to Limbic system-associated membrane protein	GO:0016021	integral component of membrane [GO:0016021]	
NM_002338		Q13449	LSAMP_HUMAN	Limbic system-associated membrane protein (LSAMP) (IgLON family member 3)	GO:0005576; GO:0005829; GO:0005886; GO:0007155; GO:0007399; GO:0031225	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; nervous system development [GO:0007399]	LSAMP IGLON3 LAMP
NM_020209		Q96IW2	SHD_HUMAN	SH2 domain-containing adapter protein D	GO:0001784	phosphotyrosine residue binding [GO:0001784]	SHD
NM_021615		Q9GZX3	CHST6_HUMAN	Carbohydrate sulfotransferase 6 (EC 2.8.2.-) (Corneal N-acetylglucosamine-6-O-sulfotransferase) (C-GlcNAc6ST) (hCGn6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta) (GST4-beta) (N-acetylglucosamine 6-O-sulfotransferase 5) (GlcNAc6ST-5) (Gn6st-5)	GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0016021; GO:0018146	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]	CHST6
NM_016192	NM_016192 -> Q9UIK5-1	Q9UIK5	TEFF2_HUMAN	Tomoregulin-2 (TR-2) (Hyperplastic polyposis protein 1) (Transmembrane protein with EGF-like and two follistatin-like domains)	GO:0005604; GO:0005886; GO:0007528; GO:0008045; GO:0009887; GO:0009888; GO:0016021; GO:0016358; GO:0030336; GO:0043113; GO:0044319; GO:0045720; GO:0051497	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; negative regulation of cell migration [GO:0030336]; negative regulation of integrin biosynthetic process [GO:0045720]; negative regulation of stress fiber assembly [GO:0051497]; neuromuscular junction development [GO:0007528]; receptor clustering [GO:0043113]; tissue development [GO:0009888]; wound healing, spreading of cells [GO:0044319]	TMEFF2 HPP1 TENB2 TPEF UNQ178/PRO204
NM_018433		Q9Y4C1	KDM3A_HUMAN	Lysine-specific demethylase 3A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A)	GO:0000785; GO:0000976; GO:0000979; GO:0003700; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0007290; GO:0009755; GO:0016020; GO:0030521; GO:0031490; GO:0032454; GO:0033169; GO:0036123; GO:0045893; GO:0045944; GO:0046293; GO:0050681; GO:0051213; GO:0051573; GO:0120162; GO:1990830; GO:2000036; GO:2000736	chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; DNA-binding transcription factor activity [GO:0003700]; histone demethylase activity (H3-K9 specific) [GO:0032454]; iron ion binding [GO:0005506]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; spermatid nucleus elongation [GO:0007290]	KDM3A JHDM2A JMJD1 JMJD1A KIAA0742 TSGA
NM_001099432	NM_001099432 -> Q9H6U6-1	Q9H6U6	BCAS3_HUMAN	Breast carcinoma-amplified sequence 3 (GAOB1)	GO:0001525; GO:0003682; GO:0005634; GO:0005737; GO:0005881; GO:0007030; GO:0008134; GO:0010595; GO:0010698; GO:0031023; GO:0031252; GO:0034260; GO:0035035; GO:0035148; GO:0035257; GO:0035327; GO:0042393; GO:0042594; GO:0043085; GO:0043547; GO:0045111; GO:0045944; GO:0048487; GO:0051491; GO:0051895; GO:0071391; GO:0071944; GO:0090316; GO:0090630; GO:2000114; GO:2000251	cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear hormone receptor binding [GO:0035257]; transcription factor binding [GO:0008134]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cellular response to estrogen stimulus [GO:0071391]; Golgi organization [GO:0007030]; microtubule organizing center organization [GO:0031023]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of establishment of cell polarity [GO:2000114]; response to starvation [GO:0042594]; tube formation [GO:0035148]	BCAS3
NM_024007	NM_024007 -> Q9UH73-1	Q9UH73	COE1_HUMAN	Transcription factor COE1 (O/E-1) (OE-1) (Early B-cell factor)	GO:0000790; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0007275; GO:0045944; GO:0046872; GO:0046983; GO:0070742	nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]	EBF1 COE1 EBF
NM_138980	NM_138980 -> P53779-3	P53779	MK10_HUMAN	Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3)	GO:0000122; GO:0004705; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007254; GO:0009414; GO:0009416; GO:0010468; GO:0035556; GO:0038095; GO:0042752; GO:0043005; GO:0043204; GO:0048511; GO:0051090; GO:0071474; GO:0098969; GO:0098978; GO:0099003	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; cellular hyperosmotic response [GO:0071474]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; response to light stimulus [GO:0009416]; response to water deprivation [GO:0009414]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; vesicle-mediated transport in synapse [GO:0099003]	MAPK10 JNK3 JNK3A PRKM10 SAPK1B
NM_002977		Q15858	SCN9A_HUMAN	Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel) (hNE-Na) (Peripheral sodium channel 1) (PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7)	GO:0001518; GO:0005244; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0006954; GO:0009636; GO:0009791; GO:0019228; GO:0019233; GO:0030424; GO:0031402; GO:0034765; GO:0035725; GO:0048266; GO:0086010	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; sodium ion binding [GO:0031402]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; behavioral response to pain [GO:0048266]; inflammatory response [GO:0006954]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; post-embryonic development [GO:0009791]; regulation of ion transmembrane transport [GO:0034765]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	SCN9A NENA
NM_080616	NM_080616 -> Q96MY1-1	Q96MY1	NOL4L_HUMAN	Nucleolar protein 4-like	GO:0005654; GO:0005829	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	NOL4L C20orf112 C20orf113
NM_024605		A0A2X0SFB3	A0A2X0SFB3_HUMAN	ARHGAP10 (Rho GTPase activating protein 10, isoform CRA_a)	GO:0005096; GO:0005829; GO:0007010; GO:0007165; GO:0043066	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]	ARHGAP10 hCG_1811988
NM_024605		A1A4S6	RHG10_HUMAN	Rho GTPase-activating protein 10 (GTPase regulator associated with focal adhesion kinase 2) (Graf-related protein 2) (Rho-type GTPase-activating protein 10)	GO:0005096; GO:0005829; GO:0005886; GO:0007010; GO:0007165; GO:0043066; GO:0048471; GO:0051056	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	ARHGAP10 GRAF2
NM_199051	NM_199051 -> Q76B58-1	Q76B58	BRNP3_HUMAN	BMP/retinoic acid-inducible neural-specific protein 3 (DBCCR1-like protein 1)	GO:0005576; GO:0005739; GO:0005783; GO:0007050; GO:0030425; GO:0043025; GO:0045666; GO:0045930; GO:0071300	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; cell cycle arrest [GO:0007050]; cellular response to retinoic acid [GO:0071300]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of neuron differentiation [GO:0045666]	BRINP3 DBCCR1L DBCCR1L1 FAM5C
NM_020738	NM_020738 -> Q9ULH0-1	Q9ULH0	KDIS_HUMAN	Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein)	GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]	KIDINS220 ARMS KIAA1250
NM_033274		Q8TBU7	Q8TBU7_HUMAN	ADAM19 protein (Fragment)	GO:0004222; GO:0005794; GO:0006509; GO:0016021; GO:0017124	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]; membrane protein ectodomain proteolysis [GO:0006509]	ADAM19
NM_033274	NM_033274 -> Q9H013-2	Q9H013	ADA19_HUMAN	Disintegrin and metalloproteinase domain-containing protein 19 (ADAM 19) (EC 3.4.24.-) (Meltrin-beta) (Metalloprotease and disintegrin dendritic antigen marker) (MADDAM)	GO:0001890; GO:0004222; GO:0005634; GO:0005794; GO:0005886; GO:0006509; GO:0010628; GO:0016021; GO:0017124; GO:0030198; GO:0046872; GO:0062023; GO:2000049	collagen-containing extracellular matrix [GO:0062023]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; SH3 domain binding [GO:0017124]; extracellular matrix organization [GO:0030198]; membrane protein ectodomain proteolysis [GO:0006509]; placenta development [GO:0001890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]	ADAM19 MLTNB FKSG34
NM_012257		A0A024R722	A0A024R722_HUMAN	HMG-box transcription factor 1, isoform CRA_a	GO:0003677; GO:0003723; GO:0005654; GO:0006355; GO:0016607	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]	HBP1 hCG_17934
NM_012257	NM_012257 -> O60381-1	O60381	HBP1_HUMAN	HMG box-containing protein 1 (HMG box transcription factor 1) (High mobility group box transcription factor 1)	GO:0000790; GO:0000981; GO:0003677; GO:0003723; GO:0005654; GO:0007050; GO:0016055; GO:0016607	nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; cell cycle arrest [GO:0007050]; Wnt signaling pathway [GO:0016055]	HBP1
NM_152754		O95025	SEM3D_HUMAN	Semaphorin-3D	GO:0001755; GO:0005615; GO:0005887; GO:0007411; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0050919; GO:0071526	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	SEMA3D UNQ760/PRO1491
NM_020870	NM_020870 -> Q7Z6J0-1	Q7Z6J0	SH3R1_HUMAN	E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING finger protein 142) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) (SH3 multiple domains protein 2)	GO:0001764; GO:0005078; GO:0005794; GO:0005829; GO:0006915; GO:0030027; GO:0043066; GO:0043154; GO:0043370; GO:0046330; GO:0046872; GO:0048471; GO:0051865; GO:0061630; GO:2000564; GO:2001237	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]	SH3RF1 KIAA1494 POSH POSH1 RNF142 SH3MD2
NM_022369		B3KPB8	B3KPB8_HUMAN	cDNA FLJ31563 fis, clone NT2RI2001449, highly similar to Homo sapiens stimulated by retinoic acid gene 6 homolog (STRA6), mRNA	GO:0016021; GO:0034632; GO:0038023	integral component of membrane [GO:0016021]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023]	
NM_022369	NM_022369 -> Q9BX79-1	Q9BX79	STRA6_HUMAN	Receptor for retinol uptake STRA6 (Retinol-binding protein receptor STRA6) (Stimulated by retinoic acid gene 6 protein homolog)	GO:0001523; GO:0001568; GO:0001822; GO:0003184; GO:0003281; GO:0005886; GO:0005887; GO:0007507; GO:0007612; GO:0007631; GO:0016918; GO:0019841; GO:0030324; GO:0030325; GO:0030540; GO:0032991; GO:0034632; GO:0034633; GO:0038023; GO:0042297; GO:0043010; GO:0043583; GO:0043585; GO:0048286; GO:0048520; GO:0048546; GO:0048566; GO:0048589; GO:0048745; GO:0048844; GO:0050890; GO:0050905; GO:0060322; GO:0060323; GO:0060325; GO:0060426; GO:0060539; GO:0060900; GO:0061029; GO:0061038; GO:0061143; GO:0061156; GO:0061205; GO:0071939; GO:0097070	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023]; adrenal gland development [GO:0030325]; alveolar primary septum development [GO:0061143]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; camera-type eye development [GO:0043010]; cognition [GO:0050890]; developmental growth [GO:0048589]; diaphragm development [GO:0060539]; digestive tract morphogenesis [GO:0048546]; ductus arteriosus closure [GO:0097070]; ear development [GO:0043583]; embryonic camera-type eye formation [GO:0060900]; embryonic digestive tract development [GO:0048566]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; feeding behavior [GO:0007631]; female genitalia development [GO:0030540]; head development [GO:0060322]; head morphogenesis [GO:0060323]; heart development [GO:0007507]; kidney development [GO:0001822]; learning [GO:0007612]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; neuromuscular process [GO:0050905]; nose morphogenesis [GO:0043585]; paramesonephric duct development [GO:0061205]; positive regulation of behavior [GO:0048520]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; retinoid metabolic process [GO:0001523]; retinol transport [GO:0034633]; smooth muscle tissue development [GO:0048745]; uterus morphogenesis [GO:0061038]; ventricular septum development [GO:0003281]; vitamin A import [GO:0071939]; vocal learning [GO:0042297]	STRA6 PP14296 UNQ3126/PRO10282/PRO19578
NM_001035	NM_001035 -> Q92736-1	Q92736	RYR2_HUMAN	Ryanodine receptor 2 (RYR-2) (RyR2) (hRYR-2) (Cardiac muscle ryanodine receptor) (Cardiac muscle ryanodine receptor-calcium release channel) (Type 2 ryanodine receptor)	GO:0001666; GO:0002027; GO:0003143; GO:0003220; GO:0003300; GO:0005219; GO:0005262; GO:0005509; GO:0005513; GO:0005516; GO:0005623; GO:0005790; GO:0005886; GO:0006816; GO:0006874; GO:0010460; GO:0010881; GO:0010882; GO:0014701; GO:0014808; GO:0014850; GO:0015278; GO:0016020; GO:0016529; GO:0019722; GO:0019899; GO:0030018; GO:0030659; GO:0031000; GO:0032991; GO:0033017; GO:0034220; GO:0034236; GO:0034237; GO:0034704; GO:0035584; GO:0035994; GO:0042383; GO:0042802; GO:0043621; GO:0043924; GO:0044325; GO:0048763; GO:0051209; GO:0051284; GO:0051480; GO:0051775; GO:0055117; GO:0060048; GO:0060402; GO:0070296; GO:0071313; GO:0071872; GO:0072599; GO:0086005; GO:0086029; GO:0086064; GO:0097050; GO:0098735; GO:0098904; GO:0098907; GO:0098910; GO:0098911; GO:1901896; GO:1903779	calcium channel complex [GO:0034704]; cell [GO:0005623]; cytoplasmic vesicle membrane [GO:0030659]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein self-association [GO:0043621]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; suramin binding [GO:0043924]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling [GO:0019722]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to epinephrine stimulus [GO:0071872]; detection of calcium ion [GO:0005513]; embryonic heart tube morphogenesis [GO:0003143]; establishment of protein localization to endoplasmic reticulum [GO:0072599]; ion transmembrane transport [GO:0034220]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of heart rate [GO:0010460]; positive regulation of sequestering of calcium ion [GO:0051284]; positive regulation of the force of heart contraction [GO:0098735]; Purkinje myocyte to ventricular cardiac muscle cell signaling [GO:0086029]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to muscle stretch [GO:0035994]; response to redox state [GO:0051775]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; type B pancreatic cell apoptotic process [GO:0097050]; ventricular cardiac muscle cell action potential [GO:0086005]	RYR2
NM_001024847		D2JYI1	D2JYI1_HUMAN	TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II)	GO:0001569; GO:0001570; GO:0001666; GO:0001701; GO:0001947; GO:0002053; GO:0002088; GO:0002651; GO:0002663; GO:0002666; GO:0003148; GO:0003149; GO:0003186; GO:0003214; GO:0003274; GO:0003430; GO:0005026; GO:0005524; GO:0005829; GO:0005887; GO:0005901; GO:0006898; GO:0007179; GO:0007182; GO:0007219; GO:0007224; GO:0007369; GO:0007420; GO:0007566; GO:0007568; GO:0007584; GO:0009612; GO:0009749; GO:0009897; GO:0010468; GO:0010634; GO:0031100; GO:0031435; GO:0032147; GO:0035162; GO:0042060; GO:0043011; GO:0043235; GO:0043415; GO:0043627; GO:0045766; GO:0046332; GO:0046872; GO:0048545; GO:0048565; GO:0048661; GO:0048701; GO:0050431; GO:0051138; GO:0060044; GO:0060434; GO:0060440; GO:0060443; GO:0060463; GO:0062009; GO:0070723; GO:1905007; GO:1905317; GO:1990086; GO:1990428	caveola [GO:0005901]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type II [GO:0005026]; activation of protein kinase activity [GO:0032147]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; bronchus morphogenesis [GO:0060434]; cardiac left ventricle morphogenesis [GO:0003214]; common-partner SMAD protein phosphorylation [GO:0007182]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hemopoiesis [GO:0035162]; endocardial cushion fusion [GO:0003274]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte growth [GO:0003430]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inferior endocardial cushion morphogenesis [GO:1905317]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lung lobe morphogenesis [GO:0060463]; mammary gland morphogenesis [GO:0060443]; membranous septum morphogenesis [GO:0003149]; miRNA transport [GO:1990428]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; Notch signaling pathway [GO:0007219]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell tolerance induction [GO:0002663]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction to self antigen [GO:0002651]; receptor-mediated endocytosis [GO:0006898]; regulation of gene expression [GO:0010468]; response to cholesterol [GO:0070723]; response to estrogen [GO:0043627]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; secondary palate development [GO:0062009]; smoothened signaling pathway [GO:0007224]; trachea formation [GO:0060440]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; vasculogenesis [GO:0001570]; wound healing [GO:0042060]	TGFBR2
NM_001024847	NM_001024847 -> P37173-2	P37173	TGFR2_HUMAN	TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II)	GO:0001568; GO:0001569; GO:0001570; GO:0001666; GO:0001701; GO:0001947; GO:0002053; GO:0002088; GO:0002651; GO:0002663; GO:0002666; GO:0003148; GO:0003149; GO:0003151; GO:0003181; GO:0003186; GO:0003214; GO:0003274; GO:0003430; GO:0004674; GO:0004675; GO:0005024; GO:0005026; GO:0005524; GO:0005539; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0006468; GO:0006898; GO:0006915; GO:0007179; GO:0007182; GO:0007219; GO:0007224; GO:0007369; GO:0007420; GO:0007507; GO:0007566; GO:0007568; GO:0007584; GO:0008284; GO:0009612; GO:0009749; GO:0009897; GO:0010468; GO:0010634; GO:0010718; GO:0016021; GO:0017002; GO:0018105; GO:0018107; GO:0030512; GO:0031100; GO:0031435; GO:0032147; GO:0034713; GO:0034714; GO:0035162; GO:0042060; GO:0042127; GO:0042493; GO:0043011; GO:0043235; GO:0043415; GO:0043627; GO:0045121; GO:0045766; GO:0046332; GO:0046872; GO:0048185; GO:0048545; GO:0048565; GO:0048661; GO:0048701; GO:0050431; GO:0051138; GO:0060044; GO:0060389; GO:0060412; GO:0060434; GO:0060440; GO:0060443; GO:0060463; GO:0062009; GO:0070723; GO:0071363; GO:1905007; GO:1905317; GO:1990086; GO:1990428; GO:2000379; GO:2000563	caveola [GO:0005901]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type II [GO:0005026]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type I transforming growth factor beta receptor binding [GO:0034713]; type III transforming growth factor beta receptor binding [GO:0034714]; activation of protein kinase activity [GO:0032147]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; atrioventricular valve morphogenesis [GO:0003181]; blood vessel development [GO:0001568]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; bronchus morphogenesis [GO:0060434]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to growth factor stimulus [GO:0071363]; common-partner SMAD protein phosphorylation [GO:0007182]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hemopoiesis [GO:0035162]; endocardial cushion fusion [GO:0003274]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte growth [GO:0003430]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inferior endocardial cushion morphogenesis [GO:1905317]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lung lobe morphogenesis [GO:0060463]; mammary gland morphogenesis [GO:0060443]; membranous septum morphogenesis [GO:0003149]; miRNA transport [GO:1990428]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell tolerance induction [GO:0002663]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction to self antigen [GO:0002651]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; response to cholesterol [GO:0070723]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; secondary palate development [GO:0062009]; smoothened signaling pathway [GO:0007224]; trachea formation [GO:0060440]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]	TGFBR2
NM_002841	NM_002841 -> P23470-1	P23470	PTPRG_HUMAN	Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48)	GO:0004725; GO:0005001; GO:0005887; GO:0006470; GO:0007169; GO:0007420; GO:0010633; GO:0010977; GO:0042802; GO:0070062	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	PTPRG PTPG
NM_002841		Q49A02	Q49A02_HUMAN	PTPRG protein	GO:0016021	integral component of membrane [GO:0016021]	PTPRG
NM_001143986	NM_001143986 -> Q9H808-1	Q9H808	TLE6_HUMAN	Transducin-like enhancer protein 6	GO:0003714; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0032991; GO:0060136; GO:0070491; GO:0090090	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; embryonic process involved in female pregnancy [GO:0060136]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of transcription, DNA-templated [GO:0006355]	TLE6
NM_015347	NM_015347 -> O15034-1	O15034	RIMB2_HUMAN	RIMS-binding protein 2 (RIM-BP2)	GO:0005886; GO:0007274; GO:0010923; GO:0030054; GO:0045202	cell junction [GO:0030054]; plasma membrane [GO:0005886]; synapse [GO:0045202]; negative regulation of phosphatase activity [GO:0010923]; neuromuscular synaptic transmission [GO:0007274]	RIMBP2 KIAA0318 RBP2
NM_005239		P15036	ETS2_HUMAN	Protein C-ets-2	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0001712; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0007498; GO:0019904; GO:0030154; GO:0035259; GO:0045893; GO:0045944; GO:0090009	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]	ETS2
NM_201253	NM_201253 -> P82279-1	P82279	CRUM1_HUMAN	Protein crumbs homolog 1	GO:0001917; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005913; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0016021; GO:0016324; GO:0032991; GO:0042462; GO:0045197	apical plasma membrane [GO:0016324]; cell-cell adherens junction [GO:0005913]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; cell-cell signaling [GO:0007267]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; plasma membrane organization [GO:0007009]	CRB1
NM_058170		B3KTG9	B3KTG9_HUMAN	cDNA FLJ38232 fis, clone FCBBF2004930, highly similar to Noelin-3			
NM_058170	NM_058170 -> Q96PB7-3	Q96PB7	NOE3_HUMAN	Noelin-3 (Olfactomedin-3) (Optimedin)	GO:0005615; GO:0005794; GO:0030054; GO:0032281; GO:0042462; GO:0045202	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202]; eye photoreceptor cell development [GO:0042462]	OLFM3 NOE3 UNQ1924/PRO4399
NM_001134450	NM_001134450 -> Q8N3G9-1	Q8N3G9	TM130_HUMAN	Transmembrane protein 130	GO:0000139; GO:0005794; GO:0005887	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]	TMEM130 UNQ719/PRO1383
NM_018317	NM_018317 -> Q8N5T2-1	Q8N5T2	TBC19_HUMAN	TBC1 domain family member 19	GO:0005096	GTPase activator activity [GO:0005096]	TBC1D19
NM_024582		B3KU84	B3KU84_HUMAN	cDNA FLJ39327 fis, clone OCBBF2015506, highly similar to Mus musculus FAT tumor suppressor homolog 4 (Drosophila) (Fat4), mRNA	GO:0005509; GO:0016021	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]	
NM_024582	NM_024582 -> Q6V0I7-1	Q6V0I7	FAT4_HUMAN	Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)	GO:0001658; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307; GO:0098609	apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]	FAT4 CDHF14 FATJ Nbla00548
NM_006465	NM_006465 -> Q8IVW6-4	Q8IVW6	ARI3B_HUMAN	AT-rich interactive domain-containing protein 3B (ARID domain-containing protein 3B) (Bright and dead ringer protein) (Bright-like protein)	GO:0000977; GO:0000978; GO:0000980; GO:0001228; GO:0003677; GO:0005634; GO:0005654	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]	ARID3B BDP DRIL2
NM_178450	NM_178450 -> Q86UD3-1	Q86UD3	MARH3_HUMAN	E3 ubiquitin-protein ligase MARCH3 (EC 2.3.2.27) (Membrane-associated RING finger protein 3) (Membrane-associated RING-CH protein III) (MARCH-III) (RING finger protein 173) (RING-type E3 ubiquitin transferase MARCH3)	GO:0004842; GO:0005764; GO:0005768; GO:0006897; GO:0008270; GO:0016021; GO:0016567; GO:0030659; GO:0031901; GO:0043231	cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein ubiquitination [GO:0016567]	MARCH3 RNF173
NM_004714		A0A024R0I0	A0A024R0I0_HUMAN	Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B, isoform CRA_a	GO:0004712; GO:0005524; GO:0005654; GO:0007520; GO:0046777	nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; myoblast fusion [GO:0007520]; protein autophosphorylation [GO:0046777]	DYRK1B hCG_43347
NM_004714	NM_004714 -> Q9Y463-1	Q9Y463	DYR1B_HUMAN	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (EC 2.7.12.1) (Minibrain-related kinase) (Mirk protein kinase)	GO:0003713; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0007520; GO:0018105; GO:0018107; GO:0045893; GO:0046777; GO:0060612	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transcription coactivator activity [GO:0003713]; adipose tissue development [GO:0060612]; myoblast fusion [GO:0007520]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	DYRK1B MIRK
NM_207303		Q4G0Y2	Q4G0Y2_HUMAN	ATRNL1 protein			ATRNL1
NM_207303	NM_207303 -> Q5VV63-1	Q5VV63	ATRN1_HUMAN	Attractin-like protein 1	GO:0007186; GO:0009887; GO:0009888; GO:0016021; GO:0030246	integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; animal organ morphogenesis [GO:0009887]; G protein-coupled receptor signaling pathway [GO:0007186]; tissue development [GO:0009888]	ATRNL1 KIAA0534
NM_013450	NM_013450 -> Q9UIF8-1	Q9UIF8	BAZ2B_HUMAN	Bromodomain adjacent to zinc finger domain protein 2B (hWALp4)	GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0046872	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]	BAZ2B KIAA1476
NM_006618	NM_006618 -> Q9UGL1-1	Q9UGL1	KDM5B_HUMAN	Lysine-specific demethylase 5B (EC 1.14.11.-) (Cancer/testis antigen 31) (CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1) (RBP2-H1)	GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0007338; GO:0008270; GO:0009791; GO:0010628; GO:0032452; GO:0032453; GO:0033601; GO:0034647; GO:0034648; GO:0034720; GO:0035097; GO:0042393; GO:0044344; GO:0045892; GO:0048511; GO:0051213; GO:0060444; GO:0060763; GO:0060992; GO:0061038; GO:0070306; GO:1990830; GO:1990837; GO:2000864	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]	KDM5B JARID1B PLU1 RBBP2H1
NM_182546	NM_182546 -> Q8TAG5-1	Q8TAG5	VTM2A_HUMAN	V-set and transmembrane domain-containing protein 2A	GO:0005576; GO:0010628; GO:0010884; GO:0016021; GO:0030154; GO:0042802; GO:0070352; GO:0071773; GO:0090336	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of white fat cell proliferation [GO:0070352]	VSTM2A VSTM2
NM_022166		Q86Y38	XYLT1_HUMAN	Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (XT-I) (XylT-I)	GO:0000137; GO:0000139; GO:0005615; GO:0006024; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030166; GO:0030203; GO:0030206; GO:0043931; GO:0046872; GO:0048706; GO:0050650	extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166]	XYLT1 XT1
NM_005419	NM_005419 -> P52630-3	P52630	STAT2_HUMAN	Signal transducer and activator of transcription 2 (p113)	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001932; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006952; GO:0007259; GO:0016032; GO:0019221; GO:0042127; GO:0042802; GO:0043434; GO:0044389; GO:0045944; GO:0051607; GO:0060337; GO:0090140	cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; ubiquitin-like protein ligase binding [GO:0044389]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mitochondrial fission [GO:0090140]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; type I interferon signaling pathway [GO:0060337]; viral process [GO:0016032]	STAT2
NM_005419		R9QE65	R9QE65_HUMAN	Signal transducer and activator of transcription	GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0005886; GO:0007165	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; signal transduction [GO:0007165]	STAT2 hCG_24995
NM_014912		B3KXC1	B3KXC1_HUMAN	Cytoplasmic polyadenylation element binding protein 3, isoform CRA_b (cDNA FLJ45117 fis, clone BRAWH3035403, highly similar to Mus musculus cytoplasmic polyadenylation element binding protein 3 (Cpeb3), mRNA)	GO:0003730; GO:0045182	mRNA 3'-UTR binding [GO:0003730]; translation regulator activity [GO:0045182]	CPEB3 hCG_20317
NM_014912	NM_014912 -> Q8NE35-1	Q8NE35	CPEB3_HUMAN	Cytoplasmic polyadenylation element-binding protein 3 (CPE-BP3) (CPE-binding protein 3) (hCPEB-3)	GO:0000122; GO:0000900; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0007616; GO:0008135; GO:0014069; GO:0017148; GO:0030014; GO:0030054; GO:0030425; GO:0035613; GO:0035925; GO:0043005; GO:0043022; GO:0045202; GO:0045211; GO:0045727; GO:0048167; GO:0060213; GO:0060998; GO:0060999; GO:0061158; GO:0071230; GO:0097440; GO:1900153; GO:1900248; GO:1900365; GO:1990124; GO:2000766	apical dendrite [GO:0097440]; CCR4-NOT complex [GO:0030014]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; translation factor activity, RNA binding [GO:0008135]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; long-term memory [GO:0007616]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; regulation of dendritic spine development [GO:0060998]; regulation of synaptic plasticity [GO:0048167]	CPEB3 KIAA0940
NM_018557		Q9NZR2	LRP1B_HUMAN	Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT)	GO:0005509; GO:0006898; GO:0015031; GO:0016021; GO:0043235	integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	LRP1B LRPDIT
NM_001146274	NM_001146274 -> Q9NQB0-7	Q9NQB0	TF7L2_HUMAN	Transcription factor 7-like 2 (HMG box transcription factor 4) (T-cell-specific transcription factor 4) (T-cell factor 4) (TCF-4) (hTCF-4)	GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0001103; GO:0001568; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007050; GO:0007223; GO:0008013; GO:0008134; GO:0009749; GO:0010909; GO:0016605; GO:0019901; GO:0031016; GO:0032024; GO:0032092; GO:0032350; GO:0032993; GO:0035257; GO:0042593; GO:0043433; GO:0043565; GO:0043570; GO:0044212; GO:0044334; GO:0045295; GO:0045444; GO:0045892; GO:0045944; GO:0046827; GO:0048625; GO:0048660; GO:0050679; GO:0051897; GO:0060070; GO:0070016; GO:0070369; GO:0090090; GO:1904837; GO:2000675; GO:2001237	beta-catenin-TCF7L2 complex [GO:0070369]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; transcription factor complex [GO:0005667]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; gamma-catenin binding [GO:0045295]; nuclear hormone receptor binding [GO:0035257]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; beta-catenin-TCF complex assembly [GO:1904837]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell cycle arrest [GO:0007050]; fat cell differentiation [GO:0045444]; glucose homeostasis [GO:0042593]; maintenance of DNA repeat elements [GO:0043570]; myoblast fate commitment [GO:0048625]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; pancreas development [GO:0031016]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein binding [GO:0032092]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hormone metabolic process [GO:0032350]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	TCF7L2 TCF4
NM_001145128	NM_001145128 -> Q5TCS8-4	Q5TCS8	KAD9_HUMAN	Adenylate kinase 9 (AK 9) (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2)	GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006174; GO:0006186; GO:0006756; GO:0006757; GO:0015949; GO:0031965; GO:0050145; GO:0061508; GO:0061565; GO:0061566; GO:0061567; GO:0061568; GO:0061569; GO:0061570; GO:0061571	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569]	AK9 AKD1 AKD2 C6orf199 C6orf224
NM_003537,NM_003535,NM_021018,NM_003533,NM_003532		P68431	H31_HUMAN	Histone H3.1 (Histone H3/a) (Histone H3/b) (Histone H3/c) (Histone H3/d) (Histone H3/f) (Histone H3/h) (Histone H3/i) (Histone H3/j) (Histone H3/k) (Histone H3/l)	GO:0000183; GO:0000228; GO:0000786; GO:0000788; GO:0003677; GO:0005576; GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006335; GO:0007596; GO:0016020; GO:0032200; GO:0032991; GO:0038111; GO:0044267; GO:0045296; GO:0045652; GO:0045814; GO:0046982; GO:0051290; GO:0060964; GO:0060968; GO:0070062	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear chromosome [GO:0000228]; nuclear nucleosome [GO:0000788]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; blood coagulation [GO:0007596]; cellular protein metabolic process [GO:0044267]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; DNA replication-dependent nucleosome assembly [GO:0006335]; interleukin-7-mediated signaling pathway [GO:0038111]; negative regulation of gene expression, epigenetic [GO:0045814]; nucleosome assembly [GO:0006334]; protein heterotetramerization [GO:0051290]; regulation of gene silencing [GO:0060968]; regulation of gene silencing by miRNA [GO:0060964]; regulation of megakaryocyte differentiation [GO:0045652]; telomere organization [GO:0032200]	H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J
NM_021072		O60741	HCN1_HUMAN	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Brain cyclic nucleotide-gated channel 1) (BCNG-1)	GO:0005222; GO:0005248; GO:0005249; GO:0005267; GO:0005886; GO:0005887; GO:0022843; GO:0030424; GO:0030425; GO:0030552; GO:0034765; GO:0035725; GO:0042391; GO:0042802; GO:0045176; GO:0046549; GO:0051289; GO:0071320; GO:0071805; GO:0098855	axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]	HCN1 BCNG1
NM_021072		Q86WJ6	Q86WJ6_HUMAN	Hyperpolarization activated cyclic nucleotide-gated potassium channel	GO:0005249; GO:0005887; GO:0030552; GO:0034765; GO:0035725	integral component of plasma membrane [GO:0005887]; cAMP binding [GO:0030552]; voltage-gated potassium channel activity [GO:0005249]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]	HCN1
NM_007185	NM_007185 -> Q5SZQ8-1	Q5SZQ8	CELF3_HUMAN	CUGBP Elav-like family member 3 (CELF-3) (Bruno-like protein 1) (CAG repeat protein 4) (CUG-BP- and ETR-3-like factor 3) (ELAV-type RNA-binding protein 1) (ETR-1) (Expanded repeat domain protein CAG/CTG 4) (RNA-binding protein BRUNOL-1) (Trinucleotide repeat-containing gene 4 protein)	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0007283; GO:0008380; GO:0016604; GO:0030317; GO:0030575; GO:0036002; GO:0048026; GO:0097322; GO:0098781; GO:1990904	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 7SK snRNA binding [GO:0097322]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; flagellated sperm motility [GO:0030317]; mRNA splice site selection [GO:0006376]; ncRNA transcription [GO:0098781]; nuclear body organization [GO:0030575]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]	CELF3 BRUNOL1 CAGH4 ERDA4 TNRC4
NM_004725	NM_004725 -> O43684-1	O43684	BUB3_HUMAN	Mitotic checkpoint protein BUB3	GO:0000070; GO:0000776; GO:0000777; GO:0005654; GO:0005829; GO:0006511; GO:0007094; GO:0008608; GO:0031145; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:1901990; GO:1990298	bub1-bub3 complex [GO:1990298]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; ubiquitin binding [GO:0043130]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]	BUB3
NM_001143854	NM_001143854 -> Q9Y2J0-1	Q9Y2J0	RP3A_HUMAN	Rabphilin-3A (Exophilin-1)	GO:0005509; GO:0005544; GO:0005546; GO:0005829; GO:0006886; GO:0008021; GO:0008270; GO:0008430; GO:0017137; GO:0019898; GO:0030054; GO:0030141; GO:0030672; GO:0032991; GO:0042301; GO:0043005; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0061669; GO:0070679; GO:1901981	cell junction [GO:0030054]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; selenium binding [GO:0008430]; zinc ion binding [GO:0008270]; intracellular protein transport [GO:0006886]; spontaneous neurotransmitter secretion [GO:0061669]	RPH3A KIAA0985
NM_015267		O14529	CUX2_HUMAN	Homeobox protein cut-like 2 (Homeobox protein cux-2)	GO:0000122; GO:0000139; GO:0000790; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0007614; GO:0010628; GO:0043565; GO:0048193; GO:0050775; GO:0050890; GO:0051965; GO:0061003; GO:0070062; GO:0071310; GO:2000463	extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to organic substance [GO:0071310]; cognition [GO:0050890]; Golgi vesicle transport [GO:0048193]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of synapse assembly [GO:0051965]; short-term memory [GO:0007614]	CUX2 CUTL2 KIAA0293
NM_001040429	NM_001040429 -> O14917-1	O14917	PCD17_HUMAN	Protocadherin-17 (Protocadherin-68)	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030534; GO:0050805; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099560; GO:1904071; GO:2000807	GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; calcium ion binding [GO:0005509]; adult behavior [GO:0030534]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of synaptic transmission [GO:0050805]; presynaptic active zone assembly [GO:1904071]; regulation of synaptic vesicle clustering [GO:2000807]; synaptic membrane adhesion [GO:0099560]	PCDH17 PCDH68 PCH68
NM_006988		B2RB33	B2RB33_HUMAN	cDNA, FLJ95281, highly similar to Homo sapiens a disintegrin-like and metalloprotease (reprolysintype) with thrombospondin type 1 motif, 1 (ADAMTS1), mRNA	GO:0004222; GO:0007229; GO:0008270; GO:0031012	extracellular matrix [GO:0031012]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; integrin-mediated signaling pathway [GO:0007229]	
NM_006988		Q9UHI8	ATS1_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAM-TS 1) (ADAM-TS1) (ADAMTS-1) (EC 3.4.24.-) (METH-1)	GO:0001542; GO:0001822; GO:0004222; GO:0005604; GO:0007229; GO:0008201; GO:0008237; GO:0008270; GO:0008285; GO:0031410; GO:0060347; GO:1900087; GO:1904707; GO:1904754	basement membrane [GO:0005604]; cytoplasmic vesicle [GO:0031410]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; heart trabecula formation [GO:0060347]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; negative regulation of cell population proliferation [GO:0008285]; ovulation from ovarian follicle [GO:0001542]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]	ADAMTS1 KIAA1346 METH1
NM_001142343	NM_001142343 -> Q99788-1	Q99788	CML1_HUMAN	Chemokine-like receptor 1 (G-protein coupled receptor ChemR23) (G-protein coupled receptor DEZ)	GO:0001501; GO:0002430; GO:0004930; GO:0004950; GO:0005623; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0007186; GO:0007200; GO:0007204; GO:0010759; GO:0016021; GO:0032088; GO:0032695; GO:0038023; GO:0045600; GO:0050848; GO:0120162	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemokine receptor activity [GO:0004950]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; regulation of calcium-mediated signaling [GO:0050848]; skeletal system development [GO:0001501]	CMKLR1 CHEMR23 DEZ
NM_002912	NM_002912 -> O60673-1	O60673	REV3L_HUMAN	DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (hREV3)	GO:0000166; GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005730; GO:0006261; GO:0016035; GO:0042276; GO:0046872; GO:0051539; GO:0090305	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]	REV3L POLZ REV3
NM_002912		Q9UG47	Q9UG47_HUMAN	Uncharacterized protein DKFZp566H033	GO:0000166; GO:0003677; GO:0016035; GO:0019985	zeta DNA polymerase complex [GO:0016035]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; translesion synthesis [GO:0019985]	DKFZp566H033
NM_015460	NM_015460 -> Q8NFW9-1	Q8NFW9	MYRIP_HUMAN	Rab effector MyRIP (Exophilin-8) (Myosin-VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C) (SlaC2-c) (Slp homolog lacking C2 domains c)	GO:0000145; GO:0001750; GO:0003779; GO:0006886; GO:0008270; GO:0017022; GO:0017137; GO:0030133; GO:0030864; GO:0031045; GO:0032024; GO:0042470; GO:0045202; GO:0048471; GO:0051018	cortical actin cytoskeleton [GO:0030864]; dense core granule [GO:0031045]; exocyst [GO:0000145]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; synapse [GO:0045202]; transport vesicle [GO:0030133]; actin binding [GO:0003779]; myosin binding [GO:0017022]; protein kinase A binding [GO:0051018]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; intracellular protein transport [GO:0006886]; positive regulation of insulin secretion [GO:0032024]	MYRIP SLAC2C
NM_153184	NM_153184 -> Q8N3J6-3	Q8N3J6	CADM2_HUMAN	Cell adhesion molecule 2 (Immunoglobulin superfamily member 4D) (IgSF4D) (Nectin-like protein 3) (NECL-3) (Synaptic cell adhesion molecule 2) (SynCAM 2)	GO:0005886; GO:0007155; GO:0016021; GO:0030054; GO:0030424; GO:0034332; GO:0045202	axon [GO:0030424]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; adherens junction organization [GO:0034332]; cell adhesion [GO:0007155]	CADM2 IGSF4D NECL3
NM_152491	NM_152491 -> Q6GTS8-1	Q6GTS8	P20D1_HUMAN	N-fatty-acyl-amino acid synthase/hydrolase PM20D1 (EC 3.5.1.-) (EC 4.3.-.-) (Peptidase M20 domain-containing protein 1)	GO:0006520; GO:0006807; GO:0008233; GO:0016811; GO:0016829; GO:0043604; GO:0043605; GO:0044255; GO:0046872; GO:0070062; GO:0097009; GO:1901215; GO:1990845; GO:2000275	extracellular exosome [GO:0070062]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; cellular amide catabolic process [GO:0043605]; cellular amino acid metabolic process [GO:0006520]; cellular lipid metabolic process [GO:0044255]; energy homeostasis [GO:0097009]; negative regulation of neuron death [GO:1901215]; nitrogen compound metabolic process [GO:0006807]; regulation of oxidative phosphorylation uncoupler activity [GO:2000275]	PM20D1
NM_001135242	NM_001135242 -> Q92597-1	Q92597	NDRG1_HUMAN	Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42)	GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005913; GO:0007165; GO:0008017; GO:0008285; GO:0010038; GO:0015630; GO:0017137; GO:0030330; GO:0032287; GO:0042981; GO:0043015; GO:0045296; GO:0045576; GO:0048471; GO:0055038; GO:0070062; GO:0071456; GO:0098978; GO:0099173	cell-cell adherens junction [GO:0005913]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; cadherin binding [GO:0045296]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mast cell activation [GO:0045576]; negative regulation of cell population proliferation [GO:0008285]; peripheral nervous system myelin maintenance [GO:0032287]; postsynapse organization [GO:0099173]; regulation of apoptotic process [GO:0042981]; response to metal ion [GO:0010038]; signal transduction [GO:0007165]	NDRG1 CAP43 DRG1 RTP
NM_004540	NM_004540 -> O15394-1	O15394	NCAM2_HUMAN	Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2)	GO:0005886; GO:0007158; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0042802	axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608]	NCAM2 NCAM21
NM_001148	NM_001148 -> Q01484-4	Q01484	ANK2_HUMAN	Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)	GO:0002027; GO:0003283; GO:0005200; GO:0005623; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0006897; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043194; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	ANK2 ANKB
NM_004080		Q9Y6T7	DGKB_HUMAN	Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (90 kDa diacylglycerol kinase) (Diglyceride kinase beta) (DGK-beta)	GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007205; GO:0009617; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099175	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617]	DGKB DAGK2 KIAA0718
NM_080607	NM_080607 -> Q96N03-1	Q96N03	VTM2L_HUMAN	V-set and transmembrane domain-containing protein 2-like protein	GO:0005576; GO:0005737; GO:0005886; GO:0007156; GO:0007411; GO:0030424; GO:0043524; GO:0070593; GO:0098632	axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]	VSTM2L C20orf102
NM_018711		Q8N4V2	SVOP_HUMAN	Synaptic vesicle 2-related protein (SV2-related protein)	GO:0005887; GO:0008021; GO:0022857; GO:0030054; GO:0030672	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]	SVOP
NM_001040159	NM_001040159 -> Q9BQ16-1	Q9BQ16	TICN3_HUMAN	Testican-3 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 3)	GO:0005509; GO:0005518; GO:0005539; GO:0005615; GO:0008191; GO:0010951; GO:0019800; GO:0031012; GO:0050840; GO:2000146	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; metalloendopeptidase inhibitor activity [GO:0008191]; negative regulation of cell motility [GO:2000146]; negative regulation of endopeptidase activity [GO:0010951]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]	SPOCK3 TICN3 UNQ409/PRO771
NM_022129		A0A024QZK5	A0A024QZK5_HUMAN	Epididymis secretory protein Li 306 (Epididymis secretory sperm binding protein) (MAWD binding protein, isoform CRA_b)	GO:0003824; GO:0009058	catalytic activity [GO:0003824]; biosynthetic process [GO:0009058]	MAWBP HEL-S-306 hCG_32856
NM_022129	NM_022129 -> P30039-1	P30039	PBLD_HUMAN	Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-) (MAWD-binding protein) (MAWDBP) (Unknown protein 32 from 2D-page of liver tissue)	GO:0005737; GO:0009058; GO:0010633; GO:0010719; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0050680; GO:0060392; GO:0060394; GO:0070062	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]	PBLD MAWBP
NM_020818	NM_020818 -> Q9P2D8-2	Q9P2D8	UNC79_HUMAN	Protein unc-79 homolog	GO:0005886; GO:0016021; GO:0034220; GO:0035264; GO:0048149	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; behavioral response to ethanol [GO:0048149]; ion transmembrane transport [GO:0034220]; multicellular organism growth [GO:0035264]	UNC79 KIAA1409
NM_144966	NM_144966 -> Q5H8C1-1	Q5H8C1	FREM1_HUMAN	FRAS1-related extracellular matrix protein 1 (Protein QBRICK)	GO:0005604; GO:0007154; GO:0007160; GO:0016021; GO:0030246; GO:0046872; GO:0097094	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094]	FREM1 C9orf143 C9orf145 C9orf154
NM_005302		O15354	GPR37_HUMAN	Prosaposin receptor GPR37 (Endothelin B receptor-like protein 1) (ETBR-LP-1) (G-protein coupled receptor 37) (Parkin-associated endothelin receptor-like receptor) (PAELR)	GO:0000151; GO:0004930; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0008528; GO:0030544; GO:0031072; GO:0031625; GO:0031987; GO:0036505; GO:0042277; GO:0042416; GO:0043235; GO:0043410; GO:0045964; GO:1903206	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ubiquitin ligase complex [GO:0000151]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; dopamine biosynthetic process [GO:0042416]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of MAPK cascade [GO:0043410]	GPR37
NM_001005273		B3KWV4	B3KWV4_HUMAN	cDNA FLJ43940 fis, clone TESTI4014175, highly similar to Chromodomain helicase-DNA-binding protein 3	GO:0003677; GO:0004386	DNA binding [GO:0003677]; helicase activity [GO:0004386]	
NM_001005273	NM_001005273 -> Q12873-1	Q12873	CHD3_HUMAN	Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH)	GO:0003677; GO:0003678; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006333; GO:0006355; GO:0006357; GO:0007051; GO:0007098; GO:0008270; GO:0016581; GO:0016887; GO:0034451; GO:0036121; GO:0043044; GO:0070615; GO:1901796	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA helicase activity [GO:0036121]; helicase activity [GO:0004386]; nucleosome-dependent ATPase activity [GO:0070615]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; centrosome cycle [GO:0007098]; chromatin assembly or disassembly [GO:0006333]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spindle organization [GO:0007051]	CHD3
NM_001005273		Q2TAZ1	Q2TAZ1_HUMAN	CHD3 protein (Fragment)			CHD3
NM_020814		Q9P2E8	MARH4_HUMAN	E3 ubiquitin-protein ligase MARCH4 (EC 2.3.2.27) (Membrane-associated RING finger protein 4) (Membrane-associated RING-CH protein IV) (MARCH-IV) (RING finger protein 174) (RING-type E3 ubiquitin transferase MARCH4)	GO:0000139; GO:0004842; GO:0005795; GO:0005802; GO:0008270; GO:0016021	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	MARCH4 KIAA1399 RNF174
NM_002581		B4DTA8	B4DTA8_HUMAN	cDNA FLJ50208, highly similar to Pappalysin-1	GO:0004222	metalloendopeptidase activity [GO:0004222]	
NM_002581		Q13219	PAPP1_HUMAN	Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A)	GO:0004222; GO:0005576; GO:0005615; GO:0007565; GO:0008237; GO:0008270; GO:0032354; GO:0044267; GO:0051384	extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cellular protein metabolic process [GO:0044267]; female pregnancy [GO:0007565]; response to follicle-stimulating hormone [GO:0032354]; response to glucocorticoid [GO:0051384]	PAPPA
NM_002581		Q7Z613	Q7Z613_HUMAN	Differentially placenta 1 expressed protein (Replicative senescence upregulated protein)	GO:0016021	integral component of membrane [GO:0016021]	DIPLA1
NM_001819		P05060	SCG1_HUMAN	Secretogranin-1 (Chromogranin-B) (CgB) (Secretogranin I) (SgI) [Cleaved into: PE-11; GAWK peptide; CCB peptide]	GO:0005179; GO:0005615; GO:0005788; GO:0030141; GO:0043687; GO:0044267	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; hormone activity [GO:0005179]; cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687]	CHGB SCG1
NM_001704	NM_001704 -> O60242-1	O60242	AGRB3_HUMAN	Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3)	GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007520; GO:0016021; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]; G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]	ADGRB3 BAI3 KIAA0550
NM_006763		P78543	BTG2_HUMAN	Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3)	GO:0001227; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006479; GO:0006974; GO:0006977; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0014070; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0045930; GO:0051602; GO:0060213; GO:0070062; GO:2000178	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of translation [GO:0017148]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914]	BTG2 PC3
NM_014935		Q9Y2H5	PKHA6_HUMAN	Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3)			PLEKHA6 KIAA0969 PEPP3
NM_001005473		B3KXD1	B3KXD1_HUMAN	cDNA FLJ45199 fis, clone BRCAN2003814, highly similar to Homo sapiens phosphatidylinositol-specific phospholipase C, X domain containing 3 (PLCXD3), mRNA	GO:0006629; GO:0008081	phosphoric diester hydrolase activity [GO:0008081]; lipid metabolic process [GO:0006629]	
NM_001005473		Q63HM9	PLCX3_HUMAN	PI-PLC X domain-containing protein 3	GO:0005737; GO:0007165; GO:0008081; GO:0016042	cytoplasm [GO:0005737]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]	PLCXD3
NM_020929		Q4JIV9	Q4JIV9_HUMAN	Netrin-G1 ligand splice variant 4	GO:0016021	integral component of membrane [GO:0016021]	NGL1
NM_020929		Q4JIW0	Q4JIW0_HUMAN	Netrin-G1 ligand splice variant 3	GO:0016021	integral component of membrane [GO:0016021]	NGL1
NM_020929		Q9HCJ2	LRC4C_HUMAN	Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand) (NGL-1)	GO:0005615; GO:0016020; GO:0016021; GO:0030054; GO:0050770; GO:0050804; GO:0050839; GO:0098632; GO:0098685; GO:0098978; GO:0099061; GO:0099560	cell junction [GO:0030054]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]; modulation of chemical synaptic transmission [GO:0050804]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560]	LRRC4C KIAA1580 NGL1 UNQ292/PRO331
NM_000891		P63252	KCNJ2_HUMAN	Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)	GO:0005242; GO:0005546; GO:0005623; GO:0005790; GO:0005791; GO:0005794; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0014704; GO:0014861; GO:0015693; GO:0030007; GO:0030315; GO:0031224; GO:0042802; GO:0043025; GO:0043197; GO:0051289; GO:0055119; GO:0060075; GO:0060306; GO:0061337; GO:0071260; GO:0071805; GO:0086002; GO:0086004; GO:0086008; GO:0086011; GO:0086012; GO:0086013; GO:0086091; GO:0090076; GO:1901381; GO:1990573	cell [GO:0005623]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; magnesium ion transport [GO:0015693]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of resting membrane potential [GO:0060075]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]	KCNJ2 IRK1
NM_001135691	NM_001135691 -> P54219-1	P54219	VMAT1_HUMAN	Chromaffin granule amine transporter (Solute carrier family 18 member 1) (Vesicular amine transporter 1) (VAT1)	GO:0005335; GO:0005789; GO:0005887; GO:0006836; GO:0008504; GO:0015842; GO:0015844; GO:0030054; GO:0030672; GO:0042910; GO:0043195; GO:0070083	cell junction [GO:0030054]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; xenobiotic transmembrane transporter activity [GO:0042910]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]	SLC18A1 VAT1 VMAT1
NM_001135691		Q96GL6	Q96GL6_HUMAN	Chromaffin granule amine transporter (SLC18A1 protein)	GO:0005887; GO:0042910	integral component of plasma membrane [GO:0005887]; xenobiotic transmembrane transporter activity [GO:0042910]	SLC18A1
NM_022143		Q9HBW1	LRRC4_HUMAN	Leucine-rich repeat-containing protein 4 (Brain tumor-associated protein BAG) (Nasopharyngeal carcinoma-associated gene 14 protein) (Netrin-G2 ligand) (NGL-2)	GO:0030054; GO:0043197; GO:0050804; GO:0060076; GO:0097119; GO:0098685; GO:0098978; GO:0099061; GO:0099560; GO:1904861	cell junction [GO:0030054]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; Schaffer collateral - CA1 synapse [GO:0098685]; excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560]	LRRC4 BAG NAG14 UNQ554/PRO1111
NM_005811		A0A024RB20	A0A024RB20_HUMAN	Growth differentiation factor 11, isoform CRA_a	GO:0001501; GO:0001656; GO:0001657; GO:0005615; GO:0005654; GO:0008083; GO:0008285; GO:0021512; GO:0031016; GO:0043231; GO:0045665; GO:0048469; GO:0048593; GO:0060021; GO:0060395	extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; growth factor activity [GO:0008083]; camera-type eye morphogenesis [GO:0048593]; cell maturation [GO:0048469]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; pancreas development [GO:0031016]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; spinal cord anterior/posterior patterning [GO:0021512]; ureteric bud development [GO:0001657]	GDF11 hCG_20741
NM_005811		O95390	GDF11_HUMAN	Growth/differentiation factor 11 (GDF-11) (Bone morphogenetic protein 11) (BMP-11)	GO:0001501; GO:0001656; GO:0001657; GO:0005125; GO:0005160; GO:0005615; GO:0005654; GO:0007399; GO:0007498; GO:0008083; GO:0008285; GO:0010862; GO:0021512; GO:0031016; GO:0032991; GO:0042981; GO:0043231; GO:0043408; GO:0045665; GO:0048468; GO:0048469; GO:0048593; GO:0060021; GO:0060395	extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; camera-type eye morphogenesis [GO:0048593]; cell development [GO:0048468]; cell maturation [GO:0048469]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; pancreas development [GO:0031016]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of apoptotic process [GO:0042981]; regulation of MAPK cascade [GO:0043408]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; spinal cord anterior/posterior patterning [GO:0021512]; ureteric bud development [GO:0001657]	GDF11 BMP11
NM_000812	NM_000812 -> P18505-1	P18505	GBRB1_HUMAN	Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1)	GO:0004890; GO:0005635; GO:0005737; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007214; GO:0007268; GO:0009636; GO:0015276; GO:0021954; GO:0022851; GO:0030054; GO:0030425; GO:0032570; GO:0034220; GO:0034707; GO:0042391; GO:0042698; GO:0043005; GO:0045202; GO:0045211; GO:0050811; GO:0050877; GO:0071420; GO:0098982; GO:1902476; GO:1902711; GO:1904315	cell junction [GO:0030054]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated ion channel activity [GO:0015276]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]	GABRB1
NM_000812		X5DNL6	X5DNL6_HUMAN	Gamma-aminobutyric acid A receptor beta 1 isoform A (Fragment)	GO:0004890; GO:0005253; GO:0005635; GO:0005737; GO:0005887; GO:0009636; GO:0021954; GO:0030425; GO:0032570; GO:0042698; GO:0050811; GO:0071420; GO:0098982; GO:1902711; GO:1904315	cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; anion channel activity [GO:0005253]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; ovulation cycle [GO:0042698]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]	GABRB1
NM_020987	NM_020987 -> Q12955-3	Q12955	ANK3_HUMAN	Ankyrin-3 (ANK-3) (Ankyrin-G)	GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]	ANK3
NM_020802		Q9P2H0	CE126_HUMAN	Centrosomal protein of 126 kDa	GO:0005737; GO:0005813; GO:0007052; GO:0030496; GO:0031122; GO:0060271; GO:0097546; GO:1905515	centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; midbody [GO:0030496]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515]	CEP126 KIAA1377
NM_003285		A1L306	A1L306_HUMAN	TNR protein	GO:0007155; GO:0050767; GO:0062023	collagen-containing extracellular matrix [GO:0062023]; cell adhesion [GO:0007155]; regulation of neurogenesis [GO:0050767]	TNR
NM_003285	NM_003285 -> Q92752-1	Q92752	TENR_HUMAN	Tenascin-R (TN-R) (Janusin) (Restrictin)	GO:0005576; GO:0007155; GO:0007158; GO:0007411; GO:0008306; GO:0009986; GO:0022029; GO:0022408; GO:0030198; GO:0035641; GO:0045121; GO:0048692; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0072534; GO:0098685; GO:0098978	cell surface [GO:0009986]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; Schaffer collateral - CA1 synapse [GO:0098685]; associative learning [GO:0008306]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of synaptic transmission [GO:0050805]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; synapse organization [GO:0050808]; telencephalon cell migration [GO:0022029]	TNR
NM_005668	NM_005668 -> Q92187-1	Q92187	SIA8D_HUMAN	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase (EC 2.4.99.-) (Alpha-2,8-sialyltransferase 8D) (Polysialyltransferase-1) (Sialyltransferase 8D) (SIAT8-D) (Sialyltransferase St8Sia IV) (ST8SiaIV)	GO:0000139; GO:0001574; GO:0003828; GO:0006464; GO:0006486; GO:0006491; GO:0007399; GO:0009311; GO:0016021; GO:0033691	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialic acid binding [GO:0033691]; cellular protein modification process [GO:0006464]; ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]	ST8SIA4 PST PST1 SIAT8D
NM_024944	NM_024944 -> Q9H9P2-1	Q9H9P2	CHODL_HUMAN	Chondrolectin (Transmembrane protein MT75)	GO:0005737; GO:0005789; GO:0007517; GO:0016021; GO:0030246; GO:0048471; GO:0050772	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; muscle organ development [GO:0007517]; positive regulation of axonogenesis [GO:0050772]	CHODL C21orf68 PRED12 UNQ872/PRO1890
NM_001050	NM_001050 -> P30874-1	P30874	SSR2_HUMAN	Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SRIF-1)	GO:0004930; GO:0004994; GO:0005829; GO:0005886; GO:0005887; GO:0006937; GO:0007186; GO:0007187; GO:0007193; GO:0007218; GO:0007283; GO:0008285; GO:0021549; GO:0030165; GO:0030432; GO:0030900; GO:0042277; GO:0042594; GO:0042923; GO:0071385; GO:0071392	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; peristalsis [GO:0030432]; regulation of muscle contraction [GO:0006937]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]	SSTR2
NM_001143676	NM_001143676 -> O00141-2	O00141	SGK1_HUMAN	Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)	GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0018105; GO:0030334; GO:0032411; GO:0034220; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; ion transmembrane transport [GO:0034220]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	SGK1 SGK
NM_000599		A0A024R433	A0A024R433_HUMAN	Insulin-like growth factor binding protein 5, isoform CRA_a	GO:0001558; GO:0001649; GO:0001968; GO:0005520; GO:0005576; GO:0007565; GO:0007568; GO:0031069; GO:0035556; GO:0042593; GO:0043568; GO:0043569; GO:0044342; GO:0045668; GO:0045926; GO:0048286; GO:0051146; GO:0051897; GO:0060056; GO:0060416; GO:1901862; GO:1904205	extracellular region [GO:0005576]; fibronectin binding [GO:0001968]; insulin-like growth factor binding [GO:0005520]; aging [GO:0007568]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; intracellular signal transduction [GO:0035556]; lung alveolus development [GO:0048286]; mammary gland involution [GO:0060056]; negative regulation of growth [GO:0045926]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of skeletal muscle hypertrophy [GO:1904205]; osteoblast differentiation [GO:0001649]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of cell growth [GO:0001558]; response to growth hormone [GO:0060416]; striated muscle cell differentiation [GO:0051146]; type B pancreatic cell proliferation [GO:0044342]	IGFBP5 hCG_16384
NM_000599		P24593	IBP5_HUMAN	Insulin-like growth factor-binding protein 5 (IBP-5) (IGF-binding protein 5) (IGFBP-5)	GO:0001558; GO:0001649; GO:0001968; GO:0005576; GO:0005615; GO:0005788; GO:0007165; GO:0007565; GO:0007568; GO:0014912; GO:0016942; GO:0017148; GO:0030336; GO:0031069; GO:0031994; GO:0031995; GO:0035556; GO:0042567; GO:0042593; GO:0043567; GO:0043568; GO:0043569; GO:0043687; GO:0044267; GO:0044342; GO:0045668; GO:0045926; GO:0048286; GO:0048662; GO:0051146; GO:0051897; GO:0060056; GO:0060416; GO:0071320; GO:0071407; GO:1901862; GO:1904205; GO:1904707; GO:1904754	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor binding protein complex [GO:0016942]; insulin-like growth factor ternary complex [GO:0042567]; fibronectin binding [GO:0001968]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; aging [GO:0007568]; cellular protein metabolic process [GO:0044267]; cellular response to cAMP [GO:0071320]; cellular response to organic cyclic compound [GO:0071407]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; intracellular signal transduction [GO:0035556]; lung alveolus development [GO:0048286]; mammary gland involution [GO:0060056]; negative regulation of cell migration [GO:0030336]; negative regulation of growth [GO:0045926]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of skeletal muscle hypertrophy [GO:1904205]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; post-translational protein modification [GO:0043687]; regulation of cell growth [GO:0001558]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; response to growth hormone [GO:0060416]; signal transduction [GO:0007165]; striated muscle cell differentiation [GO:0051146]; type B pancreatic cell proliferation [GO:0044342]	IGFBP5 IBP5
NM_017637	NM_017637 -> Q6ZN30-1	Q6ZN30	BNC2_HUMAN	Zinc finger protein basonuclin-2	GO:0003416; GO:0003677; GO:0005654; GO:0043586; GO:0046872; GO:0060021; GO:0060485	nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; roof of mouth development [GO:0060021]; tongue development [GO:0043586]	BNC2
NM_031418	NM_031418 -> Q9BYT9-1	Q9BYT9	ANO3_HUMAN	Anoctamin-3 (Transmembrane protein 16C)	GO:0005886; GO:0016021; GO:0016048; GO:0017128; GO:0034220; GO:0046983; GO:0050982; GO:0061590; GO:0061591; GO:1902476	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; ion transmembrane transport [GO:0034220]	ANO3 C11orf25 TMEM16C GENX-3947
NM_001627	NM_001627 -> Q13740-1	Q13740	CD166_HUMAN	CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166)	GO:0001772; GO:0002250; GO:0005102; GO:0005887; GO:0005925; GO:0007155; GO:0007157; GO:0007165; GO:0008045; GO:0009897; GO:0030424; GO:0030425; GO:0031226; GO:0031290; GO:0042802; GO:0043025; GO:0048846; GO:0070062; GO:1990138	axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body [GO:0043025]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; axon extension involved in axon guidance [GO:0048846]; cell adhesion [GO:0007155]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; motor neuron axon guidance [GO:0008045]; neuron projection extension [GO:1990138]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]	ALCAM MEMD
NM_001010898		Q9H1V8	S6A17_HUMAN	Sodium-dependent neutral amino acid transporter SLC6A17 (Sodium-dependent neurotransmitter transporter NTT4) (Solute carrier family 6 member 17)	GO:0005328; GO:0005887; GO:0007420; GO:0008021; GO:0015804; GO:0015816; GO:0015820; GO:0015824; GO:0030054; GO:0030285; GO:0032328; GO:0042995; GO:0098978; GO:0098982	cell junction [GO:0030054]; cell projection [GO:0042995]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; synaptic vesicle [GO:0008021]; neurotransmitter:sodium symporter activity [GO:0005328]; alanine transport [GO:0032328]; brain development [GO:0007420]; glycine transport [GO:0015816]; leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]	SLC6A17 NTT4
NM_015082	NM_015082 -> Q6MZW2-1	Q6MZW2	FSTL4_HUMAN	Follistatin-related protein 4 (Follistatin-like protein 4)	GO:0005509; GO:0005576; GO:0007275; GO:0030141; GO:0030154; GO:0031549; GO:0048403; GO:0048671; GO:0061000	extracellular region [GO:0005576]; secretory granule [GO:0030141]; brain-derived neurotrophic factor binding [GO:0048403]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031549]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]	FSTL4 KIAA1061
NM_015564		O43300	LRRT2_HUMAN	Leucine-rich repeat transmembrane neuronal protein 2 (Leucine-rich repeat neuronal 2 protein)	GO:0002091; GO:0030054; GO:0042043; GO:0050808; GO:0051965; GO:0060076; GO:0060291; GO:0098685; GO:0098686; GO:0098978; GO:0098982; GO:0099060; GO:0099061; GO:0099151	cell junction [GO:0030054]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic specialization membrane [GO:0099060]; Schaffer collateral - CA1 synapse [GO:0098685]; neurexin family protein binding [GO:0042043]; long-term synaptic potentiation [GO:0060291]; negative regulation of receptor internalization [GO:0002091]; positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; synapse organization [GO:0050808]	LRRTM2 KIAA0416 LRRN2
NM_000831	NM_000831 -> Q13003-1	Q13003	GRIK3_HUMAN	Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7)	GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015277; GO:0030054; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0098839; GO:0098978; GO:0099507; GO:1904315	axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]	GRIK3 GLUR7
NM_001030059	NM_001030059 -> Q5VZY2-1	Q5VZY2	PLPP4_HUMAN	Phospholipid phosphatase 4 (EC 3.1.3.4) (Phosphatidic acid phosphatase type 2 domain-containing protein 1A)	GO:0001835; GO:0005886; GO:0005887; GO:0006644; GO:0008195; GO:0016791; GO:0038096; GO:0042802; GO:0046839	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195]; blastocyst hatching [GO:0001835]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]	PLPP4 DPPL2 PPAPDC1 PPAPDC1A
NM_014268		A0A024RC33	A0A024RC33_HUMAN	Microtubule-associated protein, RP/EB family, member 2, isoform CRA_a	GO:0005925; GO:0008017; GO:0019901; GO:0032014; GO:0035371; GO:0043547; GO:0051549; GO:1903393	focal adhesion [GO:0005925]; microtubule plus-end [GO:0035371]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]	MAPRE2 hCG_24286
NM_014268	NM_014268 -> Q15555-1	Q15555	MARE2_HUMAN	Microtubule-associated protein RP/EB family member 2 (APC-binding protein EB2) (End-binding protein 2) (EB2)	GO:0005737; GO:0005815; GO:0005874; GO:0005881; GO:0005925; GO:0008017; GO:0015630; GO:0019901; GO:0031110; GO:0032014; GO:0035371; GO:0035372; GO:0042802; GO:0043547; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:0051549; GO:1903393; GO:1904825	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; focal adhesion [GO:0005925]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]	MAPRE2 RP1
NM_175607		A0A024R2E5	A0A024R2E5_HUMAN	Contactin 4, isoform CRA_c	GO:0007155; GO:0007411; GO:0007420	axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]	CNTN4 hCG_40118
NM_175607	NM_175607 -> Q8IWV2-1	Q8IWV2	CNTN4_HUMAN	Contactin-4 (Brain-derived immunoglobulin superfamily protein 2) (BIG-2)	GO:0005576; GO:0005886; GO:0007156; GO:0007158; GO:0007399; GO:0007409; GO:0007411; GO:0007413; GO:0007420; GO:0030424; GO:0031175; GO:0031225; GO:0045665; GO:0048167; GO:0070593; GO:0098632	anchored component of membrane [GO:0031225]; axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuron cell-cell adhesion [GO:0007158]; neuron projection development [GO:0031175]; regulation of synaptic plasticity [GO:0048167]	CNTN4
NM_014361	NM_014361 -> O94779-1	O94779	CNTN5_HUMAN	Contactin-5 (Neural recognition molecule NB-2) (hNB-2)	GO:0005576; GO:0005886; GO:0007155; GO:0007605; GO:0098982; GO:0099026; GO:0099054	anchored component of presynaptic membrane [GO:0099026]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; presynapse assembly [GO:0099054]; sensory perception of sound [GO:0007605]	CNTN5
NM_000933	NM_000933 -> Q15147-4	Q15147	PLCB4_HUMAN	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4) (PLC-beta-4)	GO:0004435; GO:0004629; GO:0005509; GO:0005623; GO:0005634; GO:0005790; GO:0005829; GO:0007186; GO:0014069; GO:0016042; GO:0030425; GO:0032959; GO:0043647; GO:0048015; GO:0050804; GO:0051209; GO:0098688; GO:0098978	cell [GO:0005623]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density [GO:0014069]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate biosynthetic process [GO:0032959]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol-mediated signaling [GO:0048015]; release of sequestered calcium ion into cytosol [GO:0051209]	PLCB4
NM_020686		P80404	GABT_HUMAN	4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)	GO:0001666; GO:0003867; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042135; GO:0042803; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0048148; GO:0051536; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]	ABAT GABAT
NM_020686		X5D8S1	X5D8S1_HUMAN	4-aminobutyrate aminotransferase isoform A (Fragment)	GO:0001666; GO:0003867; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009449; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0033602; GO:0035094; GO:0035640; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0048148; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; 4-aminobutyrate transaminase activity [GO:0003867]; pyridoxal phosphate binding [GO:0030170]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]	ABAT
NM_000275	NM_000275 -> Q04671-1	Q04671	P_HUMAN	P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog)	GO:0005215; GO:0005302; GO:0005737; GO:0005765; GO:0005789; GO:0006726; GO:0007286; GO:0008283; GO:0010008; GO:0016021; GO:0030318; GO:0033162; GO:0042438	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; L-tyrosine transmembrane transporter activity [GO:0005302]; transporter activity [GO:0005215]; cell population proliferation [GO:0008283]; eye pigment biosynthetic process [GO:0006726]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286]	OCA2 D15S12 P
NM_000138		P35555	FBN1_HUMAN	Fibrillin-1 [Cleaved into: Asprosin]	GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010737; GO:0030023; GO:0030198; GO:0031012; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0043687; GO:0044267; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	FBN1 FBN
NM_003155	NM_003155 -> P52823-1	P52823	STC1_HUMAN	Stanniocalcin-1 (STC-1)	GO:0001503; GO:0001886; GO:0003421; GO:0005179; GO:0005615; GO:0005623; GO:0005634; GO:0005737; GO:0006874; GO:0007566; GO:0010596; GO:0016324; GO:0030336; GO:0033280; GO:0035988; GO:0044070; GO:0046697; GO:0051926; GO:0060348; GO:0071320; GO:0071385; GO:0071456; GO:0086004; GO:0090280; GO:1903403	apical plasma membrane [GO:0016324]; cell [GO:0005623]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; hormone activity [GO:0005179]; bone development [GO:0060348]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; chondrocyte proliferation [GO:0035988]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial cell morphogenesis [GO:0001886]; growth plate cartilage axis specification [GO:0003421]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of renal phosphate excretion [GO:1903403]; ossification [GO:0001503]; positive regulation of calcium ion import [GO:0090280]; regulation of anion transport [GO:0044070]; regulation of cardiac muscle cell contraction [GO:0086004]; response to vitamin D [GO:0033280]	STC1 STC
NM_020337	NM_020337 -> Q9ULJ7-1	Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	GO:0005768; GO:0015031; GO:1990126	endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport, endosome to plasma membrane [GO:1990126]	ANKRD50 KIAA1223
NM_018398	NM_018398 -> Q8IZS8-1	Q8IZS8	CA2D3_HUMAN	Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3]	GO:0005245; GO:0005886; GO:0005891; GO:0034765; GO:0046872; GO:0061337	plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; cardiac conduction [GO:0061337]; regulation of ion transmembrane transport [GO:0034765]	CACNA2D3
NM_005654		P10589	COT1_HUMAN	COUP transcription factor 1 (COUP-TF1) (COUP transcription factor I) (COUP-TF I) (Nuclear receptor subfamily 2 group F member 1) (V-erbA-related protein 3) (EAR-3)	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0003707; GO:0003713; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006367; GO:0007165; GO:0008270; GO:0010977; GO:0030154; GO:0043565; GO:0044323; GO:0045944; GO:0048856	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription initiation from RNA polymerase II promoter [GO:0006367]	NR2F1 EAR3 ERBAL3 TFCOUP1
NM_058172	NM_058172 -> P58335-4	P58335	ANTR2_HUMAN	Anthrax toxin receptor 2 (Capillary morphogenesis gene 2 protein) (CMG-2)	GO:0004888; GO:0005576; GO:0005789; GO:0005886; GO:0009897; GO:0009986; GO:0010008; GO:0016021; GO:0022414; GO:0046872; GO:1901998	cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; reproductive process [GO:0022414]; toxin transport [GO:1901998]	ANTXR2 CMG2
NM_016048		Q96CN7	ISOC1_HUMAN	Isochorismatase domain-containing protein 1	GO:0003824; GO:0005737; GO:0005777	cytoplasm [GO:0005737]; peroxisome [GO:0005777]; catalytic activity [GO:0003824]	ISOC1 CGI-111
NM_003471	NM_003471 -> Q14722-3	Q14722	KCAB1_HUMAN	Voltage-gated potassium channel subunit beta-1 (EC 1.1.1.-) (K(+) channel subunit beta-1) (Kv-beta-1)	GO:0004033; GO:0005249; GO:0005829; GO:0005886; GO:0006813; GO:0007420; GO:0007507; GO:0007519; GO:0007611; GO:0008076; GO:0015459; GO:0019904; GO:0031234; GO:0032839; GO:0034705; GO:0043204; GO:0044224; GO:0044325; GO:0045445; GO:0055114; GO:0060539; GO:0070402; GO:1901379; GO:1902259; GO:1902260; GO:1903817; GO:1990635	cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; proximal dendrite [GO:1990635]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; ion channel binding [GO:0044325]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; voltage-gated potassium channel activity [GO:0005249]; brain development [GO:0007420]; diaphragm development [GO:0060539]; heart development [GO:0007507]; learning or memory [GO:0007611]; myoblast differentiation [GO:0045445]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; oxidation-reduction process [GO:0055114]; potassium ion transport [GO:0006813]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of potassium ion transmembrane transport [GO:1901379]; skeletal muscle tissue development [GO:0007519]	KCNAB1 KCNA1B
NM_001130834	NM_001130834 -> O43679-2	O43679	LDB2_HUMAN	LIM domain-binding protein 2 (LDB-2) (Carboxyl-terminal LIM domain-binding protein 1) (CLIM-1) (LIM domain-binding factor CLIM1)	GO:0000122; GO:0001102; GO:0001942; GO:0003712; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005886; GO:0007275; GO:0010669; GO:0019899; GO:0030274; GO:0030334; GO:0031252; GO:0035019; GO:0043549; GO:0044089; GO:0045892; GO:0045944	cell leading edge [GO:0031252]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; epithelial structure maintenance [GO:0010669]; hair follicle development [GO:0001942]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cellular component biogenesis [GO:0044089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of kinase activity [GO:0043549]; somatic stem cell population maintenance [GO:0035019]	LDB2 CLIM1
NM_182898	NM_182898 -> Q02930-1	Q02930	CREB5_HUMAN	Cyclic AMP-responsive element-binding protein 5 (CREB-5) (cAMP-responsive element-binding protein 5) (cAMP-response element-binding protein A) (CRE-BPa)	GO:0000790; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006366; GO:0045893; GO:0046872; GO:0070062	extracellular exosome [GO:0070062]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]	CREB5 CREBPA
NM_033403		B3KVM3	B3KVM3_HUMAN	HCG16695 (cDNA FLJ16746 fis, clone FCBBF2003102, moderately similar to Mus musculus doublecortin-like kinase 3 (Dclk3), mRNA)	GO:0004672; GO:0005524	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]	hCG_16695
NM_033403		Q9C098	DCLK3_HUMAN	Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3)	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:1900181	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]	DCLK3 DCAMKL3 DCDC3C KIAA1765
NM_080723		Q8IZ57	NRSN1_HUMAN	Neurensin-1 (Neuro-p24) (Vesicular membrane protein of 24 kDa) (Vesicular membrane protein p24)	GO:0007399; GO:0016021; GO:0030133; GO:0030426; GO:0031410; GO:0043005; GO:0043025	cytoplasmic vesicle [GO:0031410]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; nervous system development [GO:0007399]	NRSN1 VMP
NM_022131		Q9H4D0	CSTN2_HUMAN	Calsyntenin-2 (Alcadein-gamma) (Alc-gamma)	GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0009986; GO:0030054; GO:0030425; GO:0045211; GO:0050806; GO:0051965; GO:0098978; GO:0099061	cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]	CLSTN2 CS2
NM_206963	NM_206963 -> P49788-1	P49788	TIG1_HUMAN	Retinoic acid receptor responder protein 1 (Phorbol ester-induced gene 1 protein) (PERG-1) (RAR-responsive protein TIG1) (Tazarotene-induced gene 1 protein)	GO:0005615; GO:0008191; GO:0008285; GO:0016021; GO:0070062	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; metalloendopeptidase inhibitor activity [GO:0008191]; negative regulation of cell population proliferation [GO:0008285]	RARRES1 PEIG1 TIG1
NM_003061		A6H8V1	A6H8V1_HUMAN	Slit homolog 1 (Drosophila)	GO:0005509; GO:0005576	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]	SLIT1
NM_003061	NM_003061 -> O75093-1	O75093	SLIT1_HUMAN	Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4)	GO:0005509; GO:0005615; GO:0007097; GO:0007411; GO:0008045; GO:0008201; GO:0022028; GO:0031290; GO:0033563; GO:0048495; GO:0048846; GO:0048853; GO:0050919; GO:0051964	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]	SLIT1 KIAA0813 MEGF4 SLIL1
NM_203403		Q8IV03	LUR1L_HUMAN	Leucine rich adaptor protein 1-like	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	LURAP1L C9orf150 HYST0841
NM_014141		A0A090N7T7	A0A090N7T7_HUMAN	Contactin associated protein-like 2 (Contactin associated protein-like 2, isoform CRA_b)	GO:0016021; GO:0071205	integral component of membrane [GO:0016021]; protein localization to juxtaparanode region of axon [GO:0071205]	CNTNAP2 hCG_15499 tcag7.496
NM_014141		B2RCH4	B2RCH4_HUMAN	cDNA, FLJ96073, highly similar to Homo sapiens contactin associated protein-like 2 (CNTNAP2), mRNA	GO:0016021; GO:0071205	integral component of membrane [GO:0016021]; protein localization to juxtaparanode region of axon [GO:0071205]	
NM_014141	NM_014141 -> Q9UHC6-1	Q9UHC6	CNTP2_HUMAN	Contactin-associated protein-like 2 (Cell recognition molecule Caspr2)	GO:0005769; GO:0005794; GO:0007155; GO:0007420; GO:0007612; GO:0008038; GO:0008076; GO:0009986; GO:0016020; GO:0016021; GO:0019226; GO:0019899; GO:0021756; GO:0021761; GO:0021794; GO:0021987; GO:0030424; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0033010; GO:0035176; GO:0042297; GO:0043025; GO:0043204; GO:0044224; GO:0045163; GO:0048812; GO:0071109; GO:0071205; GO:0071625	axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076]; enzyme binding [GO:0019899]; adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]	CNTNAP2 CASPR2 KIAA0868
NM_022897		Q546R4	Q546R4_HUMAN	RAN binding protein 17, isoform CRA_b	GO:0005634; GO:0006886; GO:0008536	nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; intracellular protein transport [GO:0006886]	RANBP17 hCG_1979306
NM_022897	NM_022897 -> Q9H2T7-1	Q9H2T7	RBP17_HUMAN	Ran-binding protein 17	GO:0005049; GO:0005525; GO:0005643; GO:0005737; GO:0006606; GO:0006611; GO:0008536; GO:0051028	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; GTP binding [GO:0005525]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]	RANBP17
NM_144648		Q96M69	LRGUK_HUMAN	Leucine-rich repeat and guanylate kinase domain-containing protein	GO:0001669; GO:0002177; GO:0004385; GO:0005524; GO:0005829; GO:0007283; GO:0030154; GO:0035082; GO:0042995	acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	LRGUK
NM_001109977		Q05DH4	F16A1_HUMAN	Protein FAM160A1			FAM160A1
NM_012301	NM_012301 -> Q86UL8-1	Q86UL8	MAGI2_HUMAN	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Atrophin-1-interacting protein 1) (AIP-1) (Atrophin-1-interacting protein A) (Membrane-associated guanylate kinase inverted 2) (MAGI-2)	GO:0002092; GO:0003402; GO:0005634; GO:0005737; GO:0005770; GO:0005886; GO:0005911; GO:0005923; GO:0007165; GO:0008285; GO:0010976; GO:0014069; GO:0019902; GO:0030159; GO:0030336; GO:0030425; GO:0031697; GO:0032516; GO:0032926; GO:0032991; GO:0036057; GO:0038180; GO:0043113; GO:0045202; GO:0046332; GO:0048471; GO:0051291; GO:0051898; GO:0060395; GO:0070699; GO:0071850; GO:0072015; GO:0097118; GO:1990090; GO:2000809	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; phosphatase binding [GO:0019902]; receptor signaling complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; planar cell polarity pathway involved in axis elongation [GO:0003402]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic vesicle clustering [GO:2000809]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]	MAGI2 ACVRINP1 AIP1 KIAA0705
NM_005795		Q16602	CALRL_HUMAN	Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)	GO:0001525; GO:0001605; GO:0001635; GO:0004930; GO:0004948; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0005887; GO:0006816; GO:0007166; GO:0007186; GO:0007187; GO:0007189; GO:0007507; GO:0015031; GO:0031623; GO:0045986; GO:0048661; GO:0050728; GO:0071329; GO:1903143; GO:1990406; GO:1990408; GO:1990409; GO:1990410	adrenomedullin receptor complex [GO:1903143]; CGRP receptor complex [GO:1990406]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to sucrose stimulus [GO:0071329]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; heart development [GO:0007507]; negative regulation of inflammatory response [GO:0050728]; negative regulation of smooth muscle contraction [GO:0045986]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein transport [GO:0015031]; receptor internalization [GO:0031623]	CALCRL CGRPR
NM_001080500	NM_001080500 -> B2RUY7-1	B2RUY7	VWC2L_HUMAN	von Willebrand factor C domain-containing protein 2-like (Brorin-like)	GO:0005615; GO:0030054; GO:0030514; GO:0032281; GO:0045202; GO:0045666	AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of neuron differentiation [GO:0045666]	VWC2L
NM_025179	NM_025179 -> O75051-1	O75051	PLXA2_HUMAN	Plexin-A2 (Semaphorin receptor OCT)	GO:0001756; GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0043087; GO:0050772; GO:0051642; GO:0060037; GO:0060174; GO:0071526; GO:1902287	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756]	PLXNA2 KIAA0463 OCT PLXN2 UNQ209/PRO235
NM_002207		Q13797	ITA9_HUMAN	Integrin alpha-9 (Integrin alpha-RLC)	GO:0005518; GO:0005886; GO:0007155; GO:0007229; GO:0008305; GO:0009925; GO:0030198; GO:0030593; GO:0034679; GO:0042060; GO:0043236; GO:0046872	basal plasma membrane [GO:0009925]; integrin alpha9-beta1 complex [GO:0034679]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; integrin-mediated signaling pathway [GO:0007229]; neutrophil chemotaxis [GO:0030593]; wound healing [GO:0042060]	ITGA9
NM_002207		Q8N6H6	Q8N6H6_HUMAN	ITGA9 protein	GO:0007155; GO:0007229; GO:0008305	integrin complex [GO:0008305]; cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]	
NM_001102450	NM_001102450 -> P57771-1	P57771	RGS8_HUMAN	Regulator of G-protein signaling 8 (RGS8)	GO:0003924; GO:0005096; GO:0005634; GO:0005886; GO:0007186; GO:0007213; GO:0009968; GO:0030425; GO:0031234; GO:0032809; GO:0043204; GO:0043547; GO:0045202; GO:0060159	dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuronal cell body membrane [GO:0032809]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of dopamine receptor signaling pathway [GO:0060159]	RGS8
NM_016644	NM_016644 -> Q569H4-3	Q569H4	LARGN_HUMAN	Protein Largen (Mesenchymal stem cell protein DSC54) (Proline-rich protein 16)	GO:0045727; GO:0045793	positive regulation of cell size [GO:0045793]; positive regulation of translation [GO:0045727]	PRR16
NM_014461		A0A024R2C7	A0A024R2C7_HUMAN	Contactin 6, isoform CRA_a	GO:0005112; GO:0007155; GO:0030182; GO:0045747; GO:0098688; GO:0099026	anchored component of presynaptic membrane [GO:0099026]; parallel fiber to Purkinje cell synapse [GO:0098688]; Notch binding [GO:0005112]; cell adhesion [GO:0007155]; neuron differentiation [GO:0030182]; positive regulation of Notch signaling pathway [GO:0045747]	CNTN6 hCG_40124
NM_014461		B4DGV0	B4DGV0_HUMAN	cDNA FLJ60251, highly similar to Contactin-6	GO:0005112; GO:0007155; GO:0030182	Notch binding [GO:0005112]; cell adhesion [GO:0007155]; neuron differentiation [GO:0030182]	
NM_014461		Q9UQ52	CNTN6_HUMAN	Contactin-6 (Neural recognition molecule NB-3) (hNB-3)	GO:0005112; GO:0005886; GO:0007155; GO:0007156; GO:0007219; GO:0007411; GO:0007417; GO:0030424; GO:0045747; GO:0070593; GO:0098632; GO:0098688; GO:0099026	anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; Notch binding [GO:0005112]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]	CNTN6
NM_021643		Q92519	TRIB2_HUMAN	Tribbles homolog 2 (TRB-2)	GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006468; GO:0006469; GO:0008134; GO:0031434; GO:0031625; GO:0032436; GO:0043405; GO:0045081; GO:0045599; GO:0055106	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 biosynthetic process [GO:0045081]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]	TRIB2 TRB2
NM_003638		B4DN28	B4DN28_HUMAN	cDNA FLJ54639, highly similar to Integrin alpha-8 (Fragment)	GO:0007155; GO:0007229; GO:0008305	integrin complex [GO:0008305]; cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]	
NM_003638		P53708	ITA8_HUMAN	Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain]	GO:0001656; GO:0001822; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0007420; GO:0007613; GO:0008305; GO:0009986; GO:0014069; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0034446; GO:0034678; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0046872; GO:0048333; GO:0048745; GO:0098609; GO:2000721	apical part of cell [GO:0045177]; cell surface [GO:0009986]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; integrin alpha8-beta1 complex [GO:0034678]; integrin complex [GO:0008305]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; metal ion binding [GO:0046872]; brain development [GO:0007420]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]	ITGA8
NM_003783		O43825	B3GT2_HUMAN	Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2)	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006682; GO:0008375; GO:0008376; GO:0008499; GO:0009312; GO:0016021; GO:0047275	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]	B3GALT2
NM_004061	NM_004061 -> P55289-1	P55289	CAD12_HUMAN	Cadherin-12 (Brain cadherin) (BR-cadherin) (Neural type cadherin 2) (N-cadherin 2)	GO:0000902; GO:0005509; GO:0005886; GO:0005913; GO:0007043; GO:0007156; GO:0008092; GO:0009986; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0042803; GO:0044331; GO:0045296; GO:0098609	catenin complex [GO:0016342]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; protein homodimerization activity [GO:0042803]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	CDH12
NM_181789	NM_181789 -> Q6ZMI3-1	Q6ZMI3	GLDN_HUMAN	Gliomedin [Cleaved into: Gliomedin shedded ectodomain]	GO:0005581; GO:0005615; GO:0005886; GO:0009986; GO:0016021; GO:0030424; GO:0032528; GO:0045162; GO:0086080	axon [GO:0030424]; cell surface [GO:0009986]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; clustering of voltage-gated sodium channels [GO:0045162]; microvillus organization [GO:0032528]	GLDN COLM UNQ9339/PRO34011
NM_003716	NM_003716 -> Q9ULU8-1	Q9ULU8	CAPS1_HUMAN	Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1)	GO:0005829; GO:0006887; GO:0008289; GO:0015031; GO:0016079; GO:0019901; GO:0030054; GO:0030659; GO:0045921; GO:0046872; GO:0098793; GO:0098978; GO:1990504	cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079]	CADPS CAPS CAPS1 KIAA1121
NM_013244	NM_013244 -> Q9UBM8-1	Q9UBM8	MGT4C_HUMAN	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-acetylglucosaminyltransferase IV homolog) (hGnT-IV-H) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GlcNAc-T IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)	GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0016021; GO:0046872	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein N-linked glycosylation [GO:0006487]	MGAT4C
NM_001496	NM_001496 -> O60609-1	O60609	GFRA3_HUMAN	GDNF family receptor alpha-3 (GDNF receptor alpha-3) (GDNFR-alpha-3) (GFR-alpha-3)	GO:0000165; GO:0001764; GO:0005102; GO:0005829; GO:0005886; GO:0007165; GO:0007399; GO:0007411; GO:0007422; GO:0008046; GO:0009897; GO:0016167; GO:0019898; GO:0031225; GO:0043235; GO:0048485	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; axon guidance receptor activity [GO:0008046]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; MAPK cascade [GO:0000165]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; peripheral nervous system development [GO:0007422]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]	GFRA3 UNQ339/PRO538/PRO3664
NM_001364	NM_001364 -> Q15700-1	Q15700	DLG2_HUMAN	Disks large homolog 2 (Channel-associated protein of synapse-110) (Chapsyn-110) (Postsynaptic density protein PSD-93)	GO:0000165; GO:0004385; GO:0005829; GO:0005886; GO:0007268; GO:0010923; GO:0014069; GO:0016020; GO:0016323; GO:0019233; GO:0019900; GO:0030054; GO:0031594; GO:0035865; GO:0043005; GO:0043113; GO:0043204; GO:0044224; GO:0045197; GO:0097120; GO:0098609; GO:0098839; GO:0098919; GO:0098978; GO:0099641; GO:0099642; GO:0099645; GO:1904115; GO:2000310	axon cytoplasm [GO:1904115]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; guanylate kinase activity [GO:0004385]; kinase binding [GO:0019900]; structural constituent of postsynaptic density [GO:0098919]; anterograde axonal protein transport [GO:0099641]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; MAPK cascade [GO:0000165]; negative regulation of phosphatase activity [GO:0010923]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of NMDA receptor activity [GO:2000310]; retrograde axonal protein transport [GO:0099642]; sensory perception of pain [GO:0019233]	DLG2
NM_018010		Q9NWB7	IFT57_HUMAN	Intraflagellar transport protein 57 homolog (Dermal papilla-derived protein 8) (Estrogen-related receptor beta-like protein 1) (HIP1-interacting protein) (MHS4R2)	GO:0001843; GO:0001947; GO:0003677; GO:0005794; GO:0005813; GO:0005929; GO:0005930; GO:0006915; GO:0006919; GO:0007224; GO:0030992; GO:0032391; GO:0035735; GO:0036064; GO:0042073; GO:0042981; GO:0044292; GO:0044458; GO:0050680; GO:0060972; GO:0097542; GO:1905515	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; photoreceptor connecting cilium [GO:0032391]; DNA binding [GO:0003677]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224]	IFT57 DERP8 ESRRBL1 HIPPI
NM_004440	NM_004440 -> Q15375-1	Q15375	EPHA7_HUMAN	Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11)	GO:0001934; GO:0004713; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0006915; GO:0007169; GO:0007411; GO:0007420; GO:0008046; GO:0016310; GO:0022407; GO:0030425; GO:0031290; GO:0031594; GO:0031952; GO:0043005; GO:0043025; GO:0043235; GO:0043281; GO:0043525; GO:0045499; GO:0046875; GO:0048013; GO:0048671; GO:0048755; GO:0050730; GO:0050919; GO:0051964; GO:0070372; GO:0072178; GO:0098685; GO:0098686; GO:0098978; GO:0099061; GO:0099175	dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; ephrin receptor signaling pathway [GO:0048013]; negative chemotaxis [GO:0050919]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of synapse assembly [GO:0051964]; nephric duct morphogenesis [GO:0072178]; phosphorylation [GO:0016310]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell-cell adhesion [GO:0022407]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of postsynapse organization [GO:0099175]; regulation of protein autophosphorylation [GO:0031952]; retinal ganglion cell axon guidance [GO:0031290]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	EPHA7 EHK3 HEK11
NM_001480		P47211	GALR1_HUMAN	Galanin receptor type 1 (GAL1-R) (GALR-1)	GO:0004966; GO:0005623; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007194; GO:0007204; GO:0007218; GO:0008528; GO:0016021; GO:0017046; GO:0042923; GO:0045944; GO:0051464	cell [GO:0005623]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transcription by RNA polymerase II [GO:0045944]	GALR1 GALNR GALNR1
NM_005221	NM_005221 -> P56178-1	P56178	DLX5_HUMAN	Homeobox protein DLX-5	GO:0000790; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001649; GO:0001958; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007399; GO:0008283; GO:0021889; GO:0030154; GO:0030326; GO:0030509; GO:0030855; GO:0042472; GO:0043565; GO:0044212; GO:0045893; GO:0045944; GO:0048646; GO:0050679; GO:0060021; GO:0060166; GO:0060325; GO:0071773; GO:0071837; GO:0090263; GO:0097376; GO:1901522	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; anatomical structure formation involved in morphogenesis [GO:0048646]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; embryonic limb morphogenesis [GO:0030326]; endochondral ossification [GO:0001958]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; inner ear morphogenesis [GO:0042472]; interneuron axon guidance [GO:0097376]; nervous system development [GO:0007399]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory pit development [GO:0060166]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	DLX5
NM_005221		Q53Y73	Q53Y73_HUMAN	Distal-less homeo box 5 (Distal-less homeobox 5)	GO:0000790; GO:0000978; GO:0001228; GO:0001649; GO:0001958; GO:0005737; GO:0021889; GO:0030326; GO:0030509; GO:0030855; GO:0042472; GO:0048646; GO:0050679; GO:0060021; GO:0060166; GO:0060325; GO:0071837; GO:0090263; GO:0097376; GO:1901522	cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; HMG box domain binding [GO:0071837]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; anatomical structure formation involved in morphogenesis [GO:0048646]; BMP signaling pathway [GO:0030509]; embryonic limb morphogenesis [GO:0030326]; endochondral ossification [GO:0001958]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; inner ear morphogenesis [GO:0042472]; interneuron axon guidance [GO:0097376]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory pit development [GO:0060166]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; roof of mouth development [GO:0060021]	DLX5 hCG_40634 tcag7.302
NM_001017372		Q9Y2P4	S27A6_HUMAN	Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLCSH1) (hVLCS-H1)	GO:0000038; GO:0000166; GO:0004467; GO:0005324; GO:0005886; GO:0015909; GO:0016021; GO:0031957; GO:0042383	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; long-chain fatty acid transport [GO:0015909]; very long-chain fatty acid metabolic process [GO:0000038]	SLC27A6 ACSVL2 FACVL2 FATP1
NM_033223	NM_033223 -> Q99928-1	Q99928	GBRG3_HUMAN	Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3)	GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030054; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0042493; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:0099699; GO:1902476; GO:1902711; GO:1904315	cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; response to drug [GO:0042493]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]	GABRG3
NM_001009909	NM_001009909 -> Q86TE4-1	Q86TE4	LUZP2_HUMAN	Leucine zipper protein 2	GO:0005576	extracellular region [GO:0005576]	LUZP2 UNQ2566/PRO6246
NM_006727		Q9Y6N8	CAD10_HUMAN	Cadherin-10 (T2-cadherin)	GO:0000902; GO:0005509; GO:0005886; GO:0005913; GO:0007043; GO:0007156; GO:0008092; GO:0009986; GO:0016339; GO:0016342; GO:0034332; GO:0042803; GO:0044331; GO:0045296; GO:0098609; GO:0098978; GO:0098982; GO:0099059; GO:0099060	catenin complex [GO:0016342]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; protein homodimerization activity [GO:0042803]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	CDH10
NM_006727		X5D8X5	X5D8X5_HUMAN	Cadherin 10 type 2 isoform A (Cadherin 10, type 2 (T2-cadherin)) (Fragment)	GO:0005509; GO:0007156; GO:0098978; GO:0098982; GO:0099059; GO:0099060	GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic active zone membrane [GO:0099059]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	CDH10 hCG_36812
